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Abstract

Elucidating the Role of Endogenous Electric Fields in Regulating the
Astrocytic Response to Injury in the Mammalian Central Nervous System

By Matthew Louis Baer, Ph.D.
A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2015
Major Director: Raymond J. Colello, D. Phil.
Associate Professor, Department of Anatomy and Neurobiology

Endogenous bioelectric fields guide morphogenesis during embryonic
development and regeneration by directly regulating the cellular functions responsible
for these phenomena. Although this role has been extensively explored in many
peripheral tissues, the ability of electric fields to regulate wound repair and stimulate
regeneration in the mammalian central nervous system (CNS) has not been
convincingly established. This dissertation explores the role of electric fields in
regulating the injury response and controlling the regenerative potential of the
mammalian CNS. We place particular emphasis on their influence on astrocytes, as
specific differences in their injury-induced behaviors have been associated with
differences in the regenerative potential demonstrated between mammalian and non-

xv

mammalian vertebrates. For example, astrocytes in both mammalian and nonmammalian vertebrates begin migrating towards the lesion within hours and begin to
proliferate after an initial delay of two days; subsequently, astrocytes in non-mammalian
vertebrates support neurogenesis and assume a bipolar radial glia-like morphology that
guides regenerating axons, whereas astrocytes in mammals do not demonstrate robust
neurogenesis and undergo a hypertrophic response that inhibits axon sprouting. To test
whether injury-induced electric fields drive the astrocytic response to injury, we exposed
separate populations of purified astrocytes from the rat cortex and cerebellum to electric
field intensities associated with intact and injured mammalian tissues, as well as to
those electric field intensities measured in regenerating non-mammalian vertebrate
tissues. Upon exposure to electric field intensities associated with uninjured tissue,
astrocytes showed little change in their cellular behavior. However, cortical astrocytes
responded to electric field intensities associated with injured mammalian tissues by
demonstrating dramatic increases in migration and proliferation, behaviors that are
associated with their formation of a glial scar in vivo; in contrast, cerebellar astrocytes,
which do not organize into a demarcated glial scar, did not respond to these electric
fields. At electric field intensities associated with regenerating tissues, both cerebellar
and cortical astrocytes demonstrated robust and sustained responses that included
morphological changes consistent with a regenerative phenotype. These results support
the hypothesis that physiologic electric fields drive the astrocytic response to injury, and
that elevated electric fields may induce a more regenerative response among
mammalian astrocytes.

xvi

Chapter 1: Physiologic electric fields regulate wound repair in the CNS

Dissertation Synopsis
This dissertation explores the hypothesis that physiologic electric fields (EF)
regulate repair and regeneration in the mammal central nervous system, with a
particular emphasis on their influence over astrocytes. This hypothesis is predicated
upon three axioms: that the mammalian central nervous system (CNS) has a latent
potential to regenerate that is largely a function of the astrocytic response to injury, that
regeneration recapitulates the same physiologic mechanisms underlying
embryogenesis and thus must be conserved in mammals, and that endogenous
bioelectric fields regulate embryogenesis and regeneration by directly stimulating the
underlying cellular behaviors. However, none of these axioms is taken for granted in this
dissertation, and we thoroughly explore the existing literature underlying each
supposition in chapter one. Through this discussion, it becomes clear that astrocytes
determine the regenerative potential in the CNS, that EFs are well established in
regulating embryogenesis and regeneration in peripheral tissues, and that EFs are also
found in the CNS where they are similarly associated with embryogenesis. While this
suggests that injury-induced EFs also regulate wound repair and regeneration in the
CNS, it becomes equally clear that the role of physiologic EFs in the cellular response
to CNS injury has not been explored.
1

Thus, the discussion in chapter one culminates in the overall hypothesis of this
thesis: that physiologic EFs regulate tissue repair and the regenerative potential of the
CNS by their influence on astrocytes. Chapters two and three detail studies
investigating how electric fields regulate astrocyte behaviors associated with the injury
response; we compare how EF effects differ between cortical and cerebellar astrocytes,
and relate these differences to differences in regenerative potential and in phylogenetic
origins between these two brain regions. In chapter four, we describe efforts to develop
a protocol by which we can acquire longitudinal measurements of injury-induced EFs
over the entire duration of wound healing in the mammalian CNS, which is a necessary
prerequisite to designing an EF-based therapeutic strategy. In chapter five, we discuss
the implications of our findings in the context of the larger hypothesis that endogenous
bioelectric fields are a universal stimulus that regulates morphogenesis during both
embryogenesis and regeneration in all metazoans. We discuss established criteria by
which such a causal hypothesis is evaluated, and we explore how existing research and
theory regarding regeneration, bioelectricity, and evolution supports this proposed
causal relationship. Finally, we conclude by addressing the future experimental
directions that are necessary to advance the therapeutic implications of these
hypotheses.

Historical context, epidemiology, and morbidity of CNS injury
Injury to the CNS has fascinated human civilizations for millennia. People
suffering from CNS disorders have often been treated as pariahs or have been
presumed to suffer from demonic possession. These long-held beliefs often reflect a
tragic misunderstanding of the brain and mind, and they have spawned countless
2

attempts to cure patients from their various afflictions. Many different cultures have
embodied these fantasies of regeneration within their myths and folklore, as is
evidenced by the Grecian myth of the hydra whose head regenerated two more upon
amputation, by the Anglo-Celtic myth of Wayland the Smith who had the power to
restore lost limbs that have undergone trauma1, by the Aztec legend of the god Xolotl
who allegedly imbued the amphibian species Axolotl with the power to regenerate2, by
Catholic biblical teachings of Jesus curing blindness and leprosy, by Old Norse poems
about the “Mead of Poetry” that could revive the dead3, by the ancient Aryan drink
called “Soma” that is described in poetry as a drink of immortality4, by the ancient
Chinese goddess Woman Gua whose regenerative powers were so profound that her
guts metamorphosed into ten different deities5, and in Nigerian Yoruba mythology by
the regenerating serpent Oshunmare6. As early as eight millennia ago, cultures have
taught that trephination – the practice of removing a portion of skull without damaging
the underlying dura, meninges, or blood vessels – could treat epileptic seizures,
migraines, and mental health disorders, with examples documented worldwide including
among cultures from neolithic Europe (6500 BCE France) 7, ancient China (5000 BCE)8,
and Central America (900-1400 CE) 9. Interest in disorders of the mind and behavior
were also evident through a persistent obsession with epilepsy, which was presumed by
the Babylonians, ancient Greeks, and Catholics to be caused by demonic possession.
As science advanced through the Renaissance and into the modern era, there has been
an increasing appreciation for the role of the brain as the seat of the mind and the
source of behavior. The dualism between mind and body has gradually shifted from the
realm of philosophy to that of science as our understanding of physiology has
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progressed; the originally distinct fields of psychology and neurology have gradually
merged over the past 100 years as the neural circuitry and molecular signaling
underlying ever more complex behaviors continues to be elucidated. Yet in spite of the
persistent obsession with the role of the CNS in disorders of the mind and behavior, the
scientific understanding of how to cure them has been stubbornly intractable.
Each year, over 2.32 million Americans survive a CNS injury (an estimated 1.7
million patients suffer a traumatic brain injury (TBI) 10-12, 12,000 patients suffer a spinal
cord injury (SCI) 13-17, and 610,000 patients suffer a first-time stroke) 18, 19, which results
in direct costs for initial medical management of $45.0 - $73.4 billion annually (TBI:
$13.1 billion11, 20, 21; SCI: $10.0 - $27.3 billion11, 22; and stroke: $21.9 - $33.0 billion11, 19).
Advances in acute management of these disorders have improved survival and initial
outcomes, but there is still no clear consensus on how to treat the resulting deficits and
recover lost function. Patients often develop significant deficits that require chronic care
and rehabilitation because the adult brain does not show a significant capacity to
regenerate itself after an injury. Consequently, up to 43% of patients discharged
following TBI hospitalization develop a long-term disability12, and no more than 70% of
this population recovers sufficiently enough to return to work11, 23; upwards of 81% of
patients surviving SCI are unemployed 1 year post injury, and 39.5% of patients remain
unemployed after 25 years’ recovery11; and there is only a 50% 5-year survival rate for
patients suffering a stroke24. There is a total prevalence of 10.78 million patients living
with the long-term consequences of these diseases (TBI: 3.2 – 5.3 million patients12;
SCI: 259,000 patients14; and stroke: 6.27 million patients18, 19, 25), which represents a
total of 3.38% of the estimated 319 million people living in the of the United States of
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America in 201426; this enormous population of survivors results in indirect costs to
American society through rehabilitation, supportive care, and lost productivity that are
estimated at $84.1 - $94.9 billion annually (TBI: $63.9 billion12; SCI: $3.7 billion14; and
stroke: $16.5-27.3 billion19) 11. As the total value of the US economy (GDP) is estimated
at $16.768 trillion in 2013 as reported by the World Bank27, CNS injuries represent
0.268% - 0.438% of GDP in direct costs, and 0.502% - 0.566% of GDP in indirect costs
each year. (Note, all dollar values reported in this section are in inflation-adjusted 2013
values for the US dollar.) Thus, the gravity of this issue is enormous, and has led the
United States Congress to pass the Traumatic Brain Injury Act in 200828 that specifically
authorizes research and public health activities related to TBI. As the impact of CNS
injury is expected to grow substantially over the coming years, developing methods to
promote functional recovery is imperative to improving the outcomes for these patients.

Injury and regenerative potential in the CNS
The CNS has evolved to perform extraordinarily complex functions that are of
fundamental importance to the survival of the host organism – including regulating
internal physiology, monitoring external stimuli, and generating complex motor
programs – which requires the constant integration of diverse information. For instance,
the visual system extracts information on colors, shapes, and locations to identify faces,
avoid predators, or track prey; the auditory system extracts words from noise and can
precisely localize sounds in 3-dimensions; the motor system plans and executes
complicated behaviors and monitors the body’s position in space as these programs are
executed. Neural processing for each component of a stimulus occurs in discrete nuclei
throughout the CNS that are intricately interconnected through complex neural
5

networks. Any injury causing a disruption of these neural circuits, either by destroying
cells within the nuclei where certain information is processed or by disrupting the axon
tracts that connect discrete regions (Figure 1.1), can have profound functional
consequences by interfering with the ability of the CNS to perform these fundamental
activities. In mammals, plasticity in the remaining tissue often permits limited functional
recovery, but these deficits are often permanent because the CNS does not
demonstrate a robust ability to regenerate lost tissue.
In contrast to the absence of bona fide regeneration in the mammalian CNS,
many non-mammalian vertebrates demonstrate robust regeneration that facilitates
profound functional recovery after CNS injury. The difference in the regenerative
potential between mammalian and non-mammalian vertebrates has been attributed to
particular aspects of the injury-induced cellular response. In this section, we review the
pathophysiology following injury to the vertebrate CNS, comparing the cellular
responses inhibiting regeneration in mammals to those facilitating regeneration in nonmammalian vertebrates. Based on this understanding of the cellular behaviors
necessary for successful CNS regeneration, we will explore the possibility that the
mammalian CNS has a latent capacity to regenerate.
For the sake of the subsequent discussion, it is worth defining several terms
involved in the injury response. As defined in one of the standard textbooks on medical
pathology (page 100) 29, Tissue “[r]epair, sometimes called healing, refers to the
restoration of tissue architecture and function after an injury. (By convention, the term
repair is often used for parenchymal and connective tissues and healing for surface
epithelia)… Repair of damaged tissues occurs by two types of reactions: regeneration
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by proliferation of residual (uninjured) cells and maturation of tissue stem cells, and the
deposition of connective tissue.” Organs are composed both of parenchyma, which
refers to the functional tissue, and of stroma, which refers to the structural tissue; all
organs are lined by an epithelium, which is a type of connective tissue that lines the
surface of organs. Regeneration refers to the recovery of an organ’s function, which can
refer to any of several pathways; for the scope of this dissertation, we are exclusively
concerned with epimorphic regeneration, which is the recreation of the original structure
and function of the damaged structure(s) through the proliferation of stem cells.

Pathophysiology of CNS injury inhibits regeneration in mammals
CNS injury induces a cellular response that protects the surrounding tissue from
the damaging molecular milieu within the lesion site30-32. The etiology of the primary
injury initiating this secondary cellular response can be either hemodynamic or
traumatic: hemodynamic instability from prolonged ischemia or infarction (i.e. a stroke)
causes tissue necrosis through severe metabolic stress; mechanical impact from
traumatic injury causes tissue necrosis and axon disconnection through physical
damage to cell membranes, and also through traumatically-induced hemorrhage.
Common to the pathophysiology of both hemodynamic and traumatic injury is a local
disruption of the blood-brain barrier (BBB), the immunogenic response through which
the necrotic tissue is removed, and the cellular response within the CNS that protects
the surrounding healthy tissue by sequestering the immune response within the lesion
site33, 34. However, this initially protective cellular response to both hemodynamic and

7

traumatic injury ultimately resolves into the same maladaptive glial scar that becomes a
physical and biochemical impediment to any spontaneous attempt at regeneration33, 35.
Limited recovery can occur over time because adaptive plasticity allows the
remaining neural circuitry in the adult CNS to assume some of the function of the tissue
lost to injury, and communication between disconnected nuclei can be partially restored
as it is rerouted through remaining fiber tracts36-39. However, complete functional
recovery requires restoring the original physiology of the damaged tissue, including both
the local cytoarchitecture and the passing fiber tracts, through four basic functions
(Figure 1.1) 35, 40: 1) each of the cell types present within the damaged tissue, including
both neurons and glia, must be replaced and functionally incorporated into the
remaining neural circuitry, 2) disconnected axons, including those projecting past the
lesion from distant nuclei and those from newly-generated neurons within the lesion,
must be capable of sprouting, 3) axons must sprout past the lesion and through the
distal intact parenchyma, following local cues to their original target nuclei, and 4) axons
must be able to reestablish their appropriate connections within their target nuclei. In the
mammalian CNS, robust regeneration does not occur because these four fundamental
functions are either absent or inhibited.
Although the mammalian CNS does not spontaneously regenerate, it does
demonstrate a limited capacity for each of the cellular behaviors necessary for
regeneration. The adult mammalian brain does contain neural stem cell populations that
continue to divide throughout life, but they are only located in discrete regions and do
not demonstrate the robust neurogenesis necessary for regeneration following an injury.
Previous research has shown that axons have an inherent ability to sprout; however the
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intact parenchyma of the mammalian CNS is not conducive to sprouting, as severed
retinal ganglion cell axons cannot regenerate through the distal portion of the optic
nerve but are readily able to sprout through a peripheral nerve graft41-44. Furthermore,
axons sprout towards the lesion after axotomy, but in vivo imaging demonstrates that
they ultimately turn away and fail to regenerate after repeated efforts to pass the
lesion45, 46. Nonetheless, axon terminals demonstrate local plasticity within their target
nuclei that facilitates synaptic remodeling underlying both learning in the adult CNS and
limited functional recovery after injury, which suggests that regenerating axons would be
able to restore their original connections if they were able to regenerate past the lesion
and reach their original targets36, 47, 48. This abortive regenerative effort is due to a
cellular response at the lesion site, which is initiated by BBB disruption and cellular
injury, that is inhibitory to axon sprouting35, 49-52. However, the fact that each of the
cellular behaviors necessary for regeneration is expressed following injury suggests that
a latent and inducible capacity for regeneration may be conserved in the adult
mammalian CNS.
BBB disruption at the lesion site allows an influx of neutrophils and macrophages
that, while necessary to remove the necrotic tissue, release cytokines, enzymes, and
reactive oxidative species that are actively toxic to the CNS parenchyma45, 53.
Astrocytes contain this immune response by forming a physical barrier around the
lesion site, which is necessary to reestablish the BBB (Figure 1.2); without this
astrocytic response, these toxic metabolites produced by phagocytes would cause the
lesion to expand, thereby exacerbating the effect of the initial injury32, 54. However, by
sequestering the immune response within the lesion, this astrocytic response causes a
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pseudocystic cavity to form as the necrotic tissue is removed (Figure 1.3). This acellular
glial scar lacks a solid extracellular matrix (ECM) and thus does not have a physical
substrate to support axon sprouting; moreover, damage to the microvasculature makes
the lesion site avascular and the penumbra (the tissue immediately surrounding the
lesion) ischemic, which represents a further barrier to the tendency of axotomized axons
to spontaneously sprout. In addition to this physical barrier, astrocytes also molecularly
modify the tissue around the glial scar, depositing chondroitin sulfate proteoglycans
(CSPGs) in the ECM that further inhibit axon sprouting49, 50, 55-57.
Although the lesion site represents both a physical and biochemical barrier for
regeneration, it is clearly not an insurmountable obstacle: the CNS does not form a glial
scar after injury in embryonic and immature mammals, and instead demonstrates a
substantial regenerative capacity58, 59. Furthermore, focal lesions to the CNS of adult
non-mammalian vertebrates are often healed through complete regeneration, even
though the same variety of cells are present in these animals as are found in the injured
mammalian CNS60. By understanding why the lesion environment inhibits regeneration
neither in young mammals nor in non-mammalian vertebrates, it may be possible to
therapeutically modify the injured mammalian CNS to create a response more
conducive to regeneration.

Physiology of CNS regeneration in non-mammalian vertebrates
In contrast to the mammalian CNS, the CNS in many non-mammalian
vertebrates demonstrates a robust regenerative response following injury. Axons
regenerate across the lesion site and reconnect with their original targets, facilitating
10

functional recovery after spinal cord transection in zebrafish61 (Figure 1.3) and in the
freshwater turtle Trachemys dorbignyi62, 63. Tail amputation in Urodele and Anuran
amphibians includes loss of the caudal portion of the spinal cord, and the spinal cord
completely regenerates new tissue that becomes functionally integrated into the
remainder of the CNS64-66. The brain also demonstrates regeneration following a stab
wound in zebrafish67, 68, and both Anuran and Urodele amphibians regenerate large
portions of their brain after complete resection69, 70. The injured non-mammalian
vertebrate CNS also supports robust neurogenesis through which the injured tissue is
replaced, and these new cells are able to restore the original neural circuitry by
reconnecting with the same targets as the original cells had prior to the injury68-71.
Radial glia, which are found throughout the adult CNS in non-mammalian
vertebrates, are the predominant cell type that facilitates axon regeneration and
neurogenesis underlying regeneration following injury. Interestingly, radial glia are
functionally equivalent to, and express genetic markers associated with, both astrocytes
and ependymal cells in the mature mammalian CNS72, 73. Radial glia also express
markers of mesenchymal cells (a description of which can be found on page 19)
including smooth-muscle actin (Acta2), fibronectin, and several epithelial-mesenchymal
transition transcription factors (slug, Zeb1, Zeb2); Zeb1 is necessary to maintain radial
glia neurogenesis, while embryonic morphogens found in the spinal cord (Sonic
hedgehog, Shh; and retinoic acid, RA) can cause radial glia to differentiate into
subclasses of neurons72, 74.
In addition to being orthologous to astrocytes and ependymal cells in the adult
mammalian CNS, radial glia in the adult non-mammalian CNS also express markers
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associated with radial glia in embryonic non-mammalian vertebrates, as well as with
both radial glia and immature astrocytes in the embryonic mammalian CNS73, 75,
suggesting that they remain in an immature state throughout adulthood. Moreover,
radial glia in the adult non-mammalian vertebrates CNS continue to demonstrate
behaviors that are typically associated with neural development in the embryonic brain,
which are also those that we have previously established are necessary for
regeneration: neurogenesis, and facilitating axon outgrowth59, 72, 76. Specifically, a
subset of radial glia constitutively sustain neurogenesis throughout the adult nonmammalian vertebrate brain, and all radial glia retain a quiescent ability to function as
pleuripotent neural progenitor cells (NPCs) that is regulated through the Notch signaling
pathway67, 77, 78; thus, radial glia near the lesion are the source of new neurons and glia
that are necessary to regenerate the damaged parenchyma67. Radial glia begin to
migrate towards the lesion within hours of an injury76, 79 where they reestablish the
BBB80 and, after an initial 48 hour delay, they begin to proliferate68. Additionally, they
extend their processes across the lesion to form a highly aligned cellular bridge79, which
facilitates regeneration by promoting neovascularization80 and by guiding axons as they
sprout across the lesion towards their original target61.
Throughout the injury response, radial glia demonstrate consistent changes in
their genetic profile that emerge concurrently with their cellular behaviors that facilitate
regeneration. Radial glia express Glial Fibrillary Acidic Protein (GFAP) in the adult
Urodele and Teleost brain; upon spinal cord injury, GFAP expression decreases while
vimentin and nestin, which are markers of immaturity and pleuripotent progenitors
respectively, increase64. As Nestin expression increases, an increasing proportion of the
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radial glia daughter cells subsequently differentiate into neurons, with this neurogenesis
being regulated through Notch signaling78. Moreover, radial glia require activation of the
signaling pathways associated with the morphogens transforming growth factor beta
(TGF-β) and Wnt to control proliferation and progenitor cell fate during regeneration81,
82

. Thus, radial glia are sufficient to provide a source of new neurons in the regenerating

non-mammalian vertebrate CNS, and they are sufficient to guide regeneration of
damaged axons past the lesion site and to their original targets. Together, this shows
that radial glia are the crucial cell type that facilitates CNS regeneration in nonmammalian vertebrates; as radial glia are orthologous to mammalian astrocytes,
astrocytes may have a similarly important role in regulating regeneration in mammals.

Regenerative physiology is conserved in the mammalian CNS
CNS regeneration in non-mammalian vertebrates requires radial glia to facilitate
the proper targeting of regenerating axons, and to replace the damaged parenchyma by
producing new neurons and glia. The mammalian CNS also contains radial glia, but
they are only present during development and they differentiate into astrocytes as the
CNS matures. While there is debate about whether the radial glia in non-mammalian
vertebrates are technically astrocytes, both of these cell types, which are characterized
by robust GFAP expression, are genetically and functionally orthologous to each other.
Given that radial glia facilitate regeneration in non-mammalian vertebrates, the
astrocytic response to injury is likely to be similarly critical in determining the
regenerative potential of the mammalian CNS.
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Many of the astrocytic behaviors expressed throughout their injury response are
strikingly similar to those through which radial glia facilitate regeneration, but the injuryinduced response in mammalian astrocytes ultimately inhibits regeneration. Both
astrocytes and radial glia begin to migrate towards the lesion within hours of the initial
injury79, 83, 84. Furthermore, both astrocytes and radial glia at the lesion border begin to
proliferate after an initial delay, and the rate of proliferation peaks after 48 hours;
astrocyte proliferation subsequently declines, while radial glia continue to proliferate at
this elevated rate over at least seven days after the injury79, 85-88. The fate of their
daughter cells is remarkably different between these cell types: astrocyte proliferation is
predominantly gliogenic and these cells form a barrier that inhibits axon sprouting89, 90,
while radial glia proliferation is neurogenic and provides both a source of neurons for
regeneration and a substrate that axons use for sprouting88. These cells also
demonstrate divergent injury-induced morphologic changes: astrocyte processes
hypertrophy and they up-regulate certain cytoskeletal elements associated with
maturity91, 92; in contrast, radial glia assume a bipolar morphology resembling their
shape during embryogenesis, and they down-regulate cytoskeletal elements associated
with maturity and up-regulate those elements associated with immaturity64, 93. The fact
that both radial glia and astrocytes demonstrate many of the same initial behaviors that
develop along a similar timeline after injury suggests that both cell types respond to a
similar signal that initiates their response to injury. Consequently, the divergent effect
that astrocytes and radial glia have on facilitating regeneration is likely due to
differences in the ways in which these individual cellular behaviors are subsequently
regulated throughout the reparative response.
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Although mammalian astrocytes do not facilitate overt CNS regeneration after
injury, experimental evidence demonstrates that they retain a latent regenerative
potential. While mammalian astrocytes do not facilitate axon sprouting after injury in
vivo, multiple growth factors have been shown to make them more permissive to axon
outgrowth in vitro94-97. Astrocytes themselves are a source of some of these factors,
including fibroblast growth factor (FGF) 2, which has an autocrine effect inducing
astrocytes to promote neurite outgrowth98 and also acts directly on neurons to enhance
outgrowth and branching in vitro99. FGF-2 is also produced by reactive astrocytes
around the lesion site in vivo100 and has been shown to promote axon sprouting
following injury101, suggesting that astrocytes can facilitate axon outgrowth in adult
mammals given the appropriate molecular cues. Furthermore, while mitogenic and
neurogenic growth factors are not robustly induced in the injured mammalian CNS,
FGF-2 is induced upon injury in regenerating non-mammalian vertebrates where it
drives proliferation and neurogenesis throughout regeneration88, 102. In addition to being
able to promote neurite outgrowth, mammalian astrocytes – similarly to radial glia –
have a latent neurogenic program. While astrocytic neurogenesis is repressed through
Notch signaling in vivo77, 103-105, they can produce astrocytes, oligodendrocytes, and
neurons in vitro106, which suggests that the signaling environment within the CNS
actively inhibits neurogenesis. The fact that astrocytes can be induced to promote axon
sprouting and undergo neurogenesis strongly supports the notion that astrocytes retain
a regenerative potential, and that they may be able to facilitate robust regeneration after
CNS injury in mammals if this pathways regulating regeneration can be identified and
appropriately targeted.
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During embryonic development, immature astrocytes and radial glia facilitate
neurogenesis and axon sprouting throughout the mammalian CNS. In embryonic
vertebrates, radial glia expressing GFAP, Vimentin, and two astrocyte-specific
glutamate transporters (GLAST and GLF-1) are the first cells to differentiate from
neuroepithelial stem cells, and they function as the pleuripotent progenitors that give
rise to astrocytes, neurons, and oligodendrocytes72, 107. Radial glia help guide migrating
neuroblasts to their appropriate brain regions108, 109 where their differentiation is
specified by local inductive cues from master regulatory genes (e.g. Shh in the ventral
floor plate of the spinal cord induces differentiation into dopaminergic lower motor
neurons) 72, 73, 110, 111. Towards the end of neurogenesis, radial glia produce astrocytes,
which facilitate embryonic axon outgrowth and targeting by modifying the ECM,
including depositing some of the same CSPGs that they produce after injury112-115. In
contrast to their inhibitory role after injury, certain CSPGs produced by astrocytes
promote axon outgrowth in the embryonic CNS116, which suggests that CSPGs interact
with other signals within the CNS to determine whether their effect on axon sprouting is
inhibitory or excitatory. As astrocytes in the developing mammalian CNS demonstrate
each of the same behaviors that radial glia express during both embryogenesis and
regeneration in non-mammalian vertebrates, immature mammalian astrocytes may also
be able to facilitate CNS regeneration in mammals.
Immature astrocytes lose the ability to facilitate axon outgrowth and function as
NPCs as the CNS matures into adulthood. In the immature CNS, astrocytes and radial
glia facilitate regeneration58, 59, 117; concurrent with the ontogenetic decline in
regenerative potential is the differentiation of radial glia into astrocytes at the end of
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embryonic development, and the absence of robust regeneration in the adult
mammalian CNS has been attributed to the inability to induce a signaling environment
through which astrocytes can revert to an immature phenotype60, 97. Paralleling this
ontogenetic decline in regeneration is a decrease in the magnitude of injury-induced
proliferation and neurogenic fate of these cells85, 89, 90; reintroducing growth hormones
present in the juvenile brain enhances proliferation, drives neurogenesis, and promotes
functional recovery following injury118-121. The fact that both neurogenesis and axon
outgrowth are enhanced by treating mature mammalian astrocytes with signaling
molecules from the embryonic brain suggests that recreating the signaling environment
within the immature CNS might be able to stimulate regeneration in adult mammals.

Conclusion
It is clear that astrocytes play a crucial role in determining the regenerative
potential in the mammalian CNS: their response to injury inhibits regeneration in adults,
but they facilitate regeneration in immature and embryonic animals. Moreover,
regeneration in non-mammalian vertebrates is facilitated by radial glia, which are
orthologous to mammalian astrocytes. Although mature astrocytes do not facilitate
robust regeneration in the mammalian CNS, they retain a latent ability to demonstrate
the same behaviors necessary for axon sprouting and neurogenesis during
embryogenesis. Thus, recreating the signaling environment within the developing
mammalian CNS may induce astrocytes to revert to an immature phenotype through
which they could facilitate complete regeneration by recapitulating the same
mechanisms by which the CNS originally developed.
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Epimorphic regeneration recapitulates embryonic development
The ultimate goal of therapies and rehabilitation for CNS injury is complete
functional recovery, which requires restoring the axon tracts, neurons and glia, and
each of their connections that were destroyed by the lesion. In the previous section, we
identified astrocytes as crucial determinants for regeneration in the CNS, and we
established that they can be induced to express each of the behaviors through which
their orthologous cell types facilitate regeneration in other vertebrate clades. In this
section, we explore the physiology of spontaneous regeneration in non-mammalian
vertebrates to try and understand why CNS regeneration is absent in mammals despite
the presence of these physiologic mechanisms through which it might proceed. The
facts that this neural circuitry develops spontaneously during embryogenesis and that
many vertebrate species can completely regenerate this same circuitry following
substantial injuries belie the notion that this circuitry is so extraordinarily complex as to
be fundamentally incapable of regeneration. Indeed, regeneration in non-mammalian
vertebrates is successful because it replaces the damaged tissue through recapitulating
embryonic development, a process known as “Epimorphic Regeneration.” The
physiology of embryogenesis is conserved among all vertebrates, so it may be possible
to activate epimorphic regeneration in injured mammalian tissues if the stimulus through
which these developmental pathways are reactivated upon injury in non-mammalian
vertebrates can be identified.
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Non-mammalian vertebrates demonstrate epimorphic regeneration
Non-mammalian vertebrates are able to completely regenerate injured or
amputated tissues because the injury reactivates the same physiologic mechanisms
through which these structures originally develop during embryogenesis (Figure 1.4).
Just as embryogenesis begins with totipotent progenitors that gradually differentiate into
increasingly mature cells as development progresses, a population of progenitors
accumulates at sites of injury and supports regeneration in non-mammalian
vertebrates122. While progenitors are omnipresent in the embryo, they are not equally
ubiquitous adult animals. Instead, in vertebrates that regenerate, terminally
differentiated mesenchymal cells – those cells composing connective tissues such as
the lymphatic system, circulatory system, and musculoskeletal system – dedifferentiate
into pluripotent progenitors123, 124. Upon injury, adjacent epithelial cells migrate into the
lesion site where they form a wound epithelium that functions as the apical ectodermal
cap (AEC) and induces underlying mesenchymal cells to dedifferentiate and form a
mass called a regeneration blastema125. New tissue develops as cells within the
blastema proliferate, and gradients of morphogenic molecules guide their differentiation
into the full complement cell types that were present in the original structure123, 125, 126.
As epimorphic regeneration progresses, these newly differentiated cells form tissues
and organs that are anatomically and physiologically indistinguishable from the original
tissue that was present prior to the injury.
Newly-produced progenitor cells require extracellular spatial signals to define the
rostrocaudal (RC), mediolateral (ML), and anteroposterior (AP) body axes; these signals
guide morphogenesis of new structures throughout regeneration127. These morphogens,
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which are conserved during embryogenesis and regeneration, provide spatial cues that
cells use to determine their 3-dimensional location within the developing embryo128-130.
For example, morphogen gradients determine whether the developing limb bud will
generate a forelimb or a hindlimb based on the relative location of the limb bud within
the RC axis; ectopic limb formation, either from a transplanted limb bud or from
induction of supernumerary limb buds, results in the formation of an additional limb that
assumes distinct forelimb or hindlimb anatomy based on the position of the limb bud
along the RC body axis of the embryo130-132. Preservation of left-right symmetry and the
appropriate orientation of the new limb on the body indicate that the regeneration
blastema can detect the ML and AP axes of the limb, respectively125. Thus, these
vertebrates demonstrate a profound capacity for spontaneous regeneration because
injury induces the morphogens that pattern all three body axes within the regenerating
structure.
Vertebrate regeneration is limited neither to a distinct clade nor to a particular
type of tissue. Beyond the Urodele limb, the widespread evidence of regeneration in
different tissues and across different clades illustrates the profound evolutionary
importance of regeneration133, 134. Teleost fish, another common model of regeneration,
also demonstrate regeneration following amputation of their fins135-137. Beyond the limb,
many vertebrates can regenerate their jaw138, 139, eyes140, skin141, and tails64. Even
injuries that would prove severely debilitating – if not fatal – in humans can often be
healed by regeneration in other vertebrate species. For example, zebrafish can
regenerate their hearts after more than 40% of the ventricular wall is removed by
amputation142, 143. Urodeles also demonstrate profound cardiac regeneration, which was
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incidentally discovered when animals whose hearts had been completely bisected for
blood collection defied researchers’ expectations that the animals would die and instead
recovered completely within a week of the procedure144; subsequent research
demonstrated that the heart could regenerate up to 50% of its structure following
amputation, with formation of a clot within 30 minutes, initial regeneration of myocardial
fibers within 2 hours, and restoration of circulation within 5 hours145.
CNS regeneration is also widespread among vertebrates, demonstrating that the
mechanisms to functionally restore injured tissue are retained in adult animals. Many
vertebrates, including examples among such disparate clades as Teleosts, Urodeles,
and Reptiles, functionally reconnect their spinal cord following a complete transection62,
79, 146

. Xenopus tadpoles and adult Urodeles are both able to regenerate portions of their

spinal cord that are lost after tail amputation64, 147. The retina, which is an extension of
the CNS within the eye, also regenerates retinal pigment epithelium and ganglion cells
following ablation in Teleost fish77, 148-150 and both Anuran151 and Urodele78, 152, 153
amphibians; moreover, retinal ganglion cell axons regenerate through the optic nerve to
the optic tectum after either axotomy in the optic nerve or ablation of the retina154-158.
Furthermore, the neural circuitry within the adult CNS can be replaced, as Teleost fish
regenerate following a telencephalic stab wound67, and Anuran amphibians regenerate
large portions of the cortex following resection69. In each of these examples,
regeneration is facilitated by radial glia, which recapitulate their neurogenic and axon
guidance roles through which they facilitate embryogenesis71, 73, 77, 93, 150. Mesenchymal
cells in peripheral tissues facilitate epimorphic regeneration, and radial glia, which
express mesenchymal cell markers72, facilitate CNS regeneration through re-
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development. Thus, CNS regeneration in non-mammalian vertebrates may be an
example of epimorphic regeneration.
Among all of these examples, regeneration is a spontaneous process that begins
immediately upon injury and forms of a new structure that is anatomically and
physiologically indistinguishable from the original uninjured tissue. Moreover, while the
specific cells that facilitate regeneration vary among each tissue, the cellular behaviors
underlying regeneration are conserved among the disparate vertebrate species and
across each of the tissues in which it has been studied. Many disparate vertebrates
express epimorphic regeneration and fossil evidence demonstrates that amphibians
were capable of limb regeneration over 300-million years ago, which suggests that
epimorphic regeneration is a phylogenetically early adaptation that evolved in a
common vertebrate ancestor133, 134, 159, 160. Thus, the physiology underlying epimorphic
regeneration is likely conserved among all vertebrates in which it is observed.

Epimorphic regeneration is conserved among all vertebrates
During development, a small number of signaling molecules define the principal
body axes and regulate tissue patterning in the embryo. These morphogens, which are
called master regulatory genes, are conserved among diverse tissue types and across
all vertebrates110, 127. For example, Shh defines dorso-ventral (DV) patterning and
regulates limb outgrowth161-164; FGF regulates limb bud morphogenesis165, 166; RA
specifies the posterior-ventral-proximal portion of the embryo131, 167; Wnt signaling is
necessary for body axis extension in the mouse168 and both DV and AP axis formation
in the Xenopus embryo167; TGF-β contributes to longitudinal organization in the CNS110;
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and both Notch and bone morphogenic protein (BMP) contribute to cellular
differentiation128, 169. Gradients of these morphogens specify a Cartesian coordinate
system that defines bilateral body axes in all vertebrates, and the extraordinary diversity
in structures among different species is thought to be a function of differences in their
concentration, distribution of their gradients, and duration of expression127, 168, 170.
The profound regenerative potential in non-mammalian vertebrates is facilitated
by the injury-induced expression of the same master regulatory genes that underlie
embryogenesis171. Indeed, Shh regulates regeneration of the spinal cord and limb in
axolotl126, 163, and of the limb in Xenopus tadpoles172; FGF regulates regeneration of the
myocardium and fin in zebrafish143, 173-175, and of the limb and tail in Xenopus176, 177; RA
regulates regeneration of the limb in axolotl178, and of the fin in zebrafish179; Wnt
regulates regeneration of the limb and tail in Xenopus176, 177; TGF-β is necessary to
initiate regeneration of the limb in axolotl180; Notch regulates cellular differentiation
necessary for regeneration of the tail in Xenopus tadpoles181, of the retina in axolotl78,
and of the heart in zebrafish182, 183; and BMP regulates limb and tail regeneration in
Xenopus147, 176, 177. The role of embryonic physiology in regeneration is further
underscored by certain vertebrate species in which immature animals are highly
regenerative but lose this ability once they mature and developmental physiology
becomes dormant. For example, Xenopus laevis regenerate their limbs and tail when
they are tadpoles, but they lose this regenerative ability after they progress through
metamorphosis and become adults; axolotl are closely related to Xenopus, but they
retain an immature phenotype similar to that of the Xenopus tadpole and they continue
to regenerate in adulthood125, 147, 159. Together, these observations support the notion

23

that epimorphic regeneration is a recapitulation of embryogenesis, and that the injuryinduced expression of master regulatory genes necessary for regeneration is widely
conserved.
Given that ontogenetic physiology is conserved among all vertebrates, the basic
physiologic mechanisms of regeneration must also be conserved regardless of whether
the particular vertebrate species retains the ability to access these developmental
programs and facilitate regeneration into adulthood. Indeed, although different cell types
support regeneration in each tissue, the same set of master regulatory genes drives
epimorphic regeneration by inducing a conserved series of cellular behaviors176:
migration, dedifferentiation, proliferation, and differentiation. Following limb amputation,
TGF-β and RA are necessary to initiate regeneration in successfully regenerating
animals179, 180. FGF and Wnt induction creates a gradient that stimulates epithelial cell
migration towards the lesion site, where they form a wound epithelium within hours of
the initial injury136, 166, 184. Beneath the wound epithelium, FGF and Wnt induces
mesenchymal cell dedifferentiation into pleuripotent progenitors136, 176, 177, 185, possibly
by inhibiting Notch signaling167. These progenitors form a regeneration blastema, where
BMP and RA stimulate proliferation that causes the blastema to expand throughout
regeneration179, 186. BMP, Shh, and RA gradients define a Cartesian coordinate system
that signals the RC, AP, and ML axes of the regenerating structures126, 161, 177, 181, 187.
While the mechanisms of epimorphic regeneration are most thoroughly studied using
models of the vertebrate limb (including the zebrafish fin), the cellular mechanisms of
regeneration and the families of signaling molecules that orchestrate them are also
conserved in other tissues. Regeneration of the zebrafish ventricular myocardium
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requires the injury-induced expression of FGF, Notch, TGF-β, RA, and Shh: these
master regulatory genes induce cardiomyocyte dedifferentiation into a regeneration
blastema at the wound edge where these cells proliferate, migrate into the damaged
tissue (or, in the case of amputation, into the clot that forms at the wound edge), and
then transdifferentiate into new cardiomyocytes135, 182, 183, 188-190. Epimorphic
regeneration of the vertebrate lens and jaw has also been shown to require the
induction of FGF, RA, TGF-β, Wnt, and Shh138, 139. Among these regenerating species,
induction of these master regulatory genes is necessary for regeneration, and
interfering with these signaling pathways can block regeneration.
Differences in regenerative potential among vertebrates are associated with
differences in the master regulatory genes and concomitant cellular behaviors induced
upon injury. Manipulating these master regulatory genes restores regeneration by
inducing these cellular behaviors in those tissues where regeneration does not
spontaneously occur. Limb amputation in axolotl induces increased expression of FGF
and stimulates directional epithelial cell migration towards the injury where a wound
epithelium forms within hours, creating a structure resembling the AEC from which the
limb develops during embryogenesis, and the axolotl limb completely regenerates184. In
contrast, wing amputation in the chick does not induce increased FGF expression, there
is minimal epithelial cell migration towards the injury, a wound epithelium forms only
after multiple days, and the wing does not regenerate; however, adding FGF to the
injury site stimulates epithelial cell migration thus enhancing the rate of wound
epithelium formation, the resulting wound epithelium develops characteristics of the
AEC, and chick wing regenerates166. Cardiac muscle necrosis and ventricular
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amputation both induce Wnt and FGF expression in zebrafish, which is necessary for
regeneration through stimulating cardiomyocyte dedifferentiation142, 143, 188. In contrast,
cardiac regeneration induces neither Wnt nor FGF expression in mice, cadiomyocytes
do not dedifferentiate, a regeneration blastema does not form, and the mouse heart
does not regenerate after injury; however, Wnt expression stimulates cardiomyocyte
dedifferentiation in vitro, suggesting that this signaling pathway may be able to promote
the formation of a regeneration blastema in vivo191. Retinal regeneration in Urodeles
and Teleosts requires the transdifferentiation of Müller glia (the resident radial glia
population in the retina) into stem cells, and directly into retinal pigment epithelial cells,
through a Notch-regulated pathway77, 78, 150; similarly, transdifferentiation of mature
astrocytes and differentiation of NPCs after SCI in zebrafish requires the expression of
Wnt through which neurogenesis is released from Notch-mediated inhibition, and cell
fate is determined by expression of Shh and Wnt after injury126, 192. In contrast, SCI or
tail amputation in mice or rats does not induce Shh or Notch expression, astrocytes do
not dedifferentiate into NPCs, and the rodent spinal cord does not demonstrate robust
regeneration33, 35; however, adult astrocytes express a latent Notch-regulated
neurogenesis program in adults103, and adding FGF after injury induces astrocyte
transdifferentiation and progenitor cell differentiation into neurons100, 193-195. Thus,
master regulatory genes are sufficient to induce epimorphic regeneration in those
tissues and species where regeneration does not spontaneously occur. The
extraordinary degree of conservation among these master regulatory genes supports
the notion that all vertebrates retain a latent ability to regenerate and suggests that a
similarly robust regenerative potential is also conserved within mammals.
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Latent epimorphic regenerative potential is conserved in mammals
Mammals retain a latent regenerative potential into adulthood because they
express the same physiologic mechanisms during embryogenesis that facilitate both
embryogenesis and regeneration in non-mammalian vertebrates. That mammals have
conserved the physiology underlying regeneration is apparent in their ontogenetic
decline in regenerative potential58, 196, 197, which is similar to that in certain nonmammalian vertebrates, and in the sporadic instances of regeneration observed among
diverse mammalian species where the same cellular behaviors and physiology are
expressed. For example, spiny mice shed large portions of their skin through autotomy
as a defense mechanism to escape predation, and this wound heals by regenerating
fully functional skin198. Following autotomy, epidermal cells migrate from the wound
margin and form a wound epithelium and a regeneration blastema within 24 hours; Wnt
and BMP expression both increase after injury, recreating the signaling environment
during embryonic skin development, and sustaining the cellular proliferation and
differentiation necessary to regenerate the underlying dermis, cartilage, sebaceous
glands, and hair follicles throughout the new skin198. In contrast, rat skin wounds take 57 days to re-epithelialize, which subsequently heals through the deposition of a
collagenous scar rather than through regeneration199. Deer antlers undergo an annual
cycle of shedding and regrowth through the activation of stem cells in the pedicle
periosteum, which is a form of epimorphic regeneration as these multipotent periosteal
stem cells form a regeneration blastema that produce bone, vasculature, and an
epidermis with functional sebaceous glands and hair follicles200-202. Evidence from
microarray studies suggests that the FGF signaling pathway is up-regulated in
27

regenerating antlers, and in vitro studies demonstrate that FGFs maintain a high rate of
proliferation in cells cultured from the mesenchymal growth zone of the regenerating
antler203, 204. In certain young mammals, an amputation of the digit distal to the distal
interphalangeal (DIP) joint can heal by complete regeneration. Digit regeneration in
neonatal mice proceeds through endrochondrial ossification, which recapitulates
embryonic development of the digit. BMP signaling regulates digit regeneration:
regeneration can be induced in non-regenerating digits by applying exogenous BMP,
while Noggin, which inactivates BMP by binding to it, inhibits regeneration197, 205. Digit
regeneration is also found in humans, where finger amputation distal to the DIP joint
consistently heals by complete regeneration of the skin, muscle, vasculature, nerves,
and bone196. The expression of regeneration among different mammalian tissues and
species demonstrates that the physiology of epimorphic regeneration is conserved in a
latent state among all mammals. Thus, it may be possible to stimulate regeneration in
non-regenerating tissues by manipulating these same physiologic pathways.

Conclusion
Ontogenetic physiology is conserved among all vertebrates. Epimorphic
regeneration recapitulates embryogenesis, so all vertebrates – including mammals –
must retain this physiology regardless of their ability to spontaneously regenerate. A
small number of master regulatory genes regulate morphogenesis of each tissue
throughout the embryo; these genes control the same set of behaviors – migration,
proliferation, and differentiation – in each of the tissue-specific cell types responsible for
development. Epimorphic regeneration also requires these same cellular behaviors,
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which are regulated through the injury-induced expression of these master regulatory
genes; the timing over which these behaviors emerge ultimately determines the
regenerative potential.
In peripheral tissues, mesenchymal cells mediate regeneration in response to
these morphogens. Radial glia express markers of mesenchymal cells, and they
facilitate regeneration in the non-mammalian vertebrate CNS through the same cellular
behaviors induced by the same master regulatory genes that induce peripheral
regeneration. Astrocytes, the mammalian ortholog to radial glia, are crucial to wound
repair; while they do not spontaneously facilitate regeneration, master regulatory genes
can induce each of the behaviors necessary for regeneration. Thus, astrocytes retain a
latent ability to regenerate, even though their obstreperous response to injury actively
inhibits the spontaneous attempt of axons to regenerate.
Epimorphic regeneration emerges spontaneously within a variety of vertebrates,
so there must be a signal associated with the injury in regenerating tissues that induces
the expression of these master regulatory genes. Consequently, it is reasonable to
postulate that the failure of certain vertebrates to regenerate is due to a lack of this
injury-induced signal. Epimorphic regeneration relies on ontogenetic physiology, which
is conserved among all vertebrates, so all vertebrates should be capable of epimorphic
regeneration if the signal from the injury that induces these master regulatory genes can
be identified.

Physiologic electric fields regulate embryogenesis and regeneration
Endogenous electric fields (EFs) are physiologically produced in all biological
systems and influence the activity of many different cell types through electrostatic
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interactions with individual cellular components ranging from small ions through
biological macromolecules. Electricity was first demonstrated to have an effect on
biologic activity in the 18th century when Luigi Galvani, with dramatic aplomb, made a
dead frog leg jump by connecting its sciatic nerve to a source of electricity206. In the
early 19th century, Matteucci demonstrated that tissues produce their own bioelectricity
by showing that a dead frog leg would contract if its sciatic nerve was placed over an
incision made in the muscle from another frog207. In 1855, Kollicker and Mueller found
that, when the motor nerve to a frog’s leg was placed over a beating heart, the leg
kicked with each heartbeat208, demonstrating that the heart spontaneously produced
bioelectricity. This electrical activity from the heart was first measured through the skin
by Ludwig and Waller in the 1880s using a “capillary electrometer” 209. Hans Berger
applied this same technique to the head, leading to the development of the
electroencephalogram210, which definitively demonstrated that the brain produces
spontaneous electrical activity. Electrical activity has been subsequently demonstrated
in all tissues, and multiple clinical tools, including the electrocardiogram (EKG) and the
electroencephalogram (EEG), measure these bioelectric fields because their magnitude
and polarity vary as a function of tissue physiology.
Endogenous bioelectric fields have been identified as a putative signal upstream
of the master regulatory genes that regulates morphogenesis during development and
regeneration. Elevated EFs are associated both with body patterning during
embryogenesis, and EFs of sufficient magnitude are both necessary and sufficient for
epimorphic regeneration in many non-mammalian vertebrates. As EFs have also been
measured in the mammalian CNS, this suggests that EFs may also have a physiologic
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effect on the cellular response to injury in the mammalian CNS, and that EF-based
therapy may be able to promote regeneration.

Physics of electric fields
Two charges exhibit an electrostatic interaction between themselves because
each charged particle has a region around it within which it is able to influence other
charged particles or objects. Coulomb’s Law describes the magnitude of the force
created by this interaction:
𝐹=

𝑘𝑞! 𝑞!
  
𝑟!

where F is the electrostatic force, k is a constant, q1 and q2 are the two charges, and r is
the distance between the two charges. Newton’s third law states that, for every action,
there is an equal and opposite reaction: when a charge creates an electrostatic force on
a second charge, that second charge creates an equal and opposite electrostatic force
on the first charge. Therefore, a single charge in space cannot generate an electrostatic
force: if q2 = 0 Coulomb’s law predicts there would be no electrostatic force, and there is
no second charge to satisfy the requirement of Newton’s third law that an equal and
opposite charge be created. However, a single charge still has a region of electrical
influence around it, which is defined as its electric field (E):
𝐸=

𝑘𝑞!
  
𝑟!

EFs for an individual charge can also be defined as
𝐸=

𝐹
  
𝑞!

which is a ratio of the electrostatic force between any two charges, and the second
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charge involved in creating said force. It is worth noting that these charges can either be
free electrons or ions; as the scope of this discussion covers biological systems, which
are composed of aqueous environments, we are principally concerned with ions.
As a result of the force created by electrostatic interactions, EFs cause ions or
molecules with a net charge move (a process called electrophoresis), while neutral
molecules containing electrical dipoles (i.e. local separation of charges within the
molecule but no overall charge) align their dipole in an EF. EFs are vectors and as such
convey information about their magnitude and direction throughout their region of
influence. EFs can either be static or dynamic: a static EF is one where charges are
separated on either side of a physical barrier and do not travel between these poles; a
dynamic EF is one where moving charges (i.e. an electrical current) induces an EF in
the space around it. Electrostatic field strength is determined by the magnitude of the
voltage gradient (V) and the distance (d) of separation: 𝐸 = ∆𝑉 𝑑; electrodynamic field
strength is determined by the resistivity of the medium (ρ), the ionic current (I), and the
cross-sectional area (A): 𝐸 = 𝜌𝐼 𝐴. As Newton’s second law states, a particle that
experiences a force (F) will undergo an acceleration (a) in proportion to its mass (m): F
= ma. Therefore, a charged particle will accelerate in an external EF, but the extent to
which it will move depends on the ease of mobility of the charge in its external medium.
At the extremes of the spectrum, the external medium can be a conductor, which allows
completely free movement of a charge, or it can be an insulator, which restricts
movement of a charge. Biological samples contain both conductors and resistors, which
are created through the complex arrangements of cell membranes, the extracellular
matrix, and the macromolecules holding each of these components together211.
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Cells physiologically produce and detect bioelectric signals
Physical properties of the tissue determine the magnitude of bioelectric fields that
are produced by physiologic gradients in the transepithelial electrical potential (TEP)
through the relationships of E = ΔV/d and E = ρI/A. Voltage gradient (ΔV) is a function of
the TEP, which is determined by the metabolic activity in the cell (i.e. the number of ion
transporters and their rate of activity) and by the resistivity of the medium; resistivity of
the medium is the ability of the epithelium, or tissue parenchyma to resist the movement
of ions; distance of charge separation is a function of the epithelial thickness, which
often varies across the tissue; ionic current is affected by the magnitude of the voltage
gradient, and also on the ability of the ions to diffuse; and cross sectional area is a
function of the size of the tissue or, when the ionic current is across the epithelium, the
portion of the epithelium supporting paracellular ion diffusion. These physical properties
convert physiologic metabolic processes into EFs, which, because electrogenic ion
transport is universal among cells, are omnipresent throughout all tissues.
All cells selectively segregate ions across their membranes, either by active
transport up their concentration gradient or through ion channels that allow facilitated
diffusion down their gradient. Ions, by definition, are charged molecules, so an electrical
gradient is established when ion transport results in a net movement of charge across
the membrane (Figure 1.5). Cellular activity that establishes electrical gradients is called
electrogenic, and electrogenic activity is universal among cells because all cells use
such electrochemical ion gradients for myriad metabolic processes. Electrogenic ion
transport establishes a trans-membrane electrical potential (Vm) across the cell’s
plasma membrane, which is often characteristic for a given cell type212. Vm is generally
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constant because these electrogenic transporters are often uniformly distributed across
the cell membrane, but local variations in Vm can arise over distances as short as 2 µm
when they are segregated into domains by lipid rafts or anchored to the cytoskeleton213;
if opposite ends of the cell are organized into distinct regions, as can happen across
epithelial cells which are organized into apical and basolateral domains, the resulting
variation in Vm can create a trans-cellular voltage spanning the entire cell.
Electrogenic activity is also a hallmark of tissues because all tissues are lined by
cells containing a non-random distribution of membrane proteins that sustains a steady
trans-cellular transport of metabolites and, thus, a trans-cellular ionic current (Figure
1.5F). These cells function as a barrier that regulate access of metabolites and
molecules into and out of the tissue. In general, these cells are called epithelial cells,
which can be derived from ectodermal, mesodermal, or endodermal tissues. Epithelial
cells line most tissues, including the ventricular surface within the CNS; a notable
exception is that the sub-pial surface of the CNS is lined by astrocytic end-feet that
create the BBB which, while not a technical epithelium, regulate metabolite transfer into
and out of the CNS similarly to how epithelia function in other tissues. In general,
epithelial cells concentrate their sodium-potassium pumps (Na+/K+-ATPase) within their
basolateral membranes, while sodium (Na+) channels are concentrated in their apical
membrane. The Na+/K+-ATPase is electrogenic because it pumps 3 Na+ out of the cell
while importing only 2 K+, resulting in the net loss of 1 + charge for each adenosine
triphosphate molecule (ATP) expended. As the intracellular Na+ concentration
decreases, a concentration gradient drives Na+ diffusion from the tissue through the Na+
channel and into the cell. Together, the basolateral Na+/K+-ATPase and apical Na+
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channels support a steady inward Na+-ion current, which creates a large
electrochemical Na+ gradient (Figure 1.6); tight junctions prevent paracellular ion
diffusion, so the Na+ gradient is sustained214, 215. Epithelial cells are oriented such that
their individual trans-cellular voltage drops are aligned so they produce a large TEP.
The magnitude of the TEP is determined by the metabolic rate of the Na+/K+-ATPases,
and local variation in the TEP among epithelial cells creates EFs within the tissue.
Although EFs originate at the periphery of the tissue, they spread throughout the entire
parenchyma. Tissues are composed of ions and charged proteins, and EFs can
influence biologic systems through electrophoresis and dipole alignment of charged ions
and diffusible proteins. However, the influence of EFs throughout tissues is generally
limited to the extracellular space because high plasma membrane capacitance causes
intracellular EFs to decrease 1000x.
Extracellular EFs influence cellular activity both indirectly through effects on
extracellular soluble molecules and directly through electrostatic interactions with
membrane proteins. EFs cause electrophoresis of soluble molecules in the extracellular
matrix, creating concentration gradients that, in turn, can serve as directional cues for
cells to follow. EFs also cause electroosmosis216 of extracellular ions (Figure 1.8), with
negatively-charged anions moving towards the positive pole of the EF and positivelycharged cations moving towards the negative pole of the EF; those charged membrane
proteins that are capable of lateral diffusion through the membrane (i.e. that are not
anchored to the underlying cytoskeleton) passively diffuse along with these extracellular
ions and become redistributed to either the positive or negative pole of the cell.
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Cells can also respond to extracellular EFs directly because EFs induce a transcellular voltage drop, which affects the cell’s resting membrane potential and polarizes
the cell by establishing depolarized and hyperpolarized domains at opposite ends of the
cell such that the poles are parallel to the extracellular EF217-219. These electrochemical
effects allow cells to transduce the magnitude and direction of the applied EF through
multiple distinct mechanisms. Cells transduce the EF magnitude by inducing a
proportional depolarization of the cell membrane, causing a change in the opening
probability of voltage-gated channels that activates intracellular second messengers.
EFs also cause a polarized redistribution of membrane proteins, and the extent of this
redistribution is proportional to the magnitude of the EF; as those membrane proteins
with constitutive activity become increasingly concentrated at one area of the cell, the
amount of this basal activity can become sufficient to cause a local activation of the
downstream second messengers. EF-induced electroosmosis can transduce nondirectional cues if the activated second messenger system is, for example, mitogenic218;
electroosmosis can also facilitate transduction of the directional component of the EF
vector by causing excitatory membrane proteins to redistribute to one pole of the cell
while inhibitory proteins redistribute to the opposite pole (Figure 1.8) 220-222. Another way
cells can transduce the directional component of the EF is through depolarization and
hyperpolarization of the membrane potential at opposite ends of the cell, which can
result in activation and inhibition of certain voltage-gated channels. Together, each of
these biophysical mechanisms allow cells to transduce extracellular EFs through
multiple complex pathways, and the specific physiologic mechanisms depend on the
particular extracellular proteins present in the tissue, the membrane proteins expressed
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in the cell, basal activity of these membrane proteins, and the extent to which both the
extracellular and the membrane proteins can diffuse. Thus, EFs may result in the same
behavioral consequences on different cell types through completely independent
physiologic pathways.

Examples of established EF-transduction pathways
Extracellular EFs, whose physiological effects have largely been studied using
purified cell populations in vitro, influence the activity of both immature and terminally
differentiated cells from all three embryonic germ layers. Many different pathways have
been shown to contribute to cellular EF transduction for each cellular behavior, but the
precise pathways responsible for specific behaviors have not been fully elucidated and
are likely to vary among different cell populations. The best-studied example of EF
transduction is electrotaxis (i.e. EF-induced directional migration), where electroosmosis
of constitutively active membrane proteins to opposite ends of the cell causes increased
activation of phosphoinositide-3-kinase (PI3K) at the leading end and phosphatase and
tensin homologue (PTEN) at the lagging end of the cell, where they have excitatory and
inhibitory effects on migration, respectively; interestingly, these second messengers
have been implicated in electrotaxis in epithelial keratinocytes, hippocampal neurons,
and neutrophils, but the specific receptors responsible for activating this common
pathway vary221, 223-232.
A comprehensive study by Tseng and colleagues (2010) elucidated a pathway by
which cells can respond to the magnitude of the EF independent of its orientation147.
They demonstrated that EFs induce extracellular Na+ currents that open voltage-gated
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sodium channels (NaV), which activates the Salt Inducible Kinase (SIK) in direct
proportion to its rising intracellular concentration147. SIK is a Na+-dependent member of
the AMP-activated protein kinase (AMPK) family that modifies transcription and
translation of downstream effector molecules, including Notch147, to drive regeneration
through re-development233, 234. Interestingly, they also found that SIK is not involved in
embryogenesis, suggesting that it may be part of a signaling pathway that reactivates
developmental mechanisms to drive regeneration after injury. Furthermore, the SIK
protein that they manipulated in Xenopus demonstrates sequence homology with a
family of SIKs that was first identified in rats235 and has subsequently been
demonstrated in mammalian astrocytes236. Thus, SIK physiologically links bioelectric
fields and scalar cellular responses through a second messenger system that is
conserved among regenerating and non-regenerating vertebrates.
Another way calls can transduce EFs is through EF-induced depolarization and
hyperpolarization of opposite ends of the cell. This is thought to contribute to directional
neurite outgrowth that is towards either the anode or the cathode of the applied EF
depending on the particular type of neuron being explored237-239. Cellular morphology is
also thought to be affected by the trans-cellular voltage drop induced by EFs, as
astrocytes, Schwann cells, and fibroblasts align their processes perpendicularly to an
applied EF, possibly to minimize the voltage drop across their membranes240-243.
Elevated EFs also affect differentiation in cardiomyocytes and neurons, likely through
inducing changes in membrane potential244, 245. Together, this demonstrates that
bioelectric fields are produced throughout tissues as a consequence of physiologic
epithelial cell activity, and that these EFs are able to regulate cellular activity.
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Bioelectric field intensity varies throughout life
Endogenous bioelectric fields vary in magnitude throughout life because changes
in physiology affect the physical properties of the tissue. EF production begins early in
development: fucoid eggs produce polarized electrical signaling shortly after fertilization
when they are still unicellular246, focal ionic currents are produced by the fertilized
Xenopus egg during initial cleavage247, and epithelial cells in vertebrate embryos begin
producing directional trans-cellular ion currents that sustain EFs beginning early during
development248-253. EFs are typically elevated during embryogenesis because the
epithelial cells sustain the same transcellular ion currents that they do in adult tissues,
but the epithelium is thinner during development because the tissue is not fully
formed215, 249; a smaller epithelium means the same voltage gradient occurs over a
shorter distance, so the EF is higher. Additionally, the electrical resistivity of developing
tissue is lower than it is during adulthood because there are fewer intercellular tight
junctions between epithelial cells and the ECM in the tissue parenchyma is not fully
formed, which further contributes to higher EFs within developing tissues (Figure 1.7C).
During embryogenesis, a voltage drop of 90 mV is sustained across the developing
axolotl neural tube; the presumptive neuroepithelium is initially 50 µm wide because it
composed of only several cells, so this trans-neural-tube potential (TNTP) results in an
electric field as high as 1800 mV/mm215, 249. As neurogrenesis progresses, the EF within
the neural tube decreases because the tissue thickens but the TNTP remains constant.
EFs also increase during embryogenesis when epithelial tight junctions break down at
sites of high cellular activity, decreasing resistance to paracellular ion diffusion,
increasing the ionic currents, and inducing robust EFs253-255; this happens at the AEC in
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the developing embryo, and these large EFs have been shown to predict the site of limb
bud formation in frog, chick, and mouse embryos248, 250, 252, 253. Once development is
complete, EFs become much lower because the adult tissues become electrically
insulated as new epithelial tight junctions are formed that increase electrical resistance
to ionic currents256-259.
Physiologic EFs are a necessary signal that regulates cellular behaviors during
embryogenesis. The developing embryo produces EF gradients in the RC, ML, and AP
axes that contribute to embryonic morphogenesis by directing cellular behaviors215, 248,
255, 260

. High EFs are produced across the developing neural tube that are strongest in

the sub-ependymal layer, which is the location of embryonic neurogenesis; inhibiting
EFs either with pharmacologic antagonists or by using an implanted electrode to inject a
counter-current causes gross abnormalities in neural tube development and can prevent
closure of both the rostral and caudal neural pores261, 262. Similarly, robust EFs are
necessary for vertebrate limb development: high EFs precede initial outgrowth of the
limb bud248, 263, 264, and limbs develop abnormally if the EFs are inhibited either by
pharmacological antagonists or by applying a countercurrent through an implanted
electrode249, 250, 261, 262. Thus, physiologic EFs within the vertebrate embryo are both
necessary and sufficient to stimulate development.
EFs have also been measured in adult tissues in many vertebrate species. Ionic
currents have been measured across the mammalian skin265, respiratory epithelium266,
cornea267, 268, and brain269. Amphibians sustain an inward ionic current across the skin
that varies in magnitude across different regions of the body270. Similar ionic currents
and electrical potentials have also been measured in human skin, revealing that human
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skin produces a TEP that varies in magnitude across the body256, 257, 271, 272. Although
ionic currents and electrical potentials have been measured in a variety of adult
vertebrate tissues, demonstrating that EFs have a role in regulating physiological
activity in adults is more difficult than it is in developing animals. In adult tissues, cell
populations typically do not demonstrate overt migration, proliferation, dynamic changes
in protein expression, or marked changes in morphology. It is far more difficult to test
the hypothesis that low EFs regulate cellular activity in adult tissues: the hypothesis is
that the stimulus will not induce a response, but absence of evidence is not evidence of
absence. However, one study has shown that a low dcEF (3-5 mV/mm) is present in the
rostral migratory stream (RMS) in the adult CNS, which is a path through which nascent
neuroblasts produced in the sub-ventricular zone (SVZ) migrate to the olfactory bulb.
Low EFs have not been shown to elicit robust behavioral responses on other cell types
in vitro, which makes intuitive sense: low EFs are found in adult tissues, so they should
not be able to induce dramatic cellular behaviors in these mature cell populations.
However, neuroblasts in vitro migrate cathodally upon exposure to a 3.5 mV/mm EF,
which is the same direction in which neuroblasts are known to migrate in the adult CNS
where EFs of this strength are present269. This suggests that, similarly to their role in the
embryonic CNS, physiologic EFs may regulate cellular activity in adult tissues.

Injury-induced electric fields regulate wound healing and regeneration
Physiologic EFs are produced in embryonic and adult tissues, and the magnitude
of these EFs reflects the physiologic properties of the developing tissues. Injury also
induces a robust increase in EFs because epithelial damage creates an aqueous bridge
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that short-circuits the trans-epithelial electrical resistance; this changes the physical
properties of the tissue, instantly causing the TEP to collapse to 0 mV and consequently
inducing large EFs between the lesion and the surrounding tissue (Figure 1.7).
Kirchoff’s Current Law states that the current entering any point has to be the same as
the current leaving that point, such that the algebraic sum of currents in a network being
zero; the ionic current at the injury site reverses direction and establishes a current loop
with the intact tissue at the lesion margin, so the total current flux through the lesion
must be equal to the total current flux through the surrounding tissue. The intact tissue
can be thought of as a concentric area surrounding the lesion site with a cross-sectional
area of 2πr (assuming that there is only current parallel to the plane of the epithelium),
where r is the distance from the injury site; given that the total current I is constant
throughout the circuit, the current density (µ) through any given part of the tissue
decreases as the distance from the injury site increases. Moreover, Kirchoff’s Voltage
Law states that the net voltage change through a circuit is 0, and Ohm’s Law states that
the Resistance = V/I; as the surrounding intact tissue occupies a greater area than the
injured tissue with a lower I at any individual point, the V within the healthy tissue must
be smaller than that within the injury site. Thus, both the ionic current density and the
voltage change within the tissue must vary spatially throughout the tissue, being low at
the periphery and increasing substantially throughout the tissue approaching the lesion.
The injury-induced EF is a function of changing electrical resistance across the
damaged epithelium, so it passively emerges instantly upon injury and is sustained
throughout the entire repair process. As the TEP remains unchanged across the
surrounding intact epithelium, the voltage gradient between the injury site and the
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uninjured tissue must be larger in magnitude than those EFs typically found within intact
tissues, and these EFs must be radially oriented between the lesion and the surround.
Because these elevated EFs emerge automatically upon injury and are inherently
directional with a vector directly towards the lesion, they are an ideal cue both to initiate
the cellular response to injury and to direct surrounding cells to the lesion site. For
tissues with an inward constitutive current, including the skin and cornea, the lesion site
becomes the cathode of the injury-induced EF; epithelial keratinocytes, epidermal
fibroblasts, and corneal fibroblasts, all of which are necessary for a regenerative healing
response in their respective field, migrate towards the cathode upon exposure to an EF
in vitro223, 228, 230, 273, suggesting that these injury-induced EFs recruit these cells to the
lesion site in vivo.
The magnitude of injury-induced EFs is correlated with the regenerative potential
of the injured tissue. EFs increase 50-100 fold in upon limb or tail amputation in axolotl,
and this depolarization is sustained throughout the entire duration of regeneration270, 274,
275

. Tail amputation in Xenopus tadpoles induces robust ionic currents that are

sustained throughout regeneration but, after tadpoles progress through metamorphosis,
limb amputation induces a smaller current and the structure does not regenerate276-278.
Skin puncture in axolotl also induces strong EFs that are sustained throughout healing,
during which time fully functional skin is regenerated141, 279. In contrast, skin wounding in
mice induces smaller ionic currents, and the skin heals by forming a collagenous scar
rather than regenerating fully functional skin265. In rats and cows, corneal injury induces
an EF increase within the tissue surrounding the lesion; in rats, pharmacologically
modifying the EF intensity causes a proportional change in the rate of wound healing
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that occurs267, 268. Together, this shows that injury-induced EFs are more robust in those
tissues that demonstrate epimorphic regeneration than they are in tissues that fail to
regenerate. Moreover, these data suggest that the magnitude of these injury-induced
EFs is closely associated with the regenerative potential of the tissue.
Elevated EFs are necessary and sufficient to stimulate epimorphic regeneration
in injured tissues. Large ionic currents emerge from the amputated stump of the newt
forelimb, and these currents persist throughout epimorphic limb regeneration270,	
  274.
Newt limb regeneration can be inhibited by attenuating these injury-induced EFs
through either pharmacological or physical antagonists280,	
  281, demonstrating that the EF
itself, rather than any of the individual ions composing the associated injury current, is
necessary for regeneration. In Xenopus tadpoles, a Na+ current induced by tail
amputation is necessary for regeneration, and regeneration can be blocked by either
injecting a countercurrent through an electrode or by genetically knocking out the
sodium channel that allows the current’s creation147,	
  276. In adult frogs, limb amputation
produces relatively low EFs and the wound heals through a scar formation without
robust regenerative outgrowth; enhancing the injury-induced EF through implanted
electrodes promotes regenerative wound healing that is much more robust than the
healing in animals without a functional stimulating electrode277,	
  278,	
  282. Interestingly,
although mammalian limbs do not regenerate after amputation and heal instead by scar
formation, Robert Beck showed that electrical stimulation of the wound in rats promotes
regenerative outgrowth of the amputation site with partial restoration of histologically
normal tissue replete with vasculature, bone, and skin if the cathode of the applied EF is
at the amputation site283,	
  284. Together, this further supports the notion that endogenous
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bioelectric fields are a main component of the signaling environment in injured tissue
that regulates repair, and are both necessary and sufficient to induce regeneration.

The CNS produces extracellular EFs
Physiologic EFs have been measured throughout the mammalian CNS for over
100 years285. Richard Caton was the first person to measure EFs in the mammalian
cerebral cortex when, in 1875, he demonstrated that the exposed cerebral hemispheres
of rabbits and monkeys produce electrical phenomena286. Adolf Beck subsequently
demonstrated that the spontaneous rhythmic electrical activity in the brain changed
upon exposure to light, suggesting that this activity provides insight into the underlying
function of the brain287. The first recording of these extracellular electric fields in living
animals was made in 1912 by Ukrainian physiologist Vladimir Vladimirovich PravdichNeminsky, who measured evoked potentials in dogs288. Hans Berger invented the
electroencephalogram (EEG) to measure this spontaneous electrical activity, and he
used it to record the first human EEG in 1924210. The EEG measures extracellular EFs
on the cortical surface using electrodes attached to the surface of the scalp with a
conducting adhesive. By comparing the electric potential between two different
electrodes, EFs can be calculated between different points of the brain. For clinical
measurements, electrodes are typically applied in a standard configuration, and either
the “absolute” EF is measured by comparing the individual electrode’s voltage to a
ground electrode positioned far from the recording electrode, or relative EFs are
measured between two locations within the cortex. These readings are often reported
as voltages but, because they rely on differences in voltage at two electrodes separated
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in space, there must be a voltage gradient (i.e. an EF) between the two locations. These
voltages arise because the cytoarchitecture of the brain is highly organized, so
synchronous activity among populations of cells results in large changes in the local
electrical potentials. Even though the ions sustaining the electrical currents are relatively
free to diffuse through the brain, the steady cellular activity and the highly organized
cytoarchitecture result in local dcEFs that, cumulatively, are robust enough to be
measured by the recording electrodes on the skin.
At the basic level, EEGs infer extracellular EFs within the brain parenchyma from
recordings taken on the skin; while the 5 layers of tissue composing the scalp, the
cranium, 3 layers of dura, and CSF separate the electrical activity in the brain
parenchyma from the recording electrodes, the electrical signals produced by neural
activity are so strong that these surface electrodes are able to filter out the ambient
electrical noise and provide an accurate measurement of the surface cortical activity.
Each pair of electrodes used to record an EEG measurement is called a lead, and only
the change in electric potential in the vector parallel to the lead will be recorded; any
component of electric activity perpendicular to the lead axis does not contribute to the
difference in electric potential between the leads because the axis perpendicular to the
lead vector falls along an isoelectric line for that lead and thus cannot be measured.
EEG leads are arranged to measure electrical activity with an axis of measurement
through the center of the head, which means that the EEG preferentially measures the
portion of the cerebral cortex that is parallel to the skull (i.e. the outermost portion of the
gyri), while the electric fields from cortical surface within the sulci cannot be measured
because they are perpendicular to the electrodes. Moreover, the sulci are, necessarily,
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anatomically arranged so that they are opposite each other, with the net result being
that electrical activity in adjacent sulci cancels each other out. Nonetheless, EFs have
been measured throughout the entire brain using electrocorticography, which uses a
grid of electrodes applied directly to the surface of the brain to record electrical field
potentials with much greater resolution than can be achieved with an EEG.
EEG and electrocorticography measurements are limited to the surface of the
cerebral cortex, but subsequent research has demonstrated that extracellular EFs are
present throughout the entire mammalian brain. Electrophysiological recording
techniques for field potentials measure the voltage at an electrode implanted
somewhere within the brain and compare it to a reference point either elsewhere within
the brain, or in a bathing solution outside the brain; similarly to the EEG, these
measurements produce a voltage recording that represents the net electrical activity of
all cells within a certain distance (the recording sensitivity) of the electrode, and this field
potential can be converted into an EF when compared to the recorded voltage at
another recording electrode located at a known distance from the first. Multiunit
extracellular electrodes are similarly implanted in the brain; they have a greater
sensitivity than electrodes used for recording field potentials, so they are used to
measure action potential activity from multiple axons within the region of the recording
electrode. All of these recordings are traditionally used to measure action potential
firings from increasingly small populations of cells, which result in alternating current
(AC) signals of varying frequency. Nonetheless, these recording methodologies also
consistently demonstrate a background dcEF in the CNS parenchyma, as the resting
extracellular potential as compared to ground is not 0. (Of note, the EEG can also
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measure dcEFs, although these measurements are not currently of clinical use and so
are only typically recorded in experimental protocols.) However, experiments employing
these techniques rarely report the extracellular dcEFs because they were developed to
measure populations of axons firing action potentials; the measurement of interest for
these types of recordings is the difference between electrical activity during the action
potential and at rest, so the resting electric potential (i.e. the steady-state dcEF) is
typically subtracted out of the measurement as the recordings are being made so that
the baseline reading is 0 (using a direct current (DC) offset through a filter in the
preamplifier that is attached to most electrophysiology set-ups).
Although dcEFs have been consistently disregarded as little more than
background noise, a growing number of studies has specifically sought to measure
these endogenous electrical signals. Physiologic EFs have been found in the vertebrate
CNS during embryogenesis249, 251, 252, in adulthood269, and following injury289. While it is
clear physiologic EF strengths in the CNS vary in magnitude similarly to how EFs vary
in peripheral tissues – high during developing and following injury, low in mature tissues
– the precise magnitudes of these EFs have been less thoroughly explored because
their measurements are more difficult to obtain. Shi and Borgens demonstrated that the
axolotl neural tube maintains a voltage of 40-90 mV across itself249, while Hotary and
Robinson measured a voltage of 21 ± 2 mV across the Xenopus neural tube251. A
recent study by Cao and colleagues (2013) used an ex vivo preparation to demonstrate
that a low EF of 2 – 5.7 mV/mm is present in the rostral migratory stream of the adult
mouse brain, and that this EF is likely sustained due to a constitutive inward Na+ current
of 1.5 ± 0.6 µA/cm2 across the pial surface in the SVZ of the lateral ventricles and a
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constitutive outward Na+ current of 1.6 ± 0.4 µA/cm2 across the surface of the olfactory
bulb (OB) 269. These ionic currents are produced by asymmetric distributions of the
Na+/K+-ATPase in the lining of the brain, with the transporters located along the
basolateral domain of ependymal cells in the SVZ and along the apical domain of
astrocyte end feet in the glia limitans of the olfactory bulb269. Assuming that the outward
ionic current over the intact olfactory cortex is representative of the direction of ionic
current across the entire mammalian cortex, and knowing that the ionic current changes
direction upon injury, this suggests that the orientation of an injury-induced EF in the
mammalian brain would place the anode at the lesion site while the cathode would be in
the surrounding intact tissue. A subsequent study used an ex vivo preparation to
demonstrate that the EF within adult mouse SVZ is 31.8 ± 4.5 mV/mm, but they
measured this EF within a slice culture 300 µm thick so this reported EF seems to be
more representative of a reading from an injured brain than one from an uninjured
brain290. While the EF strength has not been measured upon injury in the mammalian
brain, a group from the lab of Richard Borgens used an ex vivo guinea pig SCI model to
explore how extracellular EFs change in the injured CNS. By measuring the ionic
current density around the spinal cord before and after a complete transection, they
found that the injury induced an initial 100-fold increase in over 60 seconds, but that the
EF decayed to a 10-fold increase that was sustained for at least the subsequent hour291.
However, the Borgens lab’s experiment suffered from the same problem as did those
experiments from by Cao: they used an ex vivo model to measure electrical activity
within the allegedly-intact spinal cord, neglecting the fact that removing the spinal cord
from the animal is itself a severe injury that disconnects the tissue from its vascular
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supply and disrupts its epithelia (for a further discussion of the problems of using ex vivo
models and invasive recording techniques for measuring EFs, see Chapter 4:
Considerations when measuring bioelectricity, page 174). Nonetheless, these biased
studies suggest that the embryonic CNS produces EFs about 100-fold greater than
those in the adult CNS, and that injury induces only a 10-fold increase in EFs over
baseline. The reported change in EF intensity induced by injury in the mammalian CNS
is similar to the magnitude of EFs induced by injury in other mammalian tissues. While
neither the CNS nor peripheral tissues typically demonstrate robust regeneration in
mammals, therapeutic EFs have been shown to promote regeneration in several
peripheral tissues, suggesting that therapeutic EFs may similarly be able to promote a
regenerative cellular injury response in the injured mammalian CNS.

Extracellular EFs regulate cellular physiology in the CNS
Physiologic dcEFs have been measured throughout the mammalian CNS, and
EFs of these intensities influence the behavior of multiple neuronal and glial cell types in
vitro269, 290, 291. Many cell types from the CNS respond to exogenous EFs, but the
magnitude of EFs used in these studies often far exceeds the physiologic range
reported in the CNS, which <10 mV/mm in the rostral migratory stream269, and up to 50
mV/mm in the hippocampus (sustained only for several minutes following an evoked
potential) 292. Upon exposure to extracellular EFs in culture ranging from 4-1,000
mV/mm for 3-20 hours, neurons from the Xenopus laevis neural tube preferentially grow
towards the cathode and retract from the anode237, 239, 293-295. The rate of cathodal
neurite outgrowth of Xenopus laevis neurons is dependent on Ca2+296. The orientation of
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EF-induced neurite outgrowth likely involves multiple mechanisms as some studies
demonstrate that this directionality is Ca2+ dependent297 while other groups have found
that neurite outgrowth remains directional even in Ca2+-free media298; spinal neurites
have also been shown to mediate EF-induced neurite outgrowth through acetylcholine
receptors in their growth cones, which are activated through autocrine acetylcholine
release299. Neurons from dorsal root ganglia (DRGs) in chick embryos also increase
their rate of outgrowth300 and preferentially grow towards the cathode of an EF of 15140 mV/mm over 3.7-6.3 hours294. Mammalian neurons similarly increase neurite
outgrowth length parallel to an applied EF with a preference towards the cathode293,
and outgrowth is further improved by co-culture with Schwann cells301 or astrocytes240.
While the general conclusions from these studies are that neurons preferentially
extend neurites towards the cathode and retract those facing the anode, the effects are
often mixed, suggesting that there may be a heterogeneous response to EF exposure
that depends on the sub-type of neuron tested. This is reinforced by observations that
PC12 cells, which are a neuronal cell line derived from the rat adrenal medulla, extend
neurites towards the anode over 48 hours’ exposure to 5-100 mV/mm EF302, while
neurite outgrowth from neurons derived from embryonic zebrafish is unaffected by a
100 mV/mm EF after 20 hours303. EFs may also interact with the culture media and
substrate to affect the orientation of Xenopus laevis neurite outgrowth239, and
chemoattractive and repulsive effects of CSPGs are modified by dcEFs in vitro304.
Moreover, the substrate through which neurites sprout interacts with EFs to determine
the orientation of these sprouting neurites. DRG neurites project parallel to the polarity
of a 50 mV/mm EF, and they will follow the orientation of their culture substrate when
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grown without an EF; if the DRG is cultured on a substrate oriented perpendicularly to
an EF, the substrate cue overrides the 50 mV/mm EF and the neurites will grow
perpendicularly to the EF orientation305. Interestingly, a 50 mV/mm EF increases the
length of neurite outgrowth regardless of whether the DRGs are on a substrate growing
with an orientation parallel or perpendicular to the EF orientation, showing that the EF
effect on neurite outgrowth is independent of the orientation of the substrate305.
Neuronal populations vary throughout the CNS and send projections to unique
downstream targets through specific fiber tracts composed of different combinations of
ECM molecules. The heterogeneity of EF effects on the rate and direction of neurite
outgrowth, and the dependence of neurite outgrowth on the ECM substrate and on the
morphology of glial cells within the parenchyma, may facilitate the development of the
complex CNS cytoarchitecture: the same physiologic EFs may interact with the ECM to
create precise signaling cues that guide different subpopulations of neurons to grow in
different directions through different tracts within the CNS.
EFs also affect NPCs within the vertebrate CNS. NPCs from the mouse and rat
migrate cathodally on exposure to EFs as low as 3 mV/mm, and the speed and
directedness of this migration increases as EFs increase up to 400 mV/mm269, 290, 306-308.
EFs induce membrane asymmetry in NPCs through electroosmosis of membrane
receptors, and they require the Wnt-GSK3β signaling pathway to transduce the EF
signal into an electrotaxic response309. Interestingly, a 3-5 mV/mm dcEF was recently
been reported in the RMS, a pathway through which neuroblasts migrate from their
place of origin in the SVZ to their destination in the OB, of adult rats oriented with the
anode in the SVZ and the cathode in the olfactory bulb; as this is the same direction as
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neuroblasts migrate on exposure to the same EF intensity in vitro, it suggests that this
physiologic EF may be contributing to guiding neuroblast migration in vivo269. EF
intensity also affects NPC differentiation with 115 mV/mm and 437 mV/mm EFs
promoting neurogenesis while 46 mV/mm does not alter the normal gliogenesis from
hippocampal NPCs244, 310, and EFs have recently been shown to stimulate neuronal
differentiation from human mesenchymal stem cells311.
Astrocytes respond to EFs by aligning their processes perpendicularly to the EF
vector at strengths above 100 mV/mm, and the extent of process alignment increases
as the EF strength increases240, 241, 293. EFs affect astrocyte glycolysis, decreasing
metabolic rate at 50 mV/mm, having no effect at 100 mV/mm, and increasing the rate of
glycolysis above 150 mV/mm312. Only one study has explored EF effects on microglia,
and it has demonstrated that EFs of 100 mV/mm increase the number of processes on
the cells, and that these processes are oriented perpendicularly to the EF293.
Meanwhile, the effect of EFs on NG2 cells and on oligodendrocytes has not been
explored. Thus, it is clear that multiple cells from the mammalian CNS respond to EFs,
and that this response depends on the EF intensity and the extracellular signaling
environment. However, these studies have not explored whether physiologic EFs
contribute to the cellular response to injury and the regenerative potential in the CNS.
Although the ability of EFs to induce cellular behaviors associated with
regeneration has not been explored in vivo, circumstantial observations suggest that
EFs may be involved in certain cellular responses to injury. NPCs migrate
physiologically from the SVZ to the OB, but they can be redirected to migrate towards
sites of cortical injury313, 314; as the cortical EFs presumably demonstrate a similar
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change in EF magnitude upon injury to that change observed in other tissues (see page
48), this injury-induced EF may direct NPC migration. In spite of the NPC migration
towards the lesion site, there is not robust neurogenesis upon injury in the mammalian
CNS74, 121. Elevated EFs are sufficient to drive neurogenesis from NPCs244, 310, but EFs
produced by the non-regenerating tissues such as the mammalian cortex are known to
be lower than those EFs found in regenerating tissues215, 227, 315. As NPCs undergo
electrotaxis at much lower EFs than are necessary to drive neurogenesis244, injuryinduced EFs in the mammalian cortex may be robust enough to drive NPC electrotaxis
to the lesion site but insufficient to induce neurogenesis from NPCs once they arrive at
the injured tissue. Assuming that physiologic EFs are involved in the NPC response to
injury, this suggests that elevating the EFs at the lesion site would cause a more robust
NPC migration and that it would also stimulate neurogenesis among NPCs at the lesion.
In vivo evidence supports the hypothesis that therapeutic EFs may promote
regeneration when used in the mammalian CNS. Fehlings & Tator (1992) used axon
tracing to show that dcEFs promoted functional recovery of acutely injured spinal axons
following clip compression injury in a rat model of SCI, and that the polarity of the
applied EF was important to this effect316. A series of studies by the Borgens lab
showed that applied EFs promote recovery of the cutaneous trunci muscle (CTM) reflex
in 25% of guinea pigs following spinal cord hemisection (0% of control guinea pigs
demonstrated improvements) 317; qualitative observations showed that guinea pig
sensory neurons projected axons towards a spinal cord hemisection and that EF
application promoted their regeneration past the lesion and then through their original
tract318. In this study, the applied EF was oriented with the cathode rostral along the
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spinal cord, and they emphasized sensory neurons because they previously found that
spinal neurites preferentially projected towards the cathode. In a subsequent study, they
reversed the orientation of the applied dcEF every 15 minutes following spinal cord
transection in dogs under the assumption that all neurites project towards the cathode,
so that the periodic EF reversal would promote outgrowth of all neurites (remember,
according to the in vitro studies, EF-induced neurite cathodal outgrowth is faster than
anodal retraction); while they found that dcEFs improved functional recovery after both
6 weeks and 6 months of treatment, the sample size was small and they did not
histologically evaluate the impact of EFs on axon regeneration319. Using rats, Borgens
found that oscillating extracellular EFs after a spinal cord transection improved astrocyte
alignment perpendicularly to the lesion site, and that the applied EF (technically a 40 µA
current, with the EF neither measured nor calculated) decreased the number of GFAP+
astrocytes at the lesion site320. However, these studies apply extraordinarily low EF
intensities in vivo without measuring the magnitude of the EFs that are actually induced
by this application at the lesion site, and these treatments are attempted in spite of the
fact that neither the magnitude nor the physiologic role of injury-induced EFs in the
cellular response to injury have been elucidated in the mammalian CNS. Moreover, the
studies that reverse the orientation of the applied EF every 15 minutes do not apply EFs
in a way that recreates the physiologic signaling environment that would otherwise allow
regeneration to proceed spontaneously; instead, they use EFs to try and artificially
promote axon regeneration by taking advantage of the fact that spinal axons
preferentially grow towards the cathode faster than they retract from the anode.
Although these studies have found that EFs promote axon regeneration, the EFs are
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not applied in a way that recreates the physiologic lesion environment. Thus, these
experiments do not actually test the hypothesis that physiologic EFs activate the
otherwise latent physiology that would allow for spontaneous regeneration.

Conclusion
We have seen that bioelectric fields are physiologically produced in all tissues –
including the CNS – in both mammalian and non-mammalian vertebrates, and that
these endogenous EFs vary in intensity as a function of physiologic state. Evidence
strongly suggests that elevated EFs are both necessary and sufficient to influence
embryonic development and epimorphic regeneration in multiple vertebrate species.
Moreover, EFs regulate a consistent series of behaviors – migration, proliferation, and
differentiation – in a diverse variety of cell types from different tissues and germ cell
layers. Physiologic EFs have been found in the mammalian CNS, and elevated EFs
regulate these same behaviors in cells from the CNS; however, the EF intensities
explored in these experiments have not generally been within the range previously
demonstrated in the CNS, and effects of physiologically-relevant EF intensities have not
been explored. Furthermore, therapeutically-applied EFs appear to promote histological
and functional recovery after CNS injury, but these approaches did not attempt to
recreate the physiologic EFs found in the CNS of regenerating animals. Thus, evidence
suggests that endogenous EFs have the potential to serve as an important signal that
regulates the cellular response to injury and determines the regenerative potential in the
injured mammalian CNS, but the relevance of physiologic EF intensities on cellular
activity needs to be explored.
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Chapter Conclusions
Although mammals do not spontaneously regenerate, they retain a latent
regenerative potential through which each of the cell types involved in wound repair can
be stimulated to promote regeneration. Epimorphic regeneration proceeds through
specific cellular behaviors – migration, proliferation, dedifferentiation, and differentiation
– that are fundamentally important for regeneration. These behaviors are regulated by
injury-induced expression of master regulatory genes: differences in the injury-induced
expression of master regulatory genes, and the cellular behaviors that they stimulate,
are associated with differences in regeneration; and master regulatory genes can
induce regeneration in tissues where it is typically not expressed.
Endogenous electric fields are elevated at sites of injury and they have been
shown to regulate each of the cellular behaviors necessary for epimorphic regeneration.
Elevated EFs are necessary and sufficient to stimulate both embryogenesis and
epimorphic regeneration in mammalian and non-mammalian vertebrates alike. This
suggests that EFs may be the stimulus that initiates and regulates these processes,
either by acting upstream of the master regulatory genes and inducing their expression,
or by direct electrostatic interactions with the cellular receptors that transduce these
genes. Physiologic EFs and their role in repair and regeneration have largely been
studied in peripheral tissues; endogenous EFs have also been measured in the
mammalian CNS, which suggests that physiological EFs similarly regulate wound repair
and regeneration in the mammalian CNS. However, there is a remarkable dearth of
evidence exploring the effect of physiologic EFs on each of the cellular behaviors
necessary for the injury response and regeneration in the CNS.

57

The work presented in this dissertation was conducted with the overarching
hypothesis is that the role of EFs in regulating wound repair and regeneration in
peripheral tissues is conserved in the mammalian CNS. Specifically, we hypothesized
that physiologic EFs induce a cellular response to injury characteristic of that observed
in vivo, and EF intensities associated with regenerating tissues would modify the cellular
response towards one associated with regeneration. We chose to explore how EFs
influence astrocytes, because the astrocytic response to injury is a key determinant in
CNS regeneration, and because astrocytes facilitate regeneration in non-mammalian
vertebrates through the same behaviors required for epimorphic regeneration in the
periphery. We describe experiments in which we explore the role of EFs associated with
intact, injured mammalian, and regenerating non-mammalian vertebrate tissues on
regulating behaviors in cortical and cerebellar astrocytes in chapters two and three,
respectively. In chapter four, we explore an approach to measure bioelectricity in the
mammalian brain longitudinally after injury. While we were also interested in the
mechanisms by which astrocytes transduced these behaviors, these studies are limited
to an exploration of behaviors as the question of underlying physiology is ancillary to
that of whether physiologic EFs induce the necessary astrocytic response: if EFs do not
induce the behaviors necessary for regeneration, the mechanisms by which astrocytes
transduce EFs are irrelevant. Instead, we discuss the physiologic implications of our
findings together with the evolutionary origins of EFs and regeneration in chapter five,
where we explore the concept of bioelectricity as a unifying force that regulates
development and regeneration among all vertebrates.
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Figure 1.1: Requirements for CNS regeneration
A simplified illustration of how injury to the CNS disrupts neural circuitry, using
spinal cord injury as an example. (A) In the intact spinal cord, lower motor neurons
(diamonds) receive descending projections from upper motor neurons through the
corticospinal tract, as well as local connections between spinal interneurons (filled
circles). (B) After a focal injury, the original neural circuitry is disrupted both because
neurons within the lesion site have been damaged, and also because axons in the
corticospinal tract passing through the lesion site have been disconnected from their
original targets. Functional recovery through the complete regeneration of the original
neural circuitry requires four basic steps: 1) each of the cell types present within the
damaged tissue (in this example, the lower motor neurons and the interneurons) must
be replaced, 2) disconnected axons, including those projecting past the lesion from
distant nuclei and those from newly-generated neurons, must be capable of sprouting,
3) axons must sprout past the lesion and through the distal intact parenchyma, following
local cues to their original target nuclei, and 4) axons must be able to reestablish their
appropriate connections within their target nuclei. (This image was modified from BenHur, 201040 and is reprinted here under the “fair use” limitation in title 107 of the U.S.
copyright law.)
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Figure 1.2: Astrocytic response to CNS injury and the glial scar
An illustration and matching image GFAP-immunolabeled astrocytes, illustrating
the morphological changes that astrocytes undergo as they become reactive; the
images are aligned such that the illustrations are directly over their matching
immunolabeled counterparts. (A) Healthy astrocytes in the intact parenchyma. (B)
Reactive astrocytes become hypertrophic, developing thicker processes and increasing
their expression of certain cytoskeletal elements, including GFAP (notice the brighter
staining in the immunolabeled images). (C) Astrocytes in the glial scar border (white
notched arrow) are hypertrophic and extend their processes circumferentially around
the lesion; this response restricts immune cells (yellow cells in the illustration) to the
lesion site, but it also prevents axons from sprouting past the lesion border. (The
immunolabeled images are from unpublished observations in the Colello lab. The
illustration in this image was modified from Sofroniew, 200933 and is reprinted here
under the “fair use” limitation in title 107 of the U.S. copyright law.)
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Figure 1.2: Astrocytic response to CNS injury and the glial
scar
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Figure 1.3: Comparison of astrocytes in wound repair among vertebrates
The astrocytic response to injury results in the formation of a chronic glial scar
that inhibits axon regeneration in mammals, while astrocytes in non-mammalian
vertebrates facilitate axon regeneration. (A, B) 3 weeks after a contusive spinal cord
injury in the rat, astrocytes, which are immunolabeled for the intermediate filaments
vimentin (A) and GFAP (B), surround the lesion site; these astrocytes form a barrier
past which axons cannot sprout so, instead of regenerating, this cystic cavity resolves
into a chronic glial scar. In contrast, 3 weeks after a complete spinal cord transection in
zebrafish (C-F), astrocytes expressing both GFAP (C) and nestin (D) migrate into the
injury site and extend elongated processes across the lesion cavity. (E, F) Astrocytes
(immunolabeled for GFAP, red) function as a cellular bridge that facilitates axon
regeneration (green) past the injury site. (The immunolabeled images in panels A and B
are from unpublished observations in the Colello lab. The images in panels C-F are
modified from Goldshmit et al, 201279 and are reprinted here under the “fair use”
limitation in title 107 of the U.S. copyright law.)
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Figure 1.3: Comparison of astrocytes in wound repair among
vertebrates

64

Figure 1.4: Mechanisms of epimorphic regeneration
Certain vertebrates, including Urodele amphibians, demonstrate robust
epimorphic regeneration. (Top left) A newt is shown several months after tail
amputation, demonstrating complete regeneration of a new tail past the amputation
plain (indicated by the black line) with the new tail being anatomically and histologically
indistinguishable from the original tail (gross anatomical images before amputation are
shown at the top right). The basic cellular processes underlying epimorphic
regeneration are conserved among all of the tissues and species in which these
regenerative processes have been studied. These processes are illustrated for the
Urodele amphibian limb, and matching gross anatomical images of the regenerating
newt tail corresponding to these illustrations are shown. Immediately upon amputation,
epidermal cells from the wound margin (indicated in yellow) migrate to the wound and
cover it in a wound epithelium. The wound epithelium, which assumes the same
function as the apical ectodermal cap during embryonic limb development, induces
mesenchymal cells to dedifferentiate into pleuripotent progenitors (light blue). These
progenitors form a cell mass called a Regeneration Blastema immediately beneath the
wound epithelium and replace the amputated tissue through sustained proliferation. As
the regenerating limb elongates, progenitor cells at the base of the blastema redifferentiate into cells from both ectodermal and mesodermal lineages, replacing the full
complement of tissues and structures that were originally present. (The illustration was
modified from Stewart et al, 2007123, and the images of the newt tail were modified from
McLean & Vickaryous, 201165; both sets of images are reprinted here under the “fair
use” limitation in title 107 of the U.S. copyright law.)
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Figure 1.5: Electrogenic cellular ion transport produces bioelectricity
(A-C) An illustration of the physiologic mechanisms of electrogenic ion transport
across cell membranes. Two Na+/K+-ATPases are shown in a portion of the cell
membrane, as are only those cations (Na+ and K+) together with their counter-ions (Cl-)
that are transported. (A) A hypothetical starting point where there is an equal number of
anions and cations both on the intracellular and extracellular compartments. (B) The
Na+/K+-ATPases transport 3 Na+ ions out of the cell and 2 K+ ions into the cell; this
results in a net loss of 1 positive charge for every cycle of transporter (C), which
produces a negative trans-membrane electrical potential (inside of the cell relative to the
outside). If a Na+ channel present in the cell membrane opens, Na+ diffuses through the
channel down its electrochemical gradient and across the cell membrane. (D) When the
Na+/K+-ATPases are uniformly distributed around the cell, the entire cell develops a
relatively uniform membrane potential. (E) If the cell is organized into distinct domains,
the transmembrane potential and concentration gradients may not be uniform across
the cell. For example, in epithelial cells (F), Na+/K+-ATPases are concentrated in the
basolateral domain and produce an electrochemical gradient just across this portion of
the membrane (F, left). (F, center) Na+ diffuses down the resulting concentration
gradient into the cell through Na+ channels, which are concentrated in the apical
domain, and the outside of tissue consequently develops a negative charge. (F, right)
Continued transport of Na+ across the basolateral membrane sustains this net Na+
current across epithelial cells and into the tissue, and produces a tissue-positive transepithelial electrical potential (VTEP).
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Figure 1.6: Physiology of electric field generation by tissues
An illustration demonstrating how electrogenic ion transport across epithelial cells
and physical properties of tissues result in the formation of endogenous electric fields.
Three adjacent epithelial cells are shown bound together through tight junctions
(indicated by the green ovals); consequently, distinct apical and basolateral domains
form that segregate different membrane proteins and result in a net inward Na+ current
(see Figure 1.5F for further details). (A) Across the intact epithelium, these tight
junctions prevent paracellular ion diffusion, so the net inward current is sustained. Upon
injury to the epithelium (B), damage to the cells decreases this resistance and allows
Na+ to diffuse down its electrochemical gradient, resulting in a reversal of the current at
the lesion site. (C) During embryogenesis, tight junctions disappear at sites of rapid
tissue growth, so resistance to paracellular ion diffusion decreases and results in large
currents being produced.
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Figure 1.7: Magnitude of electric fields in injured tissues
Epithelial damage short-circuits the trans-epithelial potential and allows Na+ to
diffuse down its electrochemical gradient across the epithelium and out of the tissue.
Within the tissue, large EFs develop between the intact tissue at the margin of the
lesion and the lesion epicenter; the intact tissue becomes the anode of this injuryinduced EF because it sustains its inward-positive TEP, while the lesion site becomes
the cathode because the TEP collapses to 0 mV upon injury. The total charge must be
conserved, so a current loop develops between the wound and the surrounding tissue
such that the total current traveling through the lesion site (IW) must be equal to the total
current traveling through the surrounding healthy tissue (IT) such that ΣIW – ΣIT = 0.
Because the intact tissue has a greater surface area, less current travels through any
individual point of intact tissue than through the wound. Consequently, the EFs are
greatest at the wound, and decrease in magnitude with distance. The relationship
between the relative magnitude of the injury-induced EF within the tissue and the
distance from the lesion epicenter (r) is illustrated by the graph.
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Figure 1.8: Cellular transduction of electric fields by electroosmosis
(A) An illustration of a cell with membrane proteins randomly distributed
throughout its membrane, and a uniform distribution of Na+ and Cl- ions in the
surrounding environment. The exemplar membrane proteins are ligand receptors
responsible for chemotaxis, with receptors mediating a chemoattractive effect (green)
having a relative positive charge while those receptors mediating a chemorepulsive
effect (red) have a relative negative charge. (B) The cell is exposed to an external
electric field, with the anode (+) towards the right side of the cell and the cathode (-)
towards the left of the cell; the lines indicate the orientation of the EF vector, which is
the direction that a freely-diffusible positive charge would move within the electric field.
(C) The external EF interacts with the ions around the cell, creating electrostatic forces
on each ion (the direction of which is indicated by the dashed arrows). As a result of the
electrostatic force created by the external EF, Na+ and Cl- ions redistribute towards the
cathode and anode, respectively (D); this results in an accumulation of anions and
cations at opposite ends of the cell, which, in turn, results in an electrostatic force acting
on the charged membrane receptors (indicated by dashed lines). (E) As a result of the
electrostatic forces between the ions and the membrane proteins, the membrane
proteins undergo lateral diffusion through the membrane to opposite faces of the cell,
resulting in a non-random distribution of these proteins such that chemoattractive
receptors accumulate towards the anodal side of the cell while chemorepulsive
receptors accumulate cathodally. (F) An illustration demonstrating how a stronger
external EF results in a greater redistribution of these membrane proteins. Illustration by
Matthew Baer, using ChemBioDraw v. 13.0.
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Chapter 2: Cortical Astrocytes

Chapter overview
The previous chapter provides a review of CNS injury, establishing that the CNS
in all vertebrates has a latent regenerative potential, and emphasizing the role of
astrocytes and radial glia in determining whether tissue repair occurs through scar
formation or regeneration. In summary, physiologic EFs regulate cellular physiology,
and the magnitude of EFs induced by injury determines whether wound repair occurs
through scar formation or epimorphic regeneration: a 50-100 fold increase is necessary
to stimulate epimorphic regeneration, while a 10-fold increase is associated with scar
formation. A 10-fold EF increase has been found in many mammalian tissues, including
the CNS, and experimentally increasing these EFs has been shown to enhance
regenerative outcomes in peripheral tissues. With this in mind, we hypothesized that the
role of EFs in regulating wound repair and stimulating regeneration is conserved in the
mammalian CNS. Consequently, physiologic EFs should induce a cellular response
characteristic of that seen in vivo, and EFs elevated above those found physiologically
in the mammalian CNS should alter this response to induce a more regenerative
outcome. As the astrocytic response to CNS injury in mammals is crucial in determining
the reparative outcome, we exposed cortical astrocytes to EF intensities associated with
intact and injured mammalian tissues, as well as to those EF intensities measured in
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regenerating non-mammalian vertebrate tissues, to determine whether physiologic EFs
regulate astrocytic behaviors in the intact CNS, stimulate behaviors associated with
their characteristic response to injury, and modify this injury response towards one
associated with regeneration.

(Except for a portion of the methods, a portion of the results, Figure 2.3 and
Figure 2.7, and table 2.1, this chapter is included in a manuscript in submission in: Baer
ML, Henderson SC, Colello RJ. Elucidating the Role of Injury-Induced Electric Fields
(EFs) in Regulating the Astrocytic Response to Injury in the Mammalian Central
Nervous System. PLoS One; Manuscript submitted for publication.)

Introduction
The mammalian central nervous system (CNS) demonstrates limited functional
recovery following traumatic injury, in large part because of the astrocytic response to
the injury35, 60. In contrast, many non-mammalian vertebrates demonstrate a profound
capacity to regenerate their tail64 and spinal cord after amputation88, reconnect their
spinal cord after complete transection63, 93, and even replace large regions of their brain
lost to injury69. Common among both groups of vertebrates, injury to the CNS induces
an astrocytic response that has been well documented and is characterized by
directional migration to the lesion site, by an enhanced rate of proliferation, and by
changes in morphology79, 83, 91, 321, 322. Each of these behaviors occurs in a similar
temporal profile, relative to the onset of the injury, for both phylogenies86, 87. Unique
among regenerating species, astrocytes also form a cellular bridge across the lesion
consisting of highly-aligned bipolar processes that guide sprouting axons past the injury
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site79, 323. The absence of regeneration in mammals, despite the highly conserved
astrocytic behaviors that occur following injury, suggests that all vertebrates use a
conserved stimulus to induce the injury response and that this stimulus does not reach
the threshold necessary to induce regeneration in mammals60. If this is the case, this
stimulus would be an ideal therapeutic target whose modification to recreate the
environment present in regenerating tissues may enhance regeneration in the
mammalian CNS.
One stimulus candidate found within the injury site that may direct astrocyte
behavior is direct-current extracellular electric fields (EFs). EFs are produced by spatial
variations in epithelial cell ion pump activity (see Chapter 1: Cells physiologically
produce and detect bioelectric signals, page 33), which create voltage gradients within
tissues. EFs have been measured in many different vertebrate tissues and have been
shown to directly regulate multiple cellular behaviors227, 324. For example, ionic currents
ranging from 1 to 1000 µA/cm2 have been recorded in intact, injured, and developing
tissues and have been shown to influence cellular migration243, 273, 325, proliferation232,
326, 327

, differentiation245, 328, metabolism312 and process formation237, 239, 294 in a variety

of ectodermally and mesodermally-derived cell types in vitro214, 215. These currents,
which are low in mature tissues and are elevated during development and after injury at
the site of growth or other cellular activity, generate corresponding electric fields that
generally range from 1 to 200 mV/mm and have been reported to be as great as 1800
mV/mm249, 269. During embryogenesis, elevated EFs are necessary for limb
development and neurulation124, 249-252. EFs also increase after injury, and a 50-100-fold
increase is necessary for limb and tail regeneration in non-mammalian vertebrates123,
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274, 279, 329

. Moreover, inhibiting EFs blocks regeneration275, 281, 330, 331, whereas

regeneration can be stimulated in non-regenerating amphibians by experimentally
increasing EFs at the amputation site277, 283, 284, 319, 332-334. Studies have also established
that EF’s are present in the mammalian CNS269, 290, 291. Although EFs have not been
measured in the mammalian CNS in vivo, ex vivo recordings of the mammalian brain
demonstrate that low (3.5-5 mV/mm) EFs are present within the rostral migratory
stream, and that EFs of this magnitude can direct neuroblast migration in vitro269.
Furthermore, slice culture induces approximately a 10-fold increase of these EFs to
31.8 ± 4.5 mV/mm290, and spinal cord injury has been shown to induce a rapid 10-fold
increase in current density ex vivo291. As EFs and current density are proportional to the
resistivity of the tissue335, it is reasonable to assume that injury to the CNS induces a
similar elevation in EF intensity. Together, these studies suggest that the physiologic
EFs produced by the injured CNS may be capable of, and consequently responsible for,
driving the astrocytic response to injury. Moreover, the EF intensities recorded in
regenerating tissues in non-mammalian vertebrates may represent an intensity
threshold that is necessary to induce astrocytic behaviors more favorable for
regeneration in the mammalian CNS.
Previous work from our lab and others has shown that EFs elevated at levels
associated with non-mammalian vertebrates cause mammalian astrocytes to assume a
bipolar morphology and align their processes240, 241, which is consistent with their
demonstrated morphological changes during regeneration in vivo. Furthermore, we
have shown that the processes of these EF-exposed astrocytes are significantly more
permissive to neurite outgrowth240. Similarly, Schwann cells exposed to high EF’s
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produce processes that are more conducive to neurite outgrowth301. However, it is
unclear whether EFs contribute to the astrocytic response in the injured mammalian
CNS. In the current study, we tested the hypothesis that the EFs produced
physiologically by the injured mammalian CNS are sufficient to induce behaviors
associated with the astrocytic injury response. Furthermore, we hypothesized that
increasing these EFs to levels found in regenerating non-mammalian vertebrates would
stimulate a more robust behavioral response, and that only these elevated EFs would
cause morphological changes that are closely associated with regeneration in vivo. Our
findings in this study suggest that injury-induced EFs are an important stimulus for the
astrocytic response to injury, and that EFs may represent a novel target to enhance the
regenerative potential in the mammalian CNS.

Methods

Cell source and culture methods
Rat cortical astrocytes harvested from the cerebral cortex of animals at post-natal
day 2 (P2) were purchased from ScienCell (cat # R1800). Cultures have greater than
99% purity as determined with GFAP immunolabeling by ScienCell; all of the astrocytes
used for these experiments came from the first five passages after the initial thaw.
Astrocyte cultures were maintained according to the protocol recommended by
ScienCell. Briefly, astrocytes were thawed into poly-L- lysine (ScienCell # 0413) coated
T75 culture flasks containing astrocyte media (pH 7.4; ScienCell AM-a 1831)
supplemented with 2% fetal bovine serum (FBS; ScienCell # 0010) and 1%
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penicillin/streptomycin (ScienCell # 0503). Cultures were maintained in a humidified 37
degree Celsius (°C) incubator with a 5% carbon dioxide (CO2) atmosphere, and culture
media was changed every 2-3 days. Once the cultures reached confluence,
approximately 5,000 astrocytes were sub-cultured into each EF chamber (see
description below) for migration, proliferation, and morphology experiments. For
proliferation assays, the nucleotide anologue bromo-deoxyuridine (BrdU; Invitrogen, cat
# 00-0103 diluted 1:100 in astrocyte media) was added to the culture for the last 6 hours
of the electric field exposure. Each experiment was replicated at least three times using
cortical astrocytes derived from different animals (different lot numbers of astrocytes
were purchased from ScienCell), with all cells used in a given experiment being sister
cultures derived from the same passage.

Electric field application and chamber design
Electric field chambers were constructed in a similar manner to those described
by Babona-Filipos et al (2012) and Song et al (2007), with some modifications (Figure
2.1) as described below308, 330. EF chambers were coated with fibronectin (ScienCell #
8248) for 30 minutes, rinsed twice with deionized water, and allowed to dry. For EF
experiments lasting longer than 24 hours, culture media and salt bridges were
completely replaced every 24 hours. Constant-current electric fields were applied to the
cells by connecting the EF chamber to a power supply; the anode and cathode
determine the orientation of the electric field and are indicated in figures as either A/C or
+/-, respectively. The magnitude of the electric fields were calculated according to the
formula 𝐸 =    𝜌𝐼 𝐴, where E is the electric field strength (millivolts per millimeter;
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mV/mm), the resistivity of the media (ρ) was measured as 700 Ohm-millimeters (Ωmm),
and the cross-sectional area of the electric field chamber (A) is calculated in mm2
(Figure 2.1B). EF strength is controlled by specifying the applied current and by
changing the cross-sectional area of the cell culture chamber (by using coverslip
spacers of different thicknesses, or by changing the width of the cell culture chamber).
Two constant current power supplies were used, including Bio-Rad 1000 Power Pack,
and Stoelting Precision Current Source 51413, in order to provide the full range of
currents needed for these experiments. Ammeters in series with the electric field
chambers were used to monitor the value of the applied current throughout the
experiments. The power-packs were connected to Ag/AgCl electrodes (made by
washing silver wire, Alfa Aesar 45852, in an HCl/HNO3 solution for 15 seconds and then
rinsing it in dH2O), which were immersed in 50 mL flasks containing Steinberg Solution;
these were connected to the electric field chambers through salt bridges made from a
2% agarose solution suspended in 2 mL plastic pipets that were bent into a U shape.
EF chambers were constructed using 50 x 7 mm glass-bottom petri dishes (Ted
Pella, #14027) (Figure 2.1). Acid-washed 22 mm x 22 mm - 1.5 coverslips (average
thickness 0.17 mm) were cut into two equal rectangles (11 mm x 22 mm) using a
diamond knife. These coverslips were adhered to the bottom of the petri dish with hot
dental wax to create a 10 mm x 22 mm x 0.17 mm central chamber and then sterilized
under a UV light for at least 30 minutes. 5000 astrocytes were seeded onto these
chambers and allowed to adhere to the dish overnight (at least 16 hours). At the start of
the experiment, a 22x22-1.5 coverslip was used to create a roof for the EF chamber by
using sterilized silicone vacuum grease (Dow corning # 1966898-0712) to seal it to the
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cut coverslip spacers on either side of the cell culture lane. Double-sided tape placed
over the coverslip roof on either end of the lane created wells for additional culture
media; the junction between the double-sided tape and the edges of the petri dish were
made water-tight by sealing the gaps with additional silicone vacuum grease. We
applied an electric field of 0, 4, 40, or 400 mV/mm throughout the entire experiment by
delivering a constant current of either 0, 10, 100, or 1000 µA. It is important that a good
seal is maintained so that the only aqueous connection between the wells on either end
of the culture dish is through the central trough containing the cells; otherwise, the
applied current may leak around the area where the cells are, which would cause the
actual applied electric field to be less than the calculated EF.

Time-lapse imaging
Electric field chambers were placed on a Zeiss AxioObserver Z1 inverted
microscope (Carl Zeiss, Jena Germany) equipped with a fully automated and
programmable Mährhäuser scanning stage, an Axiocam MRm camera, and a stage
incubator system that regulates temperature, O2, and CO2 throughout the experiment.
The cell culture chamber was placed on the stage, heated to 37°C, and the incubation
chamber was maintained with a humidified 5% CO2 environment at 37°C. A 20x 0.8
numerical aperture (NA) Plan-Apochromat objective lens was used to acquire images
with differential interference contrast (DIC) optics every 3 minutes for the duration of the
experiment, and these images were subsequently stitched together into time-lapse
videos. Image acquisition was automated using the Zen Blue (2012, version 1.1.2.0)
software package. We began imaging the first time-lapse video approximately 16 hours
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after the cells were seeded into the EF chambers. Cells were imaged for at least 30
minutes prior to the start of the electric field to establish baseline cellular behavior, and
then for at least 12 hours after electric field onset. As only one dish could be imaged at
a time and each experiment ran for 15 hours, the last group that was imaged had been
growing in the EF chamber for up to 36 hours longer than the first culture had been. To
control for potential sequence effects (i.e. cells changing their responsiveness to EF
exposure as a function of the length of time that has elapsed since they were subcultured into the EF chamber), the order in which the cells were exposed to each of the
EF strengths was varied between experiments. We also directly tested whether the
delay between sub-culturing the cells and beginning the EF exposure had any effect on
the cellular response to the EF by exposing sister cultures to 40 mV/mm for 12 hours
beginning either 16 or 48 hours after sub-culturing into the EF chamber. We found no
evidence to suggest that this delay affected the response to the EF exposure, so data
were pooled across experiments for the analysis.

Optimizing migration analysis
Note: this section was not included in the publication in which the rest of this
chapter was first printed; it was added to the thesis to further explain the rationale for
the experimental design.
We used pilot studies of astrocytes exposed to either 0 or 400 mV/mm to
empirically determine the optimal frequency with which we would measure cell location
to calculate velocity throughout these experiments. The time-lapse videos, which we
described more fully above (page 82), revealed that astrocytes demonstrate a baseline
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degree of movement with random direction in vitro, and that they responded to EF
exposure within minutes (a detailed discussion of how EFs affect astrocyte migration
can be found on page 97). In our initial attempt to measure astrocyte migration, we
sampled cell position once every hour beginning at the time the EF was turned on;
consequently, the first time point for which we could measure speed (as speed is
calculated from a change in position over a certain period of time) was 1 hour after the
start of the experiment and there was already a statistically significant difference
between those astrocytes exposed to 0 mV/mm and those in the 400 mV/mm groups.
We realized that we needed to modify our experimental design and methods of analysis
so that we could demonstrate that the cell populations had the same baseline speed at
the start of the experiment, and so that we could determine just how quickly the
astrocytic response to EF exposure occurs. However, the optimal frequency for
measuring cells is limited by the random measurement error caused by the imprecision
in our tracking. Specifically, each cell is tracked by manually selecting the location
corresponding to the center of its nucleus; this measurement is approximate and, thus,
there is some variability in the location. As cell position is tracked with increasing
frequency, the cells have less time to move so their displacement diminishes, but the
amount of measurement error is constant so the proportion of the calculated cell speed
that is represented by sampling error increases. However, at the other extreme of
insufficient frequency, cells displaying randomly-directed migration may travel along a
much greater path length than their net displacement over the tracking interval would
indicate. Thus, an optimal measuring frequency would optimize the temporal resolution
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of cell tracking while minimizing the proportion of the calculated speed represented by
sampling error.
In order to empirically determine the optimal measurement frequency for cell
tracking, we tracked each astrocytes used in this analysis every 3 minutes over the first
60 minutes of the experiment. We calculated the cell speed from these measured
positions, using the location in every 1, 2, 5, 10, or 20 frames to calculate the cell speed
with a frequency of 3, 6, 15, 30, or 60 minutes, respectively. (Each DIC image in the
time-lapse videos was taken 3 minutes apart.) Because the astrocytes exposed to 400
mV/mm demonstrated an initial change in speed that plateaued within 30 minutes of EF
onset (see Electric fields affect the speed of cortical astrocyte migration, page 97), we
used the calculated cell speed over the last tracking interval (i.e. the last 3, 6, 15, 30, or
60 minutes of the first hour). As the same cell was used to calculate the cell speed for
each of the tracking intervals, and as these cells were tracked over time, the data reflect
a repeated measures design.
We tested the null hypothesis that there would be no significant measurement
error at any of our measuring intervals against the alternative hypothesis that at least
one of our sampling intervals would result in measurement error as measured either by
an change in the standard deviation of the measured speeds or by an increase in the
mean speed measured with a given interval. We used two different statistical
approaches to test the overall hypothesis that certain tracking intervals would result in
measuring error that would significantly affect the measured cell speed. We tested the
null hypothesis that the sampling interval would have no effect on the mean cell speed
against the alternative hypothesis that measurement frequency would cause sampling
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error that would affect mean speed using a standard least squares analysis with a
mixed-effects linear regression model to analyze whether the tracking interval
influenced the measured velocity. The regression equation used for this analysis is:
𝑌!" = 𝛽! + 𝒩(0, 𝜎!! ) + 𝜖!"   
where Yij is the estimated cell speed for each observation (i) at each tracking interval
(j); βj is the coefficient parameter representing the mean value of cell speed at each
tracking interval; 𝒩(0, 𝜎!! ) represents the normal distribution of mean cell speeds for
each cell, which we are using to estimate their variance (σb2) only; and 𝜖!" represents
the error function of each observation (i) around the mean value for each factor level (j),
which is synonymous with the within-groups variance and is also known as the normal
distribution. We also tested the null hypothesis that measurement error does not vary
among the different tracking intervals against the alternative hypothesis that more
frequent measurements would cause an increase in measurement error; this error is
reflected in the standard deviation of the observed cell speeds, and we used normal
quantile plots with 95% confidence intervals to assess whether the studentized
residuals of the model’s predicted values are normally distributed (i.e. the z-score of the
difference between each actual and predicted measurement based on our regression
model). We then compared these residuals between tracking intervals using a Levene
test centered at the sample mean with a threshold of significance of α = 0.05.
We ran separate regression models for cells exposed to 0 and 400 mV/mm
because we were using this study to make inferences about differences in speed as a
function of EF strength. In this model, we treated the tracking interval as an ordinal fixed
variable and each cell was treated as a continuous random variable. The model
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calculates an overall F-statistic for the fixed effect (i.e. the tracking interval) from which it
calculates a p-value for the overall significance of the inferential statistic; the model also
estimates both the cell speed for each tracking interval and the difference in cell speed
between adjacent intervals (e.g. between 3 and 6 minutes, but not between 3 and 15
minutes), and then it calculates a t-score and p-value for each difference. The F-statistic
and parameter estimates in this mixed-model approach correspond to the F-score and
post-hoc tests that are traditionally associated with a 1-way ANOVA and we interpreted
these statistics in the same way (the mixed-effect model has the added statistical
benefit of accounting for the fact that the speed calculated at different tracking intervals
from the same cell would exhibit some degree of dependence). We controlled for type 1
error using α = 0.05 as our threshold of significance for the overall model, and for each
parameter estimate (note, the p-value reported for each parameter estimate is adjusted
for multiple comparisons because the regression model accounts for multiple
comparisons when calculating the individual parameter estimates). We performed
standard regression diagnostics to assess deviations from the model’s assumptions that
would affect the predictive nature of the model (notably, we are using this model for
inferential statistics, but we evaluated the predictive assumptions because we used one
of these assumptions to evaluate effects of measurement error). We calculated the cell
speeds that are predicted by the model (based on the tracking interval), and calculated
the studentized residuals (i.e. the difference between the actual measured velocity and
the measured velocity predicted by the model, normalized such that the predicted value
= 0 and the standard deviation around the predicted value, which is equivalent to the
error, is equal to 1; 𝑡! =    !

!
!!!!!

where ti is the studentized residual, σ and ε represent
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the estimated population parameters of the standard deviation and error function,
respectively, and hii represents the leverage of each residual (the relative weight of each
measurement on the entire model)). We assessed the assumption that the residuals are
normally distributed by plotting the studentized residuals for each tracking interval with a
Normal Quantile Plots (QQ-plots) with a 95% confidence interval (CI); the error function
was determined to be normally distributed if the residuals fell within the 95% CI. We
then tested the hypothesis that the tracking interval would affect the magnitude of the
error by using the Levine test to assess heteroscedasticity (i.e. differences in standard
deviation) among each of the tracking intervals using the actual residual values (not
studentized); we used α = 0.05 as our threshold of significance, so that a p-value < 0.05
indicates that the standard deviation is statistically different among at least one of the
groups. As part of this analysis, we will report the overall F-statistic for the regression
model, the estimated cell speed for each tracking interval (mean ± standard error of the
mean), the parameter coefficients (mean ± standard error of the mean) with their t-score
and p-value, and the F-ratio and p-value for the Levene test; the data are visually
represented using box-plots. The data analysis and graphing were completed using the
packages ggplot2336, reshape337, multcomp338, car339, and nlme340 with the statistical
software R341 to calculate the regression model, evaluate the model assumptions,
calculate the Levene test, and graph the data.

Migration analysis
To analyze astrocyte migration, time-lapse videos were imported into ImageJ and
analyzed using the plugin MTrackJ342. To track each cell, the point corresponding to the
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center of each cell’s nucleus was manually selected in every 5th frame (15 minutes)
throughout the 12-hour experiment; these positions were used to calculate the
magnitude of the velocity (i.e. speed) and the direction of migration at each 15-minute
interval (Figure 2.2). At least 8 fields of view were required for each experiment, and a
minimum of 30 cells were tracked for each time point for each experiment, resulting in
an overall n ≥ 90 cells for each EF strength at each time point once data for all 3
experiments were pooled. All data on cell tracking produced by MTrackJ for the
migration analysis were compiled in Microsoft Excel 2011, saved as comma separated
values files, and then imported into the statistical program R341. All data analysis was
performed using R (including the packages Circular343, Ggplot2336, Pastecs344,
Reshape337, and Multcomp338), with RStudio345. The vector representing each cell’s
velocity was broken down into the speed and direction components, and each
component was analyzed individually. Mean cell speed was compared at each time
point for statistical significance using a 1-way ANOVA with Tukey HSD post-hoc tests,
with an overall threshold for significance at each time point of p = 0.05. The ability of
each EF to induce directional cell movement was assessed at each time point using
Rayleigh’s test, using a p-value = .05 with a Bonferroni correction for the number of
comparisons (196 comparisons: 4 EF levels; 49 time points). For those EF strengths
and time points where there was directional migration we measured the mean direction
of alignment (µ ± SEM), the dispersion of direction about the mean angle with the
concentration parameter (κ), and the circular standard deviation.
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Analysis of EF effects on the orientation of the axis of cell division
To determine whether the EF exposure aligned the axis of cell division, each
mitotic event in the time-lapse live cell videos was identified. The orientation of the axis
of cell division was measured by drawing a line between the centers of each of the
daughter nuclei in the first frame where the two daughter nuclei are distinctly
identifiable. Image analysis was completed using the program Fiji346. The angle of this
line relative to the axis of the electric field was measured. Alignment of the mitotic axis
was determined for each EF strength using a Rayleigh’s test, using p < 0.01 as the
threshold for determining significance (p < 0.01 was chosen as a conservative
adjustment for multiple comparisons based on a nominal p < 0.05 for 4 different
groups). If the sample showed statistically significant alignment, the mean angle,
concentration parameter (κ), and angular standard deviation are reported.

Immunocytochemistry
Cells from each independently-derived population were immunolabeled for
GFAP, vimentin, and nestin to determine the purity and maturational state of the
astrocyte population. For immuno-labeled astrocytes after EF exposure, cells were
rinsed with ice-cold phosphate-buffered saline (PBS) (pH 7.4) and then fixed with 4%
paraformaldehyde in 0.1M PBS for at least 12 hours. Cells were washed 3 times with
PBS, blocked and permeabilized (4% normal goat serum, 0.5% bovine serum albumin,
and 1% Triton X100 in 0.1M PBS) for 30 minutes at 25°C, and then incubated with the
primary antibodies diluted in the blocking solution either for 2 hours at 25°C or overnight
at 4°C. Cells were then washed 3 times with PBS, incubated with fluorescent-tagged
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secondary antibodies (diluted in PBS) for 2 hours, counter-stained with DAPI (NucBlue
Fixed Cell ReadyProbes kit, diluted per manufacturer’s instruction; Molecular Probes #
R37606), and mounted under glass coverslips with Vectashield (Vector Labs # H-1000).
For cells stained for BrdU, an additional acid wash series was used to expose the BrdU
for antibody binding prior to the start of the immunolabeling protocol: cell DNA was
denatured for 10 minutes in 1N HCl on ice, 10 minutes in 2N HCl at 25°C, and 20
minutes in 2N HCl at 37°C, and then neutralized with 0.1M borate buffer for 10 minutes
at 25°C. Primary antibodies used in the immunocytochemistry studies included the
following: mouse IgG1k anti-BrdU (1:1,000; Dako # M0744), polyclonal rabbit anti-GFAP
(1:5,000; Dako # Z0334), polyclonal chicken IgY anti-Vimentin (1:1,000; Millipore #
AB5733), mouse IgG1 anti-Nestin (1:1,000; clone rat-401, Millipore # MAB353).
Secondary antibodies used were Goat IgG anti-rabbit Alexa-488 (Molecular Probes # A11008), Goat IgG anti-chicken IgG Alexa-568 (compatible with chicken IgY primary
antibody; Molecular Probes # A-11041), and Goat IgG anti-mouse Alexa-647 (Molecular
Probes # A-21236). All secondary antibodies were diluted at 1:200. All cells except
those stained for BrdU were counterstained with DAPI NucBlue Fixed Cell Stain
(Molecular Probes, # R37606).

Confocal microscopy
Immuno-labeled cells were imaged by laser-scanning confocal microscopy (LSM710, Zeiss, Jena, Germany) configured around an AxioObserver 21 (inverted) stand
with a motorized XY stage. Image acquisition was performed using the Zen Black
edition (Carl Zeiss, 2011; 64 bit, version 8.1.5.484) software package. 16 bit images
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were acquired with a 20x/0.8 NA plan apochromat objective lens, with a pixel dwell time
of 0.99 µsec and a pixel size of 0.13 µm2. Images were acquired using 4x line
averaging, with simultaneous scanning of the 405 Diode and 633 HeNe lasers, and a
sequential scan for the 488 Argon and 561 DPSS lasers. The 488 laser line was also
used to generate a transmitted light DIC image. At least 5 fields of view (424.84 µm2)
were acquired for each condition (EF strength x time), and each experiment was
repeated at least 3 times. Detector windows for each channel were adjusted to assure
no cross talk between channels as follows: 405 nm (410 – 483 nm), 488 nm (492 – 560
nm), 561 nm (580 – 629 nm), and 633 nm (637 – 735 nm).

Image analysis
Images were imported into Fiji (an ImageJ distribution built for the Life Sciences;
http://fiji.sc/Fiji) 346 for quantifying cellular and nuclear morphology. To assess alignment
of cell processes, gray-scale images of vimentin expression were analyzed using the 2D
Fast Fourier Transform (FFT) algorithm and Oval Profile plugin (authored by Bill
O’Connell, http://rsb.info.nih.gov/ij/plugins/oval-profile.html) as described previously347349

. The 2D FFT produces an image that is the graphical representation of the spatial

frequencies of the original images, which is related to directionality. With the Oval
Profile Plugin, the radial summation of pixel intensities is used to determine whether
these pixels are randomly distributed around the axis (i.e. are unaligned), or show
clustering around a particular orientation (i.e. demonstrate alignment). The pixel
intensities (in arbitrary greyscale units) are normalized for each image by dividing the
value at each angle measure by the minimum radial pixel intensity sum for that image
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and then subtracting 1). Normalized pixel intensities for each angle measure in the oval
profile are averaged across all images acquired from each group, and then those
averaged values were normalized again. A graphical representation of orientation in the
original image is obtained by plotting the summed pixel intensities between 0° and 180°
(the directionality information is axial and does not distinguish between objects pointing
in opposite directions; the data were plotted from 0° to 360° because double-plotting the
data helped aid in visualizing directionality). It should be noted that the FFT image was
first rotated 90° counterclockwise because the results of the FFT yields frequencies
orthogonal to those in the original image. In our experiments, this rotation also defines
the direction of the electric field application along the 0-180° axis (horizontal).

Fluorescence microscopy and proliferation assay
Digital images of BrdU-immunolabeled cells were acquired with a 25x/0.8 NA
Plan-Neofluar objective lens using DIC optics and a GFP filter cube (filter set FS 38HE,
Zeiss, Jena Germany) using a Zeiss Axiovert 200 inverted microscope (Zeiss, Jena
Germany) equipped with a Hamamatsu ORCA ER CCD camera, Colibri LED
illumination unit (blue, green, red), and a white light LED. Image acquisition was
performed using the Zeiss Axiovision (version 4.8.2 sp1) software package. At least 20
fields of view were randomly acquired for each slide, allowing at least 1,000 cells to be
counted for each group. The number of BrdU-positive or negative cells were counted
using the Cell Counter plugin for Fiji (authored by Kurt De Vos,
http://rsb.info.nih.gov/ij/plugins/cell-counter.html). For each time point within each
experiment, we evaluated our hypothesis that EFs induce increased proliferation
93

against the null hypothesis that EFs have no effect on proliferation using a test of
homogeneity of proportions; if a significant effect was detected, we then performed
individual X2 tests between EF strengths to determine which specific groups were
different. Results from individual experiments were used to develop a sense of trends of
how EFs affect proliferation over time. To evaluate the effects that EF exposure has on
proliferation at each time point among all of the experiments, we compiled the
percentage of BrdU-positive cells from each of the individual experiments and
compared these percentages between EF exposures using a Kruskal-Wallis test (using
a threshold of significance of p < 0.05 at each time point) with nonparametric
comparisons between each EF exposure and the 0 mV/mm control at each time point
using the Dunn Method for Joint Ranking.

Statistical analysis
All data analysis and graphing were performed using R (including packages
Ggplot2, Pastecs, Reshape, and Multcomp) 336-338, 341, 344, with RStudio345. Directional
data were evaluated using the Rayleigh test, which tests the research hypothesis of
non-random directionality against a null hypothesis of random directionality based on
the test statistic of the mean resultant vector (R). Circular statistics, including the
circular mean direction (µ), circular standard deviation, and concentration parameter (κ)
were calculated using the R package Circular343. For all experiments, the nominal
threshold for significance was set at *p < 0.05, unless otherwise noted. Unless
otherwise noted, data are reported as mean ± SEM. All figures were prepared using the
ImageJ plugin FigureJ350.
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Results

Characterizing the cortical astrocytic population
The cortical astrocytes (rat primary cultures) used in these experiments were
purified populations (>99%) as verified by the provider (ScienCell), with GFAP
immunolabeling. Immunofluorescence labeling against GFAP, vimentin, and nestin, as
well as morphological characteristics as visualized with DIC microscopy, were used to
evaluate the purity and maturation of these astrocytes before each experiment (Figure
2.4). These cultured astrocytes expressed GFAP at varying levels of intensity, while
vimentin and nestin were more consistently expressed in all cells. Morphologically, the
astrocytes included both bipolar and lamellipodial morphologies. Together, this
confirmed that >99% of the cells were astrocytes at varying degrees of maturation.

Optimizing the migration analysis protocol
Note: this section was not included in the publication in which the rest of this
chapter was first printed; it was added to the thesis to further explain the rationale for
the experimental design.
To determine the optimal interval to track astrocytes for migration measurements,
we measured cell speed with different tracking frequencies (every 3, 6, 15, 30, or 60
minutes), and compared mean speeds measured among each group using a mixedeffects generalized linear regression model. We found that there was a statistically
significant difference among the mean cell speeds measured with each tracking interval
for astrocytes exposed to 0 mV/mm (n = 31 in each tracking interval, F4 = 24.7501, p =
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5.995 x 10-15), and the Tukey-HSD post hoc test demonstrated that there was a steady
increase in the mean speed as the tracking interval increased (summarized in Figure
2.3 and Table 2.1); we found a similar trend towards increasing astrocyte speed
measured as the tracking frequency increased for astrocytes exposed to 400 mV/mm (n
= 44, F4 = 14.7062, p = 2.362 x 10-10). Together, these results demonstrate that
sampling error may affect the accuracy of the estimated mean cell speed. Each
individual post-hoc comparison made with the Tukey-HSD test is reported in Table 2.1;
the estimated differences for each comparison are reported, along with the t-score and
adjusted p-values. The estimated group differences are also graphically demonstrated
in Figure 2.3, where the measured migration speeds are plotted separately for 0 and
400 mV/mm. From this analysis of the means, there is no difference between tracking
intervals of 30 or 60 minutes, but the mean speed begins to increase at intervals of 15
and 6 minutes, and becomes robustly larger in both groups at 3 minutes. In reviewing
the model assumptions, we found that the residuals were normally distributed within
each of the tracking intervals; however, the Levene test demonstrated
heteroscedasticity among the different tracking intervals both with 0 mV/mm (F4 =
4.5879, p = 0.001597) and with 400 mV/mm (F4 = 2.8128, p = 0.02637), thus
suggesting that measurement error significantly affects the precision of the measured
cell speed. We calculated the standard deviation (SD) of the residuals for each tracking
interval and found that there was a steady increase in SD with an interval of 3 minutes
for astrocytes exposed to either 0 or 400 mV/mm, the SD for astrocytes tracked every 6
minutes in 400 mV/mm was slightly above the SDs for 15, 30 and 60 minutes (0
mV/mm: 3 min = 17.782; 6 min = 8.466; 15 min = 7.911; 30 min = 9.071; 60 min =
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7.568. 400 mV/mm: 3 min = 15.570; 6 min = 10.788; 15 min = 10.000; 30 min = 9.109;
60 min = 10.049). Together, these results clearly demonstrate that a tracking interval of
3 minutes is prone to significant error; a 6 minute interval also appeared to have some
error, although it was considerably less than 3 minutes; the lower measured mean and
SD for cells tracked every 15 minutes indicated to us that the effect of measurement
error was adequately controlled with this sampling interval. Thus, we determined that a
tracking interval of every 15 minutes would provide us with the greatest temporal
resolution without creating a significant component of measurement error and we used
this interval for each of the cell migration experiments described hereafter.

Electric fields affect the speed of cortical astrocyte migration
To test our overall hypothesis that electric fields are capable of directing the
astrocytic response to injury, we explored how EF exposure affects each of the
behaviors that astrocytes characteristically display after injury in both mammalian and
non-mammalian vertebrates. The first of these behaviors is migration, as astrocytes
must move towards the lesion as they are recruited to restore BBB integrity and isolate
the lesion environment from the surrounding healthy tissue. To assess the extent to
which EFs influence astrocyte migration, time-lapse DIC live cell microscopy was used
to record the astrocytic response to dcEF exposure over a 12-15 hour period. The
migration of astrocytes following exposure to EF intensities associated with intact (4
mV/mm), injured mammalian (40 mV/mm), and injured non-mammalian vertebrate
tissues (400 mV/mm) were compared to an untreated control (0 mV/mm). No evidence
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of cell death was found during these experiments as a function of either EF exposure or
of phototoxicity from repeated exposure to light.
Time-lapse videos show that, in the absence of any EF, astrocytes displayed
heterogeneous morphologies (bipolar, stellate and lamellipodial) and displayed nondirectional movement. Cells exposed to 4 mV/mm showed similar morphologies but
demonstrated reduced speed as compared to astrocytes cultured in the absence of any
EF. In contrast, time-lapse videos showed that cells exposed to 40 mV/mm or 400
mV/mm responded rapidly to the EF exposure, with the entire cell population migrating
towards the anode of the EF within the first hour of the EF exposure.
To qualitatively evaluate the EF-induced effect on migration, the paths of
migration over the first six hours of EF exposure were plotted for individual astrocytes;
the starting position was normalized to the origin of the graph (0, 0), and the direction
was displayed relative to the orientation of the EF (Figure 2.5). An analysis of the mean
speeds for astrocytes exposed to each of the EF intensities showed that the mean
speed of cells in the control group (0 mV/mm) did not change over time (data not
shown), and that there were different effects on speed for each of the EF exposures
(Figure 2.6A). Differences in cell speeds were compared among all EF exposure groups
at each time point using a 1-factor ANOVA with a Tukey-HSD post-hoc test (Figure 2.6B
graphs this analysis for cells at the start of the experiment, and after 30 minutes and 4
hours of EF exposure). We found that the mean cell speed was equivalent among all
groups prior to the EF onset (0 mV/mm: 13.4 µm/hr; 4 mV/mm: 14.3 µm/hr; 40 mV/mm:
16.5 µm/hr; 400 mV/mm: 14.9 µm/hr; 1-factor ANOVA: p = 0.20) (Figure 2.6B, left
panel). However, astrocytes exposed to 40 and 400 mV/mm displayed a rapid increase
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in migration speed within 30 minutes of EF exposure as compared to astrocytes
exposed to 0 or 4 mV/mm (mean speed: 0 mV/mm: 12.7 µm/hr; 4 mV/mm: 14.9 µm/hr;
40 mV/mm: 22.3 µm/hr; 400 mV/mm: 21.5 µm/hr; 1-factor ANOVA: p = 1.1 x 10-6;
Figure 2.6B, middle panel). Interestingly, astrocytes exposed to 40 mV/mm sustained
this increased speed for only one hour and returned to the baseline speed 1.75 hours
after the EF onset. Similarly, astrocytes exposed to 400 mV/mm initially increased their
migrational speed to that observed for astrocytes exposed to 40 mV/mm, but this initially
robust increase in speed was sustained for over 4 hours, after which time it returned
towards baseline while maintaining an increased speed that hovered between
significant and a non-significant trend. Cells exposed to 4 mV/mm did not show an initial
change in migration speed upon EF exposure, but the mean speed decreased relative
to cells exposed to 0 mV/mm beginning 3.5 hours after the EF onset and persisting for
the remainder of the experiment. Thus, EF strengths comparable to those present in
intact tissue induced cortical astrocytes to decrease their speed, whereas EFs
intensities comparable to those present in injured mammalian tissue initiated a rapid
increased speed of migration by these cells. This migrational response was more
pronounced and sustained in astrocytes exposed to EF intensities associated with
regenerating tissues in non-mammalian vertebrates.
As the migrational assays were done sequentially, it was necessary to assess
whether the time interval between when the cells were sub-cultured in the EF chamber
and when EF exposure began had any effect on the cellular responsiveness to the
electric field. Consequently, sister cultures were exposed to 40 mV/mm for 12 hours,
beginning either 16 or 48 hours after the cells were sub-cultured into the EF chamber,
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and migration speed was assessed. No difference in the mean migration speed
between these groups was found (Figure 2.7), indicating that the sequence in which
groups were exposed to each EF within an experiment does not serve as a confounding
variable in these study.

Electric fields are a directional cue for cortical astrocyte migration
Having demonstrated that EF exposure alters cell speed in an intensity- and
time-dependent manner, we assessed the extent to which EFs also serve as an
orientational cue by causing directional migration. Directionality was assessed for each
EF intensity at each time point using Rayleigh’s test (which tests the hypothesis of a
non-random direction about a circle against the null hypothesis of a random direction),
using an overall p-value = 0.05 with a Bonferroni correction for the total number of factor
levels analyzed (196 comparisons: 4 EF levels at each of 49 time points). No directional
migration was detected by astrocytes exposed to EF intensities of either 0 or 4 mV/mm.
Interestingly, astrocytes displayed anodally-directed migration after 1.5 hours of
exposure to 40 mV/mm, while this same anodally-directed migrational response only
took 30 minutes to emerge for astrocytes exposed to 400 mV/mm (Figure 2.8). Once it
emerged, directional migration continued throughout the remainder of the recording
period. Moreover, cells exposed to 400 mV/mm moved with greater precision towards
the anode as compared to astrocytes exposed to 40 mV/mm, which displayed a greater
migrational dispersion. This was evident by a smaller circular standard deviation, and a
larger concentration parameter (κ) of directional migration (data not shown).
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As EFs rapidly induced directional migration by cortical astrocytes, we next set
out to determine whether the cells remained sensitive to changes in the extracellular EF
orientation. This was tested by exposing cells to 400 mV/mm for 6 hours, and then
reversing the polarity of the EF exposure for another 6 hours (Figure 2.8, right panel).
We found that, upon reversing the direction of the EF, cells stop moving towards the
position that used to be the anode within 15 minutes, and reestablished directional
migration towards the new anode position within 2 hours. This 2-hour loss of
directionality occurred while the cells were reorienting to the new direction of the
imposed EF, during which time half of the population turned left and the other half
turned right (as indicated by the phase-shift in the directionality data, Figure 2.8).
Together, these results indicate that the cells are capable of detecting the external EF
and move towards the anode, with the strength of the EF affecting the directionality and
speed of migration. As the lesion site within the CNS becomes the anode of the injuryinduced EF (see discussion in Chapter 1, page 48), EFs may be contributing towards
astrocyte migration towards the lesion site in vivo.

Electric fields induce cortical astrocyte proliferation
After an injury, astrocytes around the lesion site proliferate with a well-described
time course that begins within 24 hours of the injury, peaks after 48 hours, and begins
to decline by 72 hours86. This newly-proliferating population helps reestablish the
damaged BBB, and serves to replenish some of the cells lost to injury. We tested the
hypothesis that EFs associated with injured tissues (40, 400 mV/mm) may actually drive
this proliferative response. Specifically, astrocytes were exposed to an EF of either 0, 4,
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40, or 400 mV/mm for either 12, 24, 48, or 72 hours to determine whether EFs can
induce astrocyte proliferation, and whether this effect mirrors the temporal profile of the
proliferative response of astrocytes following injury in vivo. BrdU was added to the
culture media for the last 6 hours of the EF exposure, and proliferating cells were
identified using BrdU immunocytochemistry (Figure 2.9A-D). Cells were counted as
either BrdU-positive or negative, and the percentage of BrdU-labeled cells was
calculated for each group (16 groups: 4 EF strengths x 4 time points) within each
experiment (Figure 2.9E). At all 4 time points, 5-10% of cells exposed to 0 mV/mm were
BrdU-positive, and there was no statistically significant difference in BrdU labeling of
these cells over time (X23 = 6.68, p = 0.828). This was also the case for cells exposed to
4 mV/mm where, at each time point, 5-10% of cells were BrdU-positive. Likewise,
astrocytes exposed to either 40 or 400 mV/mm did not display changes in proliferation
after 12 hours of exposure. This persisted for 24 hours of exposure, when a nonsignificant trend towards increased proliferation began to emerge (X23 = 4.4643, p =
0.2155). This trend towards increased proliferation for astrocytes exposed to 40 and
400 mV/mm is non-significant likely because there was a robust increase in proliferation
only in a subset of the experimental groups exposed to 40 and 400 mV/mm for 24 hours
and the non-parametric statistical test used for these comparisons was too conservative
to detect a difference given the relatively small sample size that we had; however, this
suggests that EFs-induced proliferation begins to emerge as early as 24 hours, but that
the effect does not fully emerge until a slightly later time point. By 48 hours of exposure
to either 40 or 400 mV/mm EF, there was a statistically significant effect on proliferation
(X23 = 13.5526, p = 0.0036), with a significant increase in astrocytes exposed to 40
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mV/mm (p = 0.0088) and 400 mV/mm (p = 0.0481) relative to 0 mV/mm. This
proliferative effect persisted through 72 hours of EF exposure, but only for cells exposed
to 400 mV/mm (p = 0.0386); proliferation in cells exposed to 40 mV/mm had returned to
baseline (p = 0.1452) within this period of time. Thus, EFs are capable of stimulating
proliferation by astrocytes in an intensity- and time-dependent manner. The timedependent manner in which astrocyte proliferation is affected mirrors that observed for
astrocytes at sites of injury to the CNS. Moreover, only an EF intensity of 400 mV/mm
maintained significant astrocyte proliferation through the 72-hour exposure period,
suggesting that this EF intensity is most effective at facilitating cell replacement
following injury.
One additional observation that was apparent in the time-lapse videos of
astrocyte cultures exposed to 400 mV/mm EF is that the axis of division was related to
the orientation of the electric field vector. As the orientation of division is known to
influence cellular activity351, we set out to determine the extent to which EF exposure
influences the axis of division in mammalian astrocytes. Using the DIC time-lapse
videos, mitotic cells were identified and the angle of the axis of division was measured
relative to the EF vector by drawing a line between the two daughter nuclei in the first
frame where they became distinctly visible (Figure 2.10A-D). The distribution of these
axes relative to the EF vector are plotted for each EF strength (Figure 2.10E), with the
axial data double-plotted on the x-axis relative to the anode (A) and cathode (C) to
assist in visualizing the clustering of mitotic events perpendicularly to the EF vector.
Using the Rayleigh test for alignment, we found that EF exposure aligned the axis of cell
division for cells exposed to 400 mV/mm (n = 124, R = 0.3740, p = 2.93 x 10-8), with a
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mean direction µ ± SEM = 82.1 ± 3.53°, κ = 2.71, and SD = 39.7° (the EF axis runs from
0° to 180°; 90° is perpendicular to the EF vector). We found that there was no significant
alignment for cells exposed to 0 mV/mm (n = 176, R = 0.1127, p = 0.1071), 4 mV/mm (n
= 186, R = 0.1071, p = 0.1183), or 40 mV/mm (n = 260, R = 0.0437, p = 0.6092).

Electric fields alter cortical astrocyte morphology
Having shown that EFs can control behaviors that are necessary for the initial
astrocytic recruitment to the injury response, we tested the hypothesis that EFs can also
regulate the hypertrophic and morphologic changes characteristic of the astrocytic
response to injury in non-regenerating and regenerating animals, respectively.
Following an injury, astrocytes in non-regenerating animals characteristically upregulate the expression of the intermediate filament GFAP, relative to the intermediate
filaments vimentin and nestin, while astrocytes in regenerating animals do not undergo
this hypertrophic change. As this response generally emerges only after several days,
we exposed astrocytes to 0, 4, 40, or 400 mV/mm for 72 hours, and then used
immunofluorescence labeling for GFAP, vimentin, and nestin to determine whether EFs
affect hypertrophy (Figure 2.11A-L). We found that astrocytes exposed to 4 mV/mm,
which is an EF intensity associated with uninjured tissues, expressed low levels of
GFAP, with greater intensity of both vimentin and nestin. However, astrocytes exposed
to 40 mV/mm displayed elevated levels of both GFAP and vimentin, suggesting that
EFs associated with injured mammalian tissues caused robust hypertrophy.
Interestingly, we found that GFAP and vimentin expression in astrocytes exposed to
400 mV/mm were unchanged compared to that observed for astrocytes exposed to 4
104

mV/mm. Thus, EFs associated with injured mammalian tissues are sufficient to induce a
hypertrophic response characteristic of reactive gliosis, while those associated with
regeneration induce no such change.
Having found that EF strengths associated with non-regenerating tissues induce
cytoskeletal hypertrophy of astrocytes, we next set out to determine whether EFs
associated with regeneration induce morphological changes in astrocytes consistent
with their regenerative phenotype in vivo. Our group and others have shown that
astrocytes align their processes perpendicularly to a 500 mV/mm applied EF within 24
hours while 10 mV/mm has no effect, and we have previously shown that these EFaligned astrocytes enhance the extent of neurite outgrowth compared to unaligned 0
mV/mm controls240, 241. Our time-lapse videos from the migration studies indicate that
EF exposure to 400 mV/mm induces astrocytes to transform into a bipolar morphology
and to align their processes within the first 12 hours of EF exposure. In the current
study, we exposed astrocytes to 0, 4, 40, or 400 mV/mm for either 12 or 72 hours and
performed FFT analysis for alignment on vimentin immunolabeled images to determine
how quickly alignment occurs, whether this alignment is consistent over time, and
whether physiologic EFs found at the injury site in mammals affect process alignment
(Figure 2.11M-O). Astrocytes exposed to either 4 or 40 mV/mm EF showed no change
in their morphology at either 12 or 24 hours of exposure. However, astrocytes exposed
to 400 mV/mm showed a robust alignment of their processes perpendicular to the EF
orientation within 12 hours (not shown), and this alignment persisted through the 72
hour EF exposure. These results confirmed that only EF intensities associated with
injury in regenerating vertebrates induce dramatic changes in astrocyte morphology that
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mirror those demonstrated by astrocytes within the injury site of regenerating animals
following trauma.

Discussion
Studies that have aimed to elucidate signals for regeneration in non-mammalian
vertebrates have demonstrated that the intensity of injury-induced electric fields (EFs),
which are 50-100 fold greater than in uninjured tissues, represent a potent signal to
drive tissue repair215, 222, 227, 329, 331, 352, 353. In contrast, in many mammalian tissues
where limited regeneration occurs, injury-induced EFs are much lower in their intensity.
Interestingly, when an exogenous EF is applied to injured mammalian skin or cornea, a
more robust reparative response occurs123, 326, 334. Studies have shown that the
mammalian CNS also produces EFs269, 290 that increase in their intensity upon injury291,
so it is reasonable to assume the EFs could present an important signal to drive CNS
repair. As the astrocytic response to CNS injury is crucial to its reparative outcome, we
evaluated how astrocytes respond to three different EF exposures within the ranges
previously recorded in intact tissues (4 mV/mm) 256, 269, injured mammalian tissues (40
mV/mm) 267, 326, and highly regenerating non-mammalian vertebrate tissues (400
mV/mm) 270, 279, 280, 354, 355. At the lowest EF strength, astrocytes displayed little change
in their behavior. However, mammalian astrocytes rapidly responded to elevated EFs by
displaying robust and sustained directional migration. The directionality and speed of
this migration were dependent on the polarity and intensity of the EF, respectively.
Astrocytes also displayed a robust proliferative response upon prolonged EF exposure.
Interestingly, only EFs associated with regeneration induced morphological changes in
astrocytes that mirror those that facilitate regeneration in non-mammalian vertebrates79.
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Moreover, each of these astrocytic responses, which are necessary for CNS repair,
developed along the same time line as has been reported following an injury in vivo33, 54,
64, 79, 86, 321, 322

. These novel findings suggest that injury-induced EFs are capable of, and

may be responsible for, driving the astrocytic response at CNS injury sites, and that
manipulating EF intensity may represent a therapeutic option to promote CNS
regeneration.
The apparent role of EFs in regulating CNS regeneration is consistent with
evidence that EFs regulate regeneration in a range of non-mammalian vertebrate
tissues and structures, including skin356, 357, bone358, cornea359, lens259, 360, spinal
cord354, tail265, 276, and limb270, 274, 275, 278, 361. Injury to these tissues produces a
substantial increase in EF intensity, and these EFs remain elevated until regeneration is
complete. Furthermore, studies manipulating only the injury-induced electric field have
shown that EFs are both necessary and sufficient to drive regeneration. Specifically,
reducing or blocking EFs can attenuate or completely inhibit regeneration280, 281,
whereas increasing EF intensities can promote regeneration277, 333. Regeneration is not
ubiquitous among non-mammalian vertebrates: Anuran amphibians regenerate their
tails when they are tadpoles but they lose this ability as they progress through
metamorphosis, during which time there is a concomitant decrease in the intensity of
their injury-induced EFs276, 278. However, experimentally increasing EFs at amputation
sites in the adult frog induces regeneration147, 333. Injury-induced EFs have also been
measured in mammalian tissues, including skin256, 257, 271, 272, 362, cornea267, 268, 326,
lens363, and bone258, 364-366. In mammals, injury-induced EFs are consistently lower than
that found in regenerating vertebrates, and experimentally increasing their intensity also
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promotes regeneration in these tissues283, 284, 334, 367. Recent studies have also
established that EFs are present in the mammalian CNS. Although EFs have not been
measured in the mammalian CNS in vivo, ex vivo recordings of the mammalian brain
demonstrate that low (3.5-5 mV/mm) EFs are present within the rostral migratory
stream, and EFs of this magnitude can direct neuroblast migration in vitro269.
Furthermore, slice culture induces a 10-fold increase in these EFs to 31.8 ± 4.5
mV/mm290, and spinal cord injury has been shown to induce a rapid 10-fold increase in
current density ex vivo291. As EFs and current density are proportional to the resistivity
of the tissue, it is likely that injury to the CNS induces a similar elevation in EF intensity.
Collectively, these studies suggest that, in a variety of tissues in both non-mammalian
and mammalian vertebrates, the magnitude of injury-induced changes in electric fields
represent a crucial determinant to that tissue’s regenerative potential.
Within the vertebrate CNS, the extent of regeneration is largely determined by
the astrocytic response to injury60. Common to all vertebrates studied, astrocytes
quickly migrate towards the lesion site and begin to proliferate64, 79, 84, 321, 368. This
migration and expansion of the astrocytic population is necessary to re-establish the
BBB and to prevent the lesion from enlarging into the surrounding healthy tissue32, 54, 83.
In mammals, astrocytes have been shown to hypertrophy91 following injury and release
molecules that inhibit axon sprouting and limit regeneration35, 50. In contrast, astrocytes
facilitate axon regeneration in non-mammalian vertebrates by assuming a bipolar
morphology and creating a cellular bridge that guides sprouting axons across the lesion
site79. These similarities and differences in astrocyte behavior among vertebrates
suggests that a common signal may initiate these behaviors, but that the signal does
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not reach the threshold in injured mammals to induce the astrocytic behaviors
necessary for robust regeneration. Thus, modifying the mammalian astrocytic response
towards that seen in successfully regenerating animals may improve regeneration in
mammals.
As EFs have been shown to influence the repair of a variety of tissues through
their action on cells within these tissues123, 238, 353, it is reasonable to assume that EFs
could also affect astrocytic behavior to induce a regenerative response in neural tissue.
Our results are consistent with this notion: we found that EFs induce dramatic changes
in astrocyte migration and proliferation, and that these effects are enhanced with
increasing EF intensities. Indeed, astrocytes display rapid and sustained anodallydirected migration during EF exposure at both 40 and 400 mV/mm, and migration
induced by a 400 mV/mm exposure has a significantly greater speed and a more
precise directionality than that induced by 40 mV/mm. Previous literature suggests that
the injury site in the mammalian cortex would become the anode of the injury-induced
EF269 (see discussion in chapter one, page 48). Thus, our results that EFs induce
anodal migration are consistent with the hypothesis that EFs contribute to astrocyte
migration towards the lesion site in vivo. Interestingly, our observations that astrocytes
exposed to 4 mV/mm decrease their speed relative to cells not exposed to an EF
suggest that EFs associated with intact tissues may represent a signal that astrocytes
use to maintain their stability in vivo, as astrocytes in intact tissues are thought to
remain relatively stationary within defined domains91.
Just as astrocytes proliferate beginning two days after injury in both mammalian
and non-mammalian vertebrates in vivo, we found that both 40 mV/mm and 400
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mV/mm induce astrocyte proliferation in vitro that begins to increase after 24 hours of
exposure and peaks at 48 hours. While 40 mV/mm and 400 mV/mm induce a similar
degree of proliferation, proliferation is sustained for at least 72 hours with 400 mV/mm
exposure but decreases towards baseline during this time frame in the 40 mV/mm
exposures. This mirrors observations showing that proliferation among mammalian
astrocytes peaks two days after injury and then decreases, while proliferation among
astrocytes in regenerating non-mammalian vertebrates increases two days after injury
and remains elevated for many more days. Lastly, astrocytes maintain a more
heterogeneous morphology at lower field intensity exposures and, consistent with
previous work from our lab and others240, 241, they uniformly transform to a bipolar
morphology only when exposed to 400 mV/mm. Interestingly, we found that these
morphological changes were independent of intermediate filament expression.
Specifically, our immunolabeling suggested that 400 mV/mm did not induce changes in
GFAP, vimentin, or nestin expression, while 40 mV/mm induced an increase in GFAP
and vimentin expression that is consistent with a reactive astrocytic phenotype in
mammals. These differences in astrocyte behavior and morphology induced by 40
mV/mm and 400 mV/mm mirror the differences in astrocyte behavior following injury in
non-regenerating and regenerating vertebrates in vivo. This suggests that physiologic
EFs may direct the astrocytic response to injury in mammals, and that therapeutically
enhancing these EFs to levels found in non-mammalian vertebrates may induce an
astrocytic response that is more favorable to regeneration. Indeed, we have previously
shown that astrocytes exposed to high EF strengths generate processes that are more
permissive to neurite growth than those generated at low field strength exposures240.
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Taken together, these findings suggest that EFs are capable of controlling a number of
astrocytic behaviors that are necessary for the injury response in mammals and
regeneration in non-mammalian vertebrates. Moreover, the degree of regenerative
potential of astrocytes is a function of the EF strengths to which they are exposed.
The pronounced effects that EFs have on astrocytic behavior are likely a
consequence of nonspecific interactions with charged membrane proteins in a variety of
physiological pathways222, 369, 370. The EF vector encodes both direction and intensity,
each of which can be transduced independently. Although the mechanisms by which
astrocytes transduce EFs have not been explored, research from other cell types
suggests directional migration is a function of electroosmosis, through which external
EFs drive non-anchored membrane receptors to accumulate at opposite ends of the cell
(Figure 1.8) 221, 223, 232, 309, 371-373. The degree of membrane receptor clustering is
proportional to the EF intensity, which is consistent with the increased precision of
astrocyte migration we observed at the highest EFs tested. EF intensity may be
transduced by astrocytes by creating a voltage drop across the cell that affects the cell
membrane potential and causes ion channels to open335, 374. Interestingly, changes in
membrane potential are involved in inducing tail regeneration in the Xenopus tadpole,
which requires the voltage-gated sodium channel NaV1.2147. Regeneration is lost during
metamorphosis when NaV1.2 expression declines, whereas transfecting human NaV1.5
into these maturing tadpoles reestablishes regeneration. In Xenopus, increased
intracellular sodium through NaV’s induces regeneration through several pathways,
including Notch. Mammalian astrocytes also express the voltage-gated sodium channel
NaV1.5, which stimulates both migration and proliferation after injury by increasing
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intracellular calcium (Ca2+) through a Na+/Ca2+ exchanger375. Interestingly, in nonmammalian vertebrates, proliferating astrocytes are capable of producing neurons,
thereby having an essential role in neurogenesis88. Mammalian astrocytes also have a
capacity for neurogenesis, which is regulated by Notch signaling103, 376. Higher EFs may
promote regeneration by inducing a neurogenic program in astrocytes through
regulating Notch signaling, while the lower EFs generated in the injured mammalian
CNS may not sufficiently activate NaV1.5 to regulate Notch-mediated neurogenesis in
vivo. Taken together, these studies demonstrate that multiple physiologic pathways are
involved in transducing the EF signal to drive the cellular response to injury through
affecting migration, proliferation and morphology.
We have shown that electric fields within the physiologic ranges reported in
injured mammalian tissues, and in regenerating non-mammalian vertebrate tissues, are
able to elicit multiple behaviors in astrocytes that are necessary for their normal
response to injury. Furthermore, the difference in responses induced by 40 mV/mm and
400 mV/mm closely correspond to the differences between astrocytic behaviors in the
injured mammalian CNS and those in the regenerating non-mammalian vertebrate
CNS. Assuming that our results reflect the signaling environment in vivo, this suggests
that electric fields, which are induced immediately upon injury and remain elevated
throughout wound healing, may represent an important astrocyte response signal to
drive tissue repair. As specific astrocytic behaviors are induced by specific EF
strengths, and as behaviors associated with regeneration are induced only at EF
strengths greater than those reported in injured mammalian tissues, regeneration in the
mammalian CNS may be improved by therapeutically supplementing the physiological
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EFs produced at the injury site. Indeed, EF based therapy has been used successfully
to enhance bone reunion following fractures in humans in clinical practice using an
inexpensive, non-invasive application377-379. Together, this suggests that therapeuticallyapplied EFs are a strong therapeutic candidate to promote regeneration in the
mammalian CNS by inducing an astrocytic response more favorable to regeneration.
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Figure 2.1: Electric field chamber
(A) An illustration of the electric field chamber, showing how it is connected to the
circuit that creates the electric field. Wells for cell culture media are created using
double-sided tape on either end of the cell culture chamber; vacuum grease is used to
prevent any media from leaking around these barriers. Salt bridges (2% agarose in
astrocyte media) connect the EF chamber to Ag/AgCl electrodes immersed in a
Steinberg electrolyte solution. The power supply drives a redox reaction at each of the
electrodes, converting the electrical current into an ionic current through the electric field
chamber with cations moving towards the cathode (negatively-charged electrode) and
anions moving towards the anode (positively-charged electrode). (B) Enlarged view of
the electric field chamber, illustrating how specific EFs are calculated and applied. The
EF chamber is made by sealing glass coverslip spacers to the bottom of the culture
chamber with dental wax. The lane between the coverslip spacers is coated with
fibronectin, and then astrocytes are seeded onto the lane. At the start of the experiment,
a glass coverslip is sealed on top of the spacers with a thin bead of silicone vacuum
grease to create a roof. EF magnitude is calculated with the formula E = ρI/A, where ρ is
the resistivity of the media (700 Ωmm), I is the applied current, and A is the crosssectional area of the EF chamber. The cross-sectional area (A) of the EF chamber is
determined based on the thickness of the coverslip spacers (h), and the distance
between the spacers (w). Varying the width between the coverslip spacers and the
magnitude of the applied currents creates different EF strengths. (Note, Figure 2.1(A)
was illustrated by Christina Delli Santi.)
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Figure 2.1: Electric field chamber
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Figure 2.2: Methods to analyze cell migration
(A) A point in the center of each cell’s nucleus (gold arrow) is manually selected
every 5 frames (15 minutes). (B) The change in position is used to calculate the speed
(magnitude, r) and direction (θ) of migration relative to the anode and cathode at each
time point. In the example in panel B, the velocity vector measured at the 6 hour timepoint corresponds to the cell’s measured displacement and direction over the previous
15 minute interval. (C) The direction of cell migration relative to the anode and cathode
is double-plotted over time. Starting at 0°, which is indicated by the gold line segment in
(B) corresponding to the radius extending to (1, 0) on the unit circle, angle measures
increase counterclockwise such that 90° corresponds to the anode, 270° corresponds to
the cathode, 450° corresponds to the anode, and 630° corresponds to the cathode. On
the directionality double-plots (C, D), the direction relative to the anode and cathode is
plotted along the x-axis, and time is plotted along the y-axis beginning at 0:00 hours
(when the EF is turned on), and increasing in 15-minute increments over 12 hours. For
the example of cell velocity measured in (B), the cell is traveling at approximately 120° 6
hours after the start of the EF. In the sample directionality double-plot (C), this data
point is plotted along the line corresponding to the 6-hour mark both at 120° and at
480°. This double-plotting helps visualize the directionality of the data. (D) A
directionality double-plot of the full data set for cells exposed to 0 mV/mm. The uniform
distribution of cell directions visually indicates the lack of directional migration for these
cells. (Panel D corresponds to part of the same data that is displayed in Figure 2.8.)
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Figure 2.3: Optimizing the measuring interval for cell tracking
Astrocytes were exposed to either 0 or 400 mV/mm and a 20x DIC image was
acquired once ever 3 minutes for 1 hour. Individual cells were tracked by manually
selecting the position corresponding to the center of their nucleus in every frame. By
selecting sub-sets of these tracking positions, the cell speed was calculated every 3, 6,
15, 30, or 60 minutes throughout the first hour of EF exposure. We used a mixed-effects
generalized linear regression model to test the hypothesis that the sampling interval
used to track cells affected the measured cell speed by increasing the proportion of the
measured cell displacement due to random error in manual tracking. Astrocytes
exposed 0 and 400 mV/mm were analyzed separately, and box-plots summarizing the
spread of data for cells tracked every 3, 6, 15, 30, or 60 minutes are shown. The box
spans the middle two quartiles, and the central bar indicates the mean. We found that
there was a statistically significant difference in the mean speed measured among the
different tracking intervals (0 mV/mm: F4 = 4.5879, p = 0.001597; 400 mV/mm: F4 =
2.8128, p = 0.02637). We used a Tukey-HSD post-hoc test to make individual
comparisons between groups, and the results are indicated above the graphs. The
letters above each graph indicate the statistically significant differences between the
groups; groups are statistically significant (i.e. p < 0.05) if they do not share a letter.
Note: statistically significant differences exist between groups that do not share a
common letter (for a table detailing these data, see Table 2.1).
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Figure 2.3: Optimizing the measuring interval for cell tracking
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Figure 2.4: Characterizing the astrocyte population
Representative confocal images used to characterize the astrocyte population
based on immunolabeling. (A) GFAP, (B) vimentin, (C) nestin, and (D) an overlay show
that the population is morphologically heterogeneous, consisting of both lamellipodial
and process-bearing cells. The cells universally express all three markers, with the
relative levels varying among the different cells, suggesting that our population includes
astrocytes of varying degrees of maturation. Scale bar = 20 µm.
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Figure 2.4: Characterizing the astrocyte population
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Figure 2.5: Paths of astrocyte migration over the first 6 hours of EF exposure
To qualitatively evaluate the EF-induced effect on migration, the paths of
migration over the first six hours of EF exposure were plotted for individual astrocytes;
the starting position was normalized to the origin of the graph (0, 0), and the direction
was displayed relative to the orientation of the EF with the cathode (+) at the top of the
graph and the anode (-) at the bottom of the graph. 30 cells from each EF strength were
randomly selected to be included in this plot (including more than 30 cells makes it
difficult to discern individual tracks). X- and Y-units for the graph are in micrometers.
These graphs demonstrate the different effects that each EF strength have on
directional migration.

122

Figure 2.5: Paths of astrocyte migration over the first 6 hours of EF exposure
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Figure 2.6: Electric field exposure affects cortical astrocyte migration speed
(A) Astrocyte migration speed is plotted every 15 minutes for 12 hours. Within 30
minutes of EF onset, cells exposed to both 40 and 400 mV/mm show a similarly rapid
increase in mean speed. For cells exposed to 40 mV/mm, this is maintained for only the
first 2 hours and then returns to the same speed as 0 mV/mm, while this is maintained
in the group exposed to 400 mV/mm for over 4 hours. Initially, there is no effect on cells
exposed to 4 mV/mm, but the mean speed begins to decrease after 3 hours. (B) Effects
of EF exposure on speed were assessed at each time point. 3 representative time
points are shown corresponding to the start of the experiment (0 hours), and 30 minutes
and 4 hours after EF onset. Mean speed was compared between EF strengths at each
time point with a 1-factor ANOVA followed by a Tukey-HSD post hoc test. There was no
difference in mean speed between groups at the start of the experiment (F(3, 471) = 1.54,
p = 0.20). There was a significant effect of EF exposure at both 30 minutes (F(3, 474) =
10.5, p = 1.1 x 10-6) and 4 hours (F(3, 483) = 11.8, p = 1.8 x 10-7). The mean speed of
cells exposed to 0 mV/mm did not significantly change over time. All data are expressed
as mean ± SEM. #p = 0.0509; *p < 0.05; **p < 0.01; ***p < 0.001.
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Figure 2.6: Electric field exposure affects cortical astrocyte migration speed
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Figure 2.7: Assessing sequence effects on migration
Sister cultures of astrocytes were used to test whether the delay between subculturing astrocytes in the EF chamber and beginning the EF exposure affected the
astrocytes’ migrational response to EFs. To test this, sister cultures were exposed to 40
mV/mm for 12 hours, with the EF exposure beginning either 16 or 48 hours after cells
were sub-cultured (corresponding to (1) and (2) indicated in the legend, respectively).
Migrational speed for astrocytes in these groups is plotted every 15 minutes as mean ±
SEM. The same pattern of change in migrational speed over time was observed for both
groups: speed increased transiently over the first hour and returned to baseline after the
second hour. This demonstrates that there is not a robust sequence effect on these
experiments.
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Figure 2.7: Assessing sequence effects on migration
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Figure 2.8: Electric fields induce directional migration
Astrocytes preferentially migrate towards the anode of an applied electric field of
40 or 400mV/mm. The direction of migration was measured for each cell every 15
minutes over 12 hours relative to the anode (A, indicated in red) and cathode (C,
indicated in blue) of the applied EF and plotted, with each dot representing the direction
of migration of a single cell at each time point. The x-axis is double-plotted for each field
strength to help visualize the directionality (see Figure 2.2 for a description of how these
plots are generated). The random direction of cell movement in 0 and 4 mV/mm is
visually displayed by the even distribution of data points along the x-axis. Directional
migration towards the anode emerges in cells exposed to 40mV/mm after 1.5 hours.
400 mV/mm induces anodally-directed migration after 30 minutes, which is more
concentrated (greater concentration parameter, κ) towards the anode than it is for cells
exposed to 40 mV/mm. If the polarity of the 400 mV/mm EF is reversed after 6 hours
(panel labeled 400(R) mV/mm, time when current was reversed is indicated with the
dashed gold line), cells reorient to the new EF vector over the following 2 hours.
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Figure 2.8: Electric fields induce directional migration
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Figure 2.9: Electric field exposure induces cortical astrocyte proliferation
Proliferation peaks 48 hours after onset of the EF. A-D: Representative BrdU
immunolabeling overlaid on 20x DIC images of cortical astrocytes 48 hours after
exposure to 0 (A), 4 (B), 40 (C), or 400 (D) mV/mm; scale bars: 20 µm. The orientation
of the applied EF is indicated in each image, with the anode (+) to the right of the image
and the cathode (-) to the left. (E) Quantification of change in proliferation over time as a
function of EF strength by comparing the % BrdU-positive cells to the total population of
cells present. For all field strengths, there was no change in proliferation at 12 hours
(X23 = 0.7400, p = 0.8638) or 24 hours (X23 = 4.4643, p = 0.2155) after exposure. The
proliferation at 24 hours in groups exposed to 40 or 400 mV/mm is not significantly
different from 0 in spite of the visual trend indicating an increase because the nonparametric statistical test used for this evaluation is very conservative. By 48 hours after
EF onset, there was a significant increase in proliferation (X23 = 13.5526, p = 0.0036) in
astrocytes exposed to 40 mV/mm (p = 0.0088) and 400 mV/mm (p = 0.0481) relative to
0 mV/mm, while 4 mV/mm had no effect on proliferation (p = 1.0000). After 72 hours,
there was still an observed increase in proliferation (X23 = 13.0060, p = 0.0046), but only
cells exposed to 400 mV/mm remain elevated (p = 0.0386) relative to 0 mV/mm (4
mV/mm: p = 1.0000; 40 mV/mm: p = 0.1452). All data are expressed as mean ± SEM.
Kruskal-Wallis test followed by individual nonparametric comparison post-hoc tests
using the Dunn Method for Joint Ranking. *p < 0.05, **p < 0.01.
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Figure 2.9: Electric field exposure induces cortical astrocyte proliferation
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Figure 2.10: Electric field exposure aligns the axis of cell division
(A-D) Mitotic cells (arrow, A) were identified in time-lapse DIC microscopy
videos. The axis of division was defined for each cell by drawing a line through the
center of each of the daughter nuclei (line, D) and measuring the angle of this axis
relative to the applied EF (cathode (-) at the top of each image, anode (+) at the bottom
of each image). The time (in minutes) of each image is provided to illustrate the duration
of mitosis. Scale bar = 20 µm. (E) Frequency histograms representing the relative
number of nuclei counted at each orientation relative to the anode (A) and cathode (C)
(histogram bin width of 15°), with a density curve super-imposed on each graph.
Nuclear alignment is double-plotted along the x-axis to aid in observing the alignment of
these data. Each EF strength was evaluated for alignment with Rayleigh’s test, and
found that only 400 mV/mm induced alignment (n = 124, R = 0.3740, p = 2.93 x 10-8),
with a mean direction µ ± SEM = 82.1 ± 3.53°, κ = 2.71, and SD = 39.7° (the EF axis
runs from 0° to 180°, with 90° being perpendicular to the EF vector). There was no
significant alignment for cells exposed to 0 mV/mm (n = 176, R = 0.1127, p = 0.1071), 4
mV/mm (n = 186, R = 0.1071, p = 0.1183), or 40 mV/mm (n = 260, R = 0.0437, p =
0.6092).
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Figure 2.10: Electric field exposure aligns the axis of cell division
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Figure 2.11: EF effects on intermediate filament expression and morphology
Representative confocal images of astrocytes after 72 hours’ exposure to 4, 40,
or 400 mV/mm. (A-C) DAPI-labeled nuclei, with an overlay indicating the orientation of
the electric field vector (+) and (-), corresponding to the anode and cathode,
respectively. Immunolabeling for GFAP (D-F), vimentin (G-I), and nestin (J-L) show that
only 40 mV/mm induces an up-regulation of vimentin and GFAP. (M-O) FFT analysis of
normalized pixel intensity from vimentin-labeled images (averaged over 6-8 images)
shows that astrocytes exposed to 4 and 40 mV/mm for 72 hours extend their processes
in random directions, while only astrocytes exposed to 400 mV/mm display a strong
preference for process alignment perpendicularly to the vector of the EF as indicated by
the high peaks. All 4 graphs are plotted with the same scale on the vertical axis; the
horizontal axis indicates directionality relative to the anode (+) and cathode (-). Scale
bar: 50 µm.
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Figure 2.11: EF effects on intermediate filament expression
and morphology
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Table 2.1: Optimizing the measurement interval for cell tracking
Coefficient parameters for the Tukey-HSD post hoc tests, indicating the
estimated difference (µm/hour) between each group, the t-score of the difference, and
the adjusted p-value for the comparison.

0 mV/mm

400 mV/mm

Estimate

t-score

p-value

Estimate

t-score

p-value

6–3

-11.654

-3.878

1.033 x 10-3

-8.154

-3.071

0.0183

15 – 3

-18.271

-6.080

7.328 x 10-9

-9.907

-3.731

1.851 x 103

30 – 3

-22.843

-7.601

1.192 x 10-13

-15.438

-5.814

5.050 x 10-8

60 – 3

-26.962

-8.972

< 1 x 10-15

-18.679

-7.035

2.189 x 10-11

15 – 6

-6.617

-2.202

0.1789

-1.752

-0.660

0.9648

30 – 6

-11.190

-3.723

1.840 x 10-3

-7.284

-2.743

0.0477

60 – 6

-15.309

-5.094

2.355 x 10-6

-10.524

-3.964

6.735 x 10-4

30 – 15

-4.573

-1.522

0.5483

-5.532

-2.083

0.2271

60 – 15

-8.692

-2.892

0.0312

-8.772

-3.304

8.708 x 10-3

60 – 30

-4.119

-1.371

0.6466

-3.240

-1.220

0.7396

(adjusted p values are reported, using the single-step method)
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Chapter 3: Cerebellar Astrocytes

Chapter Overview
In the previous chapter, we found evidence to support our hypothesis that injuryinduced EFs determine the regenerative potential in the CNS by affecting each of the
astrocytic behaviors necessary for wound repair. However, our observations were
limited to cortical astrocytes, but astrocytes demonstrate remarkable morphological and
functional heterogeneity throughout different regions of the CNS. This heterogeneity
among sub-populations of astrocytes suggests that the astrocytic response to injury
may also vary among different regions within the mammalian CNS. Indeed, while
reactive astrocytosis in the cortex is associated with the formation of a chronic glial scar,
reactive astrocytes in the cerebellum do not reorganize into a similarly demarcated scar;
moreover, there is evidence that certain neuronal cell types within the mammalian
cerebellum regenerate. Similarly to how EFs drive behaviors associated with the
astrocytic response to injury in the mammalian cortex, we hypothesized that EFs drive a
reactive astrocytic phenotype in the cerebellum. Moreover, we hypothesized that the
effect of EFs on cerebellar astrocytes would be different than that of EFs on cortical
astrocytes, reflecting the difference in the injury response displayed by these two
different populations of astrocytes.
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Introduction
The mammalian CNS is characterized by minimal regeneration because the
astrocytic response to parenchymal injury results in the formation of a chronic glial scar
that inhibits axon regeneration33, 35. However, astrocytes demonstrate remarkable
heterogeneity in their response to injury across different regions of the brain380,
suggesting that glial scar formation and axon regeneration may be similarly variable.
Indeed, the cerebellum remains conducive to axon outgrowth, as climbing fiber axons
from olivocerebellar neurons are able to sprout through the intact parenchyma to their
original targets after being individually axotomized using laser dissection (a procedure
that does not induce tissue injury or a reactive response) 47, and these same intrinsic
regenerative properties allow them to regenerate after injury past the lesion site381; upon
reaching their original targets, they functionally re-integrate into the remaining neural
circuitry through local plasticity47, 381. Moreover, cerebellar astrocytes promote migration
of new cerebellar neurons throughout the life of the animal382. The cerebellum, which is
located in the hindbrain (Figure 3.1), is the phylogenetically oldest part of the
mammalian brain, suggesting that its relatively greater inherent regenerative capacity
may be a reflection of some vestigial phenotype that once facilitated regeneration in a
common vertebrate ancestor.
Interestingly, the heterogeneous astrocytic population in the cerebellum reflects
the phenotypic origins of the structure: astrocytes in the granular layer demonstrate a
stellate morphology that is similar to cortical astrocytes, while astrocytes in the Purkinjecell and molecular layers, which are eponymously known as Bergmann glia, more
closely resemble immature astrocytes and radial glia (Figure 3.1B). Radial glia, which
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are bipolar cells that span the entire width of the embryonic cerebellum, differentiate into
Bergmann glia through as Shh and FGF-9 signaling382, 383. As they differentiate, radial
glia retain their basal branch, and Notch signaling induces additional processes to
develop such that Bergmann glia ultimately have 3-6 branches that traverse the
molecular layer75, 107, 382. Bergmann glia express GFAP, but they are morphologically
similar to radial glia384, and they express the immature/stem-cell intermediate filament
Nestin and the transcription factor Sox2382, 385.
Following an injury, Bergmann glia and cerebellar astrocytes both develop
hypertrophic processes within 10 days of a lesion, overexpress the intermediate
filaments GFAP and vimentin, and deposit NG2 – a CSPG that inhibits axon outgrowth
– into the ECM386, 387. This response has been defined as characteristic reactive gliosis
because of the strong similarities response to injury in cortical astrocytes. Nonetheless,
cerebellar astrocytes and Bergmann glia also overexpress the intermediate filament
nestin384 and a subset of cerebellar astrocytes express the embryonic neural cell
adhesion molecule PSA-NCAM388, which is a permissive substrate for neurite
outgrowth, together suggesting that these cells also retain characteristics of immaturity
associated with radial glia. Early studies that did not distinguish between sub-layers
within the cerebellum reported a glial scar induced by injury389, and biopsies from two
case reports in human patients suggests evidence that implanted electrodes induce a
gliotic response after 3 months390. However, subsequent research suggests that
Bergmann glia do not reorganize and form a glial scar in the molecular layer92, 384;
moreover, while cerebellar astrocytes do form a glial scar in the granular layer, their
induction of PSA-NCAM expression beginning 3 months after axotomy corresponds to
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the initiation of outgrowth from axotomized Purkinje cell axons, and up to 75% of axons
sprouting past the glial scar are ensheathed by these reactive astrocytes388, 391.
Together, this suggests that cerebellar astrocytes and Bergmann glia may facilitate a
regenerative response to injury in the cerebellum because they represent an
intermediate astrocytic phenotype between that of regenerative radial glia in nonmammalian vertebrates and of non-regenerative cortical astrocytes in mammals.
In chapter one, we established that endogenous electric fields regulate wound
repair and determine regenerative outcomes after injury by directly influencing the
cellular response to injury. In chapter two, we showed that physiologic EFs regulate
behaviors from cortical astrocytes associated with their injury response, and that
elevated EFs modify this response towards a more regenerative phenotype. Based on
these observations, we hypothesized that physiologic EFs also regulate the astrocytic
response to injury in the mammalian cerebellum. Moreover, we hypothesized that the
greater regenerative potential in the cerebellum is associated with a more robust
regenerative response among cerebellar astrocytes to physiologic EFs. In the
experiments described in the current chapter, we exposed rat cerebellar astrocytes to
EFs following the same experimental design that we used in chapter two. Our findings
from these studies suggest that cerebellar astrocytes demonstrate a robust response to
EFs that is greater in its intensity and duration the response we have observed among
cortical astrocytes. This suggests that cerebellar astrocytes maintain a greater
regenerative potential because they are more intrinsically responsive to physiologic EFs
present in the injury environment.
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Methods

Cell source and culture methods
Rat cerebellar astrocytes harvested from P2 cerebellum were purchased from
ScienCell (cat # R1800). Cultures have greater than 99% purity as determined with
GFAP immunolabeling by ScienCell. The company makes no distinction among
astrocytic sub-populations from the molecular and granular layers, and GFAP staining
cannot differentiate between these cell types. Consequently, the astrocytes used in
these experiments represent a heterogenous population, similar to the mixed population
present in an injury site in vivo. All of the astrocytes used for these experiments came
from the first five passages after the initial thaw. Astrocyte cultures were maintained
according to the protocol recommended by ScienCell. Briefly, astrocytes were thawed
into poly-L- lysine (ScienCell # 0413) coated T75 culture flasks containing astrocyte
media (pH 7.4; ScienCell AM-a 1831) supplemented with 2% fetal bovine serum
(ScienCell # 0010) and 1% penicillin/streptomycin (ScienCell # 0503). Cultures were
maintained in a humidified 37°C incubator with a 5% CO2 atmosphere, and culture
media was changed every 2-3 days. Once the cultures reached confluence,
approximately 5,000 astrocytes were sub-cultured into each EF chamber (see
description below) for experiments. Methods used to design the EF chamber were
identical to the methods described in chapter two (page 80).
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Experimental design and statistical analysis
For the experiments described in this chapter, we exposed cerebellar astrocytes
to EFs of 0, 4, 40, or 400 mV/mm and repeated many of the analyses that we
completed with cortical astrocytes in chapter two. We initially characterized the
population of cerebellar astrocytes with immunolabeling for GFAP, vimentin, and nestin.
We then assessed effects on migrational speed and direction, orientation of
proliferation, and morphology. The methods and analyses used in these experiments
are identical to those methods describe in chapter two (beginning on page 82), with the
exceptions that cerebellar astrocytes used for immunocytochemistry studies were only
exposed to EFs for 12 hours.

Results

Characterizing the cerebellar astrocyte population
We used cultured rat cerebellar astrocytes to test whether the EFs that are
associated with intact and injured mammalian tissues may affect cerebellar astrocyte
behaviors in vitro. The cerebellar astrocytes used in these experiments were purchased
as purified populations from ScienCell (a company that specializes in preparing purified
primary cell cultures), who verified population purity with GFAP staining. We also
characterized the astrocytic population prior to conducting each experiment. We used
immunofluorescence labeling against GFAP, vimentin, and nestin, as well as
morphological characteristics in DIC, to evaluate the purity and maturation of these
astrocytes (Figure 3.2). These astrocytes consistently expressed high levels of GFAP
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and vimentin; in contrast, most of the cells did not express nestin, although certain subpopulations were strongly nestin-positive. Cell morphologies seemed to be consistent
with the cytoskeletal elements that they expressed: nestin-negative cells maintained a
lamellipodial morphology consistent with cerebellar astrocytes, while nestin-positive
cells tended to have a more bipolar, process-bearing morphology similar to that
characteristic of Bergmann glia. This suggests that this population contains a mixture of
cerebellar astrocytes and Bergmann glia.

Electric fields affect the speed of cerebellar astrocyte migration
To test our overall hypothesis that EFs direct the astrocytic response to injury, we
explored how EF exposure affects each of the behaviors that astrocytes
characteristically display after injury in both mammalian and non-mammalian
vertebrates. The first of these behaviors is migration, as astrocytes must move towards
the lesion as they are recruited to restore BBB integrity and isolate the lesion
environment from the surrounding healthy tissue. We tested the ability of EFs to
influence astrocyte migration by using time-lapse DIC live cell microscopy to record how
primary rat cerebellar astrocytes respond to dcEFs over a 12-15 hour period. We
compared how EF intensities associated with intact (4 mV/mm), injured mammalian (40
mV/mm), and injured non-mammalian vertebrate tissues (400 mV/mm) affect migration
relative to an untreated control (0 mV/mm). We observed no evidence of cell death
during these experiments as a function of either EF exposure or of phototoxicity from
repeated exposure to light. We measured migration by tracking cells every 15 minutes,
which was the frequency that provided the greatest temporal resolution for velocity
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measurements without adding a significant component of error in selecting cell position
(see page 95 for details). Each experiment was conducted at least 3 times using cells
derived from different animals, and at least 30 cells were tracked at each time point
from at least 5 fields of view for each experiment; results from each experiment were
pooled and analyzed together (n ≥ 90 cells for each EF strength at each time point).
Time-lapse videos show that, in the absence of any EF, astrocytes have a
heterogeneous morphology and display non-directional movement. Cells exposed to 4
mV/mm show similar morphologies and patterns of movement. In contrast to the cortical
astrocyte response to 40 mV/mm, time-lapse videos show that 40 mV/mm does not
induce directional migration or increased speed in cerebellar astrocytes. However,
cerebellar astrocytes exposed to 400 mV/mm demonstrate a rapid response to the EF
exposure, with the entire cell population migrating towards the anode of the EF within
the first hour of the EF exposure.
To qualitatively evaluate the EF-induced effect on migration, the paths of
migration over the first six hours of EF exposure were plotted for individual astrocytes;
the starting position was normalized to the origin of the graph (0, 0), and the direction
was displayed relative to the orientation of the EF (Figure 3.3). The mean cell speed is
plotted for each EF-exposure at 15-minute intervals over the 12-hour experiment
(Figure 3.4A). Using a 1-factor ANOVA, we found no significant differences in the mean
cell speed among the EF-exposure groups prior to the EF onset (0 minutes: F3, 360 =
2.13, p = 0.096; mean speed ± SEM for 0 mV/mm: 16.64 ± 1.19 µm/hr; 4 mV/mm: 21.70
± 2.62 µm/hr; 40 mV/mm: 17.89 ± 1.85 µm/hr; 400 mV/mm: 21.21 ± 1.52 µm/hr; Figure
3.4B, left panel). 15 minutes after EF onset, there is a statistically significant difference

144

in mean astrocyte speeds among the different EF-exposure groups (F3, 357 = 17.1, p =
2.12 x 10-10; mean speed ± SEM for 0 mV/mm: 16.26 ± 1.14 µm/hr; 4 mV/mm: 22.70 ±
1.69 µm/hr; 40 mV/mm: 17.42 ± 1.48 µm/hr; 400 mV/mm: 30.55 ± 2.00 µm/hr; Figure
3.4B, center panel). Using the Tukey-HSD post-hoc test, we found that cerebellar
astrocytes exposed to 400 mV/mm have a greater cell speed than cells exposed to 0
mV/mm (p = 1.761 x 10-9; estimated difference: 14.28 µm/hr, 95% CI: 8.60, 19.96), 4
mV/mm (p = 3.826 x 10-3; estimated difference: 7.85 µm/hr, 95% CI: 1.93, 13.77), and
40 mV/mm (p = 1.205 x 10-7; estimated difference: 13.12 µm/hr, 95% CI: 7.22, 19.02);
we also found that cells exposed to 4 mV/mm had an increased speed relative to 0
mV/mm (p = 2.717 x 10-2; estimated difference: 6.43.µm/hr, 95% CI: 0.51, 13.35), but
that their speed was not different from astrocytes exposed to 40 mV/mm (p = 0.1197).
Although this suggests that 4 mV/mm may transiently induce an increased migration
speed, this more likely represents an aberration or artifact than a true effect as the
difference between 0 and 4 mV/mm is relatively small, 4 mV/mm was not different from
40 mV/mm, and 0 mV/mm was not different from 40 mV/mm; moreover, 4 mV/mm was
different from neither 0 nor 40 mV/mm at 30, 45, or 60 minutes after EF onset, while the
increased speed for astrocytes exposed to 400 mV/mm was sustained at each of these
time points and throughout the rest of the 12 hour experiment. Cerebellar astrocytes
exposed to 400 mV/mm sustained this increased speed (relative to 0 mV/mm)
throughout the entire 12 hours of the experiment, while there were no differences in
mean cell speed among the cells exposed to 0, 4, or 40 mV/mm at any subsequent time
point. (Differences between cell speeds were compared between EF exposure groups
at each time point using a 1-factor ANOVA with a Tukey-HSD post-hoc test; see Figure
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3.4B for analyses at the start of the experiment, and 0, 15 minutes and 2 hours after the
EF onset.) Thus, only EFs elevated at levels associated with regenerating nonmammalian vertebrate tissues affect cerebellar astrocyte migration speed.

Electric fields are a directional cue for cerebellar astrocyte migration
Having demonstrated that EF exposure alters cell speed in an intensity- and
time-dependent manner, we tested whether EFs also serve as an orientational cue by
causing directional migration. Directionality was assessed for each EF intensity at each
time point using Rayleigh’s test (which tests the hypothesis of a non-random direction
about a circle against the null hypothesis of a random direction), using an overall pvalue = 0.05 with a Bonferroni correction for the total number of factor levels analyzed
(196 comparisons: 4 EF levels at each of 49 time points). We found that there was no
directional migration in the 0 mV/mm control group, and that neither 4 mV/mm nor 40
mV/mm caused cerebellar astrocytes to move directionally. However, 400 mV/mm
induced directional migration towards the anode within 15 minutes of EF exposure (i.e.
the first time point measured after EF onset); the mean direction in which cells traveled
was 93.29° ± 0.99°, κ = 1.56 ± 0.03, where 90° corresponds to the anode (circular mean
direction ± circular standard deviation calculated for all cell directions at time points
where there was statistically-significant directional migration) (Figure 3.5). As the lesion
site within the CNS becomes the anode of the injury-induced EF (see discussion in
Chapter 1, page 48), EFs may be contributing towards astrocyte migration towards the
lesion site in vivo. Moreover, once directionality emerged, it continued throughout the
entire recording period. We also found that, similarly to cortical astrocytes, cerebellar
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astrocytes remain very sensitive to changes in the orientation in the extracellular EFs.
We demonstrated this by exposing cerebellar astrocytes to 400 mV/mm for 6 hours and
then reversing the polarity of the EF exposure for another 6 hours. We found that
cerebellar astrocytes stop moving towards the original anode after 15 minutes of
reversing the direction of the EF, and they orient themselves to the new anode after 30
minutes of non-directional movement. From the time-lapse videos and the directionality
double-plot, this period of “non-directional” movement appears to reflect the cells
actually turning around as they reorient themselves to the new direction of the imposed
EF, during which time half of the population turned clockwise and the other half turned
counter-clockwise (as indicated by the phase-shifts in the directionality data, Figure
3.5). This rate of reversal was much more rapid than the two-hours required for cortical
astrocytes to reorient to a change in polarity of an applied EF, suggesting that cerebellar
astrocytes may be more responsive to EFs than cortical astrocytes are.

Electric fields align the axis of cell division
While reviewing the time-lapse live cell videos, we observed that cells exposed to
400 mV/mm tended to divide with an axis of division perpendicular to the EF vector. The
orientation of division is known to influence cellular activity during mammalian
embryogenesis107, and regeneration in non-mammalian vertebrates is known to
recapitulate development, so we were interested in determining whether EF exposure
aligns the axis of division in cerebellar astrocytes. Using the DIC time-lapse videos, we
identified mitotic cells and measured the angle of the axis of division relative to the EF
vector by drawing a line between the two daughter nuclei in the first frame where they
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were distinctly visible (Figure 3.6A-D). The distribution of these axes relative to the EF
vector are plotted for each EF strength (Figure 3.6E), with the axial data double-plotted
on the x-axis relative to the anode (A) and cathode (C) to assist in visualizing the
clustering of mitotic events perpendicularly to the EF vector. Using the Rayleigh test for
alignment, we found that EF exposure aligned the axis of cell division for cells exposed
to 400 mV/mm (n = 123, R = 0.1721, p = 2.61 x 10-2), with a mean direction µ ± SEM =
98.21 ± 5.97°, κ = 1.35, and SD = 61.9° (the EF axis runs from 0° to 180°, with 90°
being perpendicular to the EF vector). We found that there was no significant alignment
for cells exposed to 0 mV/mm (n = 122, R = 0.1408, p = 0.089), 4 mV/mm (n = 99, R =
0.0727, p = 0.5925), or 40 mV/mm (n = 55, R = 0.0533, p = 0.8553). Thus, only EFs
associated with regenerating tissues align the axis of division in cerebellar astrocytes.

Electric fields align cerebellar astrocytes
Cerebellar astrocytes are a heterogeneous population, with a sub-population
morphologically similar to mammalian cortical astrocytes and another sub-population
(Bergmann glia) with long processes spanning the molecular layer resembling radial glia
in non-mammalian vertebrates. These aligned processes help certain classes of
neurons to migrate through the adult cerebellum, and aligned astrocytic processes also
promote a regenerative phenotype in the mammalian and non-mammalian vertebrate
CNS. In chapter 2, we demonstrated that elevated EFs at levels associated with
regeneration promote cortical astrocytes to align their processes perpendicularly to the
polarity of the applied EF. Our time-lapse videos from the cerebellar astrocyte migration
studies suggested that EFs induce morphological changes in cerebellar astrocytes
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similar those that we observed in cortical astrocytes and, given that these morphological
changes are associated with a regenerative phenotype, we next set out to quantify
these effects on morphology using FFTs on cells immunolabeled for DAPI, GFAP,
vimentin, and nestin images (Figure 3.7). A qualitative review of these immunolabeled
images showed that there was a relatively heterogeneous astrocytic population in the
cells exposed to 0, 4, and 40 mV/mm, consisting of both lamellipodial and bipolar cells,
while astrocytes exposed to 400 mV/mm appeared to assume a more process-bearing
morphology. It also appears as though there is a relatively consistent expression of both
GFAP and vimentin among these cells, with nestin-expressing cells intermittently
present. We analyzed the vimentin-immunolabeled cells for alignment using an FFT
analysis (Figure 3.8). These FFTs show that astrocytes exposed to 400 mV/mm align
their processes perpendicularly to the applied EF; astrocytes exposed to 0, 4, and 40
mV/mm also demonstrate some periodicity in the alignment of their processes, but this
is much smaller in magnitude than the alignment induced by 400 mV/mm, it is focused
at an arbitrary orientation, and it is consistent among the 0, 4, and 40 mV/mm groups,
and it may represent some sort of artifact rather than an actual alignment effect. These
results summarize data from only one experiment, so we are unable to determine
whether the alignment demonstrated by astrocytes exposed to 4 and 40 mV/mm
represents something real about these cells or if it instead is an artifact.

Discussion
Increasing evidence supports the notion that bioelectric fields interact with all
cells, and that injury-induced EFs regulate the cellular response to injury215, 315, 392. This
is evidenced by multiple studies demonstrating that elevated EFs induce the same
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behaviors necessary for epimorphic regeneration among diverse cell types from many
different tissues147, 315, 324, 392. We have previously described evidence that mammalian
astrocytes, which are necessary for the cellular response to injury in the CNS, respond
to elevated EFs through the same induced behaviors as are expressed by cells in other
tissues upon EF exposure (chapter two). Our findings in the current study, that
cerebellar astrocytes respond to elevated EFs, are consistent with the notion that EFs
are a universal signal that regulates cellular activity and wound repair. We found that
cerebellar astrocytes did not respond to EFs of 40 mV/mm; as 40 mV/mm induces
behaviors in cortical astrocytes associated with glial scar formation, this suggests that
cerebellar astrocytes may not form a glial scar because they do not respond to the
injury-induced EFs within the cerebellum. In contrast, cerebellar astrocytes responded
to EFs associated with regenerating tissues similarly to the response demonstrated by
cortical astrocytes, demonstrating a rapid increase in cell speed and migrating towards
the anode; we also found that only EFs associated with regeneration induced
morphological changes in astrocytes that mirror those that facilitate regeneration in nonmammalian vertebrates79. The difference between the EF intensities necessary to
induce responses in cortical and cerebellar astrocytes also illustrates that the cellular
response to EFs is an active one, whereby the cells are “choosing” to respond in certain
nuanced ways; if instead cells were being forced to respond to gross electrochemical
forces, both astrocytic sub-types should have had the same response. Assuming that
the injury-induced EFs within the cerebellum are similar to those that are present in
other injured mammalian tissues (and to the EFs within a hippocampal slice culture
preparation290), this would suggest that physiologic EFs within the injury site do not
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induce a robust reactive astrocytic response but that therapeutically elevated EFs may
still induce regenerative behaviors in cerebellar astrocytes.
This observed difference between the EF-induced response in cortical and
cerebellar astrocytes is consistent with differences in their response to injury in vivo.
Specifically, cortical astrocytes rapidly respond to an injury by restoring the BBB, but
this response evolves into the formation of a glial scar33, 393; cerebellar astrocytes
hypertrophy following an injury, but do not form a similarly robust glial scar92, 389, 391.
However, it does not explain why the same injury-induced EF would have different
effects on these astrocytic behaviors. One possibility is that 40 mV/mm may induce only
a subset of the behaviors necessary for regeneration in cortical astrocytes, so they form
a glial scar once they are stimulated to migrate to and proliferate at the lesion site, but
EF-intensity does not reach the threshold necessary to induce neurogenesis or to
promote axon sprouting; in contrast, the EF-induced threshold for each of the
regenerative behaviors in cerebellar astrocytes remains within a close range of each
other so that these behaviors are induced together in an all-or-none regenerative effort,
and 40 mV/mm is not sufficiently intense to reach this threshold. Alternatively, it is
possible that injury-induced EFs within the cerebellum are higher than they are in the
cortex, so the lack of response among cerebellar astrocytes to 40 mV/mm could reflect
the fact that these EFs are not within the range necessary to induce injury-associated
behaviors. In either case, the underlying axiom of these experiments is that injuryinduced EFs determine the regenerative potential of the injured tissue. As the
regenerative potential in the cerebellum is different from that in the cortex, and the
astrocytic response to injury largely determines the regenerative potential of the injured
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CNS, it is reasonable to assume either that the same injury-induced EFs are present in
the cortex and cerebellum but that they have different effects on the resident astrocytes,
or that different injury-induced EFs are present in these tissues which explains why the
resident astrocytes respond differently to injury in each of these tissues. However, there
is very little information as to the actual EF intensities within the intact and injured
cerebral cortex, and there is no information about EFs within the cerebellum. Therefore,
additional research is needed to explore the EFs throughout the mammalian CNS as we
try to understand how physiologic EFs regulate the regenerative potential in the CNS.
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Figure 3.1: Heterogeneity of cerebellar astrocytes
(A) Parasagittal section of the rat brain, Nissl stain. Astrocytes used in the
experiments described in chapter two came from the cortex (black arrows), which is the
phylogenetically newest region of the mammalian CNS. However, the resolution of CNS
injury demonstrates regional variability throughout the CNS. The cerebellum (white
arrowheads) is one of the phylogenetically oldest regions of the mammalian CNS and is
thought to most closely resemble the CNS of non-mammalian vertebrates. (B) The rat
cerebellum immunolabeled for GFAP, demonstrating the regional heterogeneity of the
resident astrocyte populations. Bergmann glia have highly aligned processes spanning
the molecular layer (white arrowhead) and resemble the radial glia found throughout the
CNS of adult non-mammalian vertebrates; cerebellar astrocytes in the granular layer
(white arrow with rounded base) have a stellate morphology more closely resembling
that of cortical astrocytes in the adult mammalian CNS. (These images come from
unpublished observations in the Colello lab.)
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Figure 3.2: Characterizing the cerebellar astrocyte population
Representative confocal images used to characterize the astrocyte population
based on immunolabeling. (A) GFAP, (B) vimentin, (C) nestin, and (D) an overlay
shows that the population is morphologically heterogeneous, consisting of both
lamellipodial and process-bearing cells. These astrocytes consistently expressed high
levels of GFAP and vimentin; in contrast, most of the cells did not express nestin,
although certain sub-populations were strongly nestin-positive. Cell morphologies
seemed to be consistent with the cytoskeletal elements that they expressed: nestinnegative cells maintained a lamellipodial morphology consistent with cerebellar
astrocytes, while nestin-positive cells tended to have a more bipolar, process-bearing
morphology similar to that characteristic of Bergmann glia. This suggests that this
population contains a mixture of cerebellar astrocytes and Bergmann glia.
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Figure 3.2: Characterizing the cerebellar astrocyte population
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Figure 3.3: Cerebellar astrocyte migration paths in an EF
To qualitatively evaluate the EF-induced effect on migration, the paths of
migration over the first six hours of EF exposure were plotted for individual astrocytes;
the starting position was normalized to the origin of the graph (0, 0), and the direction
was displayed relative to the orientation of the EF with the cathode (+) at the top of the
graph and the anode (-) at the bottom of the graph. 30 cells from each EF strength were
randomly selected to be included in this plot (including more than 30 cells makes it
difficult to discern individual tracks). X- and Y-units for the graph are in micrometers.
These graphs demonstrate the different effects that each EF strength have on
directional migration.
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Figure 3.3: Cerebellar astrocyte migration paths in an EF
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Figure 3.4: EFs affect cerebellar astrocyte migration speed
(A) Astrocyte migration speed is plotted every 15 minutes for 12 hours. Within 15
minutes of EF onset, cells exposed to 400 mV/mm show a rapid increase in mean
speed, which is sustained throughout the entire 12-hour observation period of the
experiment. (B) Effects of EF exposure on speed were assessed at each time point and
3 representative time points are shown corresponding to the start of the experiment (0
Hours), and 15 minutes and 2 hours after EF onset. Mean speed was compared
between EF strengths at each time point with a 1-factor ANOVA followed by a TukeyHSD post hoc comparison. There was no difference in mean speed between groups at
the start of the experiment (F3, 360 = 2.13, p = 0.096). There was a significant effect of
EF exposure at both 15 minutes (F3, 357 = 17.1, p = 2.12 x 10-10) and 2 hours (F3, 363 =
7.08, p = 2.30 x 10-6). The mean speed of cells exposed to 4 or 40 mV/mm did not
significantly change over time compared to 0 mV/mm. All data are expressed as mean ±
SEM. *p < 0.05; **p < 0.01; ***p < 0.001.
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Figure 3.4: EFs affect cerebellar astrocyte migration speed
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Figure 3.5: EFs affect cerebellar astrocyte direction of migration
Astrocytes preferentially migrate towards the anode of an applied electric field of
400 mV/mm. The direction of migration was measured for each cell every 15 minutes
over 12 hours relative to the anode (A, indicated in red) and cathode (C, indicated in
blue) of the applied EF and plotted, with each dot representing the direction of migration
of a single cell at each time point. The x-axis is double-plotted for each field strength to
help visualize the directionality. The random direction of cell movement in 0, 4, and 40
mV/mm is visually displayed by the even distribution of data points along the x-axis.
Directional migration towards the anode emerges in cells exposed to 400 mV/mm after
15 minutes. If the polarity of the 400 mV/mm EF is reversed after 6 hours (panel labeled
400(R) mV/mm, time when current was reversed is indicated with the dashed gold line),
cells reorient to the new EF vector over the following 0.5 hours.
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Figure 3.5: EFs affect cerebellar astrocyte direction of migration
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Figure 3.6: EFs affect orientation of cerebellar astrocyte mitotic axis
Frequency histograms representing the relative number of nuclei counted at each
orientation relative to the anode (A) and cathode (C) (histogram bin width of 15°), with a
density curve super-imposed on each graph. Nuclear alignment is double-plotted along
the x-axis to aid in observing the alignment of these data. Each EF strength was
evaluated for alignment with Rayleigh’s test. Only 400 mV/mm induced alignment (n =
123, R = 0.1712, p = 2.61 x 10-2), with a mean direction µ ± SEM = 98.21 ± 5.97°, κ =
1.35, and SD = 61.9° (the EF axis runs from 0° to 180°, with 90° being perpendicular to
the EF vector). There was no significant alignment for cells exposed to 0 mV/mm (n =
122, R = 0.1408, p = 0.0890), 4 mV/mm (n = 99, R = 0.0727, p = 0.5925), or 40 mV/mm
(n = 55, R = 0.0533, p = 0.8553). (Note, R is the test statistic for the Rayleigh test.)
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Figure 3.6: EFs affect orientation of cerebellar astrocyte mitotic axis
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Figure 3.7: Cytoskeletal elements in cerebellar astrocytes after EF exposure
Representative confocal images showing cerebellar astrocytes after 12 hours’
exposure to 0, 4, 40, or 400 mV/mm. Each EF-exposure is listed on its own row, with
the EF intensity indicated in the left-most panel. Column (A): DAPI-labeled nuclei, with
an overlay indicating the orientation of the electric field vector (+) and (-), corresponding
to the anode and cathode, respectively. Immunolabeling for GFAP (column B), vimentin
(column C), nestin (column D), and an overlay of all of these elements (column E); the
same acquisition and display settings were used for each of these images. 400 mV/mm
produced a dramatic effect on cell morphology and cytoskeletal element expression,
with all of the astrocytes demonstrating elongated, bipolar morphologies with their
processes perpendicular to the orientation of the applied EF. Furthermore, the merged
images indicate that cells exposed to 400 mV/mm had a greater ratio of vimentin to
GFAP expression relative to those cells exposed to 0, 4, or 40 mV/mm. These images
also show that there is a heterogeneous population of cerebellar astrocytes upon
exposure to 0, 4, and 40 mV/mm for 12 hours: the majority of these cells expressed
GFAP and vimentin; while GFAP was seemingly constant, vimentin appears to vary with
greater expression in bipolar cells and lower expression in lamellipodial cells. In
contrast, nestin expression was sporadic. Scale bar: 50 µm.
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Figure 3.7: Cytoskeletal elements in cerebellar astrocytes after EF exposure
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Figure 3.8: EFs align cerebellar astrocyte processes
FFT analysis of normalized pixel intensity from vimentin-labeled images
(averaged over 4-5 images); relative orientation is plotted in arbitrary units on the y-axis
for each angle relative to the anode and cathode (in 1° increments; alignment is an axial
unit, i.e. 0° = 180°, which is represented in the double-plotting of these graphs), and the
same scale is used for the y-axis in each of the four graphs. These FFTs show that
astrocytes exposed to 400 mV/mm align their processes perpendicularly to the applied
EF; astrocytes exposed to 0, 4, and 40 mV/mm also demonstrate some periodicity in
the alignment of their processes, but this is much smaller in magnitude than the
alignment induced by 400 mV/mm, it is focused at an arbitrary orientation, it is
consistent among the 0, 4, and 40 mV/mm groups, and it may represent some sort of
artifact rather than an actual alignment effect.
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Figure 3.8: EFs align cerebellar astrocyte processes
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Chapter 4: In Vivo Experiments

Chapter Overview
In the first chapter, we discussed the physiologic EFs reported in biological
systems. Intact tissues generally produce dcEFs ≤ 10 mV/mm, injured mammalian
tissues (i.e. non-regenerating tissues) sustain an 8-15 fold EF increase, and
regenerating tissues produce a 50-100 fold EF increase. This suggests that the
magnitude of injury-induced EFs, which varies between regenerating and nonregenerating tissues, determines the regenerative outcome. In chapters two and three,
we tested the hypotheses that physiologic EFs contribute to the astrocytic response to
injury, and that a regenerative phenotype is favored by increasing the EF intensity
towards levels found in regenerating tissues. The EFs used in these experiments were
chosen based on previously published studies, but the existing literature also suggests
the actual range of injury-induced EFs is broad. Moreover, certain types of equipment
used to measure EFs is inherently biased, and the studies measuring EFs in the
mammalian CNS are entirely based on ex vivo recordings. In previous chapters, we
found that EFs induce intensity-dependent behaviors in mammalian astrocytes, and that
the highest EF strength tested promoting a regenerative response. This suggests that
physiologic injury-induced EFs may be therapeutically targeted to activate the
physiologic mechanisms necessary for spontaneous regeneration. However, technical
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challenges have prevented a thorough exploration of the strength, intensity, and
duration of ionic currents produced by CNS injury. In this chapter, we discuss these
limitations and our efforts to address them.

Introduction
Physiologic electric fields (EFs) drive the cellular response to injury and
determine the regenerative potential in many vertebrate tissues. As we described in
chapter one, EFs above a certain threshold are both necessary and sufficient to
reactivate developmental physiology and induce complete regeneration of tissues and
organs following injury or amputation. Injury-induced EFs are lower in tissues that do
not regenerate, and regeneration can be stimulated by experimentally increasing these
EFs towards levels found in highly regenerative tissues. Endogenous EFs have also
been measured ex vivo in the mammalian CNS where they are similar in magnitude to
the EFs that have been measured in other intact and injured mammalian tissues269.
Similarly to how injury-induced EFs drive the cellular response to injury in peripheral
tissues, we found that EFs within the ranges reported in the injured mammalian CNS290
induce a series of behaviors in cortical and cerebellar rat astrocytes consistent with their
physiologic response to injury (chapters two and three, respectively). Moreover, we
found that EFs associated with highly regenerative tissues modify the astrocytic
response, inducing changes that are associated with a more regenerative phenotype.
Together, these observations suggest that the therapeutic manipulation of injuryinduced EFs may be sufficient to stimulate regeneration in the mammalian CNS.
Endogenous EFs are sustained in intact tissues through an ionic current that is
relatively constant in its magnitude and orientation over time, while injury-induced EFs
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change in both magnitude and direction throughout the reparative process270. In
regenerating newts, EFs increase immediately upon injury, and they continue to rise
until they peak several days after the injury270. Moreover, the orientation of the injury
current changes throughout limb regeneration in Urodele amphibians and tail
regeneration in Anuran tadpoles: the initial outward current reverses direction after
several days, and then gradually decreases in magnitude throughout regeneration,
returning to its baseline value only once regeneration is complete270, 274, 276. Although
the differences between the injury-induced EFs produced in regenerating and nonregenerating tissues are often stated as function of the EF magnitude, this is a
simplified version of reality. Following amputation, axolotl limbs regenerate while adult
Xenopus do not, but the initial magnitude of the injury-induced current is very similar:
10-100 µA/cm2 in salamanders270, 20-40 µA/cm2 in frogs278. Instead, differences in the
injury-induced currents emerge only after several days when the current reverses
direction in salamanders but not in frogs270, 274, 278 (Figure 4.1). The importance of the
injury current’s orientation is further illustrated through studies in which Xenopus limb
regeneration was induced by an implanted electrode when the applied EF was oriented
with the cathode at the lesion site, while anodal stimulation caused the amputated limb
stump to degenerate proximal to the original plane of the injury277, 282. These same
studies have been replicated in rats283, 284, suggesting that these EF-induced effects on
regeneration are externally generalizable, and that they reflect neither an artifact nor a
feature unique among amphibians. Together, these observations clearly demonstrate
that the magnitude and orientation of the EFs within the injury site together play a
nuanced and highly choreographed role in regulating tissue regeneration in vertebrates.
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Recordings of EFs that have been made in the mammalian CNS rely on an ex
vivo model, which is prone to two obvious sources of bias. Endogenous EFs are a
physiologic product of active ion transporters, which are highly metabolically
demanding; removing the tissue from the body for an ex vivo preparation deprives it of
vascular perfusion through which it receives the oxygen and glucose necessary to
produce the ATP that drives the active transporters. While these nutrients are provided
in artificial cerebrospinal fluid (aCSF) bathing the tissue, they rely on simple diffusion to
permeate the tissue and the rate of diffusion is too low to satisfy the metabolic demands
of cells. Thus, without vascular perfusion, the explanted tissue becomes ischemic, so
the measured EFs may be less than their true value in vivo. Additionally, the ex vivo
preparation involves dissecting the CNS out of the skull, a process that causes obvious
trauma to the surrounding tissue and, if not performed correctly, to the CNS
parenchyma itself. Moreover, the process of recording EFs within the CNS parenchyma
using implanted electrodes causes damage to the tissue, which may further bias these
recordings. As the preparation itself represents a considerable injury, any recording of
current density or EF magnitude made from an ex vivo sample may actually reflect the
bioelectric phenomena within the injured CNS or an artifact of the preparation and not a
baseline recording from intact tissue. Interestingly, a previous study from the Borgens
lab, which published recordings of injury-induced currents over the first hour after SCI
ex vivo, demonstrated that the spinal cord is electrophysiologically “unstable” for the first
hour after the ex vivo preparation, thus emphasizing the potential artifact in these ex
vivo current density recordings394. This is most clearly illustrated in an experiment done
by Cao and colleagues (2015), where they created a hippocampal slice culture
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preparation that was 300-500 µm thick, measured an EF within the hippocampus of
31.8 ± 4.5 mV/mm, and declared this to be the EF within the “intact” parenchyma290.
However, current density measurements from in vivo cornea265, 268, 326 and skin256, 257,
265, 279, 357, 362, 365

, and from ex vivo spinal cord291, suggest that there are injury-induced

changes in bioelectric phenomena that extend at least up to 1 mm from the lesion site,
so the entire thickness of this slice culture preparation more likely reflects an injured
rather than an intact environment.
We found that 40 mV/mm EFs, which are comparable to the EF intensity
measured in an “injured” hippocampal slice culture290, induce behaviors in mammalian
astrocytes in vitro that are characteristic of their injury response in vivo. However, our
studies, and those from other labs, explore EF effects in vitro by applying a constant EF
throughout the duration of the experiment. Instead, in vivo evidence from nonmammalian vertebrates suggests that injury-induced EFs that drive regeneration have a
precise magnitude and direction, both of which change along a distinct temporal
profile274. Moreover, while EFs can stimulate robust regeneration in frogs and rats,
applying them with incorrect polarity can actually exacerbate the wound277, 282, 283. In the
mammalian CNS, the only current observations measure injury-induced EFs over the
first hour after an injury291. This is far shorter than the multiple days after the initial injury
over which EFs reach their apex and then reverse during axolotl limb regeneration.
While the injured mammalian CNS may indeed produce EFs that change upon injury,
the temporal profile of the magnitude and orientation of endogenous EFs has yet to be
characterized. Thus, while existing experimental data suggest that the injury-induced
EFs drive the cellular response to injury and that therapeutic EFs might be able to
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enhance regeneration, any such therapy aimed at enhancing regeneration through
stimulating physiologic mechanisms of development would be purely speculative
because the temporal and spatial dynamics of injury-induced EFs in the mammalian
CNS are unknown. These parameters must be better understood before an EF-based
therapy to promote regeneration can be developed, as certain elements of these
bioelectric signals are fundamental to the success of any such approach.

Considerations when measuring bioelectricity
Electric fields strengths can be calculated either from the ratio of an electrostatic
force to a known point charge (𝐸 = 𝐹 𝑞 where E is the electric field, F is the force
experienced by a charged particle in the presence of the electric field, and q is the
charge of the second point charge), or from the difference in electrical potentials (V)
measured at two electrodes that are a known distance apart (𝐸 = 𝑑𝑉 𝑑𝑥 where E is the
electric field, dV is the difference in voltage (i.e. dV = Vsource – Vreference), and dx is the
distance between the electrodes). (These equations are algebraically equivalent.
Coulomb’s Law defines electrostatic force as 𝐹 = 𝑘𝑞! 𝑞! 𝑟 ! where r represents the
distance between the two charges, q1 and q2, and 𝐸 = 𝑘𝑞! 𝑟 ! ; electrical potential is
calculated as 𝑉 = 𝑘𝑞! 𝑟 so
𝐸=

𝑘𝑞! 𝑟 ∆𝑉 𝑑𝑉
=
=
  
𝑟
𝑟
𝑑𝑥

as r = dx). Since it is impractical to measure an electrostatic force on a point charge in a
biological system, EF strengths are instead calculated using electrodes to measure the
electrical potential V at different points separated by a known distance. Although this
system is more practical to calculate EF strengths in biological systems because the
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distance between the two electrodes can be measured with great precision, it is still
prone to inaccuracy. The electrodes detect the voltage in the sample through an
electrochemical redox reaction at the interface between electrons in the metal electrode
and ions in the surrounding solution, but this reaction, which causes ions to aggregate
around the electrode, creates a hydration shell around the electrode that physically and
chemically impedes the very reaction that the electrode is designed to measure395. This
hydration shell, known as an “electric double layer,” insulates the recording electrode
because the EF induces the water molecules to become aligned such that their
molecular dipoles oppose the EF, causing the effective EF within the hydration shell – at
the surface of the electrode – to be less than the actual EF within the tissue. This
voltage artifact at the boundary between the electrode and the solution, which is termed
the half-cell potential, can range from 1 mV to well over 200 mV395. The half-cell
potential is dependent both upon the type of metal in the electrode and upon the ionic
composition of the aqueous environment. As the electrolyte composition of the aqueous
environment within each tissue is usually not well defined, the half-cell potential
represents a significant source of measurement error that is very difficult to predict.
Technical challenges can prevent the accurate measurement of EFs by using
electrodes. However, EFs can be calculated indirectly through measuring the ionic
currents that they induce within the solution as a result of electrostatic force created
between ions and the external EF. Jaffe and Nuccitelli first developed an ultra-sensitive
probe that can accurately measure these ionic currents and endogenous electric
potentials around biological specimens265, 396-398. Briefly, a highly-conductive platinumplated metal electrode is vibrated over a known amplitude (typically 20-30 µm). The
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electrode acts as a capacitor, so an external EF induces a voltage in the electrode as a
function of the electrode’s capacitance and the EF intensity; this voltage is continuously
measured as the probe vibrates, and the EF is calculated from the difference between
the measured voltages and the distance that the probe travels as it oscillates
(depending on the set-up of the system and the specific way in which the probe is
calibrated, some vibrating probe set-ups measure the ionic current density instead of
the EF) 397. A half-cell potential cannot occur because the oscillating probe prevents a
hydration shell from forming around the electrode, so EFs can be measured directly with
minimal interference.
The vibrating probe method cannot be used to make recordings within a tissue
because this technique requires the probe to move continuously. Instead, the vibrating
probe technique is used to measure the ionic current density outside of the tissue.
Although the extraparenchymal EF induced by the ionic current can be calculated
(𝐸 = 𝜌𝐼 𝐴 where ρ is the resistivity of the conducting media, and I/A is the ionic current
density), the EF within the tissue cannot be calculated from this measurement because
the tissue resistivity is often unknown and the current density within the tissue is not
uniformly distributed. Nonetheless, the total ionic current within the tissue is the same
as the amount of current outside of the tissue (Kirchoff’s Current Law states that the net
current in the circuit is 0, see Chapter 1: Physics of electric fields, page 31), so the EF
within the parenchyma is fundamentally proportional to the current density measured by
the vibrating probe outside of the tissue and can thus be used as a measure of
physiologic activity within the tissue362.
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Experimental goals
Although the vibrating probe can only measure current density outside of a
tissue, these measurements are often used to make inferences about the physiologic
activity and structural integrity within the tissue362. Using an ion-sensitive vibrating
probe, it was found that the physiologic ionic currents an the cornea and the limb are
principally composed of Na+ ions; and experiments with different ion-channel and
transporter blockers demonstrated that this current is sustained by constitutive activity
of the Na+/K+-ATPase147, 268, 280. Moreover, longitudinal current density measurements
have also demonstrated that the current density is correlated to wound healing215, 274,
329

. Nonetheless, while measurements of external bioelectric phenomena provide insight

into tissue physiology, they still cannot be used to calculate intraparenchymal EFs. One
method to measure these intraparenchymal EFs is described by Cao and colleagues
(2013): they implanted 4 electrodes into the brain, with the electrodes arranged in series
throughout the fiber tract; they injected a known current through the outer two
electrodes and measured the voltage drop between the inner two electrodes as a
calibration, and then turned off their current source so that they could measure the
endogenous EF269. However, even if this method adequately controls for the half-cell
reaction at the electrodes, it still does not account for the potential artifact caused by the
fact that the electrodes themselves damage the parenchyma as evidenced by studies
demonstrating glial scar formation around implanted electrodes in vivo.
In order to develop a therapeutic strategy to promote regeneration in the
mammalian CNS by manipulating EFs, we first need to establish how these
endogenous bioelectric phenomena change in magnitude and orientation throughout
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the duration of wound healing. This exploration requires that a method be developed to
measure ionic currents and EFs in the CNS in vivo for two reasons: first, wound repair is
a prolonged process and longitudinal observations will be necessary to monitor how
physiologic EFs change over time; second, in vivo recordings will obviate measurement
artifacts resulting either from ischemia or from injury occurring during the ex vivo
preparation. In this chapter, we describe our initial efforts to develop a method to record
current density in an in vivo model of CNS injury.

Methods

Animals and surgical protocol
Adult female Long-Evans rats (at least 6 months of age; n = 5) were used in
these experiments (Harlan Laboratories). All animal protocols used in these studies
were preapproved by the Virginia Commonwealth University IACUC. Rats were
anesthetized with isoflurane and placed in a stereotaxic apparatus (see illustration,
Figure 4.2); depth of anesthesia was monitored by respiratory rate and depth, and by
regular assessment of reflexes. A 10 mm diameter area of skull was exposed with a
midline scalp incision and the periosteum was removed. A plastic funnel (fabricated
from the conical base of a 50 mL conical tube, Genesee Scientific #21-106; dimensions:
approximately 15 mm tall, bottom diameter of 8-10 mm where the funnel was attached
to the skull, upper diameter of 28 mm) was affixed to the skull with superglue to
maintain a bathing solution of artificial cerebral spinal fluid (aCSF; 126.0 mM NaCl, 3.0
mM KCl, 1.25 mM NaH2PO4, 2.0 mM MgCl2, 2.0 mM CaCl2, 10.0 mM glucose, and 26.0
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mM NaHCO3) at least 7 mm deep over the recording area. The cortex was exposed by
using a Dremmel tool to remove a portion of the parietal plate approximately 2 mm wide
(ML) x 4 mm long (AP) in size; aCSF was frequently washed over the skull to prevent
overheating of the bone and thermal injury to the underlying brain. The meninges were
carefully removed to expose the intact cortex and surface vasculature was used to
identify a landmark for the scan area and target for the injury.

Measuring current with the Scanning Vibrating Electrode Technique
Measurements of current density were obtained using the Scanning Vibrating
Electrode Technique (SVET) apparatus (Applicable Electronics, New Haven, CT),
based on the technique originally described by Jaffe396, 397. Briefly, Parylene-C insulated
Platinum/Iridium electrodes attached to a gold connector and electrically arced to
expose several micrometers of bare metal at the tip are used for these recordings
(MicroProbes PI(2.5cm)0036.0A10). The electrode tips are platinum-coated by
electroplating them in a solution of 1% Platinum Chloride, H2PtCl6) and 0.01% Lead II
Acetate until they have at least a capacitance of 2.0 nanofarads (nF). The Electrode is
inserted into a gold connector pin attached to the vibrator assembly, which is connected
to a piezoelectric drive that vibrates in the X and Z planes. The probe vibration
frequency is set at around 110 hertz (Hz) in the X plane and 70 Hz in the Z plane
(optimal frequencies are at least ±10 Hz from 60 Hz to minimize electrical noise, and ±5
Hz from the resonance frequency of the probe), with an amplitude in each plane that is
approximately twice the diameter of the electrode tip. The electrode position is
controlled with a motorized 3-dimensional micromanipulator. An Optem Zoom 70 micro179

inspection videoscope lens system equipped with a 0.75x lens, a modular 1:7x zoom
lens, and a 2x auxiliary lens system (total magnification range of 1.5 – 10.5x; Qioptiq),
as well as a color uEyeLE camera (model UI-164xLE, CMOS sensor, 1280x1024
resolution, manufacturer: IDS) is used to visualize the probe and scan area. A computer
running the ASET-LV4 software package (version 3.1.0.0; Science Wares, INC,
Falmouth, MA) is connected to the SVET apparatus and is used to drive the
micromanipulator and collect the data. The probe is calibrated per the protocol from the
manufacturer, under 10.5x magnification using a 60 nanoampere (nA) current source
delivered through a glass micropipette. Calibration is performed prior to the start of each
experiment and every time a new probe is used. A region of interest is specified under
4x magnification, and the probe scans the current density approximately 50 µm above
the surface of this region by moving in a grid-pattern to scan points every 40 µm in the
x- and y-axes; a reference reading 5 mm above the brain surface is taken at the start
and end of each scan to calibrate the measurements. An insect pin (approximately 150
µm diameter) attached to a 3D-micromanipulator is used to make a 2 mm deep stab
wound in the center of the scan area. Current densities are measured immediately
before and after the stab wound. At the end of the experiment, animals were euthanized
with a single intraperitoneal injection of euthasol (350 mg/kg sodium pentobarbital, 45
mg/kg phenytoin sodium).

Analysis
Current density measurements and corresponding images were obtained for the
z-axis (perpendicular to the surface of the tissue) over the surface of the cortex, both
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before and after the injury. Data were analyzed and surface plots were generated using
the JMP v. 11.2.1 statistical software package; bar-plots were generated using the
statistical software R341. The dataset for each scan was reviewed for artifact from the
vibrating probe contacting the surface of the brain by comparing readings from the
Quadrature and In-phase channels of the recording (for a thorough discussion of how
measurements are taken by the SVET apparatus, see Scheffey, 1986399). Per the
recommendation from the company from which the SVET apparatus was purchased,
data points where the signal in the quadrature channel was >10% of the signal in the InPhase channel were deemed suspect and excluded from analysis. Images of the scan
area are automatically recorded before and after each scan, and the coordinates of
each scan location are superimposed onto these images. Using these images, we
labeled each scan location as being over intact cortex, surface vasculature (we were
unable to differentiate between arterial and venous circulation), or the lesion site; we
excluded scan locations for each animal that were on the border between two such
classifications, defined as approximately 75-100 µm from the edge of a vessel or an
injury site. We estimated the mean current density over the intact cortex and surface
vasculatures separately, using a mixed-effects linear regression model
𝑌!" = 𝛽! + 𝒩 0, 𝜎!! + 𝜖!"   
where Yij is the estimated mean current density at each scan location, βj is the mean
current density for each factor level (i.e. intact or injured cortex, or surface vasculature),
and σb2 is the variance of the mean current density between animals. As our sample
size for these pilot studies was relatively small and the only difference in mean current
density with which we were interested was between the intact and injured cortex, we ran
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separate models for the measurements over intact cortex and surface vasculature taken
before the injury; we evaluated the hypothesis that there intact cortex and surface
vasculature each sustain a current density across themselves against the null
hypothesis that there was no such current density sustained by these tissues. We then
ran a model with measurements over intact and injured cortex after the lesion
(measurements over vasculature were excluded), and evaluated the estimated mean for
each factor level as well as the difference between these groups. We used α = 0.05 as
an overall threshold for significance, and also for each of the post-hoc comparisons. We
report the mean ± SEM for each of our parameter estimates, and we report the teststatistics with the degrees of freedom adjusted for the partial dependency of the
observations made from each animal.

Results

Current density measurements
The goal of this pilot study is to develop a protocol by which we can make
recordings of current density over a lesion site in the injured brain over time, with
multiple measurements taken from the same animal at regular intervals (e.g. daily)
throughout the recovery of the animal. To accurately identify the same scan area
between measurements, especially at later time-points as the injury location becomes
less visually distinct, we needed to identify a landmark that would be constant over time.
Because the rodent brain is lissencephalic, we decided to use the surface vasculature,
which forms distinct patterns that were visible at both low and high magnification (Figure
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4.2). From pilot studies, we settled on a scan resolution (distance between adjacent
scan positions) of 40-50 µm because we found that this allowed us to detect subtle
variations in cortical current density and to distinguish between the current density
measurements over the cortex and surface vasculature. We made grid-scans over
regions of interest over the intact brain, estimating the scan to be approximately 50-75
µm above the cortical surface; however, the brain surface is not perfectly smooth so the
exact distance from the cortical surface likely varies among the scan locations.
Consistent with previously-reported results269, we found that the intact rat cortex
sustains an outward current, while the large blood vessels have an inward current over
them. This pattern of current density over scan areas of both intact cortex and
vasculature clearly reveals this pattern (Figure 4.3). We used images of the scan area
to visually categorize each scan position as either surface vasculature or intact cortex;
locations that appeared to be at the border between these two features were excluded
from the analysis. We estimated the mean current density and standard error of the
mean (SEM) over both the cortical surface and the vasculature using a mixed-effects
linear regression model, with the location (i.e. cortex or vasculature) treated as a fixed
effect and the animal treated as a random effect; we ran separate models for each
location because we were not interested in estimating the difference between them (this
is equivalent to running a 1-sample t-Test, controlling for the nested dataset). We found
that the current density over the intact cortex was 33.04 ± 10.86 µA/cm2 (mean ± SEM),
which was statistically different from 0 µA/cm2 (t4.005 = 3.04, p = 0.0383; N = 5 animals, n
= 591). We also found that there was an inward current over surface vasculature, which
we estimated at 29.21 ± 20.24 µA/cm2; however, the model did not find that this was
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significantly different from 0 µA/cm2 (t1.989 = 1.44, p = 0.2865, N = 3 animals, n = 100
observations total), likely because there were far fewer points in the sample because
the vasculature covers a small proportion of the scan area and we could not always find
large enough vessels over which we could make distinct recordings.
We next set out to determine the how current density changes upon injury to the
cortex. We used images of the scan area to categorize scan locations as either over
intact or injured cortex, excluding locations on the border between the lesion and the
surrounding intact tissue. We evaluated how the current density at the injury site
changes compared to the surrounding healthy tissue using a mixed-effects linear
regression model. Specifically, we estimated the fixed effect of the injury while
controlling for the variability in average current density among the animals by treating
the animal as a random effect. We found that there was an overall effect of injury on the
current density (F1, 667.8 = 479.22, p < 0.0001). We found that the mean current density
over the intact cortex was estimated at 13.35 ± 4.394 µA/cm2, which was significantly
different from 0 (t4.414 = 3.04, p = 0.0339); the mean current density over the injured
cortex was estimated at -34.85 ± 4.500 µA/cm2 (the negative indicates that the current
had the opposite direction as that over the intact cortex), and there was a statistically
significant difference in current between the intact and injured cortex, which was
estimated at 48.20 ± 2.162 µA/cm2 (t667.8 = 22.30, p < 0.0001). (Note, JMP v. 11.2.1 was
used for these analyses, and JMP does not provide specific p-values if they are smaller
than 0.0001.) These results demonstrate that the rodent cortex sustains a physiologic
ionic current across itself, and that the current density changes direction over sites of
injury. Together, these observations are consistent with the hypothesis that the injured
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mammalian brain produces physiologic EFs, and that these EFs change immediately
upon injury. Moreover, our methodology suggests that the surface vasculature can
provide an easily-identifiable landmark to make recordings from the same location at
regular intervals over time.

Limitations of current density measurements: artifacts
While measuring the current density over both the intact and injured cortex, we
noticed considerable variability in the current density estimates among different animals
(i.e. the estimated current density over the intact cortex for each of the five animals from
which we obtained good measurements were: 6.30 ± 1.655 µA/cm2; 39.44 ± 1.952
µA/cm2; 9.82 ± 0.560 µA/cm2; 47.66 ± 1.073 µA/cm2; and 61.97 ± 1.091 µA/cm2). While
the pattern of current densities that we measured was consistent among each animal
we used (e.g. outward current over intact cortex, inward current over intact vasculature
and injured cortex), we were concerned about this variability. Specifically, as current
density decays logarithmically as a function of the distance from the source, this
variability could reflect differences in the distance between the probe and the brain
surface due to topographical variations across the brain surface, small errors in
estimating the height above the cortical surface, or the pulsatile nature of the brain due
to the heart rate of the animal; however, it could just as easily reflect a methodological
error. Moreover, the mean current densities that we estimated were over 10-fold greater
than those over the intact cortex that have been previously published269, although they
are within the range of current density measured upon limb amputation in both
salamanders270, 274 and frogs278. To try and determine whether artifact may have
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affected the validity of our measurements, we set out to confirm that the SVET
apparatus was measuring current density accurately by rigorously testing its calibration
settings.
The protocol to calibrate the SVET apparatus specifies that the probe should be
calibrated in the x- and z-axes separately. Specifically, the point-source of current for
the calibration is defined as location (0, 0, 0) (x, y, z) in a 3-dimensional coordinate
system; the probe is brought to (-150, 0, 0) to calibrate the x-axis, and to (0, 0, 150) to
calibrate the z-axis (units are in µm). At each of these locations, the probe records a
reference reading while vibrating to establish the background noise, and then it records
while the point source passes a 60 nanoampere (nA) current. In physiologic saline, the
real current density 150 µm from a 60 nA point current source is 21.2 µA/cm2 (per the
protocol provided by Applicable Electronics, which is the company that manufactured
the SVET apparatus). This measurement is compared to the recordings made by the
probe, and is used to calibrate the phase-offset and the resistivity of the media. We
assessed the accuracy of the probe calibration by making line scans around the point
current source while it was passing 60 nA. We assessed the x-axis using a line-scan
from (-100, 100, 0) to (-100, -100, 0) (i.e. a straight line traveling only through the yaxis), and we assessed the accuracy of the z-axis by recording a line-scan from (0, 100,
100) to (0, -100, 100); we chose to have our line scan pass through the y-axis because
the probe only vibrates in the x- and z- axes and thus cannot record current in the yaxis, so these line scans isolated the current recorded in the x- and z- axis channels,
respectively. We also ran a line-scan through the y-axis to confirm that the SVET does
not have cross-talk between detectors that would cause artifact. When we ran a line-
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scan from (-100, 100, 0) to (100, 100, 0), we found that the SVET recorded a change in
current in the z-axis channel. We were unable to determine whether this signal is a real
measurement due to aberrant vibration in the y-axis, or if it represents an artifact due to
cross-talk between the channels. Thus, the specific current density values that we
estimated over the intact and injured cortex may be suspect and additional experiments
are required to identify the source of the artifact in the SVET and to confirm the values
of current density that we measured.

Considerations for improving experimental design
We assume that these potential artifacts can be addressed given sufficient
resources and further discussion with the company producing the system, so it is worth
discussing how this methodology might be optimized for these in vivo recordings. There
are two principal considerations for further improving this approach. First, the current
density produced over the cortex decreases as a function of the square of the distance
from the surface; it is difficult to measure the exact distance of the probe above the
surface, and the brain is highly contoured so this distance varies over space. Second,
the grid scans we used in these studies take over 12 minutes to complete, which limits
the temporal resolution over any individual point; these grid scans are very helpful in
identifying changes in current density between areas of vasculature and cortex, and
they help to identify the borders between intact and injured tissues. However, once
these regions are identified, the 12 minute scan over the entire area does not afford
sufficient temporal resolution to make consecutive current measurements after the
injury to assess how these currents change over time immediately after the lesion.
187

Instead of one large grid scan at a single plane in the z-axis, we propose either smaller
individual grid scans (e.g. 3x3 x, y) over regions of intact and injured cortex, or a single
line scan covering the distance between the intact and injured tissue which can reveal
how the current density changes over distance from the lesion margin. We also propose
that future experiments employ scans with a step-back protocol whereby the same (x, y)
scan pattern is repeated in multiple (at least 3) steps in the z-axis; this will allow the falloff of the current density to be measured, which can be used to better determine
distance between the measurement and the surface of the brain. (An additional
technical note is that the surface vasculature is elevated above the level of the cortex; in
several of our experiments, the vibrating probe hit a blood vessel during a scan, causing
the vessel to rupture and making it impossible to take subsequent measurements from
that scan area. By specifying smaller scans instead of relying on one large scan area, it
would be much easier to avoid this type of hemorrhage.)

Discussion
These studies demonstrate that it is practical to take in vivo measurements of
ionic current density with an SVET apparatus over the surface of the mammalian cortex,
obviating concerns about bias in these measurements due to damage sustained during
tissue dissection for ex vivo preparations or due to ischemia resulting from the fact that
the ex vivo preparation does not have a functional vascular supply. We found that the
intact rat cortex sustains a steady outward current while the surface vasculature
sustains an inward current, which suggests that there may be a net ionic transport
between the two tissues; we also found that the current over the cortex rapidly reverses
direction upon injury. Importantly, we found that the current density over a cortical injury
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reverses direction more rapidly than we were able to measure (less than 2-3 minutes),
which is consistent with measurements from other studies showing that injury-induced
changes in bioelectricity are immediate; as current density outside the tissue is
fundamentally related to electric fields within the tissue, these results strongly support
the notion that the mammalian cortex creates injury-induced electric fields within the
lesion site and surrounding parenchyma. These results are consistent with the outwards
orientation of current density that has been previously reported over mouse olfactory
bulb269, and with the rapid change in direction upon injury matches the rate of change
reported over the spinal cord, skin, and cornea265, 268, 291.
It is worth noting that the outward current density over the intact cortex that has
been measured both by us and by other groups has an orientation that is opposite that
reported in many other tissues (for a further discussion, see chapter 1, page 48). In the
intact skin and cornea, which have been much more thoroughly studied than the CNS,
there is a steady inward current that is sustained by an asymmetric distribution of
Na+/K+-ATPases in the basolateral membrane of the epithelial cells lining the tissues147,
268, 270, 280, 281, 326

. In contrast, Cao and colleagues found that the astrocyte end feet in

the glia limitans lining the cortical surface expressed Na+/K+-ATPase within the apical
portion of their membranes; moreover, they measured an inward ionic current over the
wall of the lateral ventricle, and they found that ependymal cells lining the lateral
ventricles express Na+/K+-ATPases within their basolateral membranes269. While this
suggests that the discrepancies in the direction of ionic current between the intact
mammalian cortex and other tissues may be a function of the localization of these ionic
transporters, it does not address the reason for which these differences may arise.
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Borgens and Shi found that the axolotl embryo produces ionic currents at least as early
as embryonic stage 16, and they measured an inward ionic current across the entire
ectodermal surface215, 249. The ectoderm is still a laminar structure at this stage and the
neural groove has not yet invaginated to form the neural tube, so the current across the
neural groove has the same orientation as that over the rest of the ectoderm. The
neural tube develops into the ventricular system and central canal of the spinal cord,
and the lateral ectoderm develops into the skin and cornea. Thus, these two structures
are topologically equivalent and ontogenetically derived from the same from the same
structure, so it makes sense that the distribution of ion transporters and the orientation
of the ionic current would be conserved across the skin and cornea, and the ependymal
cells lining the ventricular system. As the neural tube starts out only several cells thick,
the inward current over its apical face would be matched by an outward current across
its basolateral face; as the outer cortical surface develops from the basolateral face of
the presumptive neural tube, it is reasonable to assume that the current density across
it would have an opposite polarity.
The consistencies in our measurements in the context of previous literature, and
the consistent variations we found in current density between the intact cortex and
surface vasculature, strongly support the notion that our measurements reflect the
physiologic activity of the tissue. However, the magnitude of the current densities that
we measured over the intact cortex were approximately 10-fold greater than those
previously reported269; this could reflect the fact that our observations were made in
vivo, and the continued vascular perfusion allowed the brain to maintain a greater
metabolic rate and, consequently, more activity in the ion transporters that drive the
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ionic current. Alternatively, these differences could be methodological and reflect
differences in the distance between the probe measurement position and the cortical
surface. However, these measurements could also reflect an artifact due to a hitherto
undetermined flaw in the setup of our SVET apparatus. Thus, while we are confident
that the polarity of the current we measured reflects the true current density polarity, we
are concerned about the potential contribution of artifact to our measurements and are
therefore not confident about the accuracy of the magnitude of these measurements.
Nonetheless, our results demonstrate that in vivo recordings of ionic current density are
practical, and that this approach can be used to make repeated measurements from the
same animal throughout the recovery period.

191

Figure 4.1: Injury currents in regenerating and non-regenerating vertebrates
A graph illustrating the evolution of the injury current at the site of an amputated
limb in frogs and salamanders; these are summary data based on several studies. The
initial injury currents measured within the tissues are very similar initially, but they begin
to diverge after 2-3 days and remain different throughout the duration of regeneration.
(This image was modified from The Body Electric144 and is reprinted here under the “fair
use” limitation in title 107 of the U.S. copyright law.)

192

Figure 4.1: Injury currents in regenerating and nonregenerating vertebrates
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Figure 4.2: Scanning vibrating electrode technique
(A-D) Procedure for calibrating the vibrating probe, showing (A) the probe off, (B)
the probe vibrating only in the x-axis, (C) the probe vibrating only in the z-axis, and (D)
the probe vibrating in both the x- and z- axes. (Note, the probe cannot vibrate in the yaxis.) (E) Illustration showing where the skull was drilled, relative to bregma and
lambda, to access the cortex for SVET recordings; a piece of bone approximately 3 mm
wide and 5 mm long was removed. (F) Illustration showing the in vivo recording
configuration (courtesy of Christina Delli Santi). (G) A low-magnification view of the
exposed cortex, demonstrating the vascular landmarks that we used; the inset (H)
demonstrates the size of the scan area relative to what we expose.
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Figure 4.2: Scanning vibrating electrode technique
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Figure 4.3: In vivo current density measurements
(A) An image showing the scan area prior to the injury, which was chosen
because of the distinct landmarks made by the surface vasculature (indicated by the
arrow and double-ended arrow), with the double-image of the vibrating probe visible
(notched red arrowhead). (B) The same region, immediately after a 150 µm diameter
insect pin was used to make a stab wound (arrowhead). Surface-plots of the intact (C)
and injured (D) cortex, showing projections of the z-axis current density (µA/cm2) for
each scan position in the x- and y-axes; the grid on each surface plot indicates 0
µA/cm2 z-axis current, positive values correspond to outward current, and negative
values correspond to inward current. Arrows in these surface plots correspond to the
same areas indicated in the images of the scan area in (A, B). (Note, the surface plot in
(C) was from a 5x5 (x, y) grid scan, while the plot in (D) was from a 20x20 (x, y) grid
scan.) (E) graphical depiction of the mean current density over the intact (13.35 ± 4.394
µA/cm2) and injured (-34.85 ± 4.50 µA/cm2) cortex; the random-effects model that we
used for this analysis demonstrated that these two measurements were significantly
different (p < 0.0001).
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Figure 4.3: In vivo current density measurements
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Chapter 5: Discussion

The research project described herein was undertaken to test the hypothesis that
endogenous electric fields regulate the injury response in the mammalian CNS in an
intensity-dependent manner. Specifically, we hypothesized that physiologic injuryinduced EF intensities stimulate the characteristic cellular response to injury, while EF
intensities associated with regenerating tissues modify this response towards one
associated with regeneration. We were particularly interested in the effect of EFs on
astrocytes because differences in particular injury-induced astrocytic behaviors have
been attributed to the highly-regenerative response in non-mammalian vertebrates and
the failure of regeneration in mammals. Through the experiments described in chapters
two and three, we found evidence that EFs associated with injured mammalian tissues
(including in the mammalian CNS) induce behaviors in cortical astrocytes associated
with their response to injury (directional migration and increased proliferation), while no
such responses were found in cerebellar astrocytes; these differences are consistent
with the heterogeneous astrocytic response in vivo, where migration and proliferation of
cortical astrocytes are associated with glial scar formation, whereas cerebellar
astrocytes hypertrophy but do not form a demarcated glial scar. Most excitingly, EFs
associated with regenerating tissues modified the response in cortical astrocytes and
induced a robust response in cerebellar astrocytes, and the particular behaviors
induced were consistent with a regenerative astrocytic phenotype. Our results indicate
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that physiologic EFs regulate wound repair in the mammalian CNS, and that these EFs
may be a viable therapeutic target to promote regeneration after injury. Thus, the role of
EFs in peripheral tissues is likely conserved in the CNS, suggesting that bioelectric
fields may represent a single unifying force that regulates tissue morphogenesis during
embryogenesis and epimorphic regeneration within all vertebrate tissues.

Electric field: a unifying stimulus of embryogenesis and regeneration
The results described throughout this dissertation fit into a broader argument that
physiologic EFs regulate morphogenesis in embryonic and injured tissues. Evidence
that EFs function as morphogens during embryogenesis and regeneration is obvious:
EFs are necessary for both embryogenesis250, 261 and regeneration275, 280, and they are
sufficient for regeneration277, 284 (similarly thorough evidence that they are sufficient for
embryogenesis is currently being explored400, 401). Moreover, EFs induce the same
behavioral effects on diverse cell types in vitro as are necessary for both
embryogenesis and regeneration in vivo. However, the notion that EFs have such a
widely important role as the master regulator of both embryogenesis and regeneration
in vertebrates – and, more broadly, all metazoans – is a hypothesis of causality and,
while numerous experiments that we have described herein support this hypothesis, it is
necessary to formally address this hypothesis.
Sir Austin Bradford Hill enumerated nine criteria to establish a causal relationship
in a publication in 1965402, and these criteria have become the benchmark against
which causality has been evaluated in medicine, epidemiology, and basic science
research over the subsequent 50 years. His nine criteria are listed below, along with a
description and interpretation of each criterion that we have paraphrased from this work:
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1. Strength: the putative causal variable must have a robust effect.
2. Consistency: the association is replicated in studies in different settings
using different methods.
3. Specificity: a single putative cause produces a specific effect; as Hill
describes, this is the weakest of the criteria and is not necessary to
establish causality (he cites as an example that the diseases attributed to
cigarette smoking do not meet this criterion).
4. Temporality: the causal stimulus must necessarily always precede the
observed effect; this is the only essential criterion.
5. “Biological gradient” (i.e. dose-dependency): greater exposure to the
putative causal agent should cause a greater effect.
6. Plausibility: the association should biologically plausible, although – as Hill
points out – what is biological plausible depends on current scientific
knowledge, which can change over time.
7. Coherence: the association should not conflict with the current scientific
knowledge and theory, although occasional paradigm shifts serve as
notable exceptions to this rule.
8. Experiment: altering the causal conditions can alter the effect.
9. Analogy: the proposed causal relationship is similar to other previouslyestablished causal relationships, and alternative explanations have been
considered and, if possible, ruled out.
Importantly, establishing causality is independent of establishing an underlying
mechanism. Moreover, Hill states that there are no formal tests of significance that can
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be used to quantitatively evaluate these criteria. Inferential statistical tests are
quantitative tools that help the researcher evaluate a hypothesis objectively and answer
the question of significance with a “yes” or a “no.” In contrast, Hill’s criteria are
qualitative and are used to interpret the validity of the hypothesis in question.
Many groups have quantitatively demonstrated that EFs have a physiologic effect
on tissues and on cells, during embryogenesis and during regeneration. However, the
inference that the groups exposed to EFs are different in some characteristic from the
groups without similar exposure does not necessarily imply that EFs are causing the
effect in these experiments, nor that EFs are physiologically relevant stimuli in vivo.
Thus, It is worth comparing the current understanding of electric fields in regulating
development and regeneration against Hill’s criteria to establish whether existing
knowledge is concordant with a causal relationship and, if not, to determine which
aspects of the causal relationship are yet to be determined.

Evaluation of EFs as a causal stimulus
We have already provided evidence that EFs conform to a number of Hill’s
criteria for causality. (We refer the reader to the section in chapter one entitled
“Physiologic electric fields regulate embryogenesis and regeneration”, beginning on
page 29, for a thorough discussion of this literature.) EFs are produced by all cells and
in all tissues as a function of their normal physiologic activity, and all cells are affected
by EFs through electrostatic interactions. EFs are increased during embryogenesis, and
their elevation precedes limb bud outgrowth; EFs are also elevated upon injury and
remain elevated throughout regeneration. The intensity of injury-induced EFs is
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associated with the success of regeneration, such that tissues with lower EFs heal by
scar formation while those with higher EFs regenerate. Multiple different groups have
independently demonstrated this correlation between EF intensity and both
embryogenesis and regeneration; moreover, multiple groups have shown that blocking
EFs interferes with embryogenesis and with regeneration. In vivo, EFs have been
manipulated physically by directly applying electrical current to the tissue, manipulated
pharmacologically through multiple different ion transporters and channels, and
manipulated chemically through changing ionic content of tissues; in all of these
examples, similar effects of the manipulation have been reported. At a cellular level,
EFs have similar effects on inducing the same set of behaviors in cells from multiple
different tissues, and the behaviors that EFs induce are the same cellular behaviors that
are necessary for both embryogenesis and for regeneration. Moreover, EFs have been
shown to regulate cellular activity through the some of the same physiologic
mechanisms by which cells have previously been shown to respond to chemotaxic,
mitogenic, and fate-determining stimuli.
Cumulatively, this evidence is consistent with 7 of Hill’s criteria: strength,
consistency, temporality, dose-dependency, plausibility, coherence, and experiment. It
is worth noting that the two criteria not met, those of specificity and analogy, are actually
consistent with the hypothesized role of EFs. EFs do not demonstrate specificity of
effect on tissues or cells as master regulatory genes can stimulate the same cellular
behaviors, developmental pathways, and regenerative effects; however, EFs are
hypothesized to act upstream of the master regulatory genes, so this lack of specificity
is necessary for the putative causal relationship. EFs also do not demonstrate a causal
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relationship that is analogous to any other currently known relationship, but this lack of
analogy is justified because EFs as a stimulus are hypothesized to be unique in their
role as a trigger for morphogenesis. Of course, we could argue that EFs during
embryogenesis are analogous to EFs during regeneration, but that is a
mischaracterization of our hypothesis, which is that elevated EFs regulate the same set
of cellular behaviors independent of the cell type, the tissue, or the species, in order to
drive morphogenesis: in the embryo, morphogenesis is synonymous with embryonic
development; after injury, morphogenesis is synonymous with epimorphic regeneration.
This qualitative review is consistent with our over-arching grand hypothesis: that
EFs have a conserved effect on all cells in all tissues from all metazoans during both
embryogenesis and regeneration. The plausibility of this hypothesis as described thus
far is purely circumstantial: it is based on the fact that all cells produce electrogenic
activity and can detect external electrical cues. However, to be truly plausible, there
must be an evolutionary reason for which EFs would have developed a universal effect
on morphogenesis. Furthermore, while causality does not require an understanding of
the mechanisms underlying the effect, the plausibility of this hypothesis will be strongly
supported if potential physiologic mechanisms can be identified. Thus, we will turn our
attention now to exploring potential physiologic mechanisms and evolutionary origins of
the hypothesized universal role of bioelectric fields.

Injury-induced EFs stimulate regenerative physiology in astrocytes
The plausibility of EFs as a stimulus for development and regeneration relies
upon physiologic mechanisms through which EFs may be transduced, although it is not
necessary for these mechanisms to be elucidated for the hypothesized causal
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relationship to be valid. Nonetheless, we will turn our attention now to exploring
potential transduction mechanisms, with an emphasis on how each of the EF-induced
behaviors on astrocytes that we explored in chapters two and three may be regulated.
CNS regeneration in non-mammalian vertebrates is facilitated by radial glia,
which restore the BBB, guide regenerating axons past the lesion site, and replace the
damaged cell population by functioning as neural progenitor cells. These behaviors are
mediated by a conserved set of cellular behaviors, including migration, proliferation,
changes in differentiation, and morphological changes. Radial glia, which are the
resident GFAP+ cell in the non-mammalian vertebrate CNS, are orthologous to
astrocytes in mammals; the absence of regeneration in the mammalian CNS has been
attributed to the fact that, while astrocytes also migrate and proliferate upon injury, they
do no not undergo changes in differentiation or morphology that allow them to function
as NPCs or to promote axon sprouting. Nonetheless, ample evidence demonstrates that
astrocytes retain a latent regenerative potential as they can be induced both to function
as NPCs and to promote axon outgrowth.
Although we found that EFs stimulate multiple astrocytic behaviors associated
with wound repair and regeneration, we did not explore the mechanisms by which these
behaviors are induced. Ultimately, these transduction pathways are an ancillary
curiosity: the entire idea of exploring EF-based therapies is that EFs will activate
regeneration by regulating each of the necessary physiologic mechanisms, thus
obviating the need to individually target each of the contributing signal transduction
pathways. Nonetheless, in order to establish the causal relationship between
endogenous EFs and regeneration, they must have a plausible way of interacting with
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the known mechanisms by which each of these cellular behaviors is transduced. For the
purpose of exploring the biological significance of EF-mediated astrocytic regeneration,
we will discuss pathways by which migration, proliferation, differentiation, and
morphology are regulated in mammalian astrocytes, and explore potential ways by
which EFs may be transduced by each of these pathways.

Migration
Astrocyte migration requires the directional extension of cellular processes,
which is driven by the assembly of actin and microtubules beneath the leading ends of
these protrusions, and the breakdown of these cytoskeletal elements at the trailing end
of the cell. We observed this same type of membrane protrusion at the leading edge of
migrating astrocytes upon EF exposure, suggesting that the cytoskeletal assembly
drives astrocytes electrotaxis. Directional migration in astrocytes requires polarization of
the Golgi apparatus and the microtubule organizing center (MTOC) within the cytosol;
asymmetric activation of Rho-GTPases then drive microtubule assembly and the
stabilization of polymerized microtubules towards the leading edge403, 404. Consequently,
anything causing MTOC polarization can drive directional migration405. One such
pathway is driven by the Ca2+-mediated activation of Protein Kinase C zeta (PKCζ) at
the leading edge of the cell, which can be induced by the activation of either integrins
(through the GTPase Cdc42) 406 or transient receptor potential vanlloid-1 (TRPV1)
channels, both of which are expressed in astrocytes407-409. Integrins are heterodimeric
membrane proteins that exist in an equilibrium between an active and inactive state
and, when in their active state, an inside-out transduction pathway allows them to be
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activated even without the presence of an external ligand410; because these receptors
demonstrate constitutive activity, the concentration of integrin receptors at the leading
edge of the cell may create sufficient activation at the leading edge to drive directional
migration. TRPV1 channels have a high Ca2+ permeability411, and they have voltagesensitive S1-S4 domains similar to those on NaV-channels that may become activated
due to EF-induced depolarization of the cell membrane412. As both integrins and TRPV1
channels are transmembrane proteins, an external EF may cause their redistribution to
the leading edge of the cell through electroosmosis, thus allowing the cell to transduce
the EF221.
While the role of integrin- or TRPV1-mediated electrotaxis through PKCζ
activation has not been explored, Ca2+-sensing receptors and integrins have each been
shown to modulate migration and differentiation in cerebellar granule cell precursors413.
Moreover, a different second messenger system has been shown to contribute to the
transduction of EFs in hippocampal neurons: upon exposure to external EFs,
phosophoinositide-3-kinase (PI3K) becomes activated at the leading edge of the cell
and its negative regulator, phosphatase and tensin homologue (PTEN), becomes
activated at the opposite side of the cell (Figure 1.8 uses these receptors as an example
of cellular EF transduction through electroosmosis); this activation of antagonistic
second messengers at opposite ends of the cell causes the MTOC and Golgi apparatus
to become polarized, which establishes directional neuronal migration229, 232. Together,
this demonstrates that the polarized organization of cellular organelles necessary to
stimulate directional migration in astrocytes can be induced by external EFs.
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Proliferation
Resting membrane potential (Vm) varies throughout the cell cycle, with a relative
depolarization throughout G1/S and G2/M and a hyperpolarization in interphase216. Vm
exerts a causal role in cell cycle regulation, as hyperpolarization induces a reversible
mitotic block217, while depolarization induces DNA synthesis and mitosis in mature
neurons218, 414. Cells transduce changes in Vm through voltage-gated ion channels,
whose opening-probability, and thus conductivity to ions, changes as a function of Vm.
However, this relationship is not linear as many of the channels that determine Vm are
themselves affected by both pH and Vm, so small changes in Vm can have large
changes on ion channel conductance and intracellular ion concentration392. Increased
Na+ conductance through NaV1.5 channels has been shown to drive mammalian
astrocyte proliferation following an in vitro scratch wound; subsequently, the passive
Na+/Ca2+-exchanger (NCX) causes intracellular calcium levels to rise, which is
necessary for astrocyte proliferation following injury375. Another voltage-gated Na+
channel, NaV1.2, is necessary for the injury response in Xenopus tadpoles, where
increased intracellular Na+ stimulates Salt-Inducible Kinase (SIK), which induces
regeneration following tail amputation in Xenopus tadpoles; regeneration can be
rescued in those animals where NaV1.2 is missing by transfecting human NaV1.5 into
these cells147. SIK, which is a serine/threonine protein kinase – also known as SNF1LK
– that belongs to a family of AMP-activated protein kinases, does not directly transduce
Na+; instead, increased Na+ causes increased intracellular Ca2+ through the NCX, which
activates a calcium-calmodulin dependent kinase that, in turn, activates SIK233, 234, 415,
416

. The transcriptome of mammalian cortical astrocytes published in 2008
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demonstrates that astrocytes express two isoforms of SIK236, and SIK has also been
found in Müller glia417 (the resident astrocytes of the retina), suggesting that this same
pathway may allow astrocytes to transduce EF-induced changes in Vm and regulate
DNA synthesis and mitosis.
Extracellular EFs induce changes in Vm that cause an increase in intracellular
Na+418 that subsequently regulates Ca2+ entry into the cell392, 419, which suggests that
EFs may be transduced through the SIK pathway. Assuming injury-induced EFs drive
astrocyte proliferation after injury through a Ca2+-regulated second messenger system
(e.g. SIK), intracellular Ca2+ and proliferation should be greatest at the lesion border
where EFs are highest, and they should decline with distance to the lesion margin in
parallel with the decay in EF-intensity over distance from through the penumbra (Figure
1.7). Indeed, intracellular Ca2+ concentration increases in astrocytes upon injury, but
this dissipates with distance from the lesion408; and astrocyte proliferation following SCI
is confined to the immediate penumbra33, 420. Additionally, EFs should have a cell-type
specific effect on proliferation as voltage-sensitive membrane protein expression varies
among different sub-populations of cells, a supposition that is supported by
observations that membrane depolarization in neurons stimulates DNA synthesis and
mitosis218, 414 while 200 mV/mm EF application inhibits endothelial cell proliferation (50
and 100 mV/mm had no effect) 421. The hypothesis that EFs modify the Vm to regulate
cell cycle checkpoints that induce proliferation suggests that cells would only need to be
exposed to EFs long enough to get past these cell cycle checkpoints. Consistent with
this hypothetical mechanism, a single EF pulse stimulates the activation of members of
the fos and jun gene families, as well as the persistent activation of multiple
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transcription factors within one hour of exposure422. Moreover, astrocyte proliferation 24
hours after a scratch wound requires a Na+ current through NaV1.5 only for the first 15
minutes after injury375, and tail regeneration in Xenopus tadpoles requires only 1 hour of
Na+ current to stimulate regeneration147. Together, these observations demonstrate that
EFs regulate a signal transduction pathway that is known to stimulate astrocyte
proliferation, thus supporting the hypothesis that EFs have a causal effect in regulating
proliferation.

Differentiation and neurogenesis
In peripheral tissues, injury-induced EFs stimulate terminally differentiated cells
to revert to an immature progenitor phenotype, and these proliferating progenitors
respond to master regulatory genes that guide morphogenesis throughout regeneration.
In order for injury-induced EFs to stimulate regeneration in the mammalian CNS through
astrocytes, elevated EFs must effect changes in astrocyte gene expression, and
astrocytes must be able to respond to master regulatory genes. In the previous sections
on migration and proliferation, we discussed possible mechanisms by which astrocytes
may transduce EFs through second messenger systems associated with Ca2+, PI3K,
PKC, and SIK; these same pathways can also contribute to transcriptional modification
of genes associated with changes in differentiation, such as regulation of Notch1 and
BMP by SIK-signaling during Xenopus tadpole tail regeneration147. Moreover, we
previously described how cells transduce EF-induced changes in Vm to regulate
proliferation, and how Vm is also associated with differentiation: progenitor cells have
relatively depolarized Vm that become increasingly hyperpolarized as they
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differentiate423, changes in Vm have been shown to actively regulate differentiation of
mesenchymal stem cells424, and elevated EFs increase neurogenesis from mammalian
NPCs in vitro244. A comprehensive study of the transciptome of murine astrocytes
demonstrated that mature astrocytes express multiple receptors and downstream
mediators necessary to transduce each of the master regulatory genes associated with
epimorphic regeneration, including those for BMP, FGF, RA, Shh (the Ptch1 receptor),
TGF-β, Wnt (the Fzd receptor family, especially Fzd2); and an ingenuity pathway
analysis specifically identified Notch, Wnt/β-catenin, TGF-β, and Shh signaling
pathways as being particularly enriched in astrocytes as compared to other cell types
within the CNS236. Moreover, mature astrocytes actually express the transcripts for
BMPs, FGFs, Shh, TGF-β, Wnt, suggesting that they may be a source of these
morphogens in regenerating tissues236. It is well-established that astrocytes in the adult
mammalian CNS have an ability to function as NPCs, but that this neurogenic potential
is constitutively inhibited through Notch signaling103, 104; as astrocytes express SIK, and
SIK signaling promotes regeneration in other tissues through regulating Notch, EFs may
be able to induce regeneration in astrocytes by inhibiting Notch-mediated repression of
neurogenesis through SIK signaling.

Biophysics of EF transduction
Heretofore we have framed our discussion under the assumption that cells detect
purely the vector components of the EF: their magnitude and their orientation. However,
this is a gross oversimplification of the information encoded by EF vectors. We have
already described the fundamental relationship between EFs and ionic currents, which
210

themselves may regulate cellular physiology through magnetic interactions induced by
the moving charge and thus may have effects that are completely independent of EFs.
(These potential magnetic interactions are beyond the scope of this already expansive
disquisition and thus will not be further considered here.) Within the scope of EFs, we
have already suggested that EFs may also respond to the magnitude of the change in
EFs, and to the duration of EF exposure. In the context of our overarching hypothesis –
that EFs have an intensity-dependent effect on wound repair – we must consider that
cells are exposed to EFs both in the intact tissue prior to the injury, and in the injured
tissue immediately thereafter. Thus, cells may respond to the absolute value of the
injury-induced EF, the absolute value of the change in EF intensity induced by the
injury, the relative increase in EF-intensity upon injury, or the rate of change in EF
intensity upon injury. Moreover, as some EF-induced cellular responses only require the
initial activation of certain second messenger cascades, the duration of EF exposure
also may also be an important signal: cells may respond to the total duration of the
applied EF, or they may only require a certain EF flux (e.g. a higher EF over a shorter
duration is equivalent to a lower EF over a longer duration). Each of these signals may
be relevant in certain circumstances, and multiple properties of EF signaling may be
involved in regulating different behaviors within the same cell; for example, the initiation
of a cardiac action potential requires the myocyte to depolarize to an absolute value (i.e.
the threshold potential), but the rate of this electrical conduction through the
myocardium is dependent on the rate of cell depolarization once the action potential is
triggered. Thus, while our exploration of the relationship between EFs and regeneration
may be facilitated by this simplification, the biophysics underlying this relationship is far
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more complex. Moreover, this suggests that our experimental approach of manipulating
the absolute value of EF intensities to assess EF-induced effects on cells in vitro that
we employed in chapters two and three, and that have been employed by many other
labs, may not detect the full effect that physiologic EFs have on cellular behavior if cells
transduce components of the EF other than their absolute value.

The evolutionary relevance of electric fields
In the previous section, we established that EFs can plausibly interact with the
physiologic mechanisms regulating each of the astrocytic behaviors necessary for
epimorphic regeneration and, by extension, embryonic development. Now we turn our
attention to exploring reasons for which cells would have evolved an ability to respond
to EFs, and why EFs may play such an important role in regulating development and
regeneration. The evolution of the important role that EFs play in development and
regeneration presents a considerable conundrum given that EFs only encode bivariate
information (i.e. magnitude and direction), while the complex tissues within vertebrates
seem to require interactions among the myriad families of signaling pathways whose
necessity for morphogenesis we have already established. However, this teleological
understanding of EFs is not consistent with their evolutionary origins.

Ubiquity of EFs explains their evolutionary significance
As ontogeny recapitulates phylogeny, an understanding of when EFs begin to be
involved in embryogenesis will inform our understanding of their evolutionary origins.
The earliest endogenous bioelectric activity that has been measured in embryonic
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vertebrates is immediately prior to limb bud formation248, 250, 252, but this late
measurement reflects technical difficulties in measuring EFs at earlier embryonic time
points and is not an indication that they are absent at the start of development. Indeed,
studies have found that asymmetric electrical activity precedes polarization of the
fertilized egg from the alga Pelvetia, demonstrating that bioelectric signals are
associated with the earliest stages of eukaryotic development. Moreover, the role that
EFs play in establishing cell polarity in Pelvetia embryos246, 425 is similar to the role of
EFs in defining body axes and guiding limb development in vertebrates252, 315, 400,
suggesting that EFs played a similar developmental role in the common ancestor to
these two species – which existed before the division of the ancestral eukaryote into the
Unikonta and Bikonta supergroups that is estimated at 1100 – 2300 million years ago160,
426

. As bioelectric signaling was already involved in developmental processes in the

primordial eukaryote, it is likely that the interaction between EFs and physiology has
evolutionary origins that are far older.
According to the theory of common descent, all extant life evolved through
speciation from a universal protocellular ancestor. This protocell developed from the
aggregation of a replicating genome containing hereditable information within a
membranous vesicle that compartmentalized it from the surrounding environment427.
Consequently, these basic elements of cellular physiology – a semipermeable
membrane and a self-replicating genome – would have had the opportunity to be
conserved among all life. In turn, each of these elements originally developed from the
spontaneous formation of organic molecules from inorganic ions, and the polymerization
of these molecules into structures capable of catalyzing their own replication. These
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chemical processes developed in an acellular environment and thus they would have
been directly affected by the physical properties within the environment, including solute
concentration, heat, and electrostatic forces. Evolution has had billions of years to shed
the mechanisms by which life detects these fundamental properties of the environment,
but the fact that there are species among extant archaea, bacteria, and eukarya that still
respond to each these cues underscores the importance of these physical properties to
life.
Electric fields are the most important of the physical properties of the
environment to molecular interactions because, while temperature and solute
concentration may affect the rate of metabolic reactions (and may even affect the
stability of the tertiary and quaternary structures of larger macromolecules), the actual
interactions between different molecules are mediated through their electric fields. The
arrangement of polar and charged residues on the surface of molecules creates EFs
that propagate through the surrounding area; electrostatic interactions between the EFs
from different molecules mediate their formation into molecular complexes428, and EFs
within the active site of enzymes are necessary for their catalytic activity429. Moreover,
certain electrostatic properties appear to be evolutionarily selected in proteins to
maintain specific functions428, 429. Indeed, the earliest organic molecules may have
reacted with each other exclusively through electrostatic interactions as more elaborate
molecular signals and enzymes had yet to originate. These same charged residues
mediating intermolecular interactions also allow biological macromolecules align their
dipoles parallel to the orientation of environmental EFs. It follows that cells should also
be able to detect and respond to environmental EFs, as cells are merely aggregates of
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ions and biological macromolecules. As these basic molecules of heredity developed
prior to the origin of the protocell, interactions between external EFs and biological
molecules must predate the origin of cellular life.
Models of the membrane in primitive cells suggest that these original membranes
were composed of simple fatty acids that allowed for the passage of polar solutes
without the aid of specific transport machinery; such transport mechanisms gradually
emerged as protocells developed nutrient requirements that exceeded those available
through passive diffusion, and as the increasing complexity of membrane lipids caused
membrane permeability to decrease430. These transport mechanisms include selective
ion channels and transporters whose very activity is electrogenic because they result in
a net movement of specific ions. Consequently, not only did protocellular physiology
develop in an environment in which they were constantly exposed to EFs, but cells also
began to produce their own electrogenic signals early in evolutionary history. Moreover,
EFs have a universal effect on charged molecules, so physiologic EFs would have
allowed early cells to interact with each other prior to the evolution of specific signaling
molecules.
EFs retained their physiologic relevance in intercellular communication
throughout the evolution of multicellularity, which explains their integral role in
morphogenesis during development and regeneration. In multicellular organisms, each
tissue may have evolved a characteristic EF in parallel to the evolution of the tissue
itself: each tissue has a characteristic structure that defines its electrical properties431,
and each tissue is composed of characteristic sub-populations of cells that each may
have unique electrogenic activity212. Epithelial cells lining the embryo sustaining the
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same electrogenic activity as they do in adults but, because the undeveloped embryonic
tissue is much thinner than the mature tissue, this electrogenic activity results in EFs
that are elevated within the embryo (i.e. embryonic EFs are elevated in part because
the same voltages created by epithelial cells are spread over a much shorter distance).
Nascent tissues thicken throughout embryonic development due to EF-induced
progenitor cell proliferation, which causes EFs to gradually diminish, which
consequently drives the progressive differentiation of stem cells into increasingly-mature
populations423, 424. In the developing limb, epithelial cells in the apical ectodermal cap
(AEC) produce a high EF that may sustain progenitor cell proliferation in the underlying
blastema; these EFs dissipate with distance from the AEC, allowing more proximally
located progenitors to differentiate, and this voltage gradient may contribute to planar
cell polarity that helps pattern the proximodistal axis of the developing limb248, 252, 401.
Characteristic physical properties of tissues may have also led to the evolution of
EFs as a key signaling mechanism in the injury response. Injury changes the physical
properties of tissues, causing a passive increase in the EF intensity that is immediate
and is based purely on the physiologic electrogenic activity in the tissue prior to injury.
In contrast to the immediacy of changes in bioelectric signaling following injury,
molecular signals associated with the injury response are relatively slow as they are
actively released only upon exposure to specific triggers, and certain signaling
molecules first need to be synthesized. Moreover, molecular signaling is limited by the
relatively slow process of diffusion through the lesion site, whereas bioelectricity
propagates instantly through the tissue surrounding the lesion and dissipates only as a
function of distance. Furthermore, these elevated EFs, which have been shown to drive
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the dedifferentiation of cells into pleuripotent progenitors245, 424, may drive epimorphic
regeneration because they are the same signal that drives morphogenesis during
development. Thus, the proposed importance of EFs in regulating molecular
interactions within and between cells, and in tissue morphogenesis during development
and regeneration, is compatible with the current understanding of the origins of life and
subsequent metazoan evolution.

Evolutionary loss of EF-induced regeneration
Given the ubiquity of EFs in biological systems and their conserved role in
regulating both embryonic development and regeneration, it is particularly curious that
mammals have generally lost the ability to spontaneously regenerate. Having described
in the previous section multiple reasons for which EFs evolved to be integrally important
to development and regeneration, we must now consider how mammals have evolved
the loss of EF-induced regeneration. The form of regeneration with which we are
concerned is that which recapitulates embryogenesis so, as we described in chapter
one (page 18), these mechanisms must be conserved in mammals as they are identical
to those underlying their original embryonic development. We have also described
evidence that these pathways are expressed in mammals in a functional state, and the
experiments that we described in chapters two and three demonstrated that EFs can
induce each of the astrocytic behaviors necessary for regeneration. Furthermore, we
have discussed evidence that injury induces an increase in EFs in multiple mammalian
tissues, so the putative stimulus initiating regeneration is also clearly conserved.
Therefore, the absence of regeneration must be due to a divergence between the
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robustness of the injury-induced EFs in mammals and the sensitivity of the signal
transduction pathway through which cellular regeneration is initiated. Injury-induced EFs
may have declined in intensity due to evolutionary changes in the physical properties of
mammalian tissues – either to a changing composition of the ECM altering the dielectric
properties of the parenchyma431, or to the development of the sub-dermal lymphatic
system that electrically grounds the EF278 – or to an evolutionary diminution in the
electrogenic capacity of epithelial cells. We have already described myriad pathways
through which cells may transduce EFs; decreased efficiency of any of these pathways
– due to a necessary molecule having reduced sensitivity, expression, or activity – could
attenuate the cellular response to injury-induced EFs.

Loss of regeneration as an evolutionary adaptation
We have established that physiologic EFs regulate morphogenesis during
embryonic development and regeneration, and that the physiology by which EFs are
produced and transduced by cells is universally conserved. Therefore, the fact that
regenerative potential exhibits variable expressivity among different vertebrate clades
(Figure 5.1), and among different species within each clade, raises the question of why
regeneration is not universal given that the underlying physiologic mechanisms are.
This question is particularly pertinent in establishing the causality of endogenous
electric fields as a universal regulator of embryogenesis and regeneration: in the
previous section we posit that EFs evolved a loss-of-function mutation in certain
vertebrates such that they continue to regulate embryogenesis but are insufficient to
stimulate regeneration; for this hypothesis to be valid, we have to demonstrate that the
loss of regeneration is evolutionarily plausible and coherent with preexisting theory.
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Regeneration was a feature of the original metazoan
Two competing theories account for the observed variability in regenerative
potential (Figure 5.2): regeneration may have evolved from a common non-regenerative
ancestor independently in each lineage where it is expressed, or regeneration may have
been evolutionarily lost from a common regenerative ancestor. Under the hypothesis
that regeneration in extant vertebrates is expressed only in those species where it arose
as a gain-of-function adaptation from a non-regenerative ancestor, the underlying
physiology would be expected to vary widely among different species. Instead, the
physiologic mechanisms underlying epimorphic regeneration involve the conserved role
of endogenous EFs and master regulatory genes, which has been demonstrated in 10
extant vertebrate clades and absent only two – mammals and birds (Figure 5.1) 123, 125,
133, 136, 188

. Thus, the principal of parsimony summarized eponymously as Occam’s

Razor suggests that the common ancestor among vertebrates expressed regeneration
and that loss-of-function adaptations independently arose in separate clades (theory
posited in Figure 5.2A). However, this conclusion merely displaces the original
quandary: mammals evolved the loss of regeneration from a highly-regenerative
common ancestor, but it does not address the question of whether regeneration
originated as a gain-of-function adaptation in this common ancestor or if regeneration is
a more universal trait.
In addition to phylum Chordata61, 124, 125, 133, 142, 143, 154, 432, 433, of which Vertebrata
is a subphylum, epimorphic regeneration has also been demonstrated in phylum
Arthropoda434-436, and total body regeneration has been demonstrated in phyla
Cnidaria437-439, Platyhelminthes440, 441, and Porifera442. As regeneration has been
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conserved across these diverse phyla, it is likely that regeneration is a feature present
in the original metazoan – a multicellular organism resembling the modern sea-sponge
– and that it was preserved through speciation to the common vertebrate ancestor after
which it was subsequently lost within the mammalian clade subsequent to its
evolutionary divergence from other vertebrates in which regeneration was retained.
It may be counter-intuitive to think that the loss of regeneration may confer an
adaptive advantage to a species. However, evolution is not progressive: it is the result
of cumulative selection pressures from immediate environmental factors acting on
individuals, the culmination of which favors the emergence of a specific trait over
multiple generations. Evolution requires that these traits are heritable characteristics
with variable expression among different individuals within the population, and that
environmental pressures acting on individuals at discrete points in time favor the spread
of a subset of those characteristics over the expense of others. Not all traits are
adaptive, and those traits that are beneficial in one generation may lead to a series of
adaptations over subsequent generations that are ultimately maladaptive443, 444.
It is posited that colonies of unicellular organisms resembling choanoflagellates
gradually developed codependence, resulting in the original metazoan that is the
progenitor of all multicellular life134, 445-448; this organism likely resembled modern seasponges that are composed of individual choanocytes that are cytologically similar to
the unicellular life forms from which they descended446. These original metazoans
represent the advent of regeneration and demonstrate its fundamental importance to
multicellularity: codependence creates a situation in which the loss of an individual cell
does not equate death of the entire organism, and thus those individual cells lost to
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injury need to be replaced by the remaining cells within the animal. Similarly to colonies
of unicellular organisms, these original multicellular organisms may survive after the
death of a subset of their cellular composition, and new organisms may be regenerated
from a small number of isolated individual cells. Sea-sponges – representing the origin
of multicellularity and cellular codependence – are able to regenerate in much the same
way: loss of a portion of the sponge is replaced by regeneration while isolating small
numbers of dissociated cells results in the re-aggregation of these cells into a functional
organism442.
Selection pressures favoring cellular codependence resulted in the development
of a simple organism resembling the modern sea sponge and continued to encourage
the speciation of this metazoan into increasingly diverse phyla446. The original
regenerative capacity of sea sponges is preserved in modern hydra437, 438 and
planaria441, 449 as demonstrated by their capacity to regenerate complete organisms
from only a small number of isolated cells, and this suggests that regeneration was an
important feature worth preserving over the hundreds of millions of years of evolutionary
history since the origin of multicellularity. Deuterostomes share a common ancestor with
planaria and hydra134, 160, 426, 446 but the totipotent regenerative phenomena expressed in
planaria and hydra are lost in subset of deuterostomes from which vertebrates
emerged. Within the phylum Chordata, Urodele amphibians and Teleost fish represent
two examples of numerous non-mammalian vertebrates capable of completely
regenerating their hearts, spinal cords, limbs/fins, and other organs after significant
damage105, 122, 124, 450, 451; mammals do not exhibit these robust regenerative
properties452-454 in spite of the fact that all vertebrates share a common ancestor134.

221

Because regeneration is a process found among most multicellular organisms, the
principle of parsimony suggests that these regenerative mechanisms developed once
and that its subsequent loss represents relatively unique evolutionary adaptations.
Thus, the loss of regeneration in higher vertebrates in spite of the proficiency with which
Urodeles and Teleosts recover from injury suggests a strong selection pressure against
the ability to repair certain damaged tissues.
Mammals may have evolved an inability to regenerate, but many other
organisms retained this feature over an equally long evolutionary opportunity to lose it. It
is a fallacy to think that these early-branching organisms split from the vertebrate
lineage and became evolutionarily stagnant; they have had as much time to evolve as
have mammals. Although there has been an incredibly long time for the mechanisms
underlying regeneration in these distantly-related organisms to evolve different
mechanisms, the conservation of orthologous regenerative genes across multiple phyla
indicates that there has been a constant selection pressure favoring the preservation of
regenerative physiology. Mammals do not typically express epimorphic regeneration as
adults, but the functional preservation of the underlying genes and pathways
demonstrates that the potential to induce regeneration is retained136, 437, 455-461.
Conservation of the pathways underlying regeneration throughout hundreds of
millions of years of evolution indicates their fundamental importance. Given the extent to
which regeneration can occur in other lineages, the loss of these phenomena in
mammals is, when considered as an independent variable, likely a cause of increased
mortality in these organisms following injury. That these pathways are present but
unexpressed in mammals indicates that there must be a greater benefit afforded
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elsewhere by suppressing regeneration than is gained by completely resolving organ
damage through regeneration after injury. Understanding the selection pressures
favoring the loss of regeneration is necessary to inform the development of a
therapeutic strategy to stimulate a regenerative phenotype while compensating for
those evolutionarily adaptive traits through which it is suppressed.

Inclusive fitness: lost regeneration as an adaptive advantage
Developing a multicellular lifestyle requires a shift in fitness strategy favoring
inclusive fitness over a direct reproductive approach. The metazoan concestor likely
resembled a simplistic sea sponge that, as already discussed, was capable of
regenerating its entire body plan from small aggregates of individual cells445-448. This
totipotent regenerative capacity was conserved past this point and is still expressed
among different modern phyla including Porifera442, Cnidaria437, 438, and
Platyhelminthes441, 449. Organisms from each of these phyla show evidence of
immortality: Porifera re-aggregate upon being dissociated into individual cells442; Hydra
reproduce when offspring bud from the parent while the parent remains capable of
surviving and reproducing over the course of at least four years (the longest published
example of hydra reproduction being studied) 462; Planaria reproduce by binary fission
producing two offspring from the original parent, and injury resulting in one Planaria
being torn in two results in the regeneration of two independent organisms463, 464. This
same type of immortality is seen in many unicellular organisms447, 465 that reproduce
symmetrically to form two identical and indistinguishable daughter cells and suggests
either that immortality results from convergent evolution that returned to metazoans
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after the advent of multicellularity, or that the original metazoan concestor was a
conglomerate of immortal codependent cells. The preponderance of evolutionary
evidence and the simplicity required by Occam’s razor suggest that the totipotent
regenerative capacity in sea sponges, and the immortality of Porifera, Planaria, and
Hydra, are the result of immortality within the original metazoan.
Multicellular life most likely began with an immortal organism, so the
deuterostome clade in which modern mortal organisms must have evolved the trait of
mortality at some subsequent point in its speciation134, 137. Common ancestry between
mortal and immortal organisms implies that the concestor population from which the trait
of mortality arose contained coexisting mortal and immortal members. That this clade
survives and has undergone wildly successful speciation events over hundreds of
millions of years, and that examples of convergent evolution of mortality is seen in
examples of asymmetrically dividing prokarya in which the parent cell ages and dies466,
467

is a clear indication that mortality must offer a significant benefit to the survival of a

species.
Mortality’s survival benefit is assumed because of the evolutionary success of
organisms in which this trait exists, but a net benefit is not required for its persistence in
a population. What is necessary for the continued existence of mortality is that its
development does not yield a net loss in fitness468, 469. While numerous other phyla
developed during this era of evolutionary history, widespread extinction of entire phyla
suggests that selection pressures are extremely effective at eliminating maladaptive
traits from the evolutionary gene pool. Modern computer models of the spread of
adaptive traits that benefit decreased individual reproduction support this and show that
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novel phenotypic traits may spread rapidly through a population (within 500
generations) accompanied by the equally quick loss of the maladaptive version468.
Therefore, while the magnitude of the direct benefit offered by its evolution may be
controversial, it is established that mortality is at least not maladaptive.
The development and success of mortality, together with the loss of totipotent
regenerative potential in higher vertebrates, suggests that there must be an adaptive
advantage to eliminating individual organisms for the benefit of the entire species.
However, the adaptive benefit of death directly conflicts with the evolutionary axiom that
the organism with the greatest fitness is the one producing the most offspring. Imagining
the concestor in which mortal and immortal organisms coexisted, it is intuitively obvious
that the infinite reproductive capacity of immortal variants must have a fitness
advantage over the mortal variant that eliminates itself from the reproductive population.
This hypothetical situation, while informative, is incomplete. Interpreting the best
adaptation as the one leading to the greatest number of direct offspring is a
conceptually-simple fallacy that obfuscates the reality that, although natural selection is
based on unequal inheritance of phenotypes, the heritable unit of a phenotype is the
genotype on which it is based. Thus, although inheritance of traits is easy to
conceptualize, selection pressures favor the particular alleles that are best able to reach
the next generation regardless of the method by which they are propagated. While
individual reproduction creates immediate genetic transmission that increases the direct
fitness of an organism, the ubiquitous evolutionary loss of directly-reproducing life within
metazoans due to the distinction between somatic and germ cell lines indicates that
selection pressures beyond direct fitness must also participate in evolution.
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Following the evolution of mortality, further traits developed in which tissues lost
their totipotent regenerative route of reproduction in favor of a distinct germ cell line
from which all of that organism’s descendants arose. This development created a
situation in which a subset of cells became completely incapable of directly reproducing,
instead relegating reproduction to a specialized germ cell lineage. The remaining
somatic cells sacrifice their direct inter-generational reproductive potential in favor of
increasing the fitness of the specialized germ cells. Multicellular organisms represent an
enormous conglomerate of clonal cells that, although differentiated into different
phenotypes, are (for the most part) genetically identical. While non-germ cells forego
direct reproduction in favor of assisting the germ cells, the genetic homogeneity means
that each cell has the same reproductive fitness regardless of whether it is the direct
progenitor of the reproducing germ cell. Thus, the somatic cell population can forego
direct reproduction because it has the same fitness afforded to it by germ cell success
that it would if it was directly responsible for reproduction.
More recent examples in evolution recapitulate the same axiom: that there are
situations in which a greater reproductive benefit exists by foregoing opportunities to
reproduce directly in favor of offering a benefit to other closely-related members of the
population468, 470. Numerous examples within phylum Arthropoda illustrate the adaptive
advantage of survival strategies that employ a helper caste whose primary fitness
benefit is through assisting their close kin rather than by directly reproducing471-473.
Paper wasps employ an altruistic strategy by which fertile females forego direct
reproduction in favor of assisting the reproductive efforts of their colony’s founding
queen471; gene expression changes when females become the foundress queen of a
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new colony, which corresponds to a dramatic increase in reproductive behavior473.
Eusocial behavior is an alternative indirect fitness strategy exemplified by the honeybee
in which a morphologically distinct worker caste of sterile female functions to maintain
their closely-related hive: workers deter invaders with the kamikaze delivery of venom
through a barbed stinger, which is left embedded in the victim along with the bee’s
venom sac and abdominal viscera474, 475.
Altruism and eusocial behavior pose an evolutionary paradox first solved by
Hamilton in the 1960s. He predicted that indirect fitness would become a predominant
fitness strategy in any species in which the allelic benefit from indirect fitness
outweighed the cost of lost direct reproduction469; specifically, he predicted that indirect
fitness strategies would emerge in a population whenever rb – c > 0 (where c is the
fitness cost to the altruist, b is the benefit to the beneficiary, and r is their genetic
relatedness) 468. The extent to which evolutionary altruism is advantageous is illustrated
by multiple examples of convergent evolution towards this phenotype among different
arthropod species, of which the altruistic paper wasp and the eusocial honeybee serve
as two examples. The high degree of genetic relatedness among members of the paper
wasp471, 473, 476 and honeybee hives472, 474, 475 and the prolific reproduction of the colony
queens results in an incredibly high allelic benefit afforded by indirect fitness methods.
Kin selection also occurs within mammals, as is illustrated by the altruistic alarm
call behavior seen in Belding’s ground squirrels477. Ground squirrels selectively alert
their close kin to the presence of predators so that they will have an increased
opportunity to protect themselves, but this calling behavior significantly increases their
risk of death through predation. The benefit of increased kin survival outweighs the
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direct cost of increased predation. Similarly to the altruistic insects that forego direct
fitness to benefit their hive, ground squirrels are much more likely to give alarm calls
when they have closely related kin that stand to benefit from this behavior. However,
squirrel populations are not as genetically homogenous as those of insects: while
females stay close to their place of birth and are typically surrounded by kin, males
travel to new territories and do remain to help raise their offspring. Females, therefore,
are much more likely to have close kin that stand to benefit from altruistic behavior than
males do, and they are also much more likely to emit alarm calls than are males477.
Although a less dramatic example than the suicidal behavior in insects, this still
illustrates the benefit of foregoing individual reproductive opportunities to benefit close
relatives.
Inclusive fitness helps resolve the paradox created by the evolutionary success
of mortality and the potential benefit of an individual foregoing direct reproduction.
Initially proposed by Hamilton, the overall benefit of an individual’s fitness – described
as the sum of direct and indirect fitness – illustrates the idea that natural selection
responds to the interaction between phenotype and environment by favoring the
transmission of the responsible genes468, 469. An individual organism may increase its
genetic impact on subsequent generations through direct reproduction, or through
supporting other organisms that are genetically similar. In this context, the success of
both mortality and altruism as adaptations implies that each trait must increase the
overall inclusive fitness of the organism expressing it.
Complex organs evolved at the cost of direct fitness to the somatic tissue, which
is evolutionarily understandable in the context that the cost of lost intergenerational
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reproduction by the cells in each organ is outweighed by the benefit from a net fitness
gain through inclusive fitness. To achieve this gain, each organ must have developed in
a way that supported increasingly advantageous functions of the entire organism.
Therefore, loss of organ function following injury is understood to be detrimental to the
overall function of that organism. In non-mammalian vertebrates, and elsewhere
throughout metazoans, totipotent regeneration permits complete recovery after tissue
damage124, 125, 134, 438, 441, 449, 463. Regeneration is a feature without which an organ
cannot recover from injury, ergo the loss of regeneration in mammals must reflect an
adaptation that is ultimately beneficial to the species’ fitness.
Establishing that the loss of regeneration is associated with a survival advantage
in mammals implies that novel selection pressures, which would have arisen at the point
when this clade diverged from a regenerative concestor, must have favored this
development. It is likely that two distinct pressures drove this development in parallel to
each other: one favoring the evolution of increasingly complex organs whose
maintenance following injury required rapid recovery of function, and a second through
which injured individuals somehow compromised the fitness of the entire group.
Regeneration is energetically costly and time consuming, and the increasing importance
of each organ likely favored a reparative response to rapidly restore functional integrity
while inadvertently antagonizing the regenerative pathways. The decreased survival
(and direct fitness) of the individual created by this failure to regenerate is insignificant
when juxtaposed with the benefit to the surviving group members that no longer need to
care for those infirm injured individuals that have decreased capacity to gather food,
defend the group, or otherwise move.
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Lost regeneration is not an epiphenomenon of evolution
The CNS and the heart are two examples of organs whose obstreperous
response to injury does not support regeneration even though the pathways through
which regeneration could be facilitated are preserved in a latent state. The benefit to
inclusive fitness is only a partial explanation for why regeneration is not expressed: the
loss of regeneration may not be directly advantageous to either the clade or the
individual, but the fitness benefit resulting from regeneration was less than the fitness
provided by the reparative processes of astrogliosis and cardiac fibrosis. As the
physiology of regeneration and fibrosis directly conflict with each other, wound repair
through fibrosis out-competed regeneration. Although not expressed, the preservation
of latent regenerative physiology in mammalian tissues suggests that these
mechanisms are still important for the normal function of the species and that there has
been an active selection pressure to maintain it.
Traits may be eliminated by different mechanisms, each of which is informative
about the reason for which it was lost. Convergent evolution of atrophied organs and
genes illustrates the frequency with which obsolete functions accumulate loss-offunction mutations once the selection pressure to maintain them is removed: organs
persist as vestigial remnants (e.g. the appendix and coccyx in humans478, 479, and the
recurrent convergent atrophy of eyes in blind cave fish480), while genes become
nonfunctional pseudogenes (e.g. hundreds of human odorant receptors became
pseudogenes as they became increasingly visual animals, compared to the 1200-1500
functional receptors that remain in other olfactory vertebrates) 481. Obsolete genes and
tissues persist in vestigial or pseudogene states because, while the pressure to
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maintain them is removed, there is no selection favoring their loss. Alternatively,
maladaptive phenotypes are actively selected against and, as in the case of the Irish Elk
in which the initially adaptive enlargement of the male’s horns ultimately became too
heavy for the males to lift their heads444, may lead to the extinction of the entire species.
Together, this supports the notion that regeneration is not expressed in mammals
because it is subrogated by the gain-of-function of new physiology with which
regeneration is mutually exclusive.
Although atrophy and negative selection are common mechanisms driving
evolutionary change, neither of these mechanisms is responsible for the loss of
regeneration in mammals. Instead of being selected against or being lost to evolutionary
atrophy, regenerative physiology is maintained in a potentially functional state that may
be actively suppressed during injury42-44, 450, 482. Multiple mechanisms exist by which a
trait may be lost as a species evolves, and each pathway reflects the emergence of a
different selection pressure. While maladaptive traits often result in extinction and
obsolete traits become vestigial, unexpressed pathways are preserved when the
function they serve remains a strong benefit under specific circumstances. For
regeneration, the functional preservation of the underlying physiology is likely due to the
conserved use of these pathways during embryogenesis142, 437, 441.
Mammals do not commonly regenerate following significant damage to their
heart, CNS, or limbs, but the functional orthologous pathways promoting regeneration in
other vertebrates are conserved in mammals. This implies that tissue regeneration in
mammals was once adaptive and, while the preservation of these pathways may be due
to their involvement in embryogenesis, that they persist in adulthood suggests that a
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therapeutic program has the potential to stimulate regeneration if the physiologic
mechanism through which spontaneous regeneration is activated in other organisms
can be identified in mammals. Given the health care burden of caring for patients
suffering from long-term sequelae of CNS injury16, 21, 483, 484 and the inability to find a
substantial therapeutic intervention to promote functional recovery485-487, a strategy to
promote regeneration based on these physiologic mechanisms should be a research
priority.

Immune system and the effect on regeneration
The complex immune system in mammals responds to tissue damage with an
initial neutrophilic, and delayed macrophage, infiltrate to remove damaged tissue by
phagocytosis; a concomitant proliferation of fibroblasts is responsible for generating
scar tissue, which restores tensile strength to the injured tissue. (An exception to this is
the CNS, which lacks fibroblasts; instead, astrocytes react to injury by isolating the
lesion cavity488, 489, but there is no CNS equivalent of the fibroblast to fill the resulting
cystic cavity with any cellular or collagen-based substrate35.) Immune cells are recruited
by cytokines released from damaged tissue and they function to expedite recovery by
rapidly clear damaged tissue to make way for proliferating fibroblasts490. These
fibroblasts initially accumulate in the granulation tissue surrounding the necrotic injury
focus and gradually deposit collagen into the area cleared by the immune response490.
Neutrophils and macrophages create free radicals and other molecules that can
be directly toxic to healthy cells as part of their natural response to injury491, 492. In
addition to serving as the source of fibroblasts, the granulation tissue surrounding the
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injury site also functions to prevent the toxic compounds produced by the inflammatory
process from spreading into the adjacent healthy tissue as shown by experimental
paradigms in which attenuating the granulation tissue barrier results in a larger lesion
cavity490. Although lacking granulation tissue, the CNS exhibits a similar response to
injury by which astrocytes isolate the lesion cavity from the adjacent healthy
parenchyma to prevent the lesion from expanding due to secondary injury from toxic
metabolites31, 32, 35, 493.
Inflammation in response to injury is an incredibly important mechanism by which
injured tissue is cleared, but it also appears to have maladaptive aspects in both the
acute and chronic phases of recovery; the therapeutic efficacy of steroids in improving
outcomes by attenuating inflammation is a clear indication of this491, 492. Although
methylprednisolone was the only approved pharmacologic intervention for CNS injury
beginning on the 1990s, the therapeutic effect was small and the side effects were
numerous485-487, 494; thus, although inflammation is an important component of the injury
response, it is clearly not the only factor in the associated pathophysiology.
Within the CNS, inflammatory mediators are toxic to neurons and are contained
by a barrier of reactive astrocytes35, 50. As previously mentioned, this barrier is incredibly
important for preserving the integrity of the adjacent parenchyma and for restoring the
blood brain barrier that is disrupted by the injury. The astrocytic barrier anatomically
isolates the lesion site, allowing a cystic cavity of liquefactive necrosis to form as the
immune system removes the necrotic tissue through phagocytosis. Reactive astrocytes
also respond to injury by modifying the extracellular matrix with the addition of CSPGs,
which prevent axons from accidentally sprouting into the lesion cavity by serving as a
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repulsive cue to the growth cones49, 50. Thus, the astrocytic reaction provides an
immediate advantage by isolating a hostile lesion cavity35, 51, 495, but ultimately creates
an anatomical and functional barrier to axon regeneration.

Cardiac evolution illustrates the benefit of size over regeneration
As evolution favored the emergence of increasingly large and complex
organisms, passive diffusion ceased to be an efficient means of distributing nutrients
throughout the body. Diffusion’s failure across significant distances is apparent in the
extent to which cells expend energy on actively transporting substances through
themselves using molecular motors such as kinesins and dyneins496-498. Extracellular
transport permits nutrient and waste exchange using a circulatory system that must be
increasingly self contained and pressurized as organism size and complexity increases;
the open circulatory system in arthropods is replaced by an increasingly efficient closed
system in chordates134 that has developed the potential to generate high pressures that
is necessary to support the larger body size within the vertebrate clade142, 441. Vascular
damage can compromise myocardial integrity, and physiologic pressures increase the
risk of aneurysm formation and rupture499.
Ischemic injury in the cardiovascular system results in coagulative necrosis29.
Disruption to the muscular layer reduces vessel integrity500, 501 and recruits the immune
system to remove the necrotic tissue490-492. Granulation tissue forming at the lesion
border gradually replaces the necrotic vascular wall with fibrosis490. Cardiac fibrosis
begins within 48 hours after ischemic injury and continues over a period of 5-7 days;
during this time, cardiac integrity is compromised and there is a significantly increased
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risk of physiologic systolic pressure causing ventricular aneurysm rupture resulting in
cardiac tamponade500, 501. Fibrosis quickly restores myocardial integrity, and risk of
rupture decreases dramatically once it is completed. However, the scar tissue has
decreased structural and functional integrity relative to the healthy myocardium. The
fibrotic reparative response is necessary to obviate the morbidity associated with
ventricular aneurysm formation and rupture, but it blocks endogenous stem cell
proliferation and cardiac regeneration in the process. Because the scar tissue cannot be
replaced with intact cardiomyocytes under physiologic conditions in mammals, the
remaining myocardium undergoes compensatory hypertrophy to compensate for the
decreased contractility of the fibrotic tissue. This beneficial compensatory response can
become maladaptive and cause a progression to heart failure if it proceeds unchecked,
which is reflected in the ~65% congestive heart failure complication rate over 5 years in
patients recovering from a myocardial infarction499.
Adult hearts in Urodele amphibians and Teleost fish are capable of complete
regeneration following ventricular amputation by a combined proliferation of
endogenous cardiac stem cells and by the dedifferentiation of mature cardiomyocytes
into pleuripotent stem cells135, 143, 183; mature cardiomyocytes themselves may be
capable of undergoing karyokinesis and cytokinesis without first dedifferentiating, even
if they are multinucleated482, 502, 503. Division requires a partial disassembly of the
contractile apparatus within these cells from metaphase through cytokinesis that leaves
the cell temporarily incapable of contracting482. Thus, regeneration in these lower
vertebrates results in a transient decrease in cardiac function while the cardiomyocytes
return to the cell cycle, but this is ultimately permissive to the complete restoration of
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cardiac function. Interestingly, a major model for cardiac regeneration involves
amputation of the ventricular apex in newts142, 504 and zebrafish135, 142, an injury that
would be rapidly fatal in mammals142, 143, 450, 504. Inducing ischemic injury in newt and
zebrafish myocardium is extremely difficult because the thin tissue permits sufficient
diffusion with ventricular blood such that coronary vasculature is unnecessary. The
increased efficacy of nutrient transport by passive diffusion – rather than on active
cardiovascular circulation – is recapitulated throughout their bodies such that the
demand on the circulatory system for adequate perfusion is much less than that placed
on the mammalian circulatory system. Smaller body size and decreased circulatory
demand do not require the perfusion pressures seen in mammals, so the incision
initiating clotting in a newt or zebrafish heart would cause rapid exsanguination and
death in a mammal.
Within the hearts of lower vertebrates, cardiomyocytes and stem cells are vital
components of regeneration142. Although mammalian hearts contain both cell types, the
granulation tissue is thought to inhibit or kill the cardiac stem cells, while the fibrotic
response is thought to inhibit proliferation of cardiomyocytes490. The fibrotic and
regenerative responses are thought to be balanced such that the dominance of one
process impedes the progress of the other482, 505. The dramatically higher number of
fibroblasts in mammalian hearts likely results in the fibrotic response easily outcompeting the regenerative response, while the lower fibroblast content in nonmammalian vertebrate hearts is the reason for their successful regeneration. Studies
endorsing this theory have shown that blocking regeneration in newts results in fibrosis
and scarring instead of regeneration143, while blocking fibroblast activation in mice has
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resulted in essentially complete cardiac regeneration with function and structural
capacity reaching that of uninjured animals over a six month recovery period482.
Significantly, mouse cardiac regeneration occurred over six months, during which time
the lack of fibrosis likely compromised the cardiac integrity of these animals (although
mortality rates in these mice were not reported); the accelerated rate of restoring
structural cardiac integrity by fibrosis may result in a significant decreased human
mortality following MI than the six-month regenerative period seen in mice would afford.
Assuming a relatively constant rate of ventricular aneurysm formation and rupture
throughout the six month regenerative process comparable to that seen during the
fibrotic process in humans 0.2-0.3%, increasing the period of compromised structural
integrity to a six month window of regeneration would significantly increase the
complication rate506, 507.
In summary, the increased perfusion pressure that evolved in mammals to permit
a larger body size created a selection pressure favoring the rapid restoration of
structural integrity following an ischemic injury. Although the fibrotic process that
developed in response to this stress is inhibitory to the endogenous regenerative
physiology, blocking fibrosis can still stimulate this pathway. However, fibrosis is highly
adaptive and any treatment aimed at blocking it must compensate for the substantially
prolonged regenerative period and its concomitant decreased structural integrity.

Conclusions and implications
Throughout this dissertation we have put forth evidence supporting two
interrelated hypotheses. First we explored the hypothesis that physiologic bioelectric
fields regulate the injury response and determine regeneration in the mammalian CNS,
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in chapters two, three, and four. The validity of this hypothesis is predicated upon, and
nested within, the larger hypothesis that endogenous EFs are a universal stimulus that
regulate morphogenesis underlying embryogenesis and epimorphic regeneration in all
metazoans, the causal justification for which we explored throughout chapter five.
The implications for these findings are vast and important. First, EFs are a
promising therapeutic option to promote CNS regeneration. Specifically, as EFs
stimulate morphogenesis through endogenous physiologic pathways, therapeutic EFs
could likely change the cellular response and facilitate regeneration by releasing these
latent pathways from inhibition. Upon appropriate EF-based treatment, the tissue
contains sufficient physiologic information to completely regenerate, obviating the need
for supplemental drugs or combinatorial treatments. Beyond the CNS, the single
unifying hypothesis of EFs as the stimulus underlying morphogenesis suggests that EFbased therapies may be used to promote regeneration following injury in any tissue or
organ, and to treat structural abnormalities that arise as a consequence of congenital
defects.
The successful application of EFs-based therapies relies upon a thorough
understanding of three specific variables: the specific component of the EF that cells
transduce, the parameters of physiologic EFs produced upon injury in the target tissue,
and the parameters of EFs associated with tissues where successful regeneration
occurs. Understanding these parameters is a necessary prerequisite to developing an
EF-based therapy for stimulating regeneration. Before EFs should be therapeutically
applied, it is necessary to fully elucidate how injury-induced EFs in non-regenerating
tissues differ from those in regenerating tissues so that injury-induced EFs can
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appropriately altered. Moreover, understanding how each physical component of the EF
contributes to morphogenesis will inform the development of the most efficient
application of therapeutic EFs. Multiple options for EF-based therapies have been
explored in basic science, some of which have even been applied clinically; however,
the optimal EF-based therapy cannot be designed and applied without fully
understanding the underlying endogenous EFs.
We are left, then, with the conclusions that our research, especially when taken
in the context of previous research by countless others, supports our hypotheses that
EFs regulate wound repair in the mammalian CNS, and that this is an example of the
universally conserved role of EFs in regulating morphogenesis throughout all
metazoans. Based on these conclusions, further research is needed to identify
differences in injury-induced EFs that correspond to differences in regenerative
potential. Future projects are also needed to explore the physiologic mechanisms
through which EFs are transduced, as this will provide insight into the specific physical
attributes of bioelectricity to which cells respond. Once identified, differences in the
expression of these physiologic pathways among species can be used to develop
insight into the mechanisms underlying how certain species lost evolved the loss of
spontaneous EF-induced regeneration. A more detailed understanding of the
evolutionary role of EFs in morphogenesis is essential to the development of an optimal
EF-based therapy to promote regeneration and thus would the translation of this
approach to a clinical application.

239

Figure 5.1: Distribution of epimorphic regeneration throughout phylum Vertebrata
This figure illustrates the phylogenetic relationship among extant vertebrate
clades. The expression of epimorphic regeneration among these groups based on
published scientific literature is indicated by the colors to the left of each class: green
indicates that there is at least one species within the group that demonstrates
epimorphic regeneration, red indicates that epimorphic regeneration has been
repeatedly shown to be absent, and black indicates an absence of evidence either way.
(Note, mammals are listed as lacking epimorphic regeneration even though evidence
discussed in chapter 1, page 22.) These data are based principally on a review by Bely
and Nyberg, 2010133.
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Figure 5.1: Distribution of epimorphic regeneration throughout phylum
Vertebrata
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Figure 5.2: Evolutionary origins of epimorphic regeneration among vertebrates
Phylogenetic tree illustrating two competing hypotheses about the origins of
epimorphic regeneration in vertebrates based on the expression of epimorphic
regeneration among extant vertebrate clades as illustrated in Figure 5.1. Green lines
indicate a lineage capable of epimorphic regeneration, red lines indicates a lineage with
evidence of absent epimorphic regeneration, and black lines indicate a lineage where
no observations have been made. (A) Epimorphic regeneration was present within the
common vertebrate ancestor and was retained throughout evolution except for two
clades in which it was (mostly) lost. (B) Epimorphic regeneration was not present in the
common vertebrate ancestor, so each vertebrate clade in which regeneration is
observed evolved it independently. Assuming that epimorphic regeneration arose
immediately upon the regenerative clade diverging from a common ancestor shared
with either Mammalia or Aves, it would have had to have evolved convergently on at
least seven separate occasions. The principle of parsimony as described by Occam’s
razor suggests that the single evolutionary origin of epimorphic regeneration as posited
in (A) is more probable than the convergent evolution of epimorphic regeneration
through consistent molecular and cellular events that emerged through at least seven
independent events as posited in (B). These data are based principally on a review by
Bely and Nyberg, 2010133.
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Figure 5.2: Evolutionary origins of epimorphic regeneration among
vertebrates
243

List of References

244

List of References

1. McCoy E. Dictionary of Celtic Gods and Heroes. 1st ed. Woodbury, MN: Llewellyn
Publications; 1995.
2. Staller JC,M. Pre-Columbian Foodways: Interdisciplinary Approaches to Food, Culture, and
Markets in Ancient Mesoamerica. 1st ed. New York: Springer; 2010.
3. Obermarck P. The Mead of Poetry: A Norse Myth. Edinburgh, Scotland: Familiar Press; 2014.
4. Rig veda. In: Vol Book 8, Hymn 48. ; 1896:5-7.
5. Birrell A. Chinese Myths. 1st ed. UK: British Museum Press; 2000.
6. Michael LA. The Principles of Existence & Beyond : Revelation of Enigma of the Existence.
England: Visual Memes; 2007.
7. Piggot S. A Trepanned Skull of the Beaker Period from Dorset and the Practice of Trepanning
in Prehistoric Europe. Proceedings of the Prehistorical Society (New Series). 1940;6:112132.
8. Gross C. A Hole in the Head: More Tales in the History of Neuroscience. 1st ed. Cambridge,
MA: MIT Press; 2009.
9. Sanan A, Rengachary S, eds. Calvarial and Dural Reconstruction. 1st ed. Park Ridge, Il: The
American Association of Neurological Surgeons; 1998. Rengachary, ed.
10. Faul M, Xu L, Wald MM, Coronado VG. Traumatic Brain Injury in the United States:
Emergency Department Visits, Hospitalizations, and Deaths 2002-2006. Atlanta, GA:
Centers for Disease Control and Prevention, National Center for Injury Prevention and
Control; 2010. Available from: http://www.cdc.gov/traumaticbraininjury/pdf/blue_book.pdf.
Accessed October 22, 2012.
11. Ma VY, Chan L, Carruthers KJ. Incidence, prevalence, costs, and impact on disability of
common conditions requiring rehabilitation in the United States: stroke, spinal cord injury,
traumatic brain injury, multiple sclerosis, osteoarthritis, rheumatoid arthritis, limb loss, and
back pain. Arch Phys Med Rehabil. 2014;95:986-995.e1.
12. Report to Congress on Traumatic Brain Injury in the United States: Epidemiology and
Rehabilitation. Atlanta, GA: National Center for Injury Prevention and Control; Division of
Unintentional Injury Prevention; 2014:1-65 Accessed June 17, 2015.
13. Spinal cord injury facts and figures at a glance. J Spinal Cord Med. 2012;35:197-198.

245

14. Complete Public Version of the 2014 Annual Statistical Report for the Spinal Cord Injury
Model Systems. National Spinal Cord Injury Statistical Center. Birminham, Alabama:
University of Alabama at Birmingham; 2014:1-94 Accessed May 27, 2015.
15. DeVivo MJ, Go BK, Jackson AB. Overview of the national spinal cord injury statistical center
database. J Spinal Cord Med. 2002;25:335-338.
16. McDonald JW, Sadowsky C. Spinal-cord injury. Lancet. 2002;359:417-425.
17. Sekhon LH, Fehlings MG. Epidemiology, demographics, and pathophysiology of acute
spinal cord injury. Spine (Philadelphia, Pa.1976). 2001;26:S2-12.
18. Roger V, Go A, Lloyd Jones D, et al. Heart disease and stroke statistics--2012 update: a
report from the American Heart Association. Circulation. 2012;125:e2-e220.
19. Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics--2015 update:
a report from the American Heart Association. Circulation. 2015;131:e29-322.
20. Humphreys I, Wood RL, Phillips CJ, Macey S. The costs of traumatic brain injury: a
literature review. Clinicoecon Outcomes Res. 2013;5:281-287.
21. Leibson CL, Brown AW, Hall Long K, et al. Medical care costs associated with traumatic
brain injury (TBI) over the full spectrum of disease: A controlled population-based study. J
Neurotrauma. 2012.
22. Garcia-Altes A, Perez K, Novoa A, et al. Spinal Cord Injury and Traumatic Brain Injury: A
Cost-of-Illness Study. Neuroepidemiology. 2012;39:103-108.
23. Cuthbert JP, Harrison-Felix C, Corrigan JD, Bell JM, Haarbauer-Krupa JK, Miller AC.
Unemployment in the United States after traumatic brain injury for working-age individuals:
prevalence and associated factors 2 years postinjury. J Head Trauma Rehabil.
2015;30:160-174.
24. Ingall T. Stroke--incidence, mortality, morbidity and risk. J Insur Med. 2004;36:143-152.
25. Blackwell DL, Lucas JW, Clarke TC. Summary Health Statistics for U.S. Adults: National
Health Interview Survey, 2012. Vital Health Stat. National Center for Health Statistics.;
2014;10:260.
26. Annual Estimates of the Resident Population: April 1, 2010 to July 1, 2014. U.S. Census
Bureau, Population Division; 2014. Available from:
http://factfinder.census.gov/bkmk/table/1.0/en/PEP/2014/PEPANNRES. Accessed July 7,
2015.
27. The World Bank: GDP (current US$). Available at:
http://data.worldbank.org/indicator/NY.GDP.MKTP.CD. Accessed 06/17, 2015.
28. Hatch O. S. 793 (110th): Traumatic Brain Injury Act of 2008. U.S. Federal Government;
2008.

246

29. Kumar V, Abbas AK, Aster JC, eds. Robbins and Cotran the Pathological Pasis of Disease.
9th ed. Philadelphia, PA: Elsevier Saunders; 2015.
30. Rolls A, Shechter R, Schwartz M. The bright side of the glial scar in CNS repair. Nat Rev
Neurosci. 2009;10:235-241.
31. Myer DJ, Gurkoff GG, Lee SM, Hovda DA, Sofroniew MV. Essential protective roles of
reactive astrocytes in traumatic brain injury. Brain. 2006;129:2761-2772.
32. Faulkner J, Herrmann J, Woo M, Tansey K, Doan N, Sofroniew M. Reactive astrocytes
protect tissue and preserve function after spinal cord injury. The Journal of neuroscience.
2004;24:2143-2155.
33. Sofroniew MV. Molecular dissection of reactive astrogliosis and glial scar formation. Trends
Neurosci. 2009;32:638-647.
34. Oyinbo CA. Secondary injury mechanisms in traumatic spinal cord injury: a nugget of this
multiply cascade. Acta Neurobiol Exp (Wars). 2011;71:281-299.
35. Silver J, Miller JH. Regeneration beyond the glial scar. Nat Rev Neurosci. 2004;5:146-156.
36. Blesch A, Tuszynski MH. Spontaneous and neurotrophin-induced axonal plasticity after
spinal cord injury. Prog Brain Res. 2002;137:415-423.
37. Blesch A, Tuszynski M. Spinal cord injury: plasticity, regeneration and the challenge of
translational drug development. Trends Neurosci. 2009;32:41-47.
38. de Groat WC, Yoshimura N. Plasticity in reflex pathways to the lower urinary tract following
spinal cord injury. Exp Neurol. 2011.
39. van den Brand R, Heutschi J, Barraud Q, et al. Restoring voluntary control of locomotion
after paralyzing spinal cord injury. Science. 2012;336:1182-1185.
40. Ben-Hur T. Reconstructing neural circuits using transplanted neural stem cells in the injured
spinal cord. J Clin Invest. 2010;120:3096-3098.
41. Schnell L, Schwab ME. Axonal regeneration in the rat spinal cord produced by an antibody
against myelin-associated neurite growth inhibitors. Nature. 1990;343:269-272.
42. David S, Aguayo AJ. Axonal elongation into peripheral nervous system "bridges" after
central nervous system injury in adult rats. Science. 1981;214:931-933.
43. Richardson PM, McGuinness UM, Aguayo AJ. Axons from CNS neurons regenerate into
PNS grafts. Nature. 1980;284:264-265.
44. Aguayo AJ, David S, Bray GM. Influences of the glial environment on the elongation of
axons after injury: transplantation studies in adult rodents. J Exp Biol. 1981;95:231-240.
45. Hill CE, Beattie MS, Bresnahan JC. Degeneration and sprouting of identified descending
supraspinal axons after contusive spinal cord injury in the rat. Exp Neurol. 2001;171:153169.

247

46. Kerschensteiner M, Schwab ME, Lichtman JW, Misgeld T. In vivo imaging of axonal
degeneration and regeneration in the injured spinal cord. Nat Med. 2005;11:572-577.
47. Allegra Mascaro AL, Cesare P, Sacconi L, et al. In vivo single branch axotomy induces
GAP-43-dependent sprouting and synaptic remodeling in cerebellar cortex. Proc Natl Acad
Sci U S A. 2013;110:10824-10829.
48. Ballermann M, Fouad K. Spontaneous locomotor recovery in spinal cord injured rats is
accompanied by anatomical plasticity of reticulospinal fibers. Eur J Neurosci.
2006;23:1988-1996.
49. Massey JM, Hubscher CH, Wagoner MR, et al. Chondroitinase ABC digestion of the
perineuronal net promotes functional collateral sprouting in the cuneate nucleus after
cervical spinal cord injury. J Neurosci. 2006;26:4406-4414.
50. Massey JM, Amps J, Viapiano MS, et al. Increased chondroitin sulfate proteoglycan
expression in denervated brainstem targets following spinal cord injury creates a barrier to
axonal regeneration overcome by chondroitinase ABC and neurotrophin-3. Exp Neurol.
2008;209:426-445.
51. Busch SA, Silver J. The role of extracellular matrix in CNS regeneration. Curr Opin
Neurobiol. 2007;17:120-127.
52. Asher RA, Morgenstern DA, Moon LD, Fawcett JW. Chondroitin sulphate proteoglycans:
inhibitory components of the glial scar. Prog Brain Res. 2001;132:611-619.
53. Jones TB, McDaniel EE, Popovich PG. Inflammatory-mediated injury and repair in the
traumatically injured spinal cord. Curr Pharm Des. 2005;11:1223-1236.
54. Wanner IB, Anderson MA, Song B, et al. Glial Scar Borders Are Formed by Newly
Proliferated, Elongated Astrocytes That Interact to Corral Inflammatory and Fibrotic Cells
via STAT3-Dependent Mechanisms after Spinal Cord Injury. J Neurosci. 2013;33:1287012886.
55. Galtrey CM, Fawcett JW. The role of chondroitin sulfate proteoglycans in regeneration and
plasticity in the central nervous system. Brain Res Rev. 2007;54:1-18.
56. Morgenstern DA, Asher RA, Fawcett JW. Chondroitin sulphate proteoglycans in the CNS
injury response. Prog Brain Res. 2002;137:313-332.
57. Li HP, Komuta Y, Kimura-Kuroda J, van Kuppevelt TH, Kawano H. Roles of chondroitin
sulfate and dermatan sulfate in the formation of a lesion scar and axonal regeneration after
traumatic injury of the mouse brain. J Neurotrauma. 2013;30:413-425.
58. Varga ZM, Bandtlow CE, Erulkar SD, Schwab ME, Nicholls JG. The critical period for repair
of CNS of neonatal opossum (Monodelphis domestica) in culture: correlation with
development of glial cells, myelin and growth-inhibitory molecules. Eur J Neurosci.
1995;7:2119-2129.

248

59. Ajtai BM, Kalman M. Reactive glia support and guide axon growth in the rat thalamus during
the first postnatal week. A sharply timed transition from permissive to non-permissive
stage. Int J Dev Neurosci. 2001;19:589-597.
60. Tanaka EM, Ferretti P. Considering the evolution of regeneration in the central nervous
system. Nat Rev Neurosci. 2009;10:713-723.
61. Becker T, Wullimann MF, Becker CG, Bernhardt RR, Schachner M. Axonal regrowth after
spinal cord transection in adult zebrafish. J Comp Neurol. 1997;377:577-595.
62. Rehermann MI, Marichal N, Russo RE, Trujillo-Cenoz O. Neural reconnection in the
transected spinal cord of the freshwater turtle Trachemys dorbignyi. J Comp Neurol.
2009;515:197-214.
63. Garcia G, Libisch G, Trujillo-Cenoz O, Robello C, Russo RE. Modulation of gene expression
during early stages of reconnection of the turtle spinal cord. J Neurochem. 2012;121:9961006.
64. Dawley EM, O Samson S, Woodard KT, Matthias KA. Spinal cord regeneration in a tail
autotomizing urodele. J Morphol. 2012;273:211-225.
65. McLean KE, Vickaryous MK. A novel amniote model of epimorphic regeneration: the leopard
gecko, Eublepharis macularius. BMC Dev Biol. 2011;11:50-213X-11-50.
66. Gaete M, Munoz R, Sanchez N, et al. Spinal cord regeneration in Xenopus tadpoles
proceeds through activation of Sox2-positive cells. Neural Dev. 2012;7:13-8104-7-13.
67. Barbosa JS, Sanchez-Gonzalez R, Di Giaimo R, et al. Neurodevelopment. Live imaging of
adult neural stem cell behavior in the intact and injured zebrafish brain. Science.
2015;348:789-793.
68. Diotel N, Vaillant C, Gabbero C, et al. Effects of estradiol in adult neurogenesis and brain
repair in zebrafish. Horm Behav. 2013;63:193-207.
69. Endo T, Yoshino J, Kado K, Tochinai S. Brain regeneration in anuran amphibians. Dev
Growth Differ. 2007;49:121-129.
70. Maden M, Manwell LA, Ormerod BK. Proliferation zones in the axolotl brain and
regeneration of the telencephalon. Neural Dev. 2013;8:1-8104-8-1.
71. Kroehne V, Freudenreich D, Hans S, Kaslin J, Brand M. Regeneration of the adult zebrafish
brain from neurogenic radial glia-type progenitors. Development. 2011;138:4831-4841.
72. Dimou L, Gotz M. Glial cells as progenitors and stem cells: new roles in the healthy and
diseased brain. Physiol Rev. 2014;94:709-737.
73. Weissman T, Noctor SC, Clinton BK, Honig LS, Kriegstein AR. Neurogenic radial glial cells
in reptile, rodent and human: from mitosis to migration. Cereb Cortex. 2003;13:550-559.
74. Hugnot JP, Franzen R. The spinal cord ependymal region: a stem cell niche in the caudal
central nervous system. Front Biosci. 2011;16:1044-1059.

249

75. Gotz M, Hartfuss E, Malatesta P. Radial glial cells as neuronal precursors: a new
perspective on the correlation of morphology and lineage restriction in the developing
cerebral cortex of mice. Brain Res Bull. 2002;57:777-788.
76. Blaugrund E, Lavie V, Cohen I, Solomon A, Schreyer DJ, Schwartz M. Axonal regeneration
is associated with glial migration: comparison between the injured optic nerves of fish and
rats. J Comp Neurol. 1993;330:105-112.
77. Conner C, Ackerman KM, Lahne M, Hobgood JS, Hyde DR. Repressing notch signaling and
expressing TNFalpha are sufficient to mimic retinal regeneration by inducing Muller glial
proliferation to generate committed progenitor cells. J Neurosci. 2014;34:14403-14419.
78. Nakamura K, Chiba C. Evidence for Notch signaling involvement in retinal regeneration of
adult newt. Brain Res. 2007;1136:28-42.
79. Goldshmit Y, Sztal TE, Jusuf PR, Hall TE, Nguyen-Chi M, Currie PD. Fgf-dependent glial
cell bridges facilitate spinal cord regeneration in zebrafish. J Neurosci. 2012;32:7477-7492.
80. Alvarez JI, Katayama T, Prat A. Glial influence on the blood brain barrier. Glia.
2013;61:1939-1958.
81. Lenkowski JR, Qin Z, Sifuentes CJ, et al. Retinal regeneration in adult zebrafish requires
regulation of TGFbeta signaling. Glia. 2013;61:1687-1697.
82. Meyers JR, Hu L, Moses A, Kaboli K, Papandrea A, Raymond PA. beta-catenin/Wnt
signaling controls progenitor fate in the developing and regenerating zebrafish retina.
Neural Dev. 2012;7:30-8104-7-30.
83. Okada S, Nakamura M, Katoh H, et al. Conditional ablation of Stat3 or Socs3 discloses a
dual role for reactive astrocytes after spinal cord injury. Nat Med. 2006;12:829-834.
84. Auguste KI, Jin S, Uchida K, et al. Greatly impaired migration of implanted aquaporin-4deficient astroglial cells in mouse brain toward a site of injury. FASEB J. 2007;21:108-116.
85. Sun D, Colello RJ, Daugherty WP, et al. Cell proliferation and neuronal differentiation in the
dentate gyrus in juvenile and adult rats following traumatic brain injury. J Neurotrauma.
2005;22:95-105.
86. King LA, Mitrophanous KA, Clark LA, et al. Growth factor enhanced retroviral gene transfer
to the adult central nervous system. Gene Ther. 2000;7:1103-1111.
87. Amat JA, Ishiguro H, Nakamura K, Norton WT. Phenotypic diversity and kinetics of
proliferating microglia and astrocytes following cortical stab wounds. Glia. 1996;16:368382.
88. Zhang F, Clarke JD, Ferretti P. FGF-2 Up-regulation and proliferation of neural progenitors
in the regenerating amphibian spinal cord in vivo. Dev Biol. 2000;225:381-391.
89. Hagood SK, McGinn MJ, Sun D, Colello RJ. Characterizing the mitogenic effect of basic
fibroblast growth factor in the adult rat striatum. J Neurotrauma. 2006;23:205-215.

250

90. Chirumamilla S, Sun D, Bullock MR, Colello RJ. Traumatic brain injury induced cell
proliferation in the adult mammalian central nervous system. J Neurotrauma. 2002;19:693703.
91. Wilhelmsson U, Bushong EA, Price DL, et al. Redefining the concept of reactive astrocytes
as cells that remain within their unique domains upon reaction to injury. Proc Natl Acad Sci
U S A. 2006;103:17513-17518.
92. Ajtai BM, Kalman M. Glial fibrillary acidic protein expression but no glial demarcation follows
the lesion in the molecular layer of cerebellum. Brain Res. 1998;802:285-288.
93. Briona LK, Dorsky RI. Radial glial progenitors repair the zebrafish spinal cord following
transection. Exp Neurol. 2014;256:81-92.
94. White RE, Rao M, Gensel JC, McTigue DM, Kaspar BK, Jakeman LB. Transforming growth
factor alpha transforms astrocytes to a growth-supportive phenotype after spinal cord
injury. J Neurosci. 2011;31:15173-15187.
95. Chang IA, Kwon KB, Park YC, Namgung U. Permissive role of Cdc2 activity induced from
astrocytes in neurite outgrowth. J Neurochem. 2013;125:214-224.
96. Seo TB, Chang IA, Lee JH, Namgung U. Beneficial function of cell division cycle 2 activity in
astrocytes on axonal regeneration after spinal cord injury. J Neurotrauma. 2013;30:10531061.
97. Haas C, Fischer I. Human astrocytes derived from glial restricted progenitors support
regeneration of the injured spinal cord. J Neurotrauma. 2013;30:1035-1052.
98. Delgado-Rivera R, Harris SL, Ahmed I, et al. Increased FGF-2 secretion and ability to
support neurite outgrowth by astrocytes cultured on polyamide nanofibrillar matrices. Matrix
Biol. 2009;28:137-147.
99. Allodi I, Casals-Diaz L, Santos-Nogueira E, Gonzalez-Perez F, Navarro X, Udina E. FGF-2
low molecular weight selectively promotes neuritogenesis of motor neurons in vitro. Mol
Neurobiol. 2013;47:770-781.
100. do Carmo Cunha J, de Freitas Azevedo Levy B, de Luca BA, de Andrade MS, Gomide VC,
Chadi G. Responses of reactive astrocytes containing S100beta protein and fibroblast
growth factor-2 in the border and in the adjacent preserved tissue after a contusion injury of
the spinal cord in rats: implications for wound repair and neuroregeneration. Wound Repair
Regen. 2007;15:134-146.
101. Ramirez JJ, Finklestein SP, Keller J, Abrams W, George MN, Parakh T. Basic fibroblast
growth factor enhances axonal sprouting after cortical injury in rats. Neuroreport.
1999;10:1201-1204.
102. Zhang J, Liu J, Liu L, McKeehan WL, Wang F. The fibroblast growth factor signaling axis
controls cardiac stem cell differentiation through regulating autophagy. Autophagy.
2012;8:690-691.

251

103. Magnusson JP, Goritz C, Tatarishvili J, et al. A latent neurogenic program in astrocytes
regulated by Notch signaling in the mouse. Science. 2014;346:237-241.
104. Lim DA, Tramontin AD, Trevejo JM, Herrera DG, Garca-Verdugo JM, Alvarez Buylla A.
Noggin antagonizes BMP signaling to create a niche for adult neurogenesis. Neuron.
2000;28:713-726.
105. Dias TB, Yang YJ, Ogai K, Becker T, Becker CG. Notch signaling controls generation of
motor neurons in the lesioned spinal cord of adult zebrafish. J Neurosci. 2012;32:32453252.
106. Shimada IS, LeComte MD, Granger JC, Quinlan NJ, Spees JL. Self-renewal and
differentiation of reactive astrocyte-derived neural stem/progenitor cells isolated from the
cortical peri-infarct area after stroke. J Neurosci. 2012;32:7926-7940.
107. Miyata T, Kawaguchi A, Okano H, Ogawa M. Asymmetric inheritance of radial glial fibers
by cortical neurons. Neuron. 2001;31:727-741.
108. Rakic P. Developmental and evolutionary adaptations of cortical radial glia. Cereb Cortex.
2003;13:541-549.
109. Yamamoto H, Mandai K, Konno D, Maruo T, Matsuzaki F, Takai Y. Impairment of radial
glial scaffold-dependent neuronal migration and formation of double cortex by genetic
ablation of afadin. Brain Res. 2015.
110. Takahashi Y, Osumi N, Patel NH. Body patterning. Proc Natl Acad Sci U S A.
2001;98:12338-12339.
111. Bohner AP, Akers RM, McConnell SK. Induction of deep layer cortical neurons in vitro.
Development. 1997;124:915-923.
112. Sauvageot CM, Stiles CD. Molecular mechanisms controlling cortical gliogenesis. Curr
Opin Neurobiol. 2002;12:244-249.
113. Bellamy TC. Interactions between Purkinje neurones and Bergmann glia. Cerebellum.
2006;5:116-126.
114. Cavalcante LA, Garcia-Abreu J, Moura Neto V, Silva LC, Weissmuller G. Modulators of
axonal growth and guidance at the brain midline with special reference to glial heparan
sulfate proteoglycans. An Acad Bras Cienc. 2002;74:691-716.
115. Fitch MT, Silver J. Glial cell extracellular matrix: boundaries for axon growth in
development and regeneration. Cell Tissue Res. 1997;290:379-384.
116. Cavalcante LA, Garcia-Abreu J, Mendes FA, et al. Sulfated proteoglycans as modulators of
neuronal migration and axonal decussation in the developing midbrain. Braz J Med Biol
Res. 2003;36:993-1002.
117. Cho KS, Yang L, Lu B, et al. Re-establishing the regenerative potential of central nervous
system axons in postnatal mice. J Cell Sci. 2005;118:863-872.

252

118. McGinn MJ, Sun D, Schneider SL, Alexander JK, Colello RJ. Epidermal growth factorinduced cell proliferation in the adult rat striatum. Brain Res. 2004;1007:29-38.
119. Sun D, McGinn MJ, Zhou Z, Harvey HB, Bullock MR, Colello RJ. Anatomical integration of
newly generated dentate granule neurons following traumatic brain injury in adult rats and
its association to cognitive recovery. Exp Neurol. 2007;204:264-272.
120. Sun D, Bullock MR, McGinn MJ, et al. Basic fibroblast growth factor-enhanced
neurogenesis contributes to cognitive recovery in rats following traumatic brain injury. Exp
Neurol. 2009;216:56-65.
121. Sun D, Bullock MR, Altememi N, et al. The effect of epidermal growth factor in the injured
brain after trauma in rats. J Neurotrauma. 2010;27:923-938.
122. Song F, Li B, Stocum DL. Amphibians as research models for regenerative medicine.
Organogenesis. 2010;6:141-150.
123. Stewart S, Rojas-Muñoz A, Belmonte JCI. Bioelectricity and epimorphic regeneration.
Bioessays. 2007;29:1133-1137.
124. Tweedell KS. The urodele limb regeneration blastema: the cell potential.
ScientificWorldJournal. 2010;10:954-971.
125. Stocum DL, Cameron JA. Looking proximally and distally: 100 years of limb regeneration
and beyond. Dev Dyn. 2011;240:943-968.
126. Schnapp E, Kragl M, Rubin L, Tanaka EM. Hedgehog signaling controls dorsoventral
patterning, blastema cell proliferation and cartilage induction during axolotl tail
regeneration. Development. 2005;132:3243-3253.
127. Rogers KW, Schier AF. Morphogen gradients: from generation to interpretation. Annu Rev
Cell Dev Biol. 2011;27:377-407.
128. Tanabe Y, Jessell TM. Diversity and pattern in the developing spinal cord. Science.
1996;274:1115-1123.
129. Dubrulle J, Pourquie O. Coupling segmentation to axis formation. Development.
2004;131:5783-5793.
130. Stocum DL. A conceptual framework for analyzing axial patterning in regenerating urodele
limbs. Int J Dev Biol. 1996;40:773-783.
131. McCusker CD, Gardiner DM. Understanding positional cues in salamander limb
regeneration: implications for optimizing cell-based regenerative therapies. Dis Model
Mech. 2014;7:593-599.
132. Stocum DL. The urodele limb regeneration blastema. Determination and organization of
the morphogenetic field. Differentiation. 1984;27:13-28.
133. Bely AE, Nyberg KG. Evolution of animal regeneration: re-emergence of a field. Trends
Ecol Evol. 2010;25:161-170.

253

134. Sanchez Alvarado A. Regeneration in the metazoans: why does it happen? Bioessays.
2000;22:578-590.
135. Poss KD, Wilson LG, Keating MT. Heart regeneration in zebrafish. Science.
2002;298:2188-2190.
136. Tal TL, Franzosa JA, Tanguay RL. Molecular signaling networks that choreograph
epimorphic fin regeneration in zebrafish - a mini-review. Gerontology. 2010;56:231-240.
137. Wagner GP, Misof BY. Evolutionary modification of regenerative capability in vertebrates: a
comparative study on teleost pectoral fin regeneration. J Exp Zool. 1992;261:62-78.
138. Ghosh S, Thorogood P, Ferretti P. Regenerative capability of upper and lower jaws in the
newt. Int J Dev Biol. 1994;38:479-490.
139. Ferretti P. Re-examining jaw regeneration in urodeles: what have we learnt? Int J Dev Biol.
1996;40:807-811.
140. Filoni S. Retina and lens regeneration in anuran amphibians. Semin Cell Dev Biol.
2009;20:528-534.
141. Levesque M, Villiard E, Roy S. Skin wound healing in axolotls: a scarless process. J Exp
Zool B Mol Dev Evol. 2010;314:684-697.
142. Ausoni S, Sartore S. From fish to amphibians to mammals: in search of novel strategies to
optimize cardiac regeneration. J Cell Biol. 2009;184:357-364.
143. Lepilina A, Coon AN, Kikuchi K, et al. A dynamic epicardial injury response supports
progenitor cell activity during zebrafish heart regeneration. Cell. 2006;127:607-619.
144. Becker RO, Selden G. The Body Electric: Electromagnetism and the Foundation of Life.
2nd ed. New York, NY: William Morrow Paperbacks; 1998.
145. Becker RO, Chapin S, Sherry R. Regeneration of the ventricular myocardium in
amphibians. Nature. 1974;248:145-147.
146. Cabelguen JM, Chevallier S, Amontieva-Potapova I, Philippe C. Anatomical and
electrophysiological plasticity of locomotor networks following spinal transection in the
salamander. Neurosci Bull. 2013;29:467-476.
147. Tseng AS, Beane WS, Lemire JM, Masi A, Levin M. Induction of vertebrate regeneration
by a transient sodium current. J Neurosci. 2010;30:13192-13200.
148. Gramage E, D'Cruz T, Taylor S, Thummel R, Hitchcock PF. Midkine-a protein localization
in the developing and adult retina of the zebrafish and its function during photoreceptor
regeneration. PLoS One. 2015;10:e0121789.
149. Wan J, Zhao XF, Vojtek A, Goldman D. Retinal injury, growth factors, and cytokines
converge on beta-catenin and pStat3 signaling to stimulate retina regeneration. Cell Rep.
2014;9:285-297.

254

150. Goldman D. Muller glial cell reprogramming and retina regeneration. Nat Rev Neurosci.
2014;15:431-442.
151. Araki M. Regeneration of the amphibian retina: role of tissue interaction and related
signaling molecules on RPE transdifferentiation. Dev Growth Differ. 2007;49:109-120.
152. Beddaoui M, Coupland SG, Tsilfidis C. Recovery of function following regeneration of the
damaged retina in the adult newt, Notophthalmus viridescens. Doc Ophthalmol.
2012;125:91-100.
153. Islam MR, Nakamura K, Casco-Robles MM, et al. The newt reprograms mature RPE cells
into a unique multipotent state for retinal regeneration. Sci Rep. 2014;4:6043.
154. Meyer RL, Sperry RW. Tests for neuroplasticity in the anuran retinotectal system. Exp
Neurol. 1973;40:525-539.
155. Becker T, Becker CG, Niemann U, Naujoks-Manteuffel C, Gerardy-Schahn R, Roth G.
Amphibian-specific regulation of polysialic acid and the neural cell adhesion molecule in
development and regeneration of the retinotectal system of the salamander Pleurodeles
waltl. J Comp Neurol. 1993;336:532-544.
156. Diekmann H, Kalbhen P, Fischer D. Characterization of optic nerve regeneration using
transgenic zebrafish. Front Cell Neurosci. 2015;9:118.
157. Becker CG, Becker T. Growth and pathfinding of regenerating axons in the optic projection
of adult fish. J Neurosci Res. 2007;85:2793-2799.
158. Welte C, Engel S, Stuermer CA. Upregulation of the zebrafish Nogo-A homologue, Rtn4b,
in retinal ganglion cells is functionally involved in axon regeneration. Neural Dev.
2015;10:6-015-0034-x.
159. Frobisch NB, Bickelmann C, Witzmann F. Early evolution of limb regeneration in tetrapods:
evidence from a 300-million-year-old amphibian. Proc Biol Sci. 2014;281:20141550.
160. Hedges SB, Blair JE, Venturi ML, Shoe JL. A molecular timescale of eukaryote evolution
and the rise of complex multicellular life. BMC Evol Biol. 2004;4:2.
161. Dillon R, Gadgil C, Othmer HG. Short- and long-range effects of Sonic hedgehog in limb
development. Proc Natl Acad Sci U S A. 2003;100:10152-10157.
162. Mito T, Inoue Y, Kimura S, et al. Involvement of hedgehog, wingless, and dpp in the
initiation of proximodistal axis formation during the regeneration of insect legs, a verification
of the modified boundary model. Mech Dev. 2002;114:27-35.
163. Torok MA, Gardiner DM, Izpisua-Belmonte JC, Bryant SV. Sonic hedgehog (shh)
expression in developing and regenerating axolotl limbs. J Exp Zool. 1999;284:197-206.
164. Sugiura T, Taniguchi Y, Tazaki A, Ueno N, Watanabe K, Mochii M. Differential gene
expression between the embryonic tail bud and regenerating larval tail in Xenopus laevis.
Dev Growth Differ. 2004;46:97-105.

255

165. Cohn MJ, Izpisua-Belmonte JC, Abud H, Heath JK, Tickle C. Fibroblast growth factors
induce additional limb development from the flank of chick embryos. Cell. 1995;80:739-746.
166. Han M, Yang X, Taylor G, Burdsal CA, Anderson RA, Muneoka K. Limb regeneration in
higher vertebrates: developing a roadmap. Anat Rec B New Anat. 2005;287:14-24.
167. Holland LZ. Heads or tails? Amphioxus and the evolution of anterior-posterior patterning in
deuterostomes. Dev Biol. 2002;241:209-228.
168. Cunningham TJ, Kumar S, Yamaguchi TP, Duester G. Wnt8a and Wnt3a cooperate in the
axial stem cell niche to promote mammalian body axis extension. Dev Dyn. 2015;244:797807.
169. Pourquie O, Kusumi K. When body segmentation goes wrong. Clin Genet. 2001;60:409416.
170. Niehrs C. On growth and form: a Cartesian coordinate system of Wnt and BMP signaling
specifies bilaterian body axes. Development. 2010;137:845-857.
171. Muneoka K, Sassoon D. Molecular aspects of regeneration in developing vertebrate limbs.
Dev Biol. 1992;152:37-49.
172. Taniguchi Y, Watanabe K, Mochii M. Notochord-derived hedgehog is essential for tail
regeneration in Xenopus tadpole. BMC Dev Biol. 2014;14:27-213X-14-27.
173. Poss KD, Shen J, Nechiporuk A, et al. Roles for Fgf signaling during zebrafish fin
regeneration. Dev Biol. 2000;222:347-358.
174. Marques SR, Lee Y, Poss KD, Yelon D. Reiterative roles for FGF signaling in the
establishment of size and proportion of the zebrafish heart. Dev Biol. 2008;321:397-406.
175. Wills AA, Kidd AR,3rd, Lepilina A, Poss KD. Fgfs control homeostatic regeneration in adult
zebrafish fins. Development. 2008;135:3063-3070.
176. Lin G, Slack JM. Requirement for Wnt and FGF signaling in Xenopus tadpole tail
regeneration. Dev Biol. 2008;316:323-335.
177. Yokoyama H. Initiation of limb regeneration: the critical steps for regenerative capacity.
Dev Growth Differ. 2008;50:13-22.
178. Brockes JP. Retinoid signalling and retinoid receptors in amphibian limb regeneration.
Biochem Soc Symp. 1996;62:137-142.
179. Blum N, Begemann G. Retinoic acid signaling controls the formation, proliferation and
survival of the blastema during adult zebrafish fin regeneration. Development.
2012;139:107-116.
180. Tsukamoto-Yasui M, Sasaki T, Matsumoto W, et al. Active hippocampal networks undergo
spontaneous synaptic modification. PLoS One. 2007;2:e1250.
181. Beck CW, Christen B, Slack JM. Molecular pathways needed for regeneration of spinal
cord and muscle in a vertebrate. Dev Cell. 2003;5:429-439.

256

182. Kikuchi K. Dedifferentiation, Transdifferentiation, and Proliferation: Mechanisms Underlying
Cardiac Muscle Regeneration in Zebrafish. Curr Pathobiol Rep. 2015;3:81-88.
183. Poss KD. Getting to the heart of regeneration in zebrafish. Semin Cell Dev Biol.
2007;18:36-45.
184. Makanae A, Satoh A. Early regulation of axolotl limb regeneration. Anat Rec (Hoboken).
2012;295:1566-1574.
185. Satoh A, makanae A, Hirata A, Satou Y. Blastema induction in aneurogenic state and Prrx1 regulation by MMPs and FGFs in Ambystoma mexicanum limb regeneration. Dev Biol.
2011;355:263-274.
186. Beck CW, Christen B, Barker D, Slack JM. Temporal requirement for bone morphogenetic
proteins in regeneration of the tail and limb of Xenopus tadpoles. Mech Dev. 2006;123:674688.
187. Maden M, Keeble S. The role of cartilage and fibronectin during respecification of pattern
induced in the regenerating amphibian limb by retinoic acid. Differentiation. 1987;36:175184.
188. Sallin P, de Preux Charles AS, Duruz V, Pfefferli C, Jazwinska A. A dual epimorphic and
compensatory mode of heart regeneration in zebrafish. Dev Biol. 2015;399:27-40.
189. Zhang R, Han P, Yang H, et al. In vivo cardiac reprogramming contributes to zebrafish
heart regeneration. Nature. 2013;498:497-501.
190. Zhao L, Borikova AL, Ben-Yair R, et al. Notch signaling regulates cardiomyocyte
proliferation during zebrafish heart regeneration. Proc Natl Acad Sci U S A. 2014;111:14031408.
191. Cohen ED, Wang Z, Lepore JJ, et al. Wnt/beta-catenin signaling promotes expansion of
Isl-1-positive cardiac progenitor cells through regulation of FGF signaling. J Clin Invest.
2007;117:1794-1804.
192. Briona LK, Poulain FE, Mosimann C, Dorsky RI. Wnt/ss-catenin signaling is required for
radial glial neurogenesis following spinal cord injury. Dev Biol. 2015;403:15-21.
193. Gomes FC, Paulin D, Moura Neto V. Glial fibrillary acidic protein (GFAP): modulation by
growth factors and its implication in astrocyte differentiation. Braz J Med Biol Res.
1999;32:619-631.
194. Leavitt BR, Hernit-Grant CS, Macklis JD. Mature astrocytes transform into transitional
radial glia within adult mouse neocortex that supports directed migration of transplanted
immature neurons. Exp Neurol. 1999;157:43-57.
195. Sotelo C, Alvarado-Mallart RM, Frain M, Vernet M. Molecular plasticity of adult Bergmann
fibers is associated with radial migration of grafted Purkinje cells. J Neurosci. 1994;14:124133.

257

196. Illingworth CM. Trapped fingers and amputated finger tips in children. J Pediatr Surg.
1974;9:853-858.
197. Han M, Yang X, Farrington JE, Muneoka K. Digit regeneration is regulated by Msx1 and
BMP4 in fetal mice. Development. 2003;130:5123-5132.
198. Seifert AW, Kiama SG, Seifert MG, Goheen JR, Palmer TM, Maden M. Skin shedding and
tissue regeneration in African spiny mice (Acomys). Nature. 2012;489:561-565.
199. Soo C, Shaw WW, Zhang X, Longaker MT, Howard EW, Ting K. Differential expression of
matrix metalloproteinases and their tissue-derived inhibitors in cutaneous wound repair.
Plast Reconstr Surg. 2000;105:638-647.
200. Kierdorf U, Kierdorf H. Antler regrowth as a form of epimorphic regeneration in vertebrates
- a comparative view. Front Biosci (Elite Ed). 2012;4:1606-1624.
201. Li C, Yang F, Sheppard A. Adult stem cells and mammalian epimorphic regenerationinsights from studying annual renewal of deer antlers. Curr Stem Cell Res Ther.
2009;4:237-251.
202. Rolf HJ, Kierdorf U, Kierdorf H, et al. Localization and characterization of STRO-1 cells in
the deer pedicle and regenerating antler. PLoS One. 2008;3:e2064.
203. Gyurjan I,Jr, Molnar A, Borsy A, et al. Gene expression dynamics in deer antler:
mesenchymal differentiation toward chondrogenesis. Mol Genet Genomics. 2007;277:221235.
204. Price J, Faucheux C, Allen S. Deer antlers as a model of Mammalian regeneration. Curr
Top Dev Biol. 2005;67:1-48.
205. Yu L, Han M, Yan M, Lee EC, Lee J, Muneoka K. BMP signaling induces digit regeneration
in neonatal mice. Development. 2010;137:551-559.
206. Bresadola M. Medicine and science in the life of Luigi Galvani (1737-1798). Brain Res Bull.
1998;46:367-380.
207. Matteucci C. Memoire sur l'electricite animale. Annals de Chimie et de Physique.
1834;56:439-443.
208. Caceres C, ed. The Practice of Clinical Engineering. New York, NY: Academic Press, Inc.;
1977Clinical Engineering Series.
209. Besterman E, Creese R. Waller--pioneer of electrocardiography. Br Heart J. 1979;42:6164.
210. Jung R, Berger W. Fiftieth anniversary of Hans Berger's publication of the
electroencephalogram. His first records in 1924--1931 (author's transl). Arch Psychiatr
Nervenkr (1970). 1979;227:279-300.
211. Grimnes S, Martinsen OG. Bioempedence and Bioelectricity Basics. San Diego, CA:
Academic Press; 2000.

258

212. Wonderlin WF, Woodfork KA, Strobl JS. Changes in membrane potential during the
progression of MCF-7 human mammary tumor cells through the cell cycle. J Cell Physiol.
1995;165:177-185.
213. Martens JR, O'Connell K, Tamkun M. Targeting of ion channels to membrane
microdomains: localization of KV channels to lipid rafts. Trends Pharmacol Sci. 2004;25:1621.
214. Colello RJ, Alexander JK. Chapter 6 - electrical fields: Their nature and influence on
biological systems. In: Hadis MorkoÃ§, ed. Advanced Semiconductor and Organic NanoTechniques. San Diego: Academic Press; 2003:319.
215. McCaig CD, Rajnicek AM, Song B, Zhao M. Controlling cell behavior electrically: current
views and future potential. Physiol Rev. 2005;85:943-978.
216. Cone CD,Jr. Electroosmotic interactions accompanying mitosis initation in sarcoma cells in
vitro. Trans N Y Acad Sci. 1969;31:404-427.
217. Cone CD,Jr, Tongier M,Jr. Control of somatic cell mitosis by simulated changes in the
transmembrane potential level. Oncology. 1971;25:168-182.
218. Cone CD J, Cone C. Induction of mitosis in mature neurons in central nervous system by
sustained depolarization; Science. Science. 1976.
219. Saunders RD, Jefferys JG. A neurobiological basis for ELF guidelines. . 2007;92:596-603.
220. Lin F, Baldessari F, Gyenge CC, et al. Lymphocyte electrotaxis in vitro and in vivo. J
Immunol. 2008;181:2465-2471.
221. Zhao M, Pu J, Forrester JV, McCaig CD. Membrane lipids, EGF receptors, and intracellular
signals colocalize and are polarized in epithelial cells moving directionally in a physiological
electric field. FASEB J. 2002;16:857-859.
222. Zhao M. Electrical fields in wound healing-An overriding signal that directs cell migration.
Semin Cell Dev Biol. 2009;20:674-682.
223. Fang KS, Ionides E, Oster G, Nuccitelli R, Isseroff RR. Epidermal growth factor receptor
relocalization and kinase activity are necessary for directional migration of keratinocytes in
DC electric fields. J Cell Sci. 1999;112 ( Pt 12):1967-1978.
224. Ho E, Dagnino L. Epidermal growth factor induction of front-rear polarity and migration in
keratinocytes is mediated by integrin-linked kinase and ELMO2. Mol Biol Cell. 2012;23:492502.
225. Li L, Liu F, Salmonsen RA, et al. PTEN in neural precursor cells: regulation of migration,
apoptosis, and proliferation. Mol Cell Neurosci. 2002;20:21-29.
226. Li L, El-Hayek YH, Liu B, et al. Direct-current electrical field guides neuronal
stem/progenitor cell migration. Stem Cells. 2008;26:2193-2200.

259

227. McCaig CD, Song B, Rajnicek AM. Electrical dimensions in cell science. J Cell Sci.
2009;122:4267-4276.
228. Pullar CE, Baier BS, Kariya Y, et al. beta4 integrin and epidermal growth factor
coordinately regulate electric field-mediated directional migration via Rac1. Mol Biol Cell.
2006;17:4925-4935.
229. Yao L, McCaig CD, Zhao M. Electrical signals polarize neuronal organelles, direct neuron
migration, and orient cell division. Hippocampus. 2009;19:855-868.
230. Zhao M, Dick A, Forrester JV, McCaig CD. Electric field-directed cell motility involves upregulated expression and asymmetric redistribution of the epidermal growth factor
receptors and is enhanced by fibronectin and laminin. Mol Biol Cell. 1999;10:1259-1276.
231. Zhao M, Bai H, Wang E, Forrester JV, McCaig CD. Electrical stimulation directly induces
pre-angiogenic responses in vascular endothelial cells by signaling through VEGF
receptors. J Cell Sci. 2004;117:397-405.
232. Zhao M, Song B, Pu J, et al. Electrical signals control wound healing through
phosphatidylinositol-3-OH kinase-gamma and PTEN. Nature. 2006;442:457-460.
233. Okamoto M, Takemori H, Katoh Y. Salt-inducible kinase in steroidogenesis and
adipogenesis. Trends Endocrinol Metab. 2004;15:21-26.
234. Lang F, Strutz-Seebohm N, Seebohm G, Lang UE. Significance of SGK1 in the regulation
of neuronal function. J Physiol. 2010;588:3349-3354.
235. Stenstrom K, Takemori H, Bianchi G, Katz AI, Bertorello AM. Blocking the salt-inducible
kinase 1 network prevents the increases in cell sodium transport caused by a hypertensionlinked mutation in human alpha-adducin. J Hypertens. 2009;27:2452-2457.
236. Cahoy JD, Emery B, Kaushal A, et al. A transcriptome database for astrocytes, neurons,
and oligodendrocytes: a new resource for understanding brain development and function. J
Neurosci. 2008;28:264-278.
237. McCaig CD. Spinal neurite reabsorption and regrowth in vitro depend on the polarity of an
applied electric field. Development. 1987;100:31-41.
238. McCaig CD, Rajnicek AM, Song B, Zhao M. Has electrical growth cone guidance found its
potential? Trends Neurosci. 2002;25:354-359.
239. Rajnicek AM, Robinson KR, McCaig CD. The direction of neurite growth in a weak DC
electric field depends on the substratum: contributions of adhesivity and net surface
charge. Dev Biol. 1998;203:412-423.
240. Alexander J, Fuss B, Colello R. Electric field-induced astrocyte alignment directs neurite
outgrowth. Neuron glia biology. 2006;2:93-103.
241. Borgens RB, Shi R, Mohr TJ, Jaeger CB. Mammalian cortical astrocytes align themselves
in a physiological voltage gradient. Exp Neurol. 1994;128:41-49.

260

242. Hinkle L, McCaig CD, Robinson KR. The direction of growth of differentiating neurones and
myoblasts from frog embryos in an applied electric field. J Physiol. 1981;314:121-135.
243. McKasson MJ, Huang L, Robinson KR. Chick embryonic Schwann cells migrate anodally
in small electrical fields. Exp Neurol. 2008;211:585-587.
244. Ariza CA, Fleury AT, Tormos CJ, et al. The influence of electric fields on hippocampal
neural progenitor cells. Stem Cell Rev. 2010;6:585-600.
245. Sauer H, Rahimi G, Hescheler J, Wartenberg M. Effects of electrical fields on
cardiomyocyte differentiation of embryonic stem cells. J Cell Biochem. 1999;75:710-723.
246. Nuccitelli R, Jaffe LF. Spontaneous current pulses through developing fucoid eggs. Proc
Natl Acad Sci U S A. 1974;71:4855-4859.
247. Kline D, Robinson KR, Nuccitelli R. Ion currents and membrane domains in the cleaving
Xenopus egg. J Cell Biol. 1983;97:1753-1761.
248. Robinson KR. Endogenous electrical current leaves the limb and prelimb region of the
Xenopus embryo. Dev Biol. 1983;97:203-211.
249. Shi R, Borgens RB. Embryonic neuroepithelial sodium transport, the resulting physiological
potential, and cranial development. Dev Biol. 1994;165:105-116.
250. Altizer AM, Moriarty LJ, Bell SM, Schreiner CM, Scott WJ, Borgens RB. Endogenous
electric current is associated with normal development of the vertebrate limb. Dev Dyn.
2001;221:391-401.
251. Hotary KB, Robinson KR. The neural tube of the Xenopus embryo maintains a potential
difference across itself. Brain Res Dev Brain Res. 1991;59:65-73.
252. Hotary KB, Robinson KR. Evidence of a role for endogenous electrical fields in chick
embryo development. Development. 1992;114:985-996.
253. Jaffe LF. The role of ionic currents in establishing developmental pattern. Philos Trans R
Soc Lond B Biol Sci. 1981;295:553-566.
254. Blackshaw SE, Warner AE. Low resistance junctions between mesoderm cells during
development of trunk muscles. J Physiol. 1976;255:209-230.
255. Warner AE. The electrical properties of the ectoderm in the amphibian embryo during
induction and early development of the nervous system. J Physiol. 1973;235:267-286.
256. Foulds IS, Barker AT. Human skin battery potentials and their possible role in wound
healing. Br J Dermatol. 1983;109:515-522.
257. Barker AT, Jaffe LF, Vanable JW,Jr. The glabrous epidermis of cavies contains a powerful
battery. Am J Physiol. 1982;242:R358-66.
258. Borgens RB. Endogenous ionic currents traverse intact and damaged bone. Science.
1984;225:478-482.

261

259. Parmelee JT, Robinson KR, Patterson JW. Effects of calcium on the steady outward
currents at the equator of the rat lens. Invest Ophthalmol Vis Sci. 1985;26:1343-1348.
260. Shi R, Borgens RB. Three-dimensional gradients of voltage during development of the
nervous system as invisible coordinates for the establishment of embryonic pattern. Dev
Dyn. 1995;202:101-114.
261. Hotary KB, Robinson KR. Endogenous electrical currents and voltage gradients in
Xenopus embryos and the consequences of their disruption. Dev Biol. 1994;166:789-800.
262. Borgens RB, Shi R. Uncoupling histogenesis from morphogenesis in the vertebrate embryo
by collapse of the transneural tube potential. Dev Dyn. 1995;203:456-467.
263. Borgens RB, Rouleau MF, DeLanney LE. A steady efflux of ionic current predicts hind limb
development in the axolotl. J Exp Zool. 1983;228:491-503.
264. Borgens RB, Callahan L, Rouleau MF. Anatomy of axolotl flank integument during limb bud
development with special reference to a transcutaneous current predicting limb formation. J
Exp Zool. 1987;244:203-214.
265. Reid B, Nuccitelli R, Zhao M. Non-invasive measurement of bioelectric currents with a
vibrating probe. Nat Protoc. 2007;2:661-669.
266. Sun YH, Reid B, Fontaine JH, et al. Airway epithelial wounds in rhesus monkey generate
ionic currents that guide cell migration to promote healing. J Appl Physiol (1985).
2011;111:1031-1041.
267. Chiang M, Robinson KR, Vanable JW,Jr. Electrical fields in the vicinity of epithelial wounds
in the isolated bovine eye. Exp Eye Res. 1992;54:999-1003.
268. Song B, Zhao M, Forrester J, McCaig C. Nerve regeneration and wound healing are
stimulated and directed by an endogenous electrical field in vivo. J Cell Sci.
2004;117:4681-4690.
269. Cao L, Wei D, Reid B, et al. Endogenous electric currents might guide rostral migration of
neuroblasts. EMBO Rep. 2013;14:184-190.
270. Borgens RB, Vanable JW,Jr, Jaffe LF. Bioelectricity and regeneration: large currents leave
the stumps of regenerating newt limbs. Proc Natl Acad Sci U S A. 1977;74:4528-4532.
271. Moulin VJ, Dube J, Rochette-Drouin O, et al. Electric Potential Across Epidermis and Its
Role During Wound Healing Can Be Studied by Using an Reconstructed Human Skin. Adv
Wound Care (New Rochelle). 2012;1:81-87.
272. Nuccitelli R, Nuccitelli P, Li C, Narsing S, Pariser DM, Lui K. The electric field near human
skin wounds declines with age and provides a noninvasive indicator of wound healing.
Wound Repair Regen. 2011;19:645-655.
273. Trollinger DR, Isseroff RR, Nuccitelli R. Calcium channel blockers inhibit galvanotaxis in
human keratinocytes. J Cell Physiol. 2002;193:1-9.

262

274. Becker RO. The bioelectric factors in amphibian-limb regeneration. J Bone Joint Surg Am.
1961;43-A:643-656.
275. Altizer AM, Stewart SG, Albertson BK, Borgens RB. Skin flaps inhibit both the current of
injury at the amputation surface and regeneration of that limb in newts. J Exp Zool.
2002;293:467-477.
276. Reid B, Song B, Zhao M. Electric currents in Xenopus tadpole tail regeneration. Dev Biol.
2009;335:198-207.
277. Borgens RB, Vanable JW,Jr, Jaffe LF. Bioelectricity and regeneration. I. Initiation of frog
limb regeneration by minute currents. J Exp Zool. 1977;200:403-416.
278. Borgens RB, Vanable JW,Jr, Jaffe LF. Role of subdermal current shunts in the failure of
frogs to regenerate. J Exp Zool. 1979;209:49-56.
279. Chiang MC, Cragoe EJ,Jr, Vanable JW,Jr. Intrinsic electric fields promote epithelization of
wounds in the newt, Notophthalmus viridescens. Dev Biol. 1991;146:377-385.
280. Borgens RB, Vanable JW,Jr, Jaffe LF. Reduction of sodium dependent stump currents
disturbs urodele limb regeneration. J Exp Zool. 1979;209:377-386.
281. Jenkins LS, Duerstock BS, Borgens RB. Reduction of the current of injury leaving the
amputation inhibits limb regeneration in the red spotted newt. Dev Biol. 1996;178:251-262.
282. Smith SD. Induction of partial limb regeneration in Rana pipiens by galvanic stimulation.
Anat Rec. 1967;158:89-97.
283. Becker RO. Stimulation of partial limb regeneration in rats. Nature. 1972;235:109-111.
284. Becker RO, Spadaro JA. Electrical stimulation of partial limb regeneration in mammals.
Bull N Y Acad Med. 1972;48:627-641.
285. Swartz BE. The advantages of digital over analog recording techniques.
Electroencephalogr Clin Neurophysiol. 1998;106:113-117.
286. Ormerod W. Richard Caton (1842-1926): pioneer electrophysiologist and cardiologist. J
Med Biogr. 2006;14:30-35.
287. Coenen A, Zayachkivska O. Adolf Beck: A pioneer in electroencephalography in between
Richard Caton and Hans Berger. Adv Cogn Psychol. 2013;9:216-221.
288. Pravdich-Neminsky VV. Ein Versuch der Registrierung der elektrischen
Gehirnerscheinungen. Zbl Physiol. 1913;27:951-960.
289. Khan T, Myklebust J, Swiontek T, Sayers S, Dauzvardis M. Electrical field distribution
within the injured cat spinal cord: injury potentials and field distribution. J Neurotrauma.
1994;11:699-710.
290. Cao L, Pu J, Scott RH, Ching J, McCaig CD. Physiological electrical signals promote chain
migration of neuroblasts by up-regulating P2Y1 purinergic receptors and enhancing cell
adhesion. Stem Cell Rev. 2015;11:75-86.

263

291. Zuberi M, Liu-Snyder P, Ul Haque A, Porterfield DM, Borgens RB. Large naturallyproduced electric currents and voltage traverse damaged mammalian spinal cord. J Biol
Eng. 2008;2:17-1611-2-17.
292. Lomo T. Patterns of activation in a monosynaptic cortical pathway: the perforant path input
to the dentate area of the hippocampal formation. Exp Brain Res. 1971;12:18-45.
293. Pelletier SJ, Lagace M, St-Amour I, et al. The morphological and molecular changes of
brain cells exposed to direct current electric field stimulation. Int J Neuropsychopharmacol.
2014;18:10.1093/ijnp/pyu090.
294. Jaffe LF, Poo MM. Neurites grow faster towards the cathode than the anode in a steady
field. J Exp Zool. 1979;209:115-128.
295. Patel N, Poo MM. Orientation of neurite growth by extracellular electric fields. J Neurosci.
1982;2:483-496.
296. Erskine L, Stewart R, McCaig CD. Electric field-directed growth and branching of cultured
frog nerves: effects of aminoglycosides and polycations. J Neurobiol. 1995;26:523-536.
297. Stewart R, Erskine L, McCaig CD. Calcium channel subtypes and intracellular calcium
stores modulate electric field-stimulated and -oriented nerve growth. Dev Biol.
1995;171:340-351.
298. Palmer AM, Messerli MA, Robinson KR. Neuronal galvanotropism is independent of
external Ca(2+) entry or internal Ca(2+) gradients. J Neurobiol. 2000;45:30-38.
299. Erskine L, McCaig CD. Growth cone neurotransmitter receptor activation modulates
electric field-guided nerve growth. Dev Biol. 1995;171:330-339.
300. Wood MD, Willits RK. Applied electric field enhances DRG neurite growth: influence of
stimulation media, surface coating and growth supplements. J Neural Eng. 2009;6:0460032560/6/4/046003. Epub 2009 Jun 3.
301. Koppes AN, Seggio AM, Thompson DM. Neurite outgrowth is significantly increased by the
simultaneous presentation of Schwann cells and moderate exogenous electric fields. J
Neural Eng. 2011;8:046023-2560/8/4/046023. Epub 2011 Jun 29.
302. Cork RJ, McGinnis ME, Tsai J, Robinson KR. The growth of PC12 neurites is biased
towards the anode of an applied electrical field. J Neurobiol. 1994;25:1509-1516.
303. Cormie P, Robinson KR. Embryonic zebrafish neuronal growth is not affected by an
applied electric field in vitro. Neurosci Lett. 2007;411:128-132.
304. Erskine L, McCaig CD. Integrated interactions between chondroitin sulphate proteoglycans
and weak dc electric fields regulate nerve growth cone guidance in vitro. J Cell Sci.
1997;110 ( Pt 16):1957-1965.
305. Koppes AN, Zaccor NW, Rivet CJ, et al. Neurite outgrowth on electrospun PLLA fibers is
enhanced by exogenous electrical stimulation. J Neural Eng. 2014;11:0460022560/11/4/046002. Epub 2014 Jun 3.

264

306. Babona-Pilipos R, Droujinine IA, Popovic MR, Morshead CM. Adult subependymal neural
precursors, but not differentiated cells, undergo rapid cathodal migration in the presence of
direct current electric fields. PLoS One. 2011;6:e23808.
307. Meng X, Li W, Young F, et al. Electric field-controlled directed migration of neural
progenitor cells in 2D and 3D environments. J Vis Exp. 2012;(60). pii: 3453.
doi:10.3791/3453.
308. Babona Pilipos R, Popovic M, Morshead C. A galvanotaxis assay for analysis of neural
precursor cell migration kinetics in an externally applied direct current electric field. Journal
of Visualized Experiments. 2012.
309. Liu J, Zhu B, Zhang G, et al. Electric signals regulate directional migration of ventral
midbrain derived dopaminergic neural progenitor cells via Wnt/GSK3beta signaling. Exp
Neurol. 2014.
310. Zhao H, Steiger A, Nohner M, Ye H. Specific Intensity Direct Current (DC) Electric Field
Improves Neural Stem Cell Migration and Enhances Differentiation towards betaIII-Tubulin+
Neurons. PLoS One. 2015;10:e0129625.
311. Thrivikraman G, Madras G, Basu B. Intermittent electrical stimuli for guidance of human
mesenchymal stem cell lineage commitment towards neural-like cells on electroconductive
substrates. Biomaterials. 2014;35:6219-6235.
312. Huang R, Peng L, Hertz L. Effects of a low-voltage static electric field on energy
metabolism in astrocytes. Bioelectromagnetics. 1997;18:77-80.
313. Lalli G. Extracellular signals controlling neuroblast migration in the postnatal brain. Adv Exp
Med Biol. 2014;800:149-180.
314. Cayre M, Canoll P, Goldman JE. Cell migration in the normal and pathological postnatal
mammalian brain. Prog Neurobiol. 2009;88:41-63.
315. Levin M. Endogenous bioelectrical networks store non-genetic patterning information
during development and regeneration. J Physiol. 2014;592:2295-2305.
316. Fehlings MG, Tator CH. The effect of direct current field polarity on recovery after acute
experimental spinal cord injury. Brain Res. 1992;579:32-42.
317. Borgens RB, Blight AR, McGinnis ME. Behavioral recovery induced by applied electric
fields after spinal cord hemisection in guinea pig. Science. 1987;238:366-369.
318. Borgens RB, Blight AR, Murphy DJ, Stewart L. Transected dorsal column axons within the
guinea pig spinal cord regenerate in the presence of an applied electric field. J Comp
Neurol. 1986;250:168-180.
319. Borgens RB, Toombs JP, Breur G, et al. An imposed oscillating electrical field improves
the recovery of function in neurologically complete paraplegic dogs. J Neurotrauma.
1999;16:639-657.

265

320. Moriarty LJ, Borgens RB. An oscillating extracellular voltage gradient reduces the density
and influences the orientation of astrocytes in injured mammalian spinal cord. J Neurocytol.
2001;30:45-57.
321. Barreto GE, Sun X, Xu L, Giffard RG. Astrocyte proliferation following stroke in the mouse
depends on distance from the infarct. PLoS One. 2011;6:e27881.
322. Suzuki T, Sakata H, Kato C, Connor JA, Morita M. Astrocyte activation and wound healing
in intact-skull mouse after focal brain injury. Eur J Neurosci. 2012;36:3653-3664.
323. Lurie DI, Pijak DS, Selzer ME. Structure of reticulospinal axon growth cones and their
cellular environment during regeneration in the lamprey spinal cord. J Comp Neurol.
1994;344:559-580.
324. McCaig CD, Zhao M. Physiological electrical fields modify cell behaviour; BioEssays.
Bioessays. 1997;19:819-819-826.
325. Zhao M, Agius-Fernandez A, Forrester JV, McCaig CD. Orientation and directed migration
of cultured corneal epithelial cells in small electric fields are serum dependent. J Cell Sci.
1996;109 ( Pt 6):1405-1414.
326. Song B, Zhao M, Forrester JV, McCaig CD. Electrical cues regulate the orientation and
frequency of cell division and the rate of wound healing in vivo. Proc Natl Acad Sci U S A.
2002;99:13577-13582.
327. Zhao M, Forrester JV, McCaig CD. A small, physiological electric field orients cell division.
Proc Natl Acad Sci U S A. 1999;96:4942-4946.
328. Mie M, Endoh T, Yanagida Y, Kobatake E, Aizawa M. Induction of neural differentiation by
electrically stimulated gene expression of NeuroD2. J Biotechnol. 2003;100:231-238.
329. Levin M. Large-scale biophysics: ion flows and regeneration. Trends Cell Biol.
2007;17:261-270.
330. Song B, Gu Y, Pu J, Reid B, Zhao Z, Zhao M. Application of direct current electric fields to
cells and tissues in vitro and modulation of wound electric field in vivo. Nat Protoc.
2007;2:1479-1489.
331. Wang ET, Zhao M. Regulation of tissue repair and regeneration by electric fields. Chin J
Traumatol. 2010;13:55-61.
332. Borgens RB, Roederer E, Cohen MJ. Enhanced spinal cord regeneration in lamprey by
applied electric fields. Science. 1981;213:611-617.
333. Smith SD. Effects of electrode placement on stimulation of adult frog limb regeneration.
Ann N Y Acad Sci. 1974;238:500-507.
334. Ud-Din S, Sebastian A, Giddings P, et al. Angiogenesis is induced and wound size is
reduced by electrical stimulation in an acute wound healing model in human skin. PLoS
One. 2015;10:e0124502.

266

335. Chan CY, Nicholson C. Modulation by applied electric fields of Purkinje and stellate cell
activity in the isolated turtle cerebellum. J Physiol. 1986;371:89-114.
336. Wickham H. Ggplot2: Elegant Graphics for Data Analysis. Springer New York; 2009.
337. Wickham and Hadley. Reshaping data with the reshape package. Journal of Statistical
Software. 2007;21.
338. Hothorn T, Bretz F, Westfall P. Simultaneous Inference in General Parametric Models.
Biometrical Journal. 2008;50:346-363.
339. Fox J, Weisberg S. An R Companion to Applied Regression. Second ed. Thousand Oaks
{CA}: Sage; 2011.
340. Pinheiro J, Bates D, DebRoy S, Sarkar D, Team RC. Nlme: Linear and Nonlinear Mixed
Effects Models. ; 2015.
341. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria:
R Foundation for Statistical Computing; 2014.
342. Meijering E, Dzyubachyk O, Smal I. Methods for cell and particle tracking. Methods
Enzymol. 2012;504:183-200.
343. Agostinelli C, Lund U. R Package Circular: Circular Statistics (Version 0.4-7). CA:
Department of Environmental Sciences, Informatics and Statistics, Ca' Foscari University,
Venice, Italy. UL: Department of Statistics, California Polytechnic State University, San Luis
Obispo, California, USA: ; 2013.
344. Grosjean P, Ibanez F. Pastecs: Package for Analysis of Space-Time Ecological Series. ;
2014.
345. RStudio. RStudio. Boston, MA:2012;0.98.953. Available from: http://www.rstudio.org.
Accessed June 28, 2014.
346. Schindelin J, Arganda-Carreras I, Frise E, et al. Fiji: an open-source platform for biologicalimage analysis. Nat Methods. 2012;9:676-682.
347. Ayres C, Bowlin GL, Henderson SC, et al. Modulation of anisotropy in electrospun tissueengineering scaffolds: Analysis of fiber alignment by the fast Fourier transform.
Biomaterials. 2006;27:5524-5534.
348. Ayres CE, Jha BS, Meredith H, et al. Measuring fiber alignment in electrospun scaffolds: a
user's guide to the 2D fast Fourier transform approach. J Biomater Sci Polym Ed.
2008;19:603-621.
349. Tonar Z, Nemecek S, Holota R, et al. Microscopic image analysis of elastin network in
samples of normal, atherosclerotic and aneurysmatic abdominal aorta and its
biomechanical implications. J Appl Biomed. 2003;1:149-149-159.
350. Mutterer J, Zinck E. Quick-and-clean article figures with FigureJ. J Microsc. 2013;252:8991.

267

351. Gotz M, Huttner WB. The cell biology of neurogenesis. Nat Rev Mol Cell Biol. 2005;6:777788.
352. Haan N, Song B. Therapeutic Application of Electric Fields in the Injured Nervous System.
Adv Wound Care (New Rochelle). 2014;3:156-165.
353. Thompson DM, Koppes AN, Hardy JG, Schmidt CE. Electrical stimuli in the central
nervous system microenvironment. Annu Rev Biomed Eng. 2014;16:397-430.
354. Borgens RB, Jaffe LF, Cohen MJ. Large and persistent electrical currents enter the
transected lamprey spinal cord. Proc Natl Acad Sci U S A. 1980;77:1209-1213.
355. McGinnis ME, Vanable JW. Electrical Fields in Notophthalmus viridescens Limb Stumps.
Dev Biol. 1986;116:184-193.
356. Katz U, Scheffey C. The voltage-dependent chloride current conductance of toad skin is
localized to mitochondria-rich cells. Biochim Biophys Acta. 1986;861:480-482.
357. Scheffey C, Katz U. Current flow measurements from the apical side of toad skin. A
vibrating probe analysis. Prog Clin Biol Res. 1986;210:213-219.
358. Rubinacci A, Villa I, Dondi Benelli F, et al. Osteocyte-bone lining cell system at the origin of
steady ionic current in damaged amphibian bone. Calcif Tissue Int. 1998;63:331-339.
359. Candia OA, Zadunaisky JA, Bajandas F. Electrical potential profile of the isolated frog
cornea. Invest Ophthalmol. 1968;7:405-415.
360. Parmelee JT. Measurement of steady currents around the frog lens. Exp Eye Res.
1986;42:433-441.
361. Eltinge EM, Cragoe EJ,Jr, Vanable JW,Jr. Effects of amiloride analogues on adult
Notophthalmus viridescens limb stump currents. Comp Biochem Physiol A Comp Physiol.
1986;84:39-44.
362. Spence DW, Pomeranz B. Surgical wound healing monitored repeatedly in vivo using
electrical resistance of the epidermis. Physiol Meas. 1996;17:57-69.
363. Lois N, Reid B, Song B, Zhao M, Forrester J, McCaig C. Electric currents and lens
regeneration in the rat. Exp Eye Res. 2010;90:316-323.
364. Bassett CA, Becker RO. Generation of electric potentials by bone in response to
mechanical stress. Science. 1962;137:1063-1064.
365. Illingworth CM, Barker AT. Measurement of electrical currents emerging during the
regeneration of amputated finger tips in children. Clin Phys Physiol Meas. 1980;1:87-87-89.
366. Rubinacci A, De Ponti A, Shipley A, Samaja M, Karplus E, Jaffe LF. Bicarbonate
dependence of ion current in damaged bone. Calcif Tissue Int. 1996;58:423-428.
367. Matic M, Lazetic B, Poljacki M, Djuran V, Matic A, Gajinov Z. Influence of different types of
electromagnetic fields on skin reparatory processes in experimental animals. Lasers Med
Sci. 2009;24:321-327.

268

368. Kornyei Z, Czirok A, Vicsek T, Madarasz E. Proliferative and migratory responses of
astrocytes to in vitro injury. J Neurosci Res. 2000;61:421-429.
369. Cortese B, Palama IE, D'Amone S, Gigli G. Influence of electrotaxis on cell behaviour.
Integr Biol (Camb). 2014;6:817-830.
370. Jahanshahi A, Schonfeld LM, Lemmens E, Hendrix S, Temel Y. In vitro and in vivo
neuronal electrotaxis: a potential mechanism for restoration? Mol Neurobiol. 2014;49:10051016.
371. Orida N, Feldman JD. Directional protrusive pseudopodial activity and motility in
macrophages induced by extracellular electric fields. Cell Motil. 1982;2:243-255.
372. Poo M. In situ electrophoresis of membrane components. Annu Rev Biophys Bioeng.
1981;10:245-276.
373. Tai G, Reid B, Cao L, Zhao M. Electrotaxis and wound healing: experimental methods to
study electric fields as a directional signal for cell migration. Methods in molecular biology.
2009;571:77-97.
374. Gross D, Loew LM, Webb WW. Optical imaging of cell membrane potential changes
induced by applied electric fields. Biophys J. 1986;50:339-348.
375. Pappalardo LW, Samad OA, Black JA, Waxman SG. Voltage-gated sodium channel Nav
1.5 contributes to astrogliosis in an in vitro model of glial injury via reverse Na+ /Ca2+
exchange. Glia. 2014;62:1162-1175.
376. Buffo A, Rite I, Tripathi P, et al. Origin and progeny of reactive gliosis: A source of
multipotent cells in the injured brain. Proc Natl Acad Sci U S A. 2008;105:3581-3586.
377. Abeed RI, Naseer M, Abel EW. Capacitively coupled electrical stimulation treatment:
results from patients with failed long bone fracture unions. J Orthop Trauma. 1998;12:510513.
378. Brighton CT, Black J, Friedenberg ZB, Esterhai JL, Day LJ, Connolly JF. A multicenter
study of the treatment of non-union with constant direct current. J Bone Joint Surg Am.
1981;63:2-13.
379. Zamora-Navas P, Borras Verdera A, Antelo Lorenzo R, Saras Ayuso JR, Pena Reina MC.
Electrical stimulation of bone nonunion with the presence of a gap. Acta Orthop Belg.
1995;61:169-176.
380. Anderson MA, Ao Y, Sofroniew MV. Heterogeneity of reactive astrocytes. Neurosci Lett.
2014;565:23-29.
381. Bravin M, Savio T, Strata P, Rossi F. Olivocerebellar axon regeneration and target
reinnervation following dissociated Schwann cell grafts in surgically injured cerebella of
adult rats. Eur J Neurosci. 1997;9:2634-2649.
382. Buffo A, Rossi F. Origin, lineage and function of cerebellar glia. Prog Neurobiol.
2013;109:42-63.

269

383. Dahmane N, Ruiz i Altaba A. Sonic hedgehog regulates the growth and patterning of the
cerebellum. Development. 1999;126:3089-3100.
384. Adorjan I, Bindics K, Galgoczy P, Kalman M. Phases of intermediate filament composition
in Bergmann glia following cerebellar injury in adult rat. Exp Brain Res. 2014;232:20952104.
385. Doetsch F. The glial identity of neural stem cells. Nat Neurosci. 2003;6:1127-1134.
386. Mendis DB, Ivy GO, Brown IR. SC1, a brain extracellular matrix glycoprotein related to
SPARC and follistatin, is expressed by rat cerebellar astrocytes following injury and during
development. Brain Res. 1996;730:95-106.
387. Tan AM, Zhang W, Levine JM. NG2: a component of the glial scar that inhibits axon
growth. J Anat. 2005;207:717-725.
388. Dusart I, Morel MP, Wehrle R, Sotelo C. Late axonal sprouting of injured Purkinje cells and
its temporal correlation with permissive changes in the glial scar. J Comp Neurol.
1999;408:399-418.
389. Lagenaur C, Masters C, Schachner M. Changes in expression of glial antigens M1 and C1
after cerebellar injury. J Neurosci. 1982;2:470-476.
390. Vaquero J, Manrique M, Oya S, Bravo G. Tissue damage after chronic cerebellar
stimulation. Acta Neurochir (Wien). 1981;56:183-190.
391. Milenkovic I, Nedeljkovic N, Filipovic R, et al. Pattern of glial fibrillary acidic protein
expression following kainate-induced cerebellar lesion in rats. Neurochem Res.
2005;30:207-213.
392. Blackiston DJ, McLaughlin KA, Levin M. Bioelectric controls of cell proliferation: ion
channels, membrane voltage and the cell cycle. Cell Cycle. 2009;8:3527-3536.
393. Koyama Y. Signaling molecules regulating phenotypic conversions of astrocytes and glial
scar formation in damaged nerve tissues. Neurochem Int. 2014;78C:35-42.
394. Nehrt A, Hamann K, Ouyang H, Shi R. Polyethylene glycol enhances axolemmal resealing
following transection in cultured cells and in ex vivo spinal cord. J Neurotrauma.
2010;27:151-161.
395. Koryta J. Ions, Electrodes, and Membranes. 2nd ed. New York: John Wiley and Sons, Inc.;
1991.
396. Jaffe LF, Nuccitelli R. An ultrasensitive vibrating probe for measuring steady extracellular
currents. J Cell Biol. 1974;63:614-628.
397. Scheffey C. Two approaches to construction of vibrating probes for electrical current
measurement in solution. Review of Scientific Instruments. 1988;59:787.
398. Reid B, Zhao M. Measurement of bioelectric current with a vibrating probe. J Vis Exp.
2011;(47). pii: 2358. doi:10.3791/2358.

270

399. Scheffey C. Electric fields and the vibrating probe, for the uninitiated. Prog Clin Biol Res.
1986;210:xxv-xxxvii.
400. Levin M. Molecular bioelectricity in developmental biology: new tools and recent
discoveries: control of cell behavior and pattern formation by transmembrane potential
gradients. Bioessays. 2012;34:205-217.
401. Adams DS, Levin M. Endogenous voltage gradients as mediators of cell-cell
communication: strategies for investigating bioelectrical signals during pattern formation.
Cell Tissue Res. 2013;352:95-122.
402. Hill AB. The Environment and Disease: Association Or Causation? Proc R Soc Med.
1965;58:295-300.
403. Cook TA, Nagasaki T, Gundersen GG. Rho guanosine triphosphatase mediates the
selective stabilization of microtubules induced by lysophosphatidic acid. J Cell Biol.
1998;141:175-185.
404. Ishizaki T, Morishima Y, Okamoto M, Furuyashiki T, Kato T, Narumiya S. Coordination of
microtubules and the actin cytoskeleton by the Rho effector mDia1. Nat Cell Biol. 2001;3:814.
405. Drees BL, Sundin B, Brazeau E, et al. A protein interaction map for cell polarity
development. J Cell Biol. 2001;154:549-571.
406. Johnson DI, Pringle JR. Molecular characterization of CDC42, a Saccharomyces
cerevisiae gene involved in the development of cell polarity. J Cell Biol. 1990;111:143-152.
407. Etienne-Manneville S, Hall A. Integrin-mediated activation of Cdc42 controls cell polarity in
migrating astrocytes through PKCzeta. Cell. 2001;106:489-498.
408. Ho KW, Lambert WS, Calkins DJ. Activation of the TRPV1 cation channel contributes to
stress-induced astrocyte migration. Glia. 2014;62:1435-1451.
409. Gnanaguru G, Bachay G, Biswas S, Pinzon-Duarte G, Hunter DD, Brunken WJ. Laminins
containing the beta2 and gamma3 chains regulate astrocyte migration and angiogenesis in
the retina. Development. 2013;140:2050-2060.
410. Calderwood DA, Campbell ID, Critchley DR. Talins and kindlins: partners in integrinmediated adhesion. Nat Rev Mol Cell Biol. 2013;14:503-517.
411. Chung MK, Guler AD, Caterina MJ. TRPV1 shows dynamic ionic selectivity during agonist
stimulation. Nat Neurosci. 2008;11:555-564.
412. Liao M, Cao E, Julius D, Cheng Y. Structure of the TRPV1 ion channel determined by
electron cryo-microscopy. Nature. 2013;504:107-112.
413. Tharmalingam S, Wu C, Hampson DR. The calcium-sensing receptor and integrins
modulate cerebellar granule cell precursor differentiation and migration. Dev Neurobiol.
2015.

271

414. Stillwell EF, Cone CM, Cone CD,Jr. Stimulation of DNA synthesis in CNS neurones by
sustained depolarisation. Nat New Biol. 1973;246:110-111.
415. Carlson M, Osmond BC, Botstein D. Mutants of yeast defective in sucrose utilization.
Genetics. 1981;98:25-40.
416. Sjostrom M, Stenstrom K, Eneling K, et al. SIK1 is part of a cell sodium-sensing network
that regulates active sodium transport through a calcium-dependent process. Proc Natl
Acad Sci U S A. 2007;104:16922-16927.
417. Kuser-Abali G, Ozcan F, Ugurlu A, Uysal A, Fuss SH, Bugra-Bilge K. SIK2 is involved in
the negative modulation of insulin-dependent muller cell survival and implicated in
hyperglycemia-induced cell death. Invest Ophthalmol Vis Sci. 2013;54:3526-3537.
418. Binggeli R, Weinstein RC. Membrane potentials and sodium channels: hypotheses for
growth regulation and cancer formation based on changes in sodium channels and gap
junctions. J Theor Biol. 1986;123:377-401.
419. West AE, Chen WG, Dalva MB, et al. Calcium regulation of neuronal gene expression.
Proc Natl Acad Sci U S A. 2001;98:11024-11031.
420. Renault-Mihara F, Okada S, Shibata S, Nakamura M, Toyama Y, Okano H. Spinal cord
injury: emerging beneficial role of reactive astrocytes' migration. Int J Biochem Cell Biol.
2008;40:1649-1653.
421. Wang E, Yin Y, Zhao M, Forrester JV, McCaig CD. Physiological electric fields control the
G1/S phase cell cycle checkpoint to inhibit endothelial cell proliferation. FASEB J.
2003;17:458-460.
422. Pazmany T, Murphy SP, Gollnick SO, Brooks SP, Tomasi TB. Activation of multiple
transcription factors and fos and jun gene family expression in cells exposed to a single
electric pulse. Exp Cell Res. 1995;221:103-110.
423. Bauer CK, Schwarz JR. Physiology of EAG K+ channels. J Membr Biol. 2001;182:1-15.
424. Sundelacruz S, Levin M, Kaplan DL. Membrane potential controls adipogenic and
osteogenic differentiation of mesenchymal stem cells. PLoS One. 2008;3:e3737.
425. Peng HB, Jaffe LF. Polarization of fucoid eggs by steady electrical fields. Dev Biol.
1976;53:277-284.
426. Douzery EJ, Snell EA, Bapteste E, Delsuc F, Philippe H. The timing of eukaryotic
evolution: does a relaxed molecular clock reconcile proteins and fossils? Proc Natl Acad
Sci U S A. 2004;101:15386-15391.
427. Schrum JP, Zhu TF, Szostak JW. The origins of cellular life. Cold Spring Harb Perspect
Biol. 2010;2:a002212.
428. Sinha N, Smith-Gill SJ. Electrostatics in protein binding and function. Curr Protein Pept Sci.
2002;3:601-614.

272

429. Fried SD, Bagchi S, Boxer SG. Extreme electric fields power catalysis in the active site of
ketosteroid isomerase. Science. 2014;346:1510-1514.
430. Mansy SS. Membrane transport in primitive cells. Cold Spring Harb Perspect Biol.
2010;2:a002188.
431. Foster KR, Schwan HP. Dielectric properties of tissues and biological materials: a critical
review. Crit Rev Biomed Eng. 1989;17:25-104.
432. Langley JN. Note on Regeneration of Prae-Ganglionic Fibres of the Sympathetic. J Physiol
(Lond ). 1895;18:280-284.
433. Stocum DL. The role of peripheral nerves in urodele limb regeneration. Eur J Neurosci.
2011;34:908-916.
434. Fourtner CR, Drewes CD, Holzmann TW. Specificity of afferent and efferent regeneration
in the cockroach: establishment of a reflex pathway between contralaterally homologous
target cells. J Neurophysiol. 1978;41:885-895.
435. Nakamura T, Mito T, Bando T, Ohuchi H, Noji S. Dissecting insect leg regeneration
through RNA interference. Cell Mol Life Sci. 2008;65:64-72.
436. Nakamura T, Mito T, Miyawaki K, Ohuchi H, Noji S. EGFR signaling is required for reestablishing the proximodistal axis during distal leg regeneration in the cricket Gryllus
bimaculatus nymph. Dev Biol. 2008;319:46-55.
437. Bode H. Axis formation in hydra. Annu Rev Genet. 2011;45:105-117.
438. Bonfanti L. From hydra regeneration to human brain structural plasticity: a long trip through
narrowing roads. ScientificWorldJournal. 2011;11:1270-1299.
439. Bosch TC. Why polyps regenerate and we don't: towards a cellular and molecular
framework for Hydra regeneration. Dev Biol. 2007;303:421-433.
440. Rink JC. Stem cell systems and regeneration in planaria. Dev Genes Evol. 2013;223:6784.
441. Baguna J. The planarian neoblast: the rambling history of its origin and some current black
boxes. Int J Dev Biol. 2012;56:19-37.
442. Sutter D, Vyver G. Aggregative properties of different cell types of the fresh-water
spongeEphydatia fluviatilis isolated on ficoll gradients. Dev Genes Evol. 1977;181:151-161.
443. Morrow E, Pitcher T. Sexual selection and the risk of extinction in birds. Proceedings Royal Society.Biological sciences. 2003;270:1793-1799.
444. Lister AM, Edwards CJ, Nock DAW, et al. The phylogenetic position of the 'giant deer'
Megaloceros giganteus. Nature. 2005;438:850-853.
445. King N, Carroll SB. A receptor tyrosine kinase from choanoflagellates: molecular insights
into early animal evolution. Proc Natl Acad Sci U S A. 2001;98:15032-15037.

273

446. King N. The unicellular ancestry of animal development. Dev Cell. 2004;7:313-325.
447. Maldonado M. Choanoflagellates, choanocytes, and animal multicellularity. Invertebr Biol.
2004;123:1-22.
448. Funayama N, Nakatsukasa M, Hayashi T, Agata K. Isolation of the choanocyte in the fresh
water sponge, Ephydatia fluviatilis and its lineage marker, Ef annexin. Development, growth
differentiation. 2005;47:243-253.
449. Aboobaker AA. Planarian stem cells: a simple paradigm for regeneration. Trends Cell Biol.
2011;21:304-311.
450. Bettencourt-Dias M, Mittnacht S, Brockes JP. Heterogeneous proliferative potential in
regenerative adult newt cardiomyocytes. J Cell Sci. 2003;116:4001-4009.
451. Walsh GS, Grant PK, Morgan JA, Moens CB. Planar polarity pathway and Nance-Horan
syndrome-like 1b have essential cell-autonomous functions in neuronal migration.
Development. 2011;138:3033-3042.
452. Oh H, Bradfute SB, Gallardo TD, et al. Cardiac progenitor cells from adult myocardium:
homing, differentiation, and fusion after infarction. Proc Natl Acad Sci U S A.
2003;100:12313-12318.
453. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase
progression. Genes Dev. 1999;13:1501-1512.
454. Wu SM, Chien KR, Mummery C. Origins and fates of cardiovascular progenitor cells. Cell.
2008;132:537-543.
455. Bambakidis NC, Onwuzulike K. Sonic hedgehog signaling and potential therapeutic
indications. Vitam Horm. 2012;88:379-394.
456. Franklin RJ, Hinks GL, Woodruff RH, O'Leary MT. What roles do growth factors play in
CNS remyelination? Prog Brain Res. 2001;132:185-193.
457. Hollis ER,2nd, Zou Y. Expression of the Wnt signaling system in central nervous system
axon guidance and regeneration. Front Mol Neurosci. 2012;5:5.
458. Conover JC, Notti RQ. The neural stem cell niche. Cell Tissue Res. 2008;331:211-224.
459. Burdick JA, Ward M, Liang E, Young MJ, Langer R. Stimulation of neurite outgrowth by
neurotrophins delivered from degradable hydrogels. Biomaterials. 2006;27:452-459.
460. de Groat WC, Yoshimura N. Mechanisms underlying the recovery of lower urinary tract
function following spinal cord injury. Prog Brain Res. 2006;152:59-84.
461. Chera S, Ghila L, Wenger Y, Galliot B. Injury-induced activation of the MAPK/CREB
pathway triggers apoptosis-induced compensatory proliferation in hydra head regeneration.
Dev Growth Differ. 2011;53:186-201.
462. Aufschnaiter R, Zamir EA, Little CD, et al. In vivo imaging of basement membrane
movement: ECM patterning shapes Hydra polyps. J Cell Sci. 2011;124:4027-4038.

274

463. Tanaka EM, Reddien PW. The cellular basis for animal regeneration. Dev Cell.
2011;21:172-185.
464. Bergmann A, Steller H. Apoptosis, stem cells, and tissue regeneration. Sci Signal.
2010;3:re8.
465. Young SL, Diolaiti D, Conacci-Sorrell M, Ruiz-Trillo I, Eisenman RN, King N. Premetazoan
ancestry of the Myc-Max network. Mol Biol Evol. 2011;28:2961-2971.
466. Stewart E, Madden R, Paul G, Taddei F. Aging and death in an organism that reproduces
by morphologically symmetric division. PLoS Biology. 2005;3:e45-e45.
467. Mortimer RK, Johnston JR. Life span of individual yeast cells. Nature. 1959;183:17511752.
468. Waibel M, Floreano D, Keller L. A quantitative test of Hamilton's rule for the evolution of
altruism. PLoS Biol. 2011;9:e1000615.
469. Rose MR, Rauser CL, Benford G, Matos M, Mueller LD. Hamilton's forces of natural
selection after forty years. Evolution. 2007;61:1265-1276.
470. Agrawal AF. Kin recognition and the evolution of altruism. Proc Biol Sci. 2001;268:10991104.
471. Sumner S, Kelstrup H, Fanelli D. Reproductive constraints, direct fitness and indirect
fitness benefits explain helping behaviour in the primitively eusocial wasp, Polistes
canadensis. Proc Biol Sci. 2010;277:1721-1728.
472. Gadau J, Helmkampf M, Nygaard S, et al. The genomic impact of 100 million years of
social evolution in seven ant species. Trends Genet. 2012;28:14-21.
473. Toth AL, Varala K, Newman TC, et al. Wasp gene expression supports an evolutionary link
between maternal behavior and eusociality. Science. 2007;318:441-444.
474. Jarosch A, Stolle E, Crewe RM, Moritz RF. Alternative splicing of a single transcription
factor drives selfish reproductive behavior in honeybee workers (Apis mellifera). Proc Natl
Acad Sci U S A. 2011;108:15282-15287.
475. Begna D, Han B, Feng M, Fang Y, Li J. Differential expressions of nuclear proteomes
between honeybee (Apis mellifera L.) Queen and Worker Larvae: a deep insight into caste
pathway decisions. J Proteome Res. 2012;11:1317-1329.
476. Togni OC, Giannotti E. Colony defense behavior of the primitively eusocial wasp,
Mischocyttarus cerberus is related to age. J Insect Sci. 2010;10:136.
477. Sherman PW. Nepotism and the evolution of alarm calls. Science. 1977;197:1246-1253.
478. Belzberg AJ, Myles ST, Trevenen CL. The human tail and spinal dysraphism. J Pediatr
Surg. 1991;26:1243-1245.
479. Scott GB. The primate caecum and appendix vermiformis: a comparative study. J Anat.
1980;131:549-563.

275

480. Strecker U, Faundez VH, Wilkens H. Phylogeography of surface and cave Astyanax
(Teleostei) from Central and North America based on cytochrome b sequence data. Mol
Phylogenet Evol. 2004;33:469-481.
481. Waszak S, Hasin Y, Zichner T, et al. Systematic inference of copy-number genotypes from
personal genome sequencing data reveals extensive olfactory receptor gene content
diversity. PLoS Computational Biology. 2010;6:e1000988-e1000988.
482. Hassink RJ, Pasumarthi KB, Nakajima H, et al. Cardiomyocyte cell cycle activation
improves cardiac function after myocardial infarction. Cardiovasc Res. 2008;78:18-25.
483. French DD, Campbell RR, Sabharwal S, Nelson AL, Palacios PA, Gavin-Dreschnack D.
Health care costs for patients with chronic spinal cord injury in the Veterans Health
Administration. J Spinal Cord Med. 2007;30:477-481.
484. D'Hondt F, Everaert K. Urinary tract infections in patients with spinal cord injuries. Curr
Infect Dis Rep. 2011;13:544-551.
485. Akhtar AZ, Pippin JJ, Sandusky CB. Animal studies in spinal cord injury: a systematic
review of methylprednisolone. Altern Lab Anim. 2009;37:43-62.
486. Tator CH. Review of treatment trials in human spinal cord injury: issues, difficulties, and
recommendations. Neurosurgery. 2006;59:957-82; discussion 982-7.
487. Hawryluk GW, Rowland J, Kwon BK, Fehlings MG. Protection and repair of the injured
spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord
injury. Neurosurg Focus. 2008;25:E14.
488. Asher RA, Morgenstern DA, Fidler PS, et al. Neurocan is upregulated in injured brain and
in cytokine-treated astrocytes. J Neurosci. 2000;20:2427-2438.
489. Floyd CL, Lyeth BG. Astroglia: important mediators of traumatic brain injury. Prog Brain
Res. 2007;161:61-79.
490. Baudino TA, Carver W, Giles W, Borg TK. Cardiac fibroblasts: friend or foe? Am J Physiol
Heart Circ Physiol. 2006;291:H1015-26.
491. Frangogiannis NG. Regulation of the inflammatory response in cardiac repair. Circ Res.
2012;110:159-173.
492. Laskarin G, Zaputovic L, Persic V, Ruzic A, Sotosek Tokmadzic V. Harmful immune
reactions during acute myocardial infarction. Med Hypotheses. 2012.
493. Karimi-Abdolrezaee S, Billakanti R. Reactive astrogliosis after spinal cord injury-beneficial
and detrimental effects. Mol Neurobiol. 2012;46:251-264.
494. McDonald JW. Repairing the damaged spinal cord. Sci Am. 1999;281:64-73.
495. Grimpe B, Pressman Y, Lupa MD, Horn KP, Bunge MB, Silver J. The role of proteoglycans
in Schwann cell/astrocyte interactions and in regeneration failure at PNS/CNS interfaces.
Mol Cell Neurosci. 2005;28:18-29.

276

496. Yoon BC, Jung H, Dwivedy A, O'Hare CM, Zivraj KH, Holt CE. Local translation of
extranuclear lamin B promotes axon maintenance. Cell. 2012;148:752-764.
497. Kelley BJ, Farkas O, Lifshitz J, Povlishock JT. Traumatic axonal injury in the perisomatic
domain triggers ultrarapid secondary axotomy and Wallerian degeneration. Exp Neurol.
2006;198:350-360.
498. Stone JR, Singleton RH, Povlishock JT. Antibodies to the C-terminus of the beta-amyloid
precursor protein (APP): a site specific marker for the detection of traumatic axonal injury.
Brain Res. 2000;871:288-302.
499. Canto JG, Rogers WJ, Goldberg RJ, et al. Association of age and sex with myocardial
infarction symptom presentation and in-hospital mortality. JAMA. 2012;307:813-822.
500. Dudiy Y, Jelnin V, Einhorn BN, Kronzon I, Cohen HA, Ruiz CE. Percutaneous closure of
left ventricular pseudoaneurysm. Circ Cardiovasc Interv. 2011;4:322-326.
501. Ma L, Li C, Fan J, Jiang L. Post-traumatic coronary occlusion and left ventricular
aneurysm. J Card Surg. 2011;26:271-273.
502. van Amerongen MJ, Engel FB. Features of cardiomyocyte proliferation and its potential for
cardiac regeneration. J Cell Mol Med. 2008;12:2233-2244.
503. Pasumarthi KB, Field LJ. Cardiomyocyte cell cycle regulation. Circ Res. 2002;90:10441054.
504. Laube F, Heister M, Scholz C, Borchardt T, Braun T. Re-programming of newt
cardiomyocytes is induced by tissue regeneration. J Cell Sci. 2006;119:4719-4729.
505. Kuhn B, del Monte F, Hajjar RJ, et al. Periostin induces proliferation of differentiated
cardiomyocytes and promotes cardiac repair. Nat Med. 2007;13:962-969.
506. Hung MJ, Wang CH, Cherng WJ. Unruptured left ventricular pseudoaneurysm following
myocardial infarction. Heart. 1998;80:94-97.
507. Niimura H, Mito T, Matsunaga A, et al. Left ventricular pseudoaneurysm following acute
myocardial infarction. Intern Med. 2006;45:1221-1223.

277

Appendix 1: Miscellaneous Protocols

Solutions

General solutions procedure
Note: this protocol assumes 1L of final solution; adjust accordingly
1. Fill a 1L beaker to 900 mL with deionized water (for solutions with 1L final
volume)
2. Add a stir bar and stir a 300 RPM (approximately)
3. Weigh out solids with accuracy of ± 1% and add to the beaker of water
4. Raise the fluid volume to 950-970 mL with deionized water and continue to stir
until solution is clear
5. Adjust to specified pH
6. Transfer to a volumetric flask and fill to 1L line with deionized water
7. Clearly label container with contents, date made, initials of the person that made
it, and pH (only once it has been measured)
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Using the pH meter
Based on the instruction manual for the Accumet Basic AB15 pH meter and
Accumet Gel-Filled Electrode
General protocol for using the pH Meter
• The pH meter should always be stored in electrolyte storage solution and must
not dry out
• Never wipe the glass bulb within the electrode; wiping the electrode may scratch
the glass tip, which will render it useless
• pH should be measured while the solution is being gently stirred on a stir plate
1. Press “std” on the Accument pH meter to turn on the display
2. Carefully remove the electrode from the electrolyte storage solution
3. Rinse the electrode with deionized water, blot (do not wipe!) the bottom with a
Kim wipe, and wipe the sides of the pH meter
4. Immerse the electrode into the solution, being careful not to hit the electrode tip
with the stir bar.
• The pH meter will measure pH continuously. Measurements are complete
when “STABLE” appears.
• If calibrating the electrode, see instructions below for additional information at
this point
5. Add HCl or NaOH drop-wise until the pH adjusts to the desired range
6. Rinse the electrode with deionized water (per step 3) after measuring each
solution and before returning it to the electrolyte solution
7. When finished using the pH meter, press “stdby”
Calibration of the pH Meter
• For accurate pH measurements, it is recommended that calibration be done with
every use.
• Calibration settings are saved between uses and must be cleared before
beginning calibration
1. To clear the previously-stored standards:
• Press setup to view the %slope of the standard curve
• Press setup again to bring up the clear BUFFER icon and press enter to
clear all existing buffers
2. Immerse the electrode into the buffer solution while stirring the solution
moderately
3. Press “std” on the pH meter; the display will show a group of buffers.
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If the wrong buffer series is displayed, return to the main screen and press
setup until the correct buffer series appears, then press enter to select it.
4. Press “std” a second time to initiate the standardization. The pH meter will
recognize the buffer and return to the measure screen.
• Repeat the calibration with each of the buffered pH standards (pH = 4.01,
7, 10.01)
• At least two buffers must be used to establish the pH standard curve
5. The slope should be between 90-102% and a value in this range will return
“Good Electrode”
• A slope reading outside of this range will return “Electrode Error”
• The electrode can still be used when “Electrode Error” is present
• Clear buffer data cache (per step 1) to reset the electrode error and recalibrate the electrode
• The most common cause of an electrode error is old buffer that needs to
be replaced
•
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Phosphate-buffered saline
Note: this protocol was modified from Cold Spring Harbor Protocols
10x Phosphate-Buffered Saline (0.1M)
Note: Sodium phosphate dibasic
comes in many different hydrated
pH = 7.4
500 mL 1 L
forms; this recipe assumes that the salt
Na2HPO2 (MW: 141.96) 6.78g
13.56g
is anhydrous; if hydrated salts are
NaCl
40g
80g
used, the amount of sodium phosphate
KCl
1g
2g
added (by weight) will need to be
KH2PO4
1g
2g
increased in order to keep the resulting
molarity the same.
Autoclave the 10x Phosphate-Buffered Saline Solution (40 minutes) to sterilize it.
The mixture of salts will prevent them from crystallizing.
The following recipes are based on 10x Phosphate Buffer and 10x Normal Saline
being prepared in separate containers. 10x phosphate buffer tends to crystallize out of
solution, so the above recipe for 10x Phosphate Buffered Saline is preferable.

10x Phosphate Buffer (0.1 M)
pH = 7.4
1L
Sodium Phosphate
31.2 g
Monobasic
Sodium Phosphate Dibasic
113.5 g

10x Normal Saline (9%)

1x Phosphate-Buffered Saline (0.01 M)
pH = 7.4
1L
10x Phosphate Buffer
100 mL
10x Normal Saline
100 mL

1x PBS with 0.1% Triton X-100
pH = 7.4
1L
10x Phosphate Buffer
100 mL
10x Normal Saline
100 mL
Triton X-100
1 mL

Sodium Chloride
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1L
90g

4% paraformaldehyde
Note: Only use glassware and equipment that is labeled as “Para”; this
equipment is stored on a cart to the right of the chemical fume hood. Keep these
segregated from general purpose lab-ware as trace fixatives have been known to crosscontaminate and affect other experiments.
For 100 mL made from paraformaldehyde powder
1. Place a 250 mL beaker with a magnetic stir bar on the heater-mixer in the
chemical fume hood. Add:
a. 4 grams of paraformaldehyde (weighed in the hood)
b. 90 mL deionized water
2. Mix while heating the solution (heat setting approximately 5.5); stir until
dissolved
3. DO NOT heat above 60°C as this may result in the formation of formic acid
4. Add 1M NaOH drop-wise to the solution to help the paraformaldehyde
dissolve
5. Add 10 mL 1.0M Phosphate Buffer while continuing to mix
6. Filter entire solution through a paper funnel into a flask
7. Adjust the pH to 7.4
8. Refrigerate or chill to room temperature
For 40 mL made from 16% paraformaldehyde ampules (specifically for fixation
for electron microscopy)
16% paraformaldehyde (formaldehyde) aqueous solution is ordered from
Electron Microscopy Sciences (www.emsdiasum.com) order number RT-15710
1. Add 1 ampule (10 mL) of 16% paraformaldehyde to a marked container.
2. Rinse out the ampule with filtered 1x 0.1M PBS (to remove any crystals that may
have formed) and add to the container with 16% paraformaldehyde. Add 30 mL
total PBS for a total concentration of 4% paraformaldehyde.
3. Mix thoroughly before use.
•
•
•

Paraformaldehyde solution is allegedly stable for a week once prepared and is
ideally made fresh less than 24 hours prior to use.
Paraformaldehyde is a regulated waste; collect it in a marked waste container.
DO NOT DISPOSE DOWN THE DRAIN.
Collect solid paraformaldehyde waste (e.g. weigh-boats, contaminated gloves) in
a marked container that can be sealed (e.g. empty chemical bottle; sturdy plastic
bag, but not one of the red biohazard bags)
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Artificial cerebrospinal fluid
10x aCSF stock
MW

mM

Compound

grams in 1 Liter (for 10x)

58.44

126.0

NaCl

73.634

74.55

3.0

KCl

2.236

137.99

1.25

NaH2PO4  H2O

1.725

203.30

2.0

MgCl2  6H2O

4.066

147.02

2.0

CaCl2  2H2O

2.94

180.20

10.0

Glucose

18.02

10x Sodium Bicarbonate stock
MW
mM
Compound
84.01
26.0
NaHCO3

grams in 1 Liter (for 10x)
21.842

Note: The concentrations (mM) listed are those for the 1x working solution, not
for the 10x stock.
To make a working solution, dilute equal volumes of the two stock solutions 1:10
(e.g. for 1 Liter of 1x solution, mix 100 mL 10x aCSF with 100 mL 10x sodium
bicarbonate stock solution, and dilute with deionized water to a final volume of 1 Liter)
Note: the solution tends to form a precipitate after several hours, so make it fresh
daily.
• The precipitate can be re-dissociated into solution by mixing the solution over
gentle heat and bubbling oxygen
Note: this protocol was given to us from the Jacobs lab; it does not specify a pH
for the solution.
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Borate buffer
Used as part of the antigen retrieval protocol for BrdU immunostaining

•

0.1M Borate Buffer:
3.81 grams sodium tetraborate (Borax) per 100 mL deionized water
Mix solution until Borate dissolves
Adjust pH to 9.0

Note: Sodium Tetraborate is not acutely toxic, but it can cause respiratory and
skin irritation in large quantities. Accordingly, measure it out and dissolve it in a
chemical fume hood. Collect waste and dispose of it through OEHS.
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Cell culture protocols

Coating culture flasks

•

Powdered Poly-L-Lysine Hydrobromide (Sigma P1524-25mg) Store at -20°C
For astrocytes, recommended 2 µg / cm2 (per ScienCell)

1. Dissolve 25 mg (entire contents of vial) in 41.6 mL of sterile de-ionized water to
make 600 µg / mL (40x) stock solution.
2. Thoroughly-vortex, then use a 60 mL syringe to sterile-filter the solution through
a Millex-GP filter unit (Ref # SLGP033RS) into a sterile 50 mL plastic centrifuge
tube
3. Add 250 µL of 40x solution and 10 mL of sterile deionized water to a T-75 and
gently tilt to evenly distribute
4. Store remaining solution in 250 µL aliquots in sterile microcentrifuge tubes at 20°C
Liquid Poly-L-Lysine (10 mg / mL) (ScienCell 0413) Store at -20°C
1. Add sterile water and poly-L-lysine to flask
2. Gently tilt to evenly distribute

T-25
T-75
T-175

Water (mL)
5
10
13

Poly-L-Lysine (µL)
5 (10 mg / mL)
15 (10 mg / mL)
30 (10 mg / mL)

1x working concentration of poly-L-Lysine for astrocytes: 15 µg / mL (per
ScienCell)
1. Once poly-L-Lysine has been added to the culture flask, return it to a 37°C
incubator overnight (at least 1 hour)
2. Rinse the poly-L-lysine coated flask with sterile water twice and allow it to dry
before adding culture media and cells.
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Thawing astrocytes
•

ScienCell estimates 7.5 x 105 cells in each vial, 90% (6.75 x 105) survive the
thaw

1. Remove cryogenic vial containing astrocytes from freezer, transfer it to a 37°C
water bath to thaw
• Gently mix vial as it thaws
• Do not allow cap to be submerged in water; wrap in parafilm to protect cap
if necessary
2. Transfer the cells directly to a poly-L-Lysine coated culture flask containing
astrocyte media
• 20 mL for a T-75, 7 mL for a T-25
• Poly-L-lysine provides helps astrocytes adhere to the dish
• Do not disturb the dish for 16 hours
• Thawed cells are fragile; do not re-suspend, centrifuge, or otherwise
manipulate cells before adding them to the culture flask, as these actions
are more harmful to the cells than the effect of DMSO residue in the
culture. Return them to the culture as quickly as possible with minimal
handling.
3. Gently tilt flask to distribute cells evenly
4. Place cap on the flask and return to the incubator
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Set up Initial Culture after Receiving the Order
Prepare poly-L-lysine coated flask (recommended 1 day before thawing cells)
1. 2 µg/cm2, T-75 flask is recommended
2. Add 10 mL of sterile water to a T-75 flask
3. Add 15 µL of poly-L-lysine stock solution (10 mg/mL)
4. Leave the flask in the incubator overnight (minimum one hour at 37°C)
Prepare the Complete Medium
1. Decontaminate the external surfaces of all containers with 70% Ethanol
2. Transfer sterilized containers to sterile field
3. Aseptically add each supplement to the basal medium with a pipette.
4. Rinse each tube with medium to recover the entire volume
Take the poly-L-lysine coated flasks:
1. Rinse the poly-L-lysine coated flask with sterile water twice.
2. Add 20 mL of complete medium to the flask.
Seeding frozen cells (recommended density of 5,000 cells/cm2)
1. Place vial in 37°C waterbath, hold and rotate the vial gently.
2. Remove the vial from the waterbath as soon as they thaw completely.
3. Wipe vial down with 70% Ethanol and place in sterile field.
4. Remove cap, being careful not to touch the interior threads with fingers
5. Resuspend the vial contents carefully using a 1 mL eppendorf pipette
6. Dispense the contents into the equilibrated, poly-L-lysine coated flask
7. Replace the cap or cover, and gently rock the vessel to distribute cells
evenly. Loosen cap if necessary to permit gas exchange.
8. Return the culture vessels to the incubator (for best results, do not disturb
for at least 16 hours)
Maintenance of the Culture
Frequency of Changing the culture Medium
1. 1 day after seeding, change the medium to fresh supplemented medium
to remove residual DMSO and unattached cells
2. Until 70% Confluent: Change medium every 3 days
3. Once 70% Confluent: Change medium every 2 days
4. Once 90% Confluent: Split cells
Characteristics of Healthy Cells:
o Polygonally shaped sheets of contiguous cells
o Cell number doubles after 2-3 days in culture
Subculture (i.e. split cells) when 90% Confluent
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Acid-washing slides & coverslips
Purpose: Acid washing cleans glass to prepare it for cell culture; do not assume that
it is ready for cell culture
• Acid washing does not need to be completed in a sterile environment

1.
2.
3.
4.
5.
6.
7.

Protocol:
Assemble glass on a rack that can hold
Soak glassware in alconox for 15 minutes
Rinse slides 3 times in dH2O
Soak 20 minutes in 1N HCl
Rinse 3 times in dH2O
Soak 20 minutes in 70% ethanol
Sterilize by either:
• Place under UV light in sterile laminar flow hood until dry, at least 15 minutes
• Autoclave

If glassware was previously contaminated with a hydrophobic substance, e.g.
vacuum grease or wax:
• Clean slides by using a dehydration in ethanol (50%, 70%, 95%, 100%)
• Soak 2-3 times in xylene
• Rehydrate in ethanol (100%, 95%, 70%, 50%) then water
• Continue with acid wash starting at alconox above
Coating culture plates with fibronectin

1.
2.
3.
4.

•
•

ScienCell Catalogue # 8248 (1 mg / mL) Store at -20°C
Dilute Fibronectin in sterile 1x PBS
• For astrocytes, 10 μL Fibronectin (1 mg / mL) per 1 mL PBS
Coat the culture surface with a minimal volume
Incubate at room temperature for 2 hours OR 2-8°C overnight.
Aspirate remaining fibronectin solution and rinse with deionized water. The
culture vessels are now ready to use.
We coat glass culture substrates in fibronectin for astrocytes
Store in aliquots to minimize number of freeze-thaw cycles to which the
Fibronectin is subjected
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Sub-culturing astrocytes
Prepare Culture Dishes:
• Company recommends adding 2 µg / cm2 poly-L-Lysine to culture flasks
• Company recommends warming all media to room temperature (not to 37°C
with a water bath)
Necessary components of media (warmed to room temperature)
• Trypsin/EDTA solution
• HBSS (Hank’s Balanced Salt Solution)
• FBS (Fetal Bovine Serum)
• Trypsin Neutralization Solution (can be made from 10% FBS in HBSS)
Items to prepare prior to beginning:
• Coat new culture plates in appropriate substrate
• Clearly-labeled cryogenic vial (if freezing cells)
• Add 5 mL of fetal bovine serum (FBS) to a 50 mL conical tube (to receive the
cells)
• Ensure 10 mL of trypsin neutralization solution is prepared at room temperature
o 1 mL FBS
o 9 mL HBSS
• Bring HBSS, Astrocyte media, FBS, Trypsin, and Trypsin-Neutralization Solution
to room temperature
• Add astrocyte media to all new culture plates and place in the incubator
Dissociate astrocytes from a T-75 culture plate (adjust volumes for other plates)
1. Remove media from culture plate
2. Rinse cells in HBSS (remove serum-containing media)
3. Add 8 mL HBSS to the flask, followed by 2 mL of 0.25% Trypsin/EDTA solution
a. Gently rock flask to ensure that cells are covered
b. Incubate the flask in a 37°C incubator for 2 minutes (or until cells are
completely rounded up)
4. Use 10 mL serological pipet to wash the plate with the Trypsin-containing media
2-3 times to remove cells, then transfer the media to the 50 mL conical tube
containing 5 mL FBS
5. Return the culture plate to the incubator (no solution in the flask). After 1-2
minutes, gently tap the flask to detach remaining cells from the plate
6. Wash the plate twice with 5 mL of Trypsin Neutralization Solution (TNS) to
harvest the residual cells and transfer the solution to the 50 mL conical tube
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7. Examine the flask under the inverted microscope to make sure that the cell
harvesting was successful; if not, wash with additional TNS or add additional
Trypsin as necessary; fewer than 5% of the cells should remain.
8. Centrifuge the 50 mL centrifuge tube at 1000 rpm for 5 minutes, remove the
supernatant, and gently re-suspend the cells in 1 mL of astrocyte media.
9. Determine the concentration of cells using a hemocytometer. Then, either:
a. Pipet the appropriate number of cells into each new culture plate
b. Dilute the cells to a constant volume (e.g. 1x105 cells per mL)
NOTE:
• Estimated number of cells on a 100% confluent T-75: 2 million (26,500 cells per
cm2)
• 5 x 105 cells will produce an estimated 25% confluence
• Doubling time for astrocytes is estimated at 2-3 days (per ScienCell)

•
•
•
•

Troubleshooting: Cells not detaching from plate:
Try new Trypsin; trypsin activity can decrease on repeated freeze-thaw cycles.
Ideally, it should be stored in 1 or 2 use aliquots after initially thawed.
Forcefully re-wash / pipet liquid over cells to dislodge them
Pre-rinse cells with HBSS to remove serum-containing media prior to adding
trypsin (serum competitively inhibits trypsin activity)
Do NOT expose cells to trypsin for too much time; 2 minutes is sufficient.
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Hemocytometer
Each square of a hemocytometer, with coverslip in place, represents a total
volume of 0.1 mm3 (0.1 µL)
1. Seat coverslip onto the hemocytometer
using a small amount of water along the
edges to hold the coverslip firmly down
2. Make sure the cells are evenly distributed in
the solution by gentle pipetting
3. Place 10 µL of the cell suspension in the
grooves of the hemocytometer (figure 1)
4. Place the hemocytometer on the stage of a
Assembling the hemocytometer
microscope
5. Use a 10x objective with either phase contrast or DIC to focus on the central grid.
6. Count cells in the central 1 x 1 mm grid of the hemocytometer (figure 2); to avoid
repeat counting, count cells touching the top or right lines of the hemocytometer,
but not those touching the bottom or left lines.
7. Move backward and forward across the 5x5 grid of the hemocytometer to ensure
that all cells are counted.
• Depending on cell counts, either count the grids marked 1 – 5 (figure 2), or
count all of the grids.
• For accuracy, at least 100 cells should be counted.
8. To calculate the cells per mL:
• If only a subset of squares in the grid were counted:
cell density = average cell count per square x 25 x 104 cells
per mL
• If all the squares in the grid were counted:

cell density = cell count x 104 (per mL)
Hemocytometer layout

Example of cell counting
with a hemocytometer
291

Freezing astrocytes
1. Suspend cells to be frozen in 800 µL of astrocyte media and transfer to a
labeled cryogenic vial
2. Add 100 µL FBS
3. Add 100 µL of sterile DMSO
4. Close cryogenic vial and freeze in liquid nitrogen as quickly as possible
o If possible, transfer to -80°C for 24 hours prior to transferring to liquid
nitrogen; this theoretically limits damage to cells on freezing
Note: DMSO damages cells; minimize time between adding it to the cells and
freezing the vial
Fixing adherent cell cultures

1.

2.
3.

4.

Preparation for Immunocytochemistry
Wash culture 2-3 times with isotonic serum-free media
• Washes should be gentle to minimize the risk of washing cells off of the
culture plate
• Goal of washes is to remove soluble proteins from the culture media, as
these proteins can contribute to non-specific antibody binding.
Add 4% paraformaldehyde in 0.1M PBS (pH = 7.4) for 15-30 minutes
Wash off paraformaldehyde and replace with 0.1M PBS
• Add 0.05% sodium azide to the PBS if cells will be stored for a prolonged
period of time to minimize bacterial growth
Tightly wrap the culture dish with parafilm and store at 4°C until ready to use
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Immunostaining

BrdU Cell Proliferation Assay

•
•

5.
6.
7.
8.
9.

BrdU Preparation:
From Solid BrdU (Sigma B5002): BrdU is difficult to dissolve; use 0.007N NaOH,
place it into a heated sonicator, and vortex frequently.
From Liquid BrdU stock (Invitrogen 000103): Dilute 1:100 in culture media
Note: BrdU solution will need to be sterile-filtered before use
Protocol
Change culture media and add media containing BrdU; wash a second time to
ensure the appropriate concentration of BrdU is achieved
Incubate cells for desired period of time
Wash off BrdU-containing media and replace with fresh media
Fix cells in 4% paraformaldehyde for at least 30 minutes
Immunolabel

Antigen retrieval for BrdU staining
This protocol is used for both tissue sections and cell staining
Solutions required:
2N HCl
(Fisher SA-431)
1N HCl
Dilute 2N HCL in deionized water (1:1)
0.1M Borate Buffer dissolve 3.81 g sodium tetraborate (Borax) per 100 mL
deionized water, adjust pH to 9.0
• HCl and Borate Buffer are regulated wastes. Collect them in individual waste jars
for disposal through OEHS.

1.
2.
3.
4.
5.

Procedure
1N HCl for 10 minutes on ice
2N HCl for 10 minutes at room temperature
2N HCl for 20 minutes at 37°C (place in an oven)
0.1M borate buffer for 10 minutes at room temperature
Begin washes in PBs with 0.1% Triton X-100 per the beginning of normal
immunostaining
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Immunocytochemistry
Solutions Required:
0.1M PBS
0.1M PBS + 1% Triton X-100

(10 µL Triton per mL PBS)

Blocking Solution: 4% NGS, 0.5% BSA, 1% Triton-X100 in 0.1M PBS
1 mL
5 mL
10 mL
Normal Goat Serum (NGS)
40 µL
200 µL
400 µL
Bovine Serum Albumin (BSA)
5 mg
25 mg
50 mg
Triton X-100
10 µL
50 µL
100 µL
Primary Antibody Staining (Day 1)
1. 0.1M PBS: 3 washes for 5 minutes each
2. Blocking solution: 30 minutes
3. Primary antibody (diluted in blocking solution)
• Incubate either for 2 hours at room temperature, or overnight in the
refrigerator
• To avoid cells drying out if using a small volume of antibody solution,
cover in a piece of parafilm
• If using parafilm, float it off with media to remove
Secondary Antibody Staining (Day 2)
1. 0.1M PBS: 3 washes for 5 minutes each
2. Secondary antibody (diluted 1:200 in PBS): 2 hours
3. 0.1M PBS: 3 washes for 5 minutes each

•

•

Nuclear Stain (if using)
DAPI (1:10,000 diluted from 1 mg/mL stock): 15 minutes
Bis-Benzimide (1:10,000 from 10 mg/mL stock): 1 minute
DAPI NucBlue (2 drops/mL; from Molecular Probes R37606): 5 minutes
0.1M PBS: 3 washes for 5 minutes each after the nuclear stain

Coverslip
1. Deionized: 3 washes for 5 minutes each
• This helps to remove the salt from the buffer and prevents the formation of
salt crystals
2. Use vectashield as a mounting media
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Appendix 2: Record keeping and Checklists

Cell culture experiments can generate extraordinary numbers of samples.
Thorough records will facilitate identifying samples in the lab, confirm results, and locate
information. Each sample should have a unique, unambiguous, understandable, and
concise identifier associated with it that corresponds to a full set of records that is kept
either in hard copy or, preferably, digitally where all of the details about the experimental
conditions are recorded. For example, labeling specimens as E1, E2, E3, C1, C2, C3 for
“experiment 1” (etc) is ambiguous: it only provides information about how the samples
are related to each other without providing any other information. However, labeling
each sample with its full set of records is absurdly onerous and unnecessary. A
necessary compromise is a project name, an experiment number, the treatment group,
the replicate number, the date, and the initials of the experimenter. This way, no two
samples from a single experiment can be confused with each other, samples from each
experiment can be readily identified, and there is sufficient information to look up the
records associated with these experiments either by date or by project.
Considerations in devising a method for record-keeping should include the
human elements involved. Hand-written records may be considered traditional, but
digital records do not suffer from being incomprehensible due to hand-writing and they
can easily re-printed in the event a hard copy version is damaged. Digital records are
more readily backed-up, and they can also be easily accessed from remote locations.
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Moreover, digital records simplify and expedite duplicating lengthy information about
records, such as protocols with minor changes. And, most importantly, computers can
search through digital records for keywords far more expeditiously than an experimenter
can leaf through hard copy records.
Here, I will briefly describe my own record keeping system based on the
previously-stated requirements. As my experiments were focused on cell culture, the
following records are organized to reflect this. I devised standard forms for each level of
record keeping, and arranged them heirarchically so that I could readily find the
information I needed. Each cell line or genotype is referred to by a unique lot number,
and the Cell Culture Record Sheet is used to keep track of each dish associated with
that genotype; these records are used in real-time to help keep track of ongoing cell
culture experiments, and they are also used as reference markers to try and recreate
the history of certain cells if there are possible anomalies with analysis of experimental
data.
Each project is given a name, and each experiment (full set of treatment groups)
is assigned a unique number. A single Project Record Sheet provides an overview of
ongoing progress with each experiment, tracks experimenter participation in these
projects for subsequent attribution of credit (i.e. determining authorship on publications).
Each experiment listed in this log has a corresponding Experiment Record Sheet, in
which details of the treatment groups, the protocol, and the history of the experiment are
kept. For experiments with multiple replicates, each replicate is listed on its own line and
has a corresponding In Vitro Staining Record (for ICC, other sheets can be composed
for different types of studies); this staining record sheet includes the full staining
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protocol and records of the procedure. Importantly, these record sheets include
checklists for each experiments, allowing the experimenter to have access to the
protocol in real time during the experiment and also providing a tangible record that
each step of the procedure occurred; it also provides explicit instructions for each
solution used within the experiment, minimizing experimental error due to mistakes in
preparing solutions.
The heirarchical organization of these records can (and should) also be used for
storing these records, both digitally and in hard copy. For example each Project Record
Sheet should be assigned its own folder; each experiment within a project should be
assigned a sub-folder in which the staining records for each replicate are stored. This
organization ensures that all records for a single project are stored in one place and
thus that they are readily found. Digital images can be stored in folders on a computer,
with a heirarchical structure matching the organization of hard-copy records. (Another
note on digital images: each folder and each image should be labeled according to the
same strict guidelines established for samples. Do NOT label images as “image 1”
because you will certainly forget everything about that particular image no matter how
hard you try not to.)
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!!

In#Vitro#Experiment*Record*
Project:*

*

!

Investigator(s):*
!
Cell*Type:*
!
Cell*Lot*#:*
Culture*Plate:*
!

!

!

Experiment*#:*
SubDID*#:*
Coating:*

Replicates:* 1!
!
Media:*

*
Uncoated!

!#!

Dates:*
Time*Lapse:!
!

*

!

!

!
*

!
!
Purpose:*
!
Groups:*
!
Design:*
!
Analysis:*
Other*Comments:*
!

!
Culture*Records*
Date*
!
!
!
!
!
!
!

User*
!
!
!
!
!
!
!

Manipulation*

Comments*

!
!
!
!
!
!
!

!
!
!
!
!
!
!

*
Purpose*for*Each*Replicate*
ICC*/*Western*/*Other*
1.!
!
2.!
!
3.!
!
4.!
!
5.!
!

Purpose*
!
!
!
!
!

Stained*
!
!
!
!
!

Experiment*Comments:*

Imaged*
!
!
!
!
!

Analyzed*
Outcome*
!
!
!
!
!
!
!
!
!
!
Indicate)dates)of)staining,)imaging,)and)analysis)

Overall*Outcome:*

!

!

*

!

In#Vitro#Experiment*Record*
Project:*

Results*

!

Investigator(s):*

!

Experiment*#:*

!

Replicate*#:*

1*

!

For!each!result,!indicate!date(s)!of!analysis,!methods!used!for!analysis,!outcome!of!any!statistical!tests,!interpretation,!and!plan!

*
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'!!

In#Vitro#Staining'Record' '
Project:'

!

Investigator(s):'

Experiment'#:'

!

Replicate'#'

!

! Dates:'

!"!

!

!
Antibody!Information!
Antigen'

Host'

'
'
'

Isotype'

!
!
!

Dilution'

!
!
!

!
!
!

'

Secondary'

!
!
!

!
!
!

Label'

Dilution'

!
!
!

Host'

!
!
!

!
!
!

!
Immunocytochemistry!Protocol!
BrdU'

Secondary'

Y!!/!!N!!(If!no,!skip!to!Primary)!
!1N!HCl!x!10!min!(on!ice)!
!2N!HCl!x!10!min!(25°C)!
!2N!HCl!x!20!min!(37°C)!
!0.1M!Borate!Buffer!x!10!min!(25°C)!

Nuclear'Stain!
!None!
!DAPI!NucBlue!(2!drops!per!mL,!Molec.!Probes!R37606)!!!!5!min!
!Bis"Benzimide!(1:10,000!from!10!mg/mL)!!!!!!!!!!!!!!!!!!!!!!!!!!!!!1!min!
!DAPI!(1:10,000!from!1!mg/mL)!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!15!min!

3x!PBS!washes!(5!min)!
!!!!1.! !!!!2.! !!!!3.! !
!Secondary!(2!hours)!
3x!PBS!washes!(5!min)!
!!!!1.! !!!!2.! !!!!3.! !

Staining'Comments'

!Nuclear!Stain!(!Y!!/!!N!)!

Primary'
3x!PBS!washes!(5!min)!
!!!!1.! !!!!2.! !!!!3.! !
!Block!(30!min,!25°C)!
!!!!!Per!1!mL!0.1M!PBS:!
!!!!!!!!!4%!NGS!(40!µL)!
!!!!!!!!!1%!Triton!(10!µL)!
!!!!!!!!!0.5%!BSA!(.005g)!

!!!!!3x!PBS!washes!(5!min)!
!!!!!!!!!1.! !!!!2.! !!!!3.! !
3x!dH2O!(5!min)!
!!!!1.! !!!!2.! !!!!3.! !
!Coverslip!
!Mounting!Media!

!Primary!(diluted!in!block)!
!!!!!! !2!Hrs!(25°C)!/! !Overnight!(4°C)!

Staining:!!!!Good!!!!Bad!
Repeat:!!!!!!Yes!!!!!!!No!

!

Preliminary'Outcome'

!
Imaging!
!
Microscope:!
Label'1'
Laser/Cube:!
Notes:!
!

!

Objective:!
Label'2'
Laser/Cube:!
Notes:!
!

General!Imaging!Comments:!

!

!

Date:!
Label'3'
Laser/Cube:!
Notes:!
!

!

!

!
Analysis!
Hypothesis'Test'
!
!
!
!

Results'
!

Program'&'Method'
!
!
!
!

!
Outcome:!

!
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!

Label'4'
Laser/Cube:!
Notes:!
!

!

Appendix 3: Data manipulation and analysis using R

Overview of using scripts in R
R is a powerful statistical language that is open source and widely supported.
Data analysis in R involves writing scripts, which are algorithms involving step-by-step
instructions that the software uses to analyze data and plot graphs. Accordingly, once a
script is written to perform an analysis, new datasets can be analyzed (or old datasets
can be re-analyzed) in exactly the same way by running the new data through the old
script. This ensures that the same statistical tests are run in the same way on every
dataset that you analyze. It also means that, after a script is initially developed,
subsequent data analysis takes only as long as your computer takes to process the
data.
R does require data to be stored in particular ways in order for it to read files
correctly. All of the data files used in the scripts that I have developed should be .csv
files, and the first row of the dataset should be the titles of each column. The easiest
way to compile .csv files is with Microsoft Excel or any other spreadsheet-based
program; enter the data, and then choose file -> Save As and choose “.csv” from the
menu. The .csv files also need to be structured in the same way, with the same names
for each column; names are case sensitive. A brief description of how to compile data to
used by each script is found at the start of that section.
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R Scripts for Chapter 2

Optimizing the measuring interval for tracking cell migration
Scripts are organized in the same fashion as those for the migration analysis.
See description found on page 305 for more information.
library(ggplot2)
library(reshape)
library(multcomp)
library(car)
library(nlme)
### Load and sort data ----------------------------------------# as of 6-26-15, use data files labeled
# Tracks.csv and Points(6-26-15).csv
points1 <- read.csv(file.choose(),
header = TRUE
)
points1 <- points1[!is.na(points1$vel),
c("EF",
"Position",
"FrameInterval",
"TrackID",
"PointID",
"hours",
"vel",
"dir"
)
]
points1$FrameInterval <- factor(points1$FrameInterval)
points1$EF <- factor(points1$EF)
levels(points1$EF) <- paste(levels(points1$EF),
"mV/mm"
)
tracks1 <- read.csv(file.choose(),
header = TRUE
)
tracks2 <- tracks1
names(tracks2)[c(4:8)] <- c(3, 6, 15, 30, 60)
tracks2 <- melt(tracks2,
id = c("EF",
"Position",
"TrackID"
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),
variable_name = "interval"
)
tracks2$interval <- factor(tracks2$interval,
levels(tracks2$interval),
ordered = TRUE
)
tracks2$EF <- factor(tracks2$EF)
levels(tracks2$EF) <- paste(levels(tracks2$EF),
"mV/mm"
)
# mixed effects model -------------------------t2 <- s1h
t2$id <- paste(t2[,1],t2[,2],t2[,4], sep=".")
# random effects model and post-hoc test for 0 mV/mm
lr0 <- lme(vel ~ FrameInterval,
random = ~ 1|id,
data = t2[t2$EF == levels(t2$EF)[1],],
method = "REML"
)
lr0
lrs0 <- summary(lr0)
lrs0
lr0.anova <- anova(lr0)
lr0.anova
tuk.lr0 <- glht(lr0,
linfct = mcp(FrameInterval = "Tukey")
)
tuk.lrs0 <- summary(tuk.lr0)
tuk.lr0
tuk.lrs0
# random effects model and post-hoc test for 400 mV/mm
lr400 <- lme(vel ~ FrameInterval,
random = ~1|id,
data = t2[t2$EF == levels(t2$EF)[2],],
method = "REML"
)
lr400
lrs400 <- summary(lr400)
lrs400
lr400.anova <- anova(lr400)
lr400.anova
tuk.lr400 <- glht(lr400,
linfct = mcp(FrameInterval = "Tukey")
)
tuk.lr400
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tuk.lrs400 <- summary(tuk.lr400)
tuk.lrs400
# evaluate constant variance using residuals
# i.e. Levene test for heteroscedasticity
# 0 mV/mm
leveneTest(y = residuals(lr0),
group = lr0$data$FrameInterval,
center = "mean"
)
# 400 mV/mm
leveneTest(y = residuals(lr400),
group = lr400$data$FrameInterval,
center = "mean"
)
# plots of 0 & 400 mV/mm
opar <- par(no.readonly = TRUE)
par(mfrow = c(1,2),
mar = c(5, 4, 6, 2)
)
plot(
cld(tuk.lr0),
col = "lightgrey",
xlab = "Tracking Intervals",
ylab = expression(paste("Cell Speed (", mu, "m / hour)")),
sub = levels(t2$EF)[1]
)
plot(
cld(tuk.lr400),
col = "lightgrey",
xlab = "Tracking Intervals",
ylab = expression(paste("Cell Speed (", mu, "m / hour)")),
sub = levels(t2$EF)[2]
)
par <- opar
rm(opar)

Migration analysis
Migration analysis (including “Optimizing the measuring interval for tracking cell
migration”): track cells in time-lapse videos using the ImageJ plugin MTrackJ. (Make
sure that the time interval and distance unit in the image properties is appropriate.)
When tracking is finished, click “measure.” Two datasets will appear: one labeled
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“points” with data corresponding to each position that was clicked during tracking, and
one labeled “tracks” that has summary statistic for each track (i.e. cell). The migration
scripts use the “points” datasets from MTrackJ, including the same column labels. In
addition, 3 columns labeled “Experiment” “Position” and “EF” must be added at the start
of the dataset. (For these analyses, I made separate datasets for cells tracked before
and after the onset of the EF.)
### Load Packages ---------------------------------------------------library(circular)
library(ggplot2)
library(pastecs)
library(reshape)
library(multcomp)
library(grid)
options(digits = 3)

# prints 3 significant figures

# Define Functions --------------------------------------------------data.subsample <- function(dataset,
size,
group
) {
data1 <- dataset
data.subset <- data.frame()
data1$factor <- as.factor(group)
for (i in 1:length(names(table(data1$factor)))) {
sub1 <- sample(x = names(table(data1$id[data1$factor ==
names(table(data1$factor))[i]])),
size = size
)
data.subset <- rbind(data.subset,
data1[data1$id %in% sub1, -ncol(data1)]
)
}
data.subset
}
id.create <- function(dataset) {
paste(dataset[, "Experiment"],
dataset[, "Position"],
dataset[, "EF"],
dataset[, "TID"],
sep = "."
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)
}
# n = number of points selected per time, per group
# interval = how often the points are plotted
points.subset <- function(dataset,
n,
t.start = 0,
t.end = 12,
interval = 0.25,
group = "ef.factor"
) {
# sub-samples individual data points within each group
data1 <- dataset
levels1 <- names(table(data1[, group]))
times <- seq(from = t.start,
to = t.end,
by = interval
)
output1 <- data.frame()
for (i in 1:length(levels1)) {
ef1 <- levels1[i]
for (j in 1:length(times)) {
t1 <- times[j]
dsub <- data1[data1[ , group] == ef1 & data1$time == t1, ]
id1 <- c(1:nrow(dsub))
sub1 <- sample(x = id1,
size = n,
replace = FALSE
)
dsub <- dsub[sub1, ]
output1 <- rbind(output1,
dsub
)
}
}
output1
}
position.normalize <- function(dataset,
t.start,
t.end
) {
data1 <- dataset
data1$id <- id.create(data1)
data1 <- t.subset(dataset = data1,
t.start = t.start,
t.end = t.end
)
data1$t.norm <- data1$time - t.start
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data1$x.norm <- NA
data1$y.norm <- NA
for (i in 1:length(names(table(data1$id)))) {
cell.id <- names(table(data1$id))[i]
x0 <- data1$x..micron.[data1$id == cell.id &
data1$time == t.start]
y0 <- data1$y..micron.[data1$id == cell.id &
data1$time == t.start]
data1$x.norm[data1$id == cell.id] <data1$x..micron.[data1$id == cell.id] - x0
data1$y.norm[data1$id == cell.id] <y0 - data1$y..micron.[data1$id == cell.id]
}
data1
}
t.subset <- function(dataset,
t.start,
t.end
) {
data1 <- dataset[(dataset$time >= t.start) &
(dataset$time <= t.end),
]
cell.id <- data.frame("cell" = names(table(data1$id)))
for (i in 1:nrow(cell.id)) {
cell.id$t.min[i] <min(data1$time[data1$id == cell.id$cell[i]]) == t.start
cell.id$t.max[i] <max(data1$time[data1$id == cell.id$cell[i]]) == t.end
}
cells.to.keep <- cell.id$cell[cell.id$t.min & cell.id$t.max ]
data.new <- data1[data1$id %in% cells.to.keep &
data1$time >= t.start & data1$time <= t.end,
]
}
vel.sub <- function(dataset,
t.start = 0,
t.end = 12,
ef = "ef.factor",
time = "time",
speed = "speed",
dir = "dir"
) {
data1 <- dataset
data1 <- data1[!is.na(data1[, speed]) & data1[, time] <=
t.end & data1[, time] >= t.start & data1[, speed] != 0,
c(ef,

308

time,
speed,
dir
)
]
data1[, dir][data1[, dir] < 0] <data1[, dir][data1[, dir] < 0] + 360
data1
}
# Load Data ---------------------------------------------------------mig1 <- read.csv(file.choose(),
header = TRUE
)
# mig2 is the data set that will be used to plot cell tracks
mig2 <- mig1
mig1$time[mig1$EF == 0] <- mig1$time[mig1$EF == 0] - 0.5
mig1.baseline <- read.csv(file.choose(),
header = TRUE
)
mig1 <- rbind(mig1.baseline,
mig1
)
mig1R <- read.csv(file.choose(),
header = TRUE
)
mig1R.baseline <- read.csv(file.choose(),
header = TRUE
)
mig1R$EF <- "400(R)"
mig1R.baseline$EF <- "400(R)"
mig1R <- rbind(mig1,
mig1R,
mig1R.baseline[mig1R.baseline$time == 0,]
)
rm(mig1.baseline, mig1R.baseline)
# create a variable for EF strengths that serves as a labeled factor
mig1$ef.factor <- as.factor(mig1$EF)
mig2$ef.factor <- as.factor(mig2$EF)
mig1R$ef.factor <- as.factor(mig1R$EF)
### Create dataframe for velocity analysis --------------------------# mig.vel stands for "migration data for analyzing velocity"
# excludes any time points greater than 12 hours
mig.vel <- vel.sub(mig1)
# make separate database for directionality double-plot so that dir
variable is not coerced into class circular
mig.vel1 <- vel.sub(mig1R)
levels(mig.vel1$ef.factor) <- paste(levels(mig.vel1$ef.factor),
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"mV/mm"
)
# coerce directional data into circular
mig.vel$dir <- as.circular(mig.vel$dir,
type = "angles",
units = "degrees",
template = "none",
modulo = "2pi",
zero = 0,
rotation = "clock"
)
### aggregate mig.vel into dataframe for summary statistics ---------# create dataset of factor levels (EF level x time)
mig.vel.stats <- aggregate(mig.vel[, 3],
by = list(ef.factor = mig.vel$ef.factor,
time = mig.vel$time
),
FUN = mean
)[, c(1:2)]
# create dataset of summary statistics pertaining to migration
mig.spd.stats <- as.data.frame(
aggregate(mig.vel[, 3],
by = list(ef.factor = mig.vel$ef.factor,
time = mig.vel$time
),
FUN = function(x) c(n = length(x),
mean.speed = mean(x),
sd.speed = stats::sd(x),
sem.speed =
as.numeric(stat.desc(x)["SE.mean"]),
ci.95.speed =
as.numeric(stat.desc(x)["CI.mean.0.95"]),
med.speed = median(x),
q25 = as.numeric(quantile(x, 0.25)),
q75 = as.numeric(quantile(x, 0.75))
)
)[,3]
)
# create dataset of summary statistics pertaining to direction
mig.dir.stats <- as.data.frame(
aggregate(mig.vel[!is.na(mig.vel$dir), 4],
# !is.na(mig.vel$dir) omits any directionality data point
# labeled NA from the analysis, which would otherwise cause
# the entire function to return NA
by = list(ef.factor =
mig.vel$ef.factor[!is.na(mig.vel$dir)],
time = mig.vel$time[!is.na(mig.vel$dir)]
),
FUN = function(x) c(rayleigh.p =
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as.numeric(rayleigh.test(x)$p.value),
mean.dir =
as.numeric(mle.vonmises(x)$mu),
# estimated mean
# direction
sd.dir = deg(sd(x)),
se.mu.dir =
as.numeric(mle.vonmises(x)$se.mu),
# standard error of the
# mean direction estimate
kappa.dir =
as.numeric(mle.vonmises(x)$kappa),
# kappa parameter
# (concentration)
se.kappa.dir =
as.numeric(mle.vonmises(x)$se.kappa)
# standard error of the kappa
# parameter (concentration)
)
)[, 3]
)
# combine with statistics summary
mig.vel.stats <- cbind(mig.vel.stats,
mig.spd.stats,
mig.dir.stats
)
# remove unnecessary datasets
rm(mig.spd.stats,
mig.dir.stats
)
# store this original mig.vel dataset
mig.vel.stats.original <- mig.vel.stats
# create dataset of rayleigh results
# include a variable indicating whether the test is significant
# TRUE/FALSE depending on significance of test
# Bonferroni correction built into analysis
# (i.e. threshold for significance is divided by
# the number of factor levels)
mig.vel.stats$r.is.signif <- mig.vel.stats$rayleigh <=
.05/(length(levels(mig.vel.stats$ef.factor)) * 4 # number of EF
# strengths
length(table(mig.vel.stats$time))

# number of time points

)
# convert all circular statistical results to NA if
# the rayleigh test reveals that the time point is non-significant
mig.vel.stats[!mig.vel.stats$r.is.signif, c(12:16)] <- NA
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# character string of statistical results
mig.vel.stats$r.text <- paste("p =", signif(mig.vel.stats$rayleigh,
digits = 3))
### Display Results of Summary Stats --------------------------------# display the results of the rayleigh tests
mig.vel.stats[, c(1, 2, 11, 17)]
# display the results of the rayleigh tests for specific EF strengths
mig.vel.stats[mig.vel.stats$ef.factor == 0, c(1, 2, 11, 17, 12)]
# tabular output of rayleigh results
xtabs(r.is.signif ~ ef.factor + time,
data = mig.vel.stats
)
# Plot mean speed by time with 95% CI -----------------------mspeed.plot <- ggplot(data = mig.vel.stats,
aes(x = time,
y = mean.speed,
fill = ef.factor,
shape = ef.factor
)
) +
geom_line(size = 1.5) +
geom_point(size = 7) +
scale_shape_manual(values = c(21, 19, 15, 22)) +
scale_fill_manual(values = c("#FFBA00",
"black",
"black",
"#FFBA00"
)
) +
coord_cartesian(xlim = c(0, 12.15),
ylim = c(5, 30)
) +
scale_x_continuous(breaks = seq(0, 12,
by = 1
)
) +
scale_y_continuous(breaks = seq(0, 30,
by = 5
)
) +
theme_bw(base_size = 28) +
theme(legend.position = c(1, .95),
legend.justification = c(1, 1),
legend.direction = "horizontal",
panel.border = element_blank(),
panel.grid = element_blank(),
plot.title = element_blank(),
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axis.line = element_line(colour = "black",
lineend = "square"
)
) +
labs(y = expression(paste("Cell Speed (", mu, "m / hour)")),
x = "Duration of Electric Field Exposure (hours)",
title = "Electric Fields Affect
Cortical Astrocyte Migration Speed",
shape = "EF (mV / mm)",
fill = "EF (mV / mm)"
) +
geom_errorbar(aes(ymin = mean.speed - sem.speed,
ymax = mean.speed + sem.speed
),
width = 0,
# width of the bar-caps
size = 1,
# line thickness
colour = "black"
) +
geom_point(size = 7)
mspeed.plot
### Bar Plot of Mean Speed at Certain Times -------------------------# specify time and subset the data
time1 <- c(0, .5, 4)
mig.vel.stats.sub <- mig.vel.stats[mig.vel.stats$time %in% time1, ]
mig.vel.stats.sub$time <- paste(mig.vel.stats.sub$time,
"Hours"
)
# create bar plot
speed.bar.plot <- ggplot(data = mig.vel.stats.sub,
aes(x = ef.factor,
y = mean.speed,
fill = ef.factor
)
) +
geom_bar(stat = "identity") +
geom_errorbar(aes(ymin = mean.speed - sem.speed,
ymax = mean.speed + sem.speed
),
width = 0.25,
size = 1
) +
facet_grid(. ~ time) +
scale_y_continuous(breaks = seq(0, 50,
by = 5
)
) +
coord_cartesian(ylim = c(5, max(mig.vel.stats.sub$mean.speed +
mig.vel.stats.sub$sem.speed) + 6)) +
labs(y = expression(paste("Mean Speed (", mu, "m / hour)")),
x = "Electric Field Strength (mV/mm)"
) +
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theme_bw(base_size = 28) +
theme(legend.position = "none",
strip.background = element_rect(size = 1.5,
fill = "white",
colour = "white"
),
panel.grid = element_blank(),# Remove major & minor grid lines
panel.border = element_rect(size = 1.5,
colour = "black"
)
) +
scale_fill_grey()
speed.bar.plot
rm(time1, mig.vel.stats.sub)
### Analysis of speed at a certain times -----------------------# Statistical Analysis of differences between groups
time1 <- 4
mig.vel.sub <- mig.vel[mig.vel$time == time1, ]
means1 <- aggregate(mig.vel.sub$speed,
by = list(mig.vel.sub$ef.factor),
FUN = mean
)
means1
fit1 <- aov(mig.vel.sub$speed ~ mig.vel.sub$ef.factor)
summary(fit1)
plot(TukeyHSD(fit1))
TukeyHSD(fit1)
rm(mig.vel.sub, means1, fit1, time1)
# Analyze change in speed over time within a given EF
time1 <- c(0, .5, 4, 6)
mig.vel.sub <- mig.vel[mig.vel$time %in% time1 &
mig.vel$ef.factor == 400,]
aggregate(mig.vel.sub$speed,
# Show means for each
factor level
by = list(mig.vel.sub$time),
FUN = mean
)
fit <- aov(mig.vel.sub$speed ~ as.factor(mig.vel.sub$time))
summary(fit)
TukeyHSD(fit)
plot(TukeyHSD(fit))
rm(time1, mig.vel.sub, fit)
### Plot Direction by time (repeated x-axis) ------------------------# if you want to plot all data points (not a subset)
mig.sub <- mig.vel1
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# if you want to plot a subset of data points at each time
mig.sub <- points.subset(dataset = mig.vel1,
n = 45
)
## Generate plot
dir2.plot <- {ggplot(data = mig.sub,
aes(x = c(dir, dir+360),
y = c(time, time)
)
) +
# add lines to indicate cathode and anode, respectively
geom_vline(xintercept = c(90, 270, 90+360, 270+360),
colour = rep(c("red",
"blue"
),
2
),
size = 1.5,
alpha = 0.5
) +
# Add points
geom_point(size = 1.75,
alpha = 0.5
) +
# Black-White theme elements
theme_bw(base_size = 28) +
## facets by EF strength
facet_grid(. ~ ef.factor) +
coord_cartesian(xlim = c(0, 720),
ylim = c(-.1, 12.1)
) +
scale_x_continuous(breaks = c(90, 270, 90+360, 270+360),
labels = rep(c("A",
"C"
),
2
)
) +
scale_y_continuous(breaks = seq(0,
12,
by = 1
)
) +
## Modify axis titles
labs(x = "Direction of Astrocyte Migration Relative to the
Electric Field",
y = "Duration of EF Exposure (hours)",
title = "Electric Field Effects on Direction of Cell Migration"
) +
# Remove minor grid lines
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theme(panel.border = element_rect(colour = "black",
fill = NA,
size = 2
),
panel.grid = element_blank(),
panel.margin = unit(1,
"lines"
),
strip.background = element_rect(fill = "white",
colour = "white",
size = 1.5
),
plot.title = element_blank(),
axis.title = element_text(size = rel(1)),
axis.text.x = element_text(colour = rep(c("red", "blue"),
2
),
size = rel(1),
face = "bold"
),
strip.text = element_text(face = "bold", # modify facet header
size = rel(1)
)
) +
# adds a horizontal line to the reverse-current plot to
# indicate when the current was changed
geom_segment(data = data.frame(xmin = 0,
xmax = 720,
ymin = 5.875,
ymax = 5.875,
ef.factor =
levels(mig.sub$ef.factor)[length(levels(mig.sub$ef.factor))]
),
aes(x
= xmin,
xend = xmax,
y
= ymin,
yend = ymax
),
show_guide = FALSE,
colour = "#FFBA00",
size = 1.5,
linetype = 2
)}
dir2.plot
rm(mig.sub)
# Plot each track, normalized ---------------------------------------t.start <- 0
t.end <- 6
n = 30
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mig2.sub <- position.normalize(dataset = mig2,
t.start = t.start,
t.end = t.end
)
mig2.sub2 <- data.subsample(dataset = mig2.sub,
size = n,
group = mig2.sub$ef.factor
)
levels(mig2.sub2$ef.factor) <paste(levels(mig2.sub2$ef.factor), " mV/mm")
# change names of the levels
# so the facet labels include "mV/mm"
tracks.plot <- ggplot(data = mig2.sub2,
aes(x = x.norm,
y = y.norm,
group = id
)
) +
geom_vline(xintercept = 0,
colour = "darkgrey"
) +
geom_hline(yintercept = 0,
colour = "darkgrey"
)+
geom_path() +
labs(y = expression(paste(mu, "m")),
x = expression(paste(mu, "m"))
) +
annotate("text",
label = "+",
size = 15,
x = 0,
y = -180,
colour = "red"
) +
annotate("text",
label = "-",
size = 15,
x = 0,
y = 180,
colour = "blue"
) +
facet_grid(. ~ ef.factor) +
theme_bw(base_size = 28) +
theme(panel.grid = element_blank(),
panel.border = element_rect(colour = "black",
size = 1.5
),
panel.margin = unit(1, "lines"),
strip.background = element_rect(colour = "white",
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fill = "white"
),
axis.text = element_text(size = rel(0.75))
) +
coord_fixed(xlim = c(-201, 201),
ylim = c(-201, 201)
) +
scale_x_continuous(breaks = c(-200, -100, 0, 100, 200),
labels = c("
200", "100",
"0", "100", "200
) +
scale_y_continuous(breaks = c(-200, -100, 0, 100, 200),
labels = c(200, 100, 0, 100, 200)
)
tracks.plot

")

# Plot Total Displacement of each track -----------------------------end.plot <- ggplot(data = mig2.sub[mig2.sub$time == t.end, ],
aes(x = x.norm,
y = y.norm
)
) +
facet_grid(. ~ ef.factor) +
coord_cartesian(xlim = c(-200, 200),
ylim = c(-200, 200)
) +
theme_bw(base_size = 28) +
theme(panel.grid = element_blank(),
strip.background = element_rect(fill = "white",
colour = "white"
)
) +
geom_vline(xintercept = 0,
colour = "darkgrey"
) +
geom_hline(yintercept = 0,
colour = "darkgrey"
) +
labs(y = expression(paste(mu, "m")),
x = expression(paste(mu, "m"))
) +
annotate("text",
label = "+",
size = 15,
x = 0,
y = -180
) +
annotate("text",
label = "-",
size = 15,
x = 0,
y = 180
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) +
scale_x_continuous(breaks = c(-200, -100, 0, 100, 200),
labels = c("
200", "100", "0",
"100", "200
")
) +
scale_y_continuous(breaks = c(-200, -100, 0, 100, 200),
labels = c(200, 100, 0, 100, 200)
) +
geom_point()
end.plot

Migration following reversal of current
Scripts are organized in the same fashion as those for the migration analysis.
See description found on page 305 for more information.
### Load Packages ---------------------------------------------------library(circular)
library(ggplot2)
library(pastecs)
library(reshape)
library(multcomp)
library(grid)
options(digits = 3)

# prints 3 significant figures

# Define functions --------------------------------------------------t.subset <- function(dataset,
t.start,
t.end
) {
data1 <- dataset[(dataset$time >= t.start) &
(dataset$time <= t.end),]
cell.id <- data.frame("cell" = names(table(data1$id)))
for (i in 1:nrow(cell.id)) {
cell.id$t.min[i] <min(data1$time[data1$id == cell.id$cell[i]]) == t.start
cell.id$t.max[i] <max(data1$time[data1$id == cell.id$cell[i]]) == t.end
}
cells.to.keep <- cell.id$cell[cell.id$t.min & cell.id$t.max ]
data.new <- data1[data1$id %in% cells.to.keep &
data1$time >= t.start & data1$time <= t.end, ]
}
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id.create <- function(dataset) {
paste(dataset[, "Experiment"],
dataset[, "Position"],
dataset[, "EF"],
dataset[, "TID"],
sep = ".")
}
position.normalize <- function(dataset,
t.start,
t.end
) {
data1 <- dataset
data1$id <- id.create(data1)
data1 <- t.subset(dataset = data1,
t.start = t.start,
t.end = t.end
)
data1$t.norm <- data1$time - t.start
data1$x.norm <- NA
data1$y.norm <- NA
for (i in 1:length(names(table(data1$id)))) {
cell.id <- names(table(data1$id))[i]
x0 <- data1$x..micron.[data1$id == cell.id
data1$time ==
y0 <- data1$y..micron.[data1$id == cell.id
data1$time ==

&
t.start]
&
t.start]

data1$x.norm[data1$id == cell.id] <data1$x..micron.[data1$id == cell.id] - x0
data1$y.norm[data1$id == cell.id] <y0 - data1$y..micron.[data1$id == cell.id]
}
data1
}
data.subsample <- function(dataset,
size,
group
) {
data1 <- dataset
data.subset <- data.frame()
data1$factor <- as.factor(group)
for (i in 1:length(names(table(data1$factor)))) {
sub1 <- sample(x = names(table(data1$id[data1$factor ==
names(table(data1$factor))[i]])),
size = size
)
data.subset <- rbind(data.subset,
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data1[data1$id %in% sub1, -ncol(data1)]
)
}
data.subset
}
# Load Data --------------------------------------------# data set for directionality double-plots
mig.rev <- read.csv(file.choose(),
header = TRUE
)
# data set for plotting individual tracks
mig.rev.tracks <- read.csv(file.choose,
header = TRUE
)
### Plot Direction by time (repeated x-axis) ------------------------# only copies data if there is a value for speed (i.e. not NA)
mig.vel.rev1 <- mig.rev[!is.na(mig.rev$speed) &
mig.rev$time <= 12 & mig.rev$time >= 0,
c("EF",
"time",
"speed",
"dir"
)
]
# Convert range of angle measures for direction variable
# new range: 0-360 (degrees)
mig.vel.rev1$dir[mig.vel.rev1$dir < 0] <mig.vel.rev1$dir[mig.vel.rev1$dir < 0] + 360
# if speed == 0, MTrackJ records direction as 0
# make dir == NA if(speed == 0)
mig.vel.rev1$dir[mig.vel.rev1$speed == 0] <- NA
## Generate plot
dir.rev.plot <ggplot(data = mig.vel.rev1[is.na(mig.vel.rev1$dir) == FALSE,],
aes(x = c(dir, dir+360),
y = c(time, time)
)
) +
# Add points
geom_point(size = 2,
alpha = 0.3
) +
# Black-White theme elements
theme_bw(base_size = 28) +
## facets by EF strength
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facet_grid(. ~ EF) +
coord_cartesian(xlim = c(0, 720),
ylim = c(-.1, 12.1)
) +
scale_x_continuous(breaks = c(90, 270, 90+360, 270+360),
labels = rep(c("A",
"C"
),
2
)
) +
scale_y_continuous(breaks = seq(0,
12,
by = 1
)
) +
## Modify axis titles
labs(x = "Direction Relative to the EF",
y = "Duration of EF Exposure (hours)"
) +
# Remove minor grid lines
theme(panel.border = element_rect(colour = "black",
fill = NA,
size = 2
),
panel.grid.minor = element_blank(),
strip.background = element_rect(fill = "white",
colour = "black",
size = 1.5
),
plot.title = element_text(size = rel(1.25),
face = "bold"
),
axis.title = element_text(size = rel(1)),
axis.text.x = element_text(colour = rep(c("black", "black"),
2
),
size = rel(1),
face = "bold"
),
# modify facet header
strip.text = element_text(face = "bold",
size = rel(1)
)
) +
# remove legend
guides(colour = FALSE) +
# add colored lines to indicate cathode and anode, respectively
geom_vline(xintercept = c(90, 270, 90+360, 270+360),
colour = rep(c("black",
"black"
),
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2
),
size = 1,
alpha = 0.5
) +
# add horizontal line to indicate where the current was reversed
geom_hline(yintercept = 5.875,
colour = "black",
size = 1,
linetype = 2
)
dir.rev.plot
rm(mig.vel.rev1)
### Plot Direction by time (400-Reverse only) (repeated x-axis) -----# only copies data if there is a value for speed (i.e. not NA)
mig.vel.rev1 <- mig.rev[!is.na(mig.rev$speed) &
mig.rev$time <= 12 & mig.rev$time >= 0,
c("EF",
"time",
"speed",
"dir"
)
]
# Convert range of angle measures for direction variable
# new range: 0-360 (degrees)
mig.vel.rev1$dir[mig.vel.rev1$dir < 0] <mig.vel.rev1$dir[mig.vel.rev1$dir < 0] + 360
# if speed == 0, MTrackJ records direction as 0
# make dir == NA if(speed == 0)
mig.vel.rev1$dir[mig.vel.rev1$speed == 0] <- NA
## Generate plot
dir.rev2.plot <- ggplot(data = mig.vel.rev1[is.na(mig.vel.rev1$dir) ==
FALSE & mig.vel.rev1$EF == "400-Reverse",],
aes(x = c(dir, dir+360),
y = c(time, time)
)
) +
# Add points
geom_point(size = 2.5,
alpha = 0.4
) +
# Black-White theme elements
theme_bw(base_size = 38) +
coord_cartesian(xlim = c(0, 720),
ylim = c(-.1, 12.1)
) +
scale_x_continuous(breaks = c(90, 270, 90+360, 270+360),
labels = rep(c("A",
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"C"
),
2
)
) +
scale_y_continuous(breaks = seq(0,
12,
by = 1
)
) +
## Modify axis titles
labs(x = "Direction Relative to the EF",
y = "Time (hours)"
) +
# Remove minor grid lines
theme(panel.border = element_rect(colour = "black",
fill = NA,
size = 2
),
panel.grid = element_blank(),
axis.text.x = element_text(colour = rep(c("black", "black"),
2
),
size = rel(1),
face = "bold"
),
axis.text.y = element_text(colour = "black",
size = rel(1))
) +
# remove legend
guides(colour = FALSE) +
# add colored lines to indicate cathode and anode, respectively
geom_vline(xintercept = c(90, 270, 90+360, 270+360),
colour = rep(c("black",
"black"
),
2
),
size = 1,
alpha = 0.5
) +
# add horizontal line to indicate where the current was reversed
geom_hline(yintercept = 5.875,
colour = "black",
size = 1,
linetype = 2
)
dir.rev2.plot
rm(mig.vel.rev1)
# Plot Tracks for 400 mV/mm only ------------------------------------t.start <- 3
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t.end <- 12
n = 15
mig.rev.norm <- position.normalize(dataset = mig.rev.tracks,
t.start = t.start,
t.end = t.end
)
n = 10
norm.sub <- data.subsample(dataset = mig.rev.norm,
size = n,
group = mig.rev.norm$EF
)
tracks.plot <- ggplot(data = norm.sub,
aes(x = x.norm,
y = y.norm,
group = id
)
) +
geom_vline(xintercept = 0,
colour = "darkgrey"
) +
geom_hline(yintercept = 0,
colour = "darkgrey"
)+
geom_path() +
facet_grid(. ~ EF) +
theme_bw(base_size = 28) +
theme(panel.grid = element_blank(),
panel.border = element_rect(colour = "black",
size = 1.5
),
panel.margin = unit(1, "lines"),
strip.background = element_rect(colour = "white",
fill = "white"
),
axis.title = element_blank(),
axis.text = element_text(size = rel(0.75))
) +
coord_fixed(xlim = c(-201, 201),
ylim = c(-201, 201)
) +
scale_x_continuous(breaks = c(-200, -100, 0, 100, 200),
labels = c("
200", "100", "0", "100", "200
")
) +
scale_y_continuous(breaks = c(-200, -100, 0, 100, 200),
labels = c(200, 100, 0, 100, 200)
)
tracks.plot
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Orientation of proliferation
Data are collected using ImageJ. Column names are: “Cell” [i.e. the cell type, e.g.
cerebellar or cortical, in reference to astrocytes], “Experiment” “Position” “EF”
“Measurement” “Angle” “Frame” and “Length”.
The second part of this script includes a graph that plots the orientation of
proliferation over time. This graph was used for data exploration, but was not included in
the analysis presented in this dissertation.
### Load Packages ---------------------------------------------------library(circular)
# For circular stats (seems more thorough than
CircStats)
library(survival)
library(ggplot2)
library(grid)
### Load Data -------------------------------------------------------prolif1 <- read.csv(file.choose(),
header = TRUE
)
## limit prolif1 data range to 12 hours (241 frames)
prolif1 <- prolif1[prolif1$Frame <= 241,]
### Data Management -------------------------------------------------# Create time variable (hours)
prolif1$Time <- (prolif1$Frame - 1) / 20
# Convert angle measurements into axial measurements
# Range from 0 - 180 degrees (original range -180 to +180)
prolif1$Axial[prolif1$Angle < 0] <- prolif1$Angle[prolif1$Angle < 0] +
180
prolif1$Axial[prolif1$Angle >= 0] <- prolif1$Angle[prolif1$Angle >= 0]
prolif1$Axial[prolif1$Angle == 180] <- prolif1$Angle[prolif1$Angle ==
180] - 180
head(prolif1)
# Determine whether alignment exists --------------------------------# note: change the number for the ef1 variable to
# calculate the alignment for each EF strength
# factor levels: 0, 4, 40, 400
ef1 <- 4
a1 <- circular(prolif1$Axial[prolif1$EF == ef1],
units = "degrees",
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modulo = "pi"
)
rayleigh.test(2 * a1)[[2]]
rayleigh.test(sample(2 * a1,
size = 30
)
)[[2]]
length(a1)
mle.vonmises(a1)
# numbers in parentheses of results are the
standard error of those results
mean.circular(a1)
deg(sd.circular(a1))
# Distribution of Orientation of Mitotic Axis -----------------------prolif1.dir <- ggplot(data = prolif1,
aes(x = c(Axial, Axial + 180),
y=..density..
)
) +
geom_histogram(binwidth = 15,
size = .75,
fill = "grey"
) +
geom_line(stat = "density") +
coord_cartesian(xlim = c(0, 360),
ylim = c(0, .007)
) +
facet_grid(. ~ EF) +
theme_bw(base_size = 28) +
scale_x_continuous(breaks = seq(0, 360,
by = 90
),
labels = c("C", "", "A", "", "C")
) +
theme(panel.border = element_rect(colour = "black",
size = 2
),
panel.grid = element_blank(),
panel.margin = unit(1.25,
"lines"
),
strip.background = element_rect(colour = "white",
size = 1.5,
fill = "white"
),
axis.ticks.y = element_blank(),
axis.text.y = element_blank()
) +
labs(x = "Orientation of the axis of cell division",
y = "Relative number of cells
"
)
prolif1.dir
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# ggplot2 Orientation of Division over Time -------------------------orient1 <- ggplot(data = prolif1,
aes(x = c(Axial, Axial + 180),
y = c(Time, Time)
)
) +
## add points for each speed value
geom_point(data = prolif1,
size = 2,
alpha = 0.6
) +
scale_x_continuous(limits = c(0, 360),
breaks = seq(0,
360,
by = 90
),
labels = c("",
"Cathode",
"",
"Anode",
""
)
) +
scale_y_continuous(limits = c(0, 12),
breaks = seq(0,
12,
by = 2
)
) +
## Modify axis titles
labs(x = "Orientation of Axis of Cell Division",
y = "Duration of Electric Field Exposure\n(hours)",
title = "Electric Field Effects on the Orientation of Cell
Division over Time\n(horizontal axis repeated)"
) +
## facets by EF strength
facet_grid(. ~ EF) +
# colour scheme is black and white
theme_bw() +
# Remove minor grid lines
theme(panel.grid.minor = element_blank()) +
# add colored lines to indicate cathode and anode, respectively
geom_vline(xintercept = c(90, 270),
colour = c("red", "blue")
)
orient1
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Proliferation – BrdU experiments
Only summary statistics are needed for this data file; these were calculated in the
statistical software JMP v. 11.0.0. Column names are: “Time” “EF” “N Rows”
“Mean(Percent)” “Median(Percent)” and “Std Err(Percent)”.
library(ggplot2)
brdu1 <- read.csv(file.choose(),
header = T
)
brdu2 <- brdu1
brdu2$EF <- factor(brdu2$EF)
brdu2$Time <- factor(brdu2$Time)
levels(brdu2$Time) <- paste(levels(brdu2$Time),
"Hours"
)
levels(brdu2$Time)
# Bar Plot ----------------------------------------------------------brdu.plot <- ggplot(data = brdu2,
aes(x = EF,
y = Mean.Percent.,
fill = EF
)
) +
geom_bar(stat = "identity") +
scale_fill_grey() +
facet_grid(. ~ Time) +
labs(y = "BrdU-positive Cells (%)",
x = "Electric Field Strength (mV/mm)"
) +
theme_bw(base_size = 28) +
theme(legend.position = "none",
panel.border = element_rect(colour = "black",
size = 1.25
),
panel.grid = element_blank(),
strip.background = element_rect(fill = "white",
colour = "white"
),
axis.ticks.x = element_blank()
) +
coord_cartesian(ylim = c(0, max(brdu2$Mean.Percent. +
brdu2$Std.Err.Percent.) + 8)) +
geom_errorbar(aes(ymin = Mean.Percent. - Std.Err.Percent.,
ymax = Mean.Percent. + Std.Err.Percent.
),
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width = 0.25,
size = 0.75
)
brdu.plot

Morphology – FFT experiments
Only 3 columns are needed for this data faile: “EF” “Angle” and “Value”.
library(ggplot2)
library(grid)
# Load data
fft1 <- read.csv(file.choose(),
header = TRUE
)
# change the number in this variable to plot different EF intensities
ef.level1 <- 400
fft.plot <- ggplot(data = fft1[fft1$EF == ef.level1,],
aes(x = Angle,
y = Value,
)
) +
geom_line(size = 2) +
coord_cartesian(xlim = c(0, 360),
ylim = c(0, max(fft1$Value) + 1)
) +
scale_x_continuous(breaks = c(90, 180, 270, 360),
labels = c("Anode", "", "Cathode", "")
) +
scale_y_continuous(breaks = NULL) +
labs(x = "Orientation (Relative to the EF)",
y = "Relative Pixel Alignment
"
) +
theme_bw(base_size = 24) +
theme(legend.position = "bottom",
panel.border = element_blank(),
panel.grid.major = element_blank(),
axis.line = element_line(colour = "black",
lineend = "square",
size = 2
),
axis.ticks.x = element_line(size = 2,
lineend = "square"
),
axis.ticks.length = unit(.4, "cm"),
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axis.ticks.margin = unit(.2, "cm")
)
fft.plot

Nuclear morphology
### Load Packages ---------------------------------------------------library(circular)
library(ggplot2)
### Load Data -------------------------------------------------------nuc1 <- read.csv(file.choose(),
header = TRUE
)
head(nuc1)
t1 <- 12
boxplot(nuc1$AR[nuc1$time == t1] ~
as.factor(nuc1$EF[nuc1$time == t1]),
main = "Circularity Scores"
)
fit1 <- aov(nuc1$AR[nuc1$time == t1 & nuc1$Experiment == 2] ~
as.factor(nuc1$EF[nuc1$time == t1 & nuc1$Experiment == 2]))
summary(fit1)
TukeyHSD(fit1)
plot(TukeyHSD(fit1))
rm(t1, fit1)
# Determine whether nuclei are aligned ------------------------------ef1 <- 0
# specify EF level for the test
t1 <- 12
# create a circular data set
a1 <- circular(nuc1$Angle[nuc1$EF == ef1 & nuc1$time == t1],
units = "degrees",
modulo = "pi"
)
rayleigh.test(sample(2 * a1,
size = 30
)
)[[2]]
length(a1)
mle.vonmises(a1)
# numbers in parentheses of results are the
# standard error of those results
mean.circular(a1)
deg(sd.circular(a1))
# compare kappa between groups
n1 <- 100
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equal.kappa.test(circular(c(sample(nuc1$Angle[nuc1$EF == 400 &
nuc1$time == 12],
n1
),
sample(nuc1$Angle[nuc1$EF == 400 &
nuc1$time == 72],
n1
)
),
units = "degrees",
modulo = "pi"
),
c(rep(12, n1),
rep(72, n1)
)
)
rm(a1, ef1, n1, t1)
# Graph alignment distributions -------------------------------------t1 <- 12
nuc1.dir <- ggplot(data = nuc1[nuc1$time == t1,],
aes(x = c(Angle, Angle + 180))
) +
geom_histogram(binwidth = 15,
size = .75,
fill = "grey"
) +
facet_grid(. ~ EF) +
coord_cartesian(xlim = c(-20, 380),
ylim = c(0, 280)
) +
theme_bw(base_size = 28) +
scale_x_continuous(breaks = seq(0, 360,
by = 90
),
labels = c("C", "", "A", "", "C")
) +
theme(panel.border = element_rect(colour = "black",
size = 2
),
panel.grid = element_blank(),
strip.background = element_rect(colour = "white",
size = 1.5,
fill = "white"
)
) +
labs(x = "Orientation Relative to the Electric Field",
y = "Number of Nuclei"
)
nuc1.dir
rm(t1)
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# Compare Nucleus Aspect Ratio --------------------------------------t1 <- 72
exp1 <- c(6, 10)
nuc2 <- nuc1[nuc1$time == t1 & nuc1$Experiment %in% exp1,]
fit1 <- aov(nuc2$AR ~ as.factor(nuc2$EF))
summary(fit1)
plot(TukeyHSD(fit1))
TukeyHSD(fit1)
rm(t1, exp1, nuc2)
# Graph Nucleus Aspect Ratio ----------------------------------------t1 <- 72
exp1 <- c(6, 10)
nuc2 <- nuc1[nuc1$time == t1 & nuc1$Experiment %in% exp1,]
ar1.plot <- ggplot(data = nuc2,
aes(x = as.factor(EF),
y = AR
)
) +
geom_boxplot() +
theme_bw(base_size = 28) +
theme(panel.grid = element_blank(),
panel.border = element_blank(),
axis.line = element_line(colour = "black",
lineend = "square"
)
) +
labs(x = "Electric Field Strength (mV/mm)",
y = "Aspect Ratio"
)
rm(t1, exp1, nuc2)

R Scripts for Chapter 3
For the cerebellar astrocyte analyses, the structure of the data files and the code
for the analyses in R are identical for each of the analyses that were done for cortical
astrocytes in chapter two. The only exception is a minor modification for the analysis of
migration data. The migration analysis was identical, but the data were compiled slightly
differently for the cortical astrocytes than they were for the cerebellar astrocytes.
Specifically, the cortical astrocyte migration data for the current-reversal analysis were
333

stored in a separate .csv file, while all of the migration data for the cerebellar astrocytes
were stored in the same .csv file. The changes in the script for data loading reflects the
fact that only 1 .csv file had to be loaded, and a second data subset that did not contain
the current reversal group was created. The following script is for loading the cerebellar
astrocyte data only; the rest of the analysis (including the libraries, functions, statistical
tests, and graphs) are identical.

Migration analysis modification for cerebellar astrocytes
Scripts are organized in the same fashion as those for the migration analysis.
See description found on page 305 for more information.
# Load Data ---------------------------------------------------------mig1R <- read.csv(file.choose(),
header = TRUE
)
# mig2 is the data set that will be used to plot cell tracks
mig2 <- mig1R[mig1R$EF %in% c(0, 4, 40, 400) & mig1R$time <= 12, ]
mig2$ef.factor <- factor(mig2$EF,
levels = c(0, 4, 40, 400)
)
mig1R$time[mig1R$EF == 0] <- mig1R$time[mig1R$EF == 0] - 0.5
mig1R.baseline <- read.csv(file.choose(),
header = TRUE
)
mig1R <- rbind(mig1R.baseline,
mig1R
)
mig1R <- mig1R[mig1R$time >= 0 & mig1R$time <= 12, ]
mig1R$ef.factor <- factor(mig1R$EF,
levels = c(0, 4, 40, 400, "400-Reverse"),
labels = c("0", "4", "40", "400", "400 (R)")
)
mig1 <- mig1R[mig1R$ef.factor %in% levels(mig1R$ef.factor)[c(1:4)], ]
mig1$ef.factor <- factor(mig1$ef.factor,
levels = levels(mig1$ef.factor)[c(1:4)]
)

334

rm(mig1R.baseline)

R Scripts for Chapter 4

Plotting current density analysis
### Load Packages ---------------------------------------------------library(ggplot2)
# These values were taken from the JMP analysis that I completed
# on 7/6/15
g1 <- c("Intact", "Lesioned")
m1 <- c(13.43, -34.85)
s1 <- c(4.394, 4.500)
d1 <- data.frame(site = g1,
mean = m1,
sem = s1
)
plot1 <- ggplot(data = d1,
aes(x = site,
y = mean
)
) +
geom_bar(stat = "identity",
colour = "grey",
fill = "grey",
width = .8,
position = "dodge"
) +
geom_errorbar(aes(ymin = mean - sem,
ymax = mean + sem
),
width = 0.25,
size = 1
) +
geom_hline(yintercept = 0,
colour = "black",
size = 1.25
) +
coord_cartesian(ylim = c(-45, 30)) +
scale_y_continuous(breaks = c(seq(-40, 20, 10)),
labels = c(seq(-40, 20, 10))
) +
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theme_bw(base_size = 28) +
theme(panel.grid = element_blank(),
panel.border = element_rect(colour = "black",
size = 1.25
)
) +
labs(y = expression(paste("Current Density: ", mu, "A/cm") ^2),
x = element_blank()
) +
annotate("segment",
x = 1,
xend = 2,
y = 23,
yend = 23,
colour = "black",
size = 1.25
) +
annotate("text",
x = 1.5,
y = 25,
size = rel(8),
label = "*p < 0.0001",
colour = "black"
)
plot1
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